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Summary 
Background: In toxicological testing, effects of endocrine disrupters are in most cases more thoroughly 
investigated in males than in females.  In males the hypothesis of testicular dysgenesis syndrome (TDS) 
proposes that there is a common origin in fetal life of the increase in frequency observed in later years of for 
example incidence of boys born with hypospadias and young men with low semen quality in the human male 
population.  Furthermore, it has been observed in animal studies that exposure during fetal life to endocrine 
disrupters may lead to similar adverse reproductive effects. It has been proposed that a similar syndrome, 
called the ovarian dysgenesis syndrome (ODS), exists for females. This syndrome encompasses alterations in 
reproductive development caused by chemical exposure in sensitive windows of development that may result 
in fecundity impairments, gravid diseases, gynecological disorders or later onset adult diseases. However, 
experimental evidence on the effects of developmental exposure to environmentally relevant endocrine 
disrupting chemicals in females has been missing attention. Since chemical exposure can affect female 
reproductive development it is important to investigate effects in females both early and later in life.  
Methods: The results, presented in this thesis, were obtained in five developmental toxicology studies. Two 
studies investigated mixtures of endocrine disrupting pesticides (Pestimix), two investigated mixtures of 
endocrine disrupting chemicals based on human exposures (Contamed), and one study tested a positive 
control for estrogenic effects, ethinyl estradiol (EE2). The project with the mixture of the five pesticides 
included two range-finding studies (collectively called Pestimix RF) and a dose response study (Pestimix 
DR). In the Contamed project, mixtures were modeled based on high end human intakes, and the project 
involved two developmental mixture studies in rats, called Contamed 1 and 2. In these studies 13 chemicals 
where data on in vivo endocrine disrupting effects and information on human exposures was available, were 
selected. The tested chemicals included phthalates, pesticides, UV-filters, bisphenol A, parabens and the 
drug paracetamol. Together the chemicals represented several modes of action with regard to endocrine 
disrupting mode of action. Finally, results from a dose response study on the estrogenic drug EE2 were 
included. In all of these studies, both male and female offspring were investigated for adverse effect of the 
exposure, however, the endpoints which were focused on in this thesis, were only in females. One endpoint 
was assessed in the pregnant dams i.e. gestational length and several endpoints were investigated  in the 
female offspring including anogenital distance (AGD), number of nipples, onset of puberty, measurements of 
Anti-Müllerian hormone (AMH) and estrous cyclicity at several time point during the animals life span. 
Results and discussion: Prolonged gestational length was observed in the Pestimix studies at mixture doses 
consisting of the pesticides at doses far below their individual no observed adverse effect level (NOAELs) 
for this endpoint. The effects in the mixture groups were probably caused by the azole fungicides and 
prochloraz which have earlier been shown to cause this effect. A longer gestational length was also observed 
in dams from the EE2 study at the highest dose. 
AGD in female offspring was increased in both the Pestimix RF study and the DR study. Here effects were 
seen in the two highest mixture groups, and a similar effect was seen in females receiving epoxiconazole, 
prochloraz and tebuconazole, at doses equal to those included in the highest mixture dose. The effects in the 
mixture groups were probably caused by the azole fungicides and prochloraz, which have earlier been shown 
to affect AGD in females. An increased AGD was also observed in the highest dose group in the EE2 study. 
Puberty onset was not affected in any of the studies even in EE2 study. It is, however, recommended that in 
future studies recording of this endpoint is commenced at an earlier age than at pup day 27, which turned out 
to be too late because some of the animals had already reached puberty at that age. An increase in number of 
nipples was observed in the high dose group in the EE2 study. The mechanism behind this effect is not 
known. Estrous cyclicity was not affected in Pestimix DR but the data was not optimal as methodological 
difficulties caused a large proportion of the animals to become pseudopregnant. In the two Contamed studies 
there were no effects on estrous cyclicity in the animals at 3, 5 or 9 months of age. However, at 12 months, 
more animals were irregularly cycling in the highest mixture group compared with controls indicating an 
advance in timing of reproductive senescence. This is an important finding as premature reproductive aging 
is a serious effect and most studies will miss such an effect because the studies are terminated too early to 
observe it. There was also a significant decrease in AMH levels in 4 months old animals in the highest 
mixture group and the group treated with paracetamol. No effects on AMH were observed in the older 
animals or in the 3 months old animals in EE2 study. More works need to be done investigating if AMH can 
be a good marker of effects on ovarian reserve in rats. Power calculations revealed that generally the effect 
had to be around or above a 50% change both for effects on estrous cycle and AMH in order to be able to 
detect them with. 
Conclusion: Female rats were affected by treatment with single EDCs or mixtures of EDCs. In all 5 studies 
pregnant rats and/or female offspring were affected by exposure to single chemicals or the mixture of 
endocrine disrupting chemicals at the investigated doses. In dams mixture effects on gestational length were 
reported for the first time. The affected endpoints in the female offspring were AGD, number of nipples, 
estrous cyclicity and AMH levels but not onset of puberty. Estrous cycle was affected only in the one-year-
old female offspring and not at a younger age indicating early reproductive aging, a late effect of early 
exposure. The results indicate endocrine disrupters may be a contributing factor to effects of the reproductive 
system in women.AMH needs to be investigated more before it can be determined whether it is a marker 
useful in assessing effects in the ovaries after exposure to EDCs. More sensitive endpoints would be helpful 
when assessing effects in females and should be the focus of further studies. 
 
 
Dansk resumé 
Baggrund: I toksikologisk testning bliver effekter af hormonforstyrrende stoffer ofte undersøgt mere 
grundigt hos hanner end hos hunner. Hos hanner findes hypotesen om testikulært dysgenese syndrom (TDS), 
der siger at der er en fælles oprindelse i fostertilværelsen for blandt andet den øgede forekomst af drenge født 
med hypospadi og unge mænd med lav sædkvalitet, der er set i befolkningen i de senere år. Samtidig kan 
eksponering for hormonforstyrrende stoffer i fostertilværelsen hos forsøgsdyr medføre lignende effekter på 
forplantningsevnen og udsættelse for hormonforstyrrende stoffer mistænkes for at medvirke til de 
ovennævnte effekter på mennesker. Det er blevet foreslået, at et lignende syndrom, kaldet ovarie dysgenese 
syndrom (ODS), også findes hos hunner. Dette syndrom omfatter ligeledes ændringer af udviklingen af 
reproduktionssystemet blandt andet som følge af kemisk eksponering, og kan resultere i nedsat frugtbarhed, 
sygdomme i graviditeten, gynækologiske lidelser og sygdomme senere i livet. Der har imidlertid manglet 
viden om effekten af eksponering under udviklingen for miljørelevante hormonforstyrrende stoffer i hunner. 
Da kemisk eksponering kan påvirke den hunlige reproduktive udvikling, er det vigtigt at undersøge effekter 
hos hunner både tidligt og senere i livet. 
Metoder: De resultater, som præsenteres i denne afhandling, er fra fem toksikologiske studier, hvor parrede 
Wistar hunrotter blev doseret peroralt med miljørelevante stoffer alene eller i blandinger i drægtigheds- og 
laktationsperioden. To studier undersøgte blandinger (miks) af hormonforstyrrende pesticider (Pestimix), to 
undersøgte en blanding af hormonforstyrrende kemikalier baseret på human eksponering (Contamed), og i et 
studie blev der testet en positiv kontrol for østrogene effekter, lægemidlet ethinylestradiol (EE2). Projektet 
med blandingen af de fem pesticider omfattede to pilot studier (samlet kaldet Pestimix RF) og et dosis-
respons studie (Pestimix DR). I Contamed projektet blev der testet blandinger af kemikalier, som var 
modelleret ud fra den høje ende af  hvad mennesker kan være udsat for. Projektet omfattede to rottestudier, 
kaldet Contamed 1 og 2. I disse studier blev 13 kemikalier blandet, hvor data om in vivo hormonforstyrrende 
effekter og information om menneskelig eksponering var til rådighed. De testede stoffer inkluderede 
phthalater, pesticider, UV-filtre, bisphenol A, parabener og lægemidlet paracetamol. Sammen repræsenterede 
kemikalierne flere hormonforstyrrende virkemåder/mekanismer. Endelig er resultaterne fra et dosis-respons 
forsøg med det østrogene stof EE2 inkluderet. I alle disse undersøgelser blev både han og hun-afkom 
undersøgt for effekter af eksponeringen, men de endpoints, der blev fokuseret på i denne afhandling, var dem 
der ses hos hunnerne. De undersøgte endpoints var drægtighedslængde i de drægtige hunner, og i det hunlige 
afkom anogenital afstand (AGD), antallet af brystvorter, alder for pubertet, målinger af anti-müllerian 
hormon (AMH) samt østrus cyklus på adskillige tidspunkter i løbet af dyrene levetid. 
Resultater og diskussion: Forlænget drægtighedslængde blev observeret i Pestimix studierne i grupper 
doseret med blanding/miks af pesticider, ved doser langt under deres individuelle NOAEL for dette endpoint 
(”No Observed Adverse Effect Level ”), dvs. den højeste dosis af stoffet, som i dyreforsøg ikke har givet 
nogen skadelige effekter. Effekterne af miksen blev formentlig forårsaget af azol fungiciderne epoxiconazol 
og tebuconazol samt prochloraz som tidligere har vist sig at give denne form for effekt. Længere 
drægtighedslængde blev også observeret i drægtige rottemødre fra EE2 studiet ved den højeste dosis.  
AGD i hunafkom var øget i både Pestimix RF-studiet og DR studiet. Her blev set effekter i de to højeste 
miks-grupper, samt hos hunrotter, der modtog epoxiconazol, prochloraz og tebuconazol ved doser svarende 
til dem, der indgik i den højeste miksdosis. Effekterne i miks-grupperne blev formentlig forårsaget af 
epoxiconazol, tebuconazol og prochloraz, som tidligere har vist sig at påvirke AGD hos hunrotter. En øget 
AGD blev også observeret ved den højeste dosis i EE2 studiet. Tidspunktet for pubertetens indtræden blev 
ikke påvirket i nogen af de udførte forsøg, selv i EE2 studiet, som var en positiv kontrol. Det anbefales dog, 
at registreringen i fremtidige studier påbegyndes i en tidligere alder end ungedag 27, som viste sig at være 
for sent, fordi nogle dyr allerede havde nået puberteten i den alder. En stigning i antallet af brystvorter blev 
observeret i den høje dosisgruppe i EE2 studiet. Mekanismen bag denne virkning er ikke kendt. Østrus 
cyklus blev ikke påvirket i Pestimix DR, men data var ikke optimale da metodologiske vanskeligheder 
forårsagede at en stor del af dyrene blev pseudogravide. I de to Contamed studier var der ingen effekt på 
østrus cyklus i dyrene i 3, 5 eller 9-10 måneders alderen. Men efter 12 måneder havde flere dyr 
uregelmæssig cyklus i den højeste miksdosis-gruppe sammenlignet med kontroller. Dette indikerer en 
tidligere reproduktiv ældning (menopause/overgangsalder i mennesker). Dette er et vigtigt resultat, da for 
tidlig menopause er en alvorlig effekt, og de fleste studier vil overse sådan en effekt, fordi studierne afsluttes 
for tidligt til at observere den. Der var også et signifikant fald i AMH niveauer i 4 måneder gamle dyr i 
højeste miksdosis-gruppe og i gruppen behandlet med paracetamol. Der blev hverken observeret effekt på 
AMH  i de ældre dyr eller i de 3 måneder gamle dyr i EE2 studiet. Der skal mere viden til for at afgøre om 
AMH kan være en god markør for effekter af hormonforstyrrende stoffer på ovariefollikelreserven hos rotter. 
Power beregninger afslørede at generelt kan man måle omkring en 50% ændring både for effekter på østrus 
cyklus og AMH. 
Konklusion: Hunrotter viste sig at være følsomme for eksponering med blandinger af hormonforstyrrende 
stoffer. I alle 5 studier blev drægtige rotter og /eller hunligt afkom påvirket ved eksponering for de enkelte 
kemikalier eller miks af hormonforstyrrende kemikalier ved de undersøgte doser. For første gang er der 
rapporteret mixeffekter på gestationslængden hos drægtige rotter. I afkommet blev der set effekter på AGD, 
antal brystvorter, østrus cyklus og AMH niveauer, men ikke tidspunkt for pubertet. Effekter på østrus cyklus 
blev kun set hos de et år gamle rotter og er et tegn på sene effekter af tidlig eksponering. Resultaterne 
indikerer at hormonforstyrrende stoffer kan være medvirkende faktor til effekter i reproduktionssystemet hos 
voksne kvinder og ufødte pigebørn. AMH skal undersøges bedre for at vurdere om det er en god markør for 
effekter af hormonforstyrrende stoffers effekt på ovariefollikelreserven. Mere følsomme endpoints ville være 
nyttige ved vurderingen af effekter hos hunner og bør være i fokus i fremtidigt arbejde. 
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1 Introduction  
Endocrine disrupting chemicals/compounds (EDCs) have been defined by The World Health Organisation 
(WHO) and the International Programme for Chemical Safety (IPCS) as follows (World Health Organization 
(WHO) 2002):  
 
EDCs have been speculated to contribute to a rise in different types of reproductive problems the last couple 
of decades (Skakkebaek et al. 2001). Main center of attention has been on effects in males of developmental 
exposure to EDCs, e.g. decreasing sperm counts, increase in incidence of hypospadias and cryptorchidism in 
human and animal models, which have been extensively investigated (Christiansen et al. 2008, Gray et al. 
2001, Main et al. 2009, Main et al. 2010, Noriega et al. 2005, Wilson et al. 2008, Wohlfahrt-Veje et al. 
2009). However, in recent years more attention have been turned toward female health and exposure to 
environmental chemicals has been proposed to contribute to several gynecologic pathologies, especially 
when exposures occur during critical windows in development (Caserta et al. 2008). A similar evaluation as 
has been conducted in males encompassing clinical trends and studies, laboratory animal studies, and 
comparative biology data collected from wildlife has not been done in females to nearly the same extent 
(Caserta et al. 2008, Crain et al. 2008). Thus, more research in this area is warranted. 
Exposure to EDCs in adulthood may have very different consequences than exposure during development. 
The concept described by Barker as ”the fetal basis of adult disease” was extended by Diamanti-Kandarakis 
and co-workers to “the developmental basis of adult disease” because some organs keep undergoing 
development in early postnatal life (Barker 2003, Diamanti-Kandarakis et al. 2009).What this concept 
describes is that there can be a lag between time of exposure and the manifestation of a disorder in puberty, 
adulthood or during aging. A classical example of endocrine disruption occurring in utero leading to adult 
disease in females is the case of occurrence of rare gynecological neoplasms, vaginal adenosis and structural 
abnormalities present at birth such as cervical hoods, ridges, and T-shaped uterus in the daughters of women 
treated with the estrogenic pharmaceutical diethylstilbestrol (DES) during their pregnancy (McLachlan et al. 
2006, Mittendorf 1995). In males there is a hypothesis named testicular dysgenesis syndrome (TDS). TDS is 
based on observations made in epidemiological and partly in animal studies that hypospadia, cryptorchidism, 
An endocrine disrupter is an exogenous substance or mixture that alters function(s) of the endocrine 
system and consequently causes adverse health effects in an intact organism, or its progeny, or 
(sub)populations. A potential endocrine disruptor is an exogenous substance or mixture that possesses 
properties that might be expected to lead to endocrine disruption in an intact organism, or its progeny, or 
(sub)populations .  
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testicular cancer and possibly lowered semen quality may be associated with each other as different 
manifestations of disturbed prenatal testicular development. Endocrine disrupters may contribute to an 
observed rise of these symptoms in men in later years (Skakkebaek et al. 2001, Wohlfahrt-Veje et al. 2009). 
It has been proposed that a similar syndrome exists for females, which is called ovarian dysgenesis syndrome 
(ODS). This syndrome encompasses alterations in reproductive development caused by chemical exposure in 
sensitive windows of development that may result in or contribute to fecundity impairments, gravid diseases, 
gynecological disorders or later onset adult diseases but is less well described and defined as TDS (Buck 
Louis et al. 2011, Buck Louis et al. 2006, Fowler et al. 2012). Adverse effects on development  may result 
from either chemical exposure causing structural birth defects or changes in epigenetic programming during 
development but for the most part of the disorders the involved molecular mechanisms has yet to be 
elucidated (Buck Louis et al. 2011, Newbold and Kinyamu 2010).  
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1.1 Aim and objectives of this PhD thesis  
Presently, effects of endocrine disrupters are more thoroughly investigated in males than females, and more 
research on effects in females are warranted. Furthermore, experimental evidence has been missing on the 
effects of combined developmental exposure to environmentally relevant endocrine disrupting chemicals 
with antiandrogenic or estrogenic modes of action. Antiandrogens are not generally expected to cause effects 
on estrogen-sensitive endpoints but may potentially augment the effects of estrogens. Consequently, it is 
relevant to study combined effects of chemicals with antiandrogenic or estrogenic modes of action.  
The PhD thesis includes data from five studies, four mixture studies and a study with the positive estrogenic 
control, ethinyl estradiol. 
  
This thesis will focus on one endpoint in dams directly exposed to mixtures or single chemicals with 
endocrine disrupting properties i.e. gestational length and on several endpoints in the female offspring 
exposed during gestation and lactation, including effects on anogenital distance (AGD), number of nipples, 
puberty onset, levels of Anti-Müllerian hormone (AMH), and estrous cyclicity at several ages. Furthermore, 
some method related considerations will be discussed.  The following sections will address the main points 
of the female differentiation, the endpoints which are the focus of this thesis and a short introduction to 
mixtures.  
Overall, the aim of the PhD thesis was to investigate effects on sexual development in female rats 
perinatally exposed to single EDCs or mixtures of EDCs and on gestational length of the dams. The 
objectives were to address the following hypotheses: 
 Perinatal exposure to environmentally relevant EDCs can affect gestation length in dams and 
hormone-sensitive endpoints in female offspring 
  The endpoint estrous cyclicity is sensitive to exposure to these environmentally relevant EDCs, 
and effects of exposure can be detected on estrous cycle in aging rats 
 Measurement of serum levels of anti-müllerian hormone (AMH) is a useful marker of early 
reproductive senescence 
 Effects on hormone-sensitive endpoints in females will be observed with an estrogenic positive 
control compound. 
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2 Background 
2.1 Sexual differentiation focusing on females 
This section will cover the overall lines of sexual development in the female as this is a sensitive and 
complex process, in which a developing fetus may be vulnerable to exposure to endocrine disruptors (Gray 
1998).    
In mammals early in development, the gonads are indifferent but either being chromosomally XX (female) 
or XY (male). Development of the gonad in a male direction is dependent on the gonadal expression of the 
gene Sry (sex determining region Y) on the Y chromosome. In the absence of the Sry gene the gonad 
develops as an ovary. The Sry gene codes for a transcription factor that initiates a cascade of genes affecting 
the indifferent gonad to develop in a male direction. Many genes have also been identified as being involved 
in the development of the indifferent gonad into the ovary (Goldman and Cooper 2010). 
Figure 1 shows a sexually undifferentiated gonad with Müllerian ducts and Wolffian ducts. Anti Müllerian 
Hormone (AMH) produced by Sertoli cells in the embryonic testes induces regression of the Müllerian ducts 
and causes the Wolffian ducts to differentiate into epididymis and vas deferens tissues. In the absence of the 
hormones produced by the embryonic testes (testosterone and AMH), the Wolffian ducts degenerate and the 
Müllerian ducts develop into female structures (Goldman and Cooper 2010).    
 
Figure 1. Modified from (Goldman and Cooper 2010). The figure represents the primitive gonad with the Müllerian and Wollfian 
ducts in the sexually undifferentiated embryo.  
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As mentioned previously, it has been hypothesized that chemical exposure during the vulnerable period of 
fetal and early postnatal development may lead or contribute to effects observed later in life, a phenomenon 
in females referred to by some researchers as the ovarian dysgenesis syndrome (Buck Louis et al. 2011, Buck 
Louis et al. 2006, Fowler et al. 2012).  
Two key events in ovarian development are follicle assembly and follicle transition from primordial to 
primary follicle (initial recruitment). These processes, which are not yet fully understood, are thought to 
involve regulation with endogenous growth factors, steroids, cytokines, and a less certain role for 
gonadotropins (though, gonadotropins  are required for the later maturation of preantral follicles into the 
more mature phases of development) (Billiar et al. 2003, Eppig and O'Brien 1996, Kezele and Skinner 2003, 
Roy and Albee 2000, Skinner 2005, Uzumcu and Zachow 2007, Wang and Roy 2006). These processes 
directly affect the number of oocytes available to a female throughout her reproductive life (Kezele and 
Skinner 2003, Skinner 2005, Uzumcu and Zachow 2007).  
Critical steps in this process may be disturbed by chemical exposure to endocrine disrupters affecting 
reproductive function or the duration of reproductive lifespan (Abbott et al. 2006, Skinner 2005, Uzumcu 
and Zachow 2007). Indeed, as it has been shown for a number of endocrine disrupters that different stages of 
folliculogenesis can be affected by some endocrine disrupting chemicals, and some examples of chemicals 
that affect initial recruitment are shown in figure 2. Methoxychlor (MXC) blocks pre-antral to antral 
transition (Chapin et al. 1997, Uzumcu et al. 2006) (effects in vivo), bisphenol A (BPA) affects follicular 
assembly and induces multi-oocyte follicles (in vivo) (Suzuki et al. 2002) and also DES affects follicular 
assembly and induces multioocyte follicles (in vivo and in vitro)(Iguchi et al. 1990).  
 
Figure 2. An overview of ovarian folliculogenesis modified from (Uzumcu and Zachow 2007). Following apoptosis of some oocytes 
within the oocyte nests the primordial follicles are formed. The remaining oocytes are then surrounded by squamous precursor-type 
granulosa cells (pre-GC). The (+) and (−) denotes that the chemical has stimulatory or inhibitory effects on some of the processes 
taking place at that stage. BPA=bisphenol A, MXC=Methoxychlor, DES= diethylstilbestrol.   
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2.2 Gestational length 
In this thesis as well as in reproductive toxicology studies in general, gestational length is an important 
endpoint. Significantly longer or shorter gestation length may be caused by malfunction of the normal 
mechanism for parturition. Shortening of gestational length can lead to adverse outcomes of pregnancy such 
as decreased birth weight and survival of the offspring. Prolongation of gestational length could result in 
death or impairment of offspring if difficulty in parturition (dystocia) occurs. Dystocia is a maternal health 
threat for humans as well as experimental animals. Gestation length can easily be determined in experimental 
animals from data on day of mating and day of parturition (OECD 2008, U.S. EPA 1996).  
 
The exact physiological stimulus for parturition is not fully understood (Young 2001). At near-term 
relaxation of the pubic symphysis begins (by day 17 of gestation in rats) and is complete prior to parturition 
(on GD22-23 in rats). The hormone relaxin, produced by the corpus luteum during the second half of 
pregnancy, is involved in the cervical extensibility as well as relaxation of the pubic symphysis in the rat 
(Samuel et al. 1996). Relaxin is also involved in remodeling of the cervix in humans along with other factors 
such as prostaglandins and metalloproteinkinases (Basavarajappa et al. 2010). Progesterone and estrogen are, 
among other signaling compounds, involved in the contractions of the myometrium of the uterus 
(Basavarajappa et al. 2010). In rats progesterone levels decrease prior to onset of labor which is caused by 
regression of the corpus luteum, which in the rat is the main site of progesterone production during 
pregnancy (Challis and Lye 1994, Mesiano and Welsh 2007, Young 2001). In humans, circulating 
progesterone levels primarily originates from the placenta after the sixth to nine week of gestation and does 
not seem to decrease during labor and delivery but is thought to involve a form of progesterone withdrawal 
that does not involve a decrease in the circulating levels (Challis and Lye 1994, Mesiano and Welsh 2007).  
Progesterone’s role in maintaining pregnancy and promote myometrial relaxation seems to be a conserved 
trait in viviparous species (Mesiano and Welsh 2007). In rats, progesterone blocks myometrial activity and 
withdrawal due to luteolysis leads to onset of labor and delivery but other factors that stimulate myometrial 
activity such as estrogen, oxytocin and prostaglandins are also implicated in the process of giving birth 
(Basavarajappa et al. 2010, Kobayashi et al. 1999). In humans, progesterone also inhibits contractions while 
estrogen induces myometrial contractions and stimulates production of prostaglandins, oxytocin, contractile-
associated proteins, and estrogen receptor α (Basavarajappa et al. 2010). In most species, including the rat, 
estrogen has a stimulatory effect on myometrial contractility that is mediated by an increase in circulating 
estrogen levels prior to onset of labor and is coordinated with systemic progesterone withdrawal. In humans, 
however, circulating estrogens increase at around mid-gestation and continue to rise gradually until birth 
(Mesiano and Welsh 2007). In the last phases of parturition of both rodents and humans, prostaglandins are 
involved in the strong contractions of the myometrial of the uterus to eventually ensure delivery 
(Basavarajappa et al. 2010).  
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Chemicals that interfere with the processes of parturition could lead to prolonged or shortened gestational 
length depending on the mechanism being disrupted. There are several examples of chemical compounds 
which prolong gestational length in laboratory animals such as the industrial chemical 3,4,3’,4’-
tetrachlorobiphenyl (PCB), zeranol (food additive for cattle in USA) (Rands et al. 1982) and the pesticides 
prochloraz (Noriega et al. 2005, Vinggaard et al. 2005), epoxiconazole and tebuconazole (Taxvig et al. 
2007). The pharmaceutical finasteride has been observed to reduce gestation length in rats (Paris et al. 2011) 
and perinatal 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure in mice has been shown to cause 
premature parturition in the offspring when exposed in utero (Ding et al. 2011). In humans, the maternal 
serum levels of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene (p,pDDE) the metabolite of the pesticide 1,1,1-
trichloro-2,2-bis(p-chlorophenyl) ethane (DDT) has in some studies been associated with preterm birth and 
cord serum levels from premature newborns of hexachlorobenzene and DDE  was higher in preterm born 
children compared to babies born to term (Longnecker et al. 2001, Ribas-Fito et al. 2002). However, another 
study failed to find a significant association between exposure to p,p'-DDE and preterm birth (Torres-Arreola 
et al. 2003). 
 
2.3 Anogenital distance and nipple retention 
Two very sensitive endpoints that have been widely used as biomarkers when investigating chemicals for 
endocrine disrupting properties in rats are anogenital distance (AGD) and nipple retention (NR).   
Anogenital distance in new born rat pups is defined as the distance from the anus to the genital bud (see 
Figure 3). AGD is a sexually dimorphic secondary sex characteristic in many mammalian species including 
humans (Salazar-Martinez et al. 2004)  and is dependent on prenatal exposure to androgens, which stimulate 
the growth of the perineum (Bowman et al. 2003, Clemens et al. 1978, Ostby and Gray 2004, Zehr et al. 
2001). Thus, AGD is longer in males than in females. As a rule of thumb the AGD measure in male rats is 
about two fold greater than the distance in female rats and the same applies for humans (Clemens et al. 1978, 
Ostby and Gray 2004, Salazar-Martinez et al. 2004). The endpoint is usually measured shortly after birth in 
rodents and correction for body weight has to be performed in the analysis of the data (Gallavan et al. 1999). 
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Figure 3. AGD in a normal male rat (A) and a female rat (B) pictures modified from (Ostby and Gray 2004). 
 
Mammary glands are developed in both male and female fetal rats and adult female rats most often have 12 
nipples. However, the male nipples are regressed prenatally due to the action of androgen (in rats 
dihydrotestosterone) in the tissue leaving only nipple anlagen and rudimentary mammary glands. In males, 
these are normally not visible to the naked eye (or only very few) when pups are 13 days old, which is the 
age nipples are often assessed in rats (Barlow et al. 2004, Hotchkiss et al. 2004, Imperato-McGinley et al. 
1986, Kratochwil 1977, Ostby and Gray 2004). Figure 4 A and B shows the anlagen of a female rat and a 
male rat exposed to antiandrogen. Nipples in females are more pronounced than in males exposed to 
antiandrogens but as can be seen in the figure, they are visible to the naked eye in both sexes (Figure 4).  
Since these tissues are androgen dependent, anogenital distance and nipple retention are most often used as 
endpoints in assessing effects of endocrine disruptors (most often anti-androgens) on the male reproductive 
system and numerous chemicals has been shown to affect AGD and nipple retention in male rats (Barlow et 
al. 2004, Boberg et al. 2011, Christiansen et al. 2010, Gray et al. 1999, Noriega et al. 2005, Ostby et al. 
1999). Generally, both AGD and NR are two very sensitive and non-invasive endpoints, when investigating 
effects of anti-androgenic compounds administered during the critical period of male sexual development 
(Christiansen et al. 2010). 
There are, however, also examples where AGD in female offspring has been affected by a treatment. A 
longer AGD than in control animals may be a consequence of androgen exposure during development (Ostby 
and Gray 2004). Exposure to estrogenic acting compounds like ethinyl estradiol and genistein have also been 
shown to alter AGD in female rats, however, sometimes increased AGD is reported and sometimes shortened 
AGD is reported with exposure to these compounds (Casanova et al. 1999, Delclos et al. 2009, Levy et al. 
1995, National Toxicology Program 2010). Effects on AGD of female rat offspring manifested as increased 
AGD have also been observed after in utero exposure to some fungicides like prochloraz and epoxiconazole 
(Laier et al. 2006, Taxvig et al. 2007). There are a few reports of significant effects on the number of nipples 
in rodent females in the open literature and they are reporting androgen exposure during development 
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resulting in a lower number of nipples (Hotchkiss et al. 2007, Wolf et al. 2002, Wolf et al. 2004). No reports 
in the open literature have been found where more than the normal number of nipples is observed in female 
rats.  
2.3.1 Relevance to humans 
In rats AGD and nipple retention has been shown to be highly predictive of adverse effects of the male 
reproductive system including increased incidence of hypospadias, testosterone decrease and altered 
reproductive organ weight changes (Bowman et al. 2003, Christiansen et al. 2008, Macleod et al. 2010, van 
den Driesche et al. 2011, Welsh et al. 2008). Measurement of AGD in men has shown some interesting 
results so far as AGD have been shown to correlate with changes in semen parameters (Eisenberg et al. 2011, 
Mendiola et al. 2011). A correlation between decreased AGD and decreased testosterone level has 
furthermore been observed in men (Eisenberg et al. 2012). There has previously been reported a strong 
inverse associations between prenatal phthalate exposure (particularly the anti-androgenic di-2-ethylhexyl 
phthalate (DEHP) and dibutyl phthalate (DBP)) and shorter male AGD in human infants (Swan et al. 2005, 
Swan 2008). Nipple retention or number of nipples are not observed effect in humans but the relevance of 
this endpoint is tied to the cause of this effect, which is the ability of chemicals to impair androgen action 
during development. No papers have been found reporting effects on AGD in girls or women.  
 
Figure 4 (A), female control rat with 12 nipples present (B) a male rat exposed to anti-androgen. Arrows points to the dark areas, 
which are the nipples or “dark areas” counted (photo: Bo Herbst). 
2.4 Onset of puberty.  
Onset of puberty has been evaluated as an endpoint in toxicological tests for many years (Gray et al. 1988, 
Gray et al. 1989, Gray et al. 2004, Lewis et al. 2002). In female rats onset of puberty is often measured as the 
time of vaginal opening (VO) also called vaginal patency. After the canalization of the vagina the vaginal 
orifice remains coved by a septum in female rodents. The day when the septum is no longer present is the 
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day of VO and this is readily determined as can be seen from Figure 5. VO generally occurs with or just 
before first ovulation and is a reliable marker for onset of puberty in rats (Parker and Mahesh 1976)  and 
commonly takes place between postnatal days 30 and 37 (Clark 1999, Goldman et al. 2000).  
 
Figure 5. The figure shows the area around the anal opening and the genital tubercle of a female rat before and after the septum has 
disappeared. Modified from (Lewis et al. 2002)  
Puberty is a transitional process, characterized as a cascade of neuroendocrine events leading to maturation 
of the reproductive system and is considered to be complete in the female when regular ovulatory cycles are 
established (Crain et al. 2008, Urbanski and Ojeda 1987). In the female rat puberty encompasses vaginal 
opening (VO) and first estrous (ovulation) which are both used as markers of puberty onset (Goldman et al. 
2000, Gray et al. 1988, Gray et al. 1989). While the exact factors that trigger onset of puberty are not fully 
understood, onset of puberty in the female rat seems to be dependent both on genetic and environmental 
factors including but not limited to nutrition, light and stress (Rivest 1991) but it can also be affected by 
chemical exposure (Goldman et al. 2000).  
After Before 
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Figure 6. A generalized figure of the principal factors involved in the hypothalamic-pituitary-ovarian axis during onset of puberty in 
the female rat. For further explanation see the text (Goldman et al. 2000). 
 
The pubertal events are a consequence of progressive functional shifts in the hypothalamic-pituitary-ovarian 
axis (Ojeda and Urbanski 1994). A generalized figure of the principal factors involved in the hypothalamic-
pituitary-ovarian axis during onset of puberty in the female rat is seen in Figure 6 (Goldman 2000). When 
puberty is imminent the hypothalamus begins to secrete Gonadotropin- Releasing Hormone (GnRH) in 
pulses which in turn stimulate the pituitary to release pulses of LH and FSH in to the circulation (Crain et al. 
2008). This phenomenon is not well understood and is referred to as the GnRH pulse generator. A number of 
neurotransmitter systems participate in the release of GnRH, some stimulating e.g. (norepinephrine 
(Noradrenergic) and glutamate neurons) others inhibiting (e.g. opiate neurons and GABA neurons) release of 
GnRH (Goldman et al. 2000). For an individual transmitter system puberty can be a period of transformation 
of function. For example γ-aminobutyric acid (GABA) is stimulating gonadotropin release (probably through 
GnRH) during prepuberty but inhibits gonadotropin release in peripubertal animals. The ovary responds to 
the circulating gonadotropins and excretes estrogen and progesterone which in turn exerts feed back to the 
hypothalamus and pituitary affecting the release of GnRH and gonadotropins, respectively (Goldman et al. 
2000). In three weeks old rats estradiol excerts negative feedback on hypothalamus and the pituitary, but a 
shift in the feedback happens in four week old rats and the hypothalamus and the pituitary start reacting 
positively to estradiol feedback (Andrews and Ojeda 1981, Andrews et al. 1981, Goldman et al. 2000). As 
the system becomes more sensitive and the rat matures this feedback process leads up to the occurrence of 
VO (estrogen dependant) and a preovulatory surge of LH (Ojeda and Urbanski 1994, Ramirez and Sawyer 
1965).  Prostaglandins and kisspeptin are also involved in modulating the GnRH secretion (Ojeda et al. 1986, 
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Rage et al. 1997, Roa et al. 2008, Roa et al. 2009, Tena-Sempere 2010). Furthermore, data suggests that 
many other compounds like e.g. leptin, neuropeptid Y, growth factors and thyroid hormones also play a role 
in puberty onset (Cheung et al. 1997, Goldman et al. 2000, Gruaz et al. 1993, Ma et al. 1992, Minami and 
Sarkar 1992, Tamura et al. 1998). 
2.4.1 Types of chemicals that affect VO in the female rat 
The process of sexual maturation is as mentioned a complex neuroendocrine process and chemical insult that 
interferes with any of the involved processes may result in either an advance or a delayed onset of puberty 
for some chemicals even from exposure in utero and during lactation (Goldman et al. 2000, Grande et al. 
2007, Gray and Ostby 1995, Si et al. 2011, Urbanski and Ojeda 1987, Wang et al. 2005). Delay in onset of 
puberty can be a non-specific effect of marked general toxicity or a specific effect of a chemical, however, a 
lowered body weight gain is not always indicative of a delay in sexual maturation as with some estrogenic 
compounds which cause lower body weight but accelerated VO (Delclos et al. 2009, Goldman et al. 2000, 
Gray et al. 1989).  
Examples of types of chemicals that can advance onset of puberty in rats are chemicals with suggested 
estrogenic mechanism of action. For example, ethinyl estradiol advanced puberty in female rat offspring 
after dietary exposure from GD7 and through lactation and after weaning (National Toxicology Program 
2010). Also methoxychlor or its metabolite 2,2-bis(p-hydroxyphenyl)-1,1,1-trichloroethane (HPTE) acts both 
as an estrogen receptor agonist and androgen receptor antagonist and advances puberty when dosed by 
gavage from weaning to adult (Bulger et al. 1978, Gray et al. 1989, Maness et al. 1998). Furthermore, the 
testosterone synthesis inhibitor DEHP administered by inhalation PND22-84 advanced puberty in female rats 
(Ma et al. 2006).  
 Many types of chemicals seem to be able to cause a delay of VO in studies on rats. These includes, but are 
not limited to, treatment with the ah-receptor agonist TCDD exposed GD15 by gavage (Gray and Ostby 
1995), aromatase inhibitor (Fadrozole, PND21-40 by gavage (Marty et al. 1999)) and atrazine (reduces LH 
and prolactin) PND22-41 orally by gavage (Laws et al. 2000b). These delays were not attributable to a lower 
body weight.  
2.4.2 Human relevance 
Over a period of about 100 years until the mid twentieth century a decline in age of onset of puberty in girls 
has been observed. According to Parent et al (2003) the general improvement of living conditions has 
probably been the major explanation for the decline. Thereafter age at onset of puberty seems to have 
stabilized in most countries (Parent et al. 2003). However, in the last 15 years there seems to be a trend of 
further decline in age of puberty in the US and in Europe characterized by early onset of growth of pubic hair 
(pubarche), early breast development (thelarche) and/or age of menstruation (menarche) (Aksglaede et al. 
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2009, Euling et al. 2008, Rubin et al. 2009, Mouritsen et al. 2010). This new decline does not seem to be 
associated with any major change in socio-economic conditions and the advancement in pubertal timing 
happening rapidly over the past decades indicates an environmental etiology (Sorensen et al. 2012). Some 
factors that may affect maturation of the reproductive system are changes in frequency of obesity, fetal 
nutrition, childhood dietary habits, physical activity and also exposure to endocrine disrupting chemicals 
(Adair 2001, Den Hond et al. 2002, Georgopoulos et al. 1999, Kaplowitz et al. 2001, Mouritsen et al. 2010, 
Parent et al. 2003).   
 
Supporting the possible contribution of EDC exposure on the changes of timing of sexual maturation are 
several animal studies (some examples were mentioned in the previous section) (Gray et al. 1989, Kim et al. 
2002, Laws et al. 2000a, Ma et al. 2006). There are also examples from human studies for example 
associations between age of menarche and breast development and serum levels of for example phthalates 
and DDT (Buck Louis et al. 2008, Colon et al. 2000, Ouyang et al. 2005, Wang et al. 2005) and early 
menarche and pubic hair development in girls exposed in utero and via breastfeeding with high levels of 
brominated flame retardeants (Blanck et al. 2000). Furthermore, although the majority of chemicals have not 
been studied in both humans and animals, there are a few examples of chemicals where data seems to point 
the same way. For example TCDD has been shown to delay puberty in female rats (VO) (Gray and Ostby 
1995) and increased serum levels are associated with delayed breast development in humans (Den Hond et 
al. 2002).  
2.4.3 Differences and similarities between rodents and human 
The time of onset of puberty is affected by both genetic and environmental factors in the human as well as in 
the rat (Kaprio et al. 1995, Parent et al. 2003, Rivest 1991). Both humans and rats are regular cycling, display 
spontaneous ovulation, and have midcycle gonadotropin surges that trigger comparable follicular and oocytic 
changes in the ovaries (Buck Louis et al. 2008). In rodents GnRH secretion is maintained at low levels 
during juvenile life by steroid control whereas in humans it is regulated by central mechanisms independent 
of gonadal regulatory inputs (Urbanski and Ojeda 1987). The time frame of puberty is different between the 
species (Gray et al. 2004) and so are the puberty landmarks evaluated which in humans are breast and pubic 
hair development and menarche (Rockett et al. 2004). Still the activation at puberty of GnRH release in 
rodents and primates are initiated and regulated by similar inhibitory and stimulatory pathways making the 
rat a suitable and widely used model (Buck Louis et al. 2008). 
2.5 Estrous cycle 
A major focus in this thesis has been on estrous cycle measurements. Evaluating changes in vaginal 
epithelial cell structure has been used for decades to document the reproductive cycle in laboratory mice and 
rats and to contribute to the assessment of the functional status of the hypothalamic-pituitary-ovarian axis in 
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reproductive toxicology studies (Goldman et al. 2007). In the rat the cyclical changes of the vaginal 
histology during the estrous cycle was first described by Long and Evans (1922). In rats cycling begins 
shortly after onset of puberty as marked by vaginal opening. Initially, the rats show some irregular cycles but 
by around 45 days of age it will begin to show a regular pattern with cycle lengths normally lasting for four 
or five days (Cooper and Goldman 1999). The estrous cycle can be described by four stages each based on 
characteristic composition of cell cytology in the vaginal smear.  
The four stages of the estrous cycle are called: proestrus (P), estrus (E), metestrus (M) and diestrus (D) and 
normally occurs in the order P-E-M-D in a four day cycle (Goldman et al. 2007). Because rats cycle 
continually throughout the year (continuously polyestrous), diestrus is immediately followed by the proestrus 
stage of the next cycle. Anestrus, which is a period of reproductive rest state between estrous cycles, is not 
usually observed in healthy, cycling female rats. Normally, estrous cyclicity only stops during 
pseudopregnancy, pregnancy, and lactation. Figure 7 shows the length of each stage of the estrous cycle.  
Environmental factors, e.g. the presence of males, light/ dark cycles have an impact on the regularity of the 
estrous cycles and should be considered before smears are collected in any experiment. Smears should be 
collected approximately at the same time every day (OECD 2009c). 
 
Figure 7. Duration of the four stages of the estrous cycle in the laboratory rat as reported by Long and Evans (1922), Astwood (1939) 
and Mandl (1951) (Astwood 1939, Long and Evans 1922, Mandl 1951, OECD 2009b). 
 
2.5.1 Hormonal fluctuations and the estrous cycle  
The cyclic changes occurring in the vaginal cell morphology are initiated and regulated by the hypothalamic-
pituitary-ovarian (HPO) axis. This section will focus on the major reproductive hormones LH, FSH, 
estradiol, progesterone and inhibin. The estrous cycle is regulated by a complex system of feedback 
mechanisms between the hypothalamus, the pituitary and the ovaries involving both negative and positive 
feedback mechanisms of various hormones depending of the stage of estrous cycle which is shown in Figure 
8 (OECD 2009b). The relative levels of the hormones FSH, LH, estradiol and progesterone and how they 
vary in the estrous cycle are shown in Figure 9. 
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Figure 8. The Hypothalamus-pituitary-ovary axis showing the main interactions between compartments of the axis via the major 
hormones during the estrous cycle. From (OECD 2009d). 
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Figure 9 Modified after Goldman et al (2007) and Butcher et al 1974, (Butcher et al. 1974, Goldman et al. 2007). The figure is 
showing schematically how the hormone levels of LH, estradiol and progesterone are fluctuating during the estrous cycle of the rat. 
The surge in LH is followed by ovulation 10-12 hours later. In this figure metestrus is called diestrus 1 and diestrus is called diestrus 
2. 
FSH: In diestrus follicular growth is stimulated by the pituitary gonadotropins (in turn regulated by GnRH 
from the hypothalamus), primarily follicle stimulating hormone (FSH). FSH rises preovulatory, peaks and 
returns to base levels halfway through estrus (Butcher et al. 1974). 
Estradiol: The follicular growth is accompanied by a rise in secretion of estradiol which peaks halfway 
through proestrus.  At this point of the estrous cycle the level of estradiol is rising and estradiol is 
suppressing the release of GnRH from the hypothalamus and also exerts a direct effect on the pituitary 
inhibiting secretion of LH and FSH. Further negative feedback of pituitary FSH secretion is achieved by the 
production of inhibin in the maturing follicle (Woodruff et al. 1996). When estradiol levels have peaked the 
inhibitory effect on GnRH and gonadotropin secretion come to an end and estradiol is now exerting a 
positive feedback on the hypothalamic-pituitary system promoting GnRH release and increasing pituitary 
responsiveness to GnRH leading to a preovulatory surge in LH (OECD 2009b).  
Progesterone: Levels of ovarian progesterone also rise starting at early proestrus and peaks a few hours later 
than estradiol. Like in the case of estradiol, the feedback of progesterone to the hypothalamic-pituitary 
system can be positive or negative depending on the stage of the estrous cycle. The rising progesterone levels 
during proestrus increases hypothalamic release of GnRH and promotes (in concert with estradiol) the 
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preovulatory LH surge. Post ovulation (ovulation happens early in the estrus stage) progesterone (as with 
estradiol) inhibits gonadotropin secretion (OECD 2009b).  
LH: During the estrous cycle the level of  Luteinizing hormone (LH) remains low but a peak in the 
concentration happens at the day of vaginal proestrus and the surge in LH is followed by ovulation 10-12 
hours later (Cooper and Goldman 2010). The LH surge is released from the anterior pituitary in response to 
GnRH.  
The sequential rise of the ovarian hormone estradiol followed by progesterone affects the hypothalamus and 
pituitary and controls the amount and timing of the LH surge (Cooper and Goldman 2010). In turn the LH 
surge starts the final stage of oocytic and ovarian follicular maturation that comes before the ovulatory 
rupture of the follicle (Goldman et al. 2007). 
2.5.2 Types of chemicals that can insult the HPO system thereby affecting estrous cyclicity 
In principle chemicals that interfere with any target along the HPO- axis including excretion and production 
of hormones could disrupt the estrous cycle and block ovulation. A disruption of cycling caused by chemical 
exposure can induce an acyclicity characterized by a persistent estrus, a persistent diestrus, or cause an 
irregular pattern with cycles of abnormal duration (Goldman et al. 2007). A regular cycle is not; however, 
necessarily proof that a chemical is not a reproductive toxicant as a cycle can still be anovulatory (Cooper 
and Goldman 1999). Examples of classes of chemicals that can disrupt normal estrous cyclicity include 
pesticides as well as chemicals used in production. Some examples of chemicals that disrupt estrous cycle 
are: atrazine, which probably acts through a hypothalamic mechanism (Cooper et al. 1996, Eldridge et al. 
1999), estrogenic (e.g. methoxychlor, nonylphenol, BPA (Okazaki et al. 2001, Woo et al. 2007)), chemicals 
that can destroy follicles (e.g. 4-vinylcyclohexene (Lohff et al. 2005, Mayer et al. 2002)), androgens  (e.g. 
17α-methyltestosterone, oxymetholone (Clark et al. 1998, Okazaki et al. 2002)) and aniandrogens 
(vinclozolin, DEHP (Hirosawa et al. 2006, Schneider et al. 2011)). As many chemicals probably have more 
than one mode of action it is not always easy to predict how an estrogenic or antiandrogenic chemical affects 
the cycle specifically. For example have perinatal exposure to BPA been reported to induce extended periods 
of diestrus in some animals and extended periods of diestrus and/or estrus in other animals (Rubin et al. 
2001) while the effects of e.g. estrogenic chemicals can also be different at high and low doses (Goldman et 
al. 2007).  
2.5.3 The relevance of estrous cycle evaluation in toxicology  
Commonly used classes of chemicals have both been shown to cause cycle irregularities in rats and also 
revealed an association to cycle effects in humans in epidemiological studies. For example the 
polychlorinated biphenyls (PCBs) and dioxins, which are associated with cycle irregularities in both rats and 
humans (Brezner et al. 1984, Chao et al. 2007, Li et al. 1995, Meerts et al. 2004, Yang et al. 2005). This also 
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seems to be the case in both rats and humans for some agricultural pesticides, including herbicides and 
fungicides, like DDT, atrazine, lindane and mancozeb (Baligar and Kaliwal 2001, Chadwick et al. 1988, 
Cragin et al. 2011, Eldridge et al. 1999, Farr et al. 2004, Gotz et al. 2001, Heinrichs et al. 1971, Lahiri et al. 
1985, Windham et al. 2005). Care should of course be taken when interpreting epidemiological data as there 
are many confounding factors when dealing with a human population. 
There are some differences among the estrous cycle of the female rat and women that one should keep in 
mind: The rat has a 4- to 5-day estrous cycle and corpus luteum is not sustained if mating does not occur. 
Corpora luteal function is sustained for approximately 10-16 days by mating-induced cervical stimulatory 
prolactin surges in rats. Humans have a menstrual cycle around 28 days in duration and do not have periods 
of peak behavioral estrus during the cycle. Human menstrual cycle has a spontaneous luteal phase of 10 to 14 
days after ovulation as opposed to the rat. The female rat displays sexual receptivity only during estrus (Gray 
et al. 2004). Furthermore, other biomarkers are more useful in assessing the human ovarian cycle than 
vaginal cytology, like blood hormone measurements, menses or alterations in vaginal pH (Bretveld et al. 
2006, Goldman et al. 2007).  
With these differences between rodents and humans in mind, evaluation of rodent cyclicity can still be of 
value when considering potential adverse effects in women. Many of the underlying endocrine mechanisms 
associated with successful follicular development, ovulation, pregnancy, and parturition are homologous 
between the species (Bretveld et al. 2006, Cooper and Goldman 1999, Goldman et al. 2007, Gray et al. 
2004). Also the hormone profile during the estrous and menstruation cycle is similar between rodents and 
women (Ben-Jonathan et al. 2008).  For this reason, a chemical induced inhibition of ovarian cycles in 
female rats should suggest that a compound may be a reproductive toxicant in women.  
2.6 Female reproductive senescence in rats and humans 
In this thesis, some emphasis has been placed on effects on the female system which become evident later in 
life compared to the time of exposure. One such effect is the time of reproductive senescence.  
Rodents begin to exhibit irregular cycles at 9–12 months with differences between strains (Maffucci and 
Gore 2006).  When the aging female rat starts getting irregular cycles, it typically displays elongated cycles 
dispersed between regular cycles and gradually becomes more irregular. The irregularly cycling rats have 
prolonged cycles of 6 days or more, and acyclic rats are in persistent estrus or persistent diestrus (LeFevre 
and McClintock 1988, Rubin 2000).  
In humans, menopause is defined as a permanent cessation of menstruation and is clinically diagnosed after 
one year of amenorrhea (absence of a menstrual period) (Kermath and Gore 2012, Maffucci and Gore 2006, 
World Health Organization (WHO) 1996). The mean age for women to reach menopause is 51 years and at 
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menopause the ovarian follicular reserve has been exhausted (Wu et al. 2005). The menopause is preceded 
by a period of irregular menstrual cycles, hormone fluctuations and decreased fertility that normally occurs 
between ages 45 and 54 and this period is termed perimenopause and lasts till one year after last 
menstruation (Fitzgerald et al. 1998, Nejat and Chervenak 2010, Santoro et al. 1996, Soules et al. 2001). 
Timing of reproductive senescence is determined by both genetic and environmental factors (Gore et al. 
2011, Kok et al. 2005).  
Most research has been considering the genetic factors but there is growing evidence that environmental 
factors like for example cigarette smoking (Midgette and Baron 1990) and exposure with endocrine 
disrupters can affect timing of menopause and thereby shorten a person’s duration of reproductive life (Gore 
et al. 2011). In mammals the total ovarian reserve of follicles has been believed to be established before birth 
or soon thereafter, and anything that could decrease the total follicle pool can theoretically result in early 
menopause (Diamanti-Kandarakis et al. 2009). There has, however, been some evidence that in juvenile and 
adult mice a recruitment of ovarian follicles may be possible later in life (Johnson et al. 2004, Johnson et al. 
2005a).  This matter has been subject to some skepticism (Byskov et al. 2005, Johnson et al. 2005b, Telfer et 
al. 2005, Tilly and Johnson 2007) and in any event the follicle reserve decreases with age in women with 
very few remaining at menopause (Wallace and Kelsey 2010).  
Earlier it was believed that menopause was just a result of depletion of follicular reserve and that the changes 
in hypothalamic and pituitary hormones accompanying menopause was a result of ovarian failure (vom Saal 
et al. 1994). There is, however, evidence from studies on rats that their hypothalamic and pituitary systems 
also undergo aging (Peng and Huang 1972, Rubin 2000) and there also seems to be an aging of the HPO axis 
in women (Kermath and Gore 2012, Shaw et al. 2009, Weiss et al. 2004). It has been hypothesized that this 
may be involved in the accelerated decrease in follicle numbers observed in women the last decade up until 
menopause (Faddy and Gosden 1996, Richardson et al. 1987, Wise et al. 1997). 
Menopause decreases fertility in late reproductive years and since many women choose to delay childbirth 
because of careers, birth control and other considerations (Fitzgerald et al. 1998, Wu et al. 2005) a 
chemically induced earlier menopause may give rise to problems conceiving for some women. Furthermore, 
menopause affects women’s risk of getting chronic diseases associated with decreased levels of reproductive 
hormones (Farr et al. 2006). In fact menopause is associated with increased risk of diseases in the 
cardiovascular system (Chae and Derby 2011), bone density (Lo et al. 2011) and possibly effects on 
cognitive performance (Rocca et al. 2011, Sherwin 2006, Zandi et al. 2002).  
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2.6.1 Differences and similarities between women and rats and relevance of measuring onset of 
estropause in rodents 
Rodents do not have a menstrual cycle and the process of reproductive aging may more correctly be called 
estropause instead of menopause. Nevertheless, rats undergo reproductive failure in middle age that in many 
ways resembles what happens in humans in the perimenopausal transition. Some similarities and differences 
will be considered in the following section.   
When reproductive decline is imminent an increase in FSH is observed in both humans and rats at middle 
age (DePaolo 1987, Klein and Soules 1998, Rubin 2000, Wise et al. 2002). Also Inhibin B levels decrease in 
both rats and women (Kermath and Gore 2012, Rubin 2000, Sowers et al. 2008).  
LH secretion changes in women and rats as they enter the perimenopausal transition and cycle length in both 
women and in the rat become greatly variable (LeFevre and McClintock 1988, Sherman et al. 1976, Wise et 
al. 2002). In rats there is an attenuation and delay of the LH surge and a decrease in fertility, similar to 
humans (Rubin 2000, Van Kempen et al. 2011, Wise et al. 2002). Women in perimenopause transition have 
estrogen levels comparable or increased compared to young women but the levels fluctuate (Kermath and 
Gore 2012, Santoro et al. 1996) which is similar to what is observed in rats entering irregular cycles (Wise et 
al. 2002). Progesterone declines with age in humans as well as in female rats (Klein and Soules 1998, Lu et 
al. 1979, Santoro et al. 1996) but the levels are not as reduced in rats as in humans (Van Kempen et al. 2011). 
A major difference between rat and human menopause is that although a decline in follicular reserve is 
observed in middle aged female rats they retain a much higher number of follicles resulting in a higher level 
of estrogens than is the case in menopausal women, who has almost exhausted the ovarian follicle pool at the 
time of menopause (see Figure 10) (Klein and Soules 1998, Mandl and Shelton 1959, Rubin 2000, Wallace 
and Kelsey 2010). Aging at the hypothalamus - pituitary level seems to play a very important role in the 
onset of irregular estrous cycles in the rat (Maffucci and Gore 2006, Peng and Huang 1972, Rubin 2000).  
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Figure 10. The profile of estrogen levels during the reproductive periods of a lifetime, modified from (Maffucci and Gore 2006). The 
rat estrogen levels stay higher later in the reproductive aging process than the levels in humans and mice. 
 
Because of the similarities between rats and humans in reproductive aging in the transition state the intact rat 
is often considered a good model for the perimenopausal woman but due to the difference in estrogen levels 
and follicle reserve between human and rat later in the process, it is not as good a model for human 
postmenopause (Kermath and Gore 2012, Rubin 2000, Wise et al. 2002).  
Onset of estrous cycle irregularities has been used to measure effects on reproductive senescence for a 
number of chemicals. Examples of chemicals that induces early onset of irregular estrous cycles in rats are 
Methoxychlor, Bisphenol A, and dioxin (Adewale et al. 2009, Armenti et al. 2008, Gore et al. 2011, Shi et al. 
2007). Methoxychlor exposure to 100 mg/kg bw/day perinatally, induced a significantly higher proportion of 
irregularly cycling female rat offspring compared with control at 13 months of age (Gore et al. 2011). In a 
study on bisphenol A only 33% in the groups of rats neonatally treated with 50 mg/kg bw/day and 86% of 
the animals treated with 50 µg/kg bw/day had regular estrous cycle at 15 weeks after VO compared to 100% 
in vehicle control (Adewale et al. 2009). Oral exposure to TCDD GD14, 21 and PND 7 and 14 of female rat 
dams caused accelerated transition to reproductive senescence, measured as a decrease in the number of 
regularly cycling female offspring compared with control, in a dose-responsive manner beginning at 9 
months of age in groups receiving 50 or 200 ng/kg/week (Shi et al. 2007). 
2.7 Anti-Müllerian hormone an endpoint used to assess ovarian reserve.  
Anti-Müllerian hormone (AMH) is a member of the growth factor-beta family which acts on tissue growth 
and differentiation. AMH is also known as Müllerian inhibiting substance (MIS) (La Marca et al. 2010, Yeh 
et al. 2007). In the fetal testis it is produced by the Sertoli cells and induces regression of the Müllerian ducts 
(Lee and Donahoe 1998, Visser et al. 2006).  
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In the ovary, AMH is involved in inhibition of the early stages of follicle growth (Carlsson et al. 2006, 
Durlinger et al. 2001, Durlinger et al. 2002, Visser et al. 2006) and may regulate the responsiveness of 
growing follicles to FSH by inhibiting the sensitivity to FSH. AMH is produced primarily by the granulosa 
cells of preantral/primary and small antral follicles of the ovary and is not expressed in the final FSH-
dependent stages of follicle growth (figure 11) (Durlinger et al. 2002, Kelsey et al. 2011, Visser et al. 2006).  
This is a great advantage of AMH as a biomarker because it means that levels of AMH in plasma are quite 
stable across cycle and also between cycles in the same individual (Cook et al. 2000, Fanchin et al. 2005, La 
Marca et al. 2004). It has been shown to decline with age in humans, rats, and mice and in humans it is used 
as a predictor of fertility/reproductive aging (Kevenaar et al. 2006, Visser et al. 2006, Yeh et al. 2007). The 
levels of AMH in blood are proportional to the number of developing follicles in the ovaries which is 
indirectly reflecting the number of primordial follicles, or the ovarian reserve (Broekmans et al. 2008). Since 
the serum levels of AMH have been shown to correlate with follicle pool also in rats (Yeh et al. 2007) it 
could have the potential to be used as an endpoint in toxicological tests when assessing exhaustion of follicle 
reserve due to chemical insult. Indeed, it has been used as a biomarker to assess the degree of ovarian 
damage caused by exposure to the chemotherapeutic agent cisplatin (Yeh et al. 2006). 
 
Figure 11. Model of AMH action in the ovary, figure modified from (Broekmans et al. 2008). The known role of AMH in normal 
ovarian follicle development is shown (the red centre represents the oocyte, the grey area represents the granulosa cell layer and the 
white area represents follicle fluid in the antrum). AMH is expressed in small and large preantral follicles (broken arrows) and in 
small antral follicles (unbroken arrow). Initial recruitment is a continuous process, whereas cyclic recruitment is driven by a rise in 
FSH serum levels at the end of a previous menstrual cycle. Inhibitory effects of AMH on follicle development are on (a) the initial 
recruitment of primary follicles from the resting primordial follicle pool and (b) on the sensitivity of antral follicles for FSH. 
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2.8 Mixtures of chemicals 
As has been outlined in the previous sections, the endocrine system can be affected by many types of 
chemical compounds. With a few exceptions, chemical risk assessment considers only the effects of single 
substances. Toxicity of mixtures are important, as humans are likely to be exposed to several endocrine 
disruptive compounds simultaneously and from multiple sources like cosmetics, food, water, air and dust, 
rather than just one chemical at a time. Exposure scenarios are complex, however, mixture effects are 
necessary to include in risk assessment, since assessment based solely on single compounds can possibly 
underestimate the risk (Kortenkamp et al. 2010). Indeed, in vitro as well as in vivo reproductive toxicity  
studies have shown that certain endocrine disrupting chemicals are able to contribute to the overall effect of a 
mixture, even when the individual components of the mixture are present at concentrations below the 
threshold of statistically detectable effects (Christiansen et al. 2008, Christiansen et al. 2009, Hass et al. 
2007, Rajapakse et al. 2002, Rider et al. 2008, Silva et al. 2002).  Since it is not possible in practice to test all 
possible combinations of chemicals in mixture studies, models that can predict joint effects of mixtures on 
the basis of data obtained from testing single chemicals are greatly needed in chemical risk assessment 
(Cedergreen et al. 2008, Kortenkamp et al. 2010).   
 
The two most commonly used models to predict effects of mixtures are the concept of dose addition (DA) 
introduced by Loewe and Muischnek (Loewe and Muischnek 1926) and independent action (IA) introduced 
by Bliss (Bliss 1939). Both models are based on the assumption that there is no interaction (physically, 
chemically, or biologically) between the compounds in the mixtures, in other words, one compound does not 
influence the toxicity of the other compounds (Cedergreen et al. 2008). 
The IA model assumes that each chemical in a mixture has its own unique mechanism of action (dissimilar 
acting). The DA model is based on the assumptions that the chemicals in the mixture act on the same site or 
has the same effects and can be considered as dilutions of one another differing only in their individual 
potency (similar action). Similar action, however, can be interpreted in a very broad or a very strict sense 
either comprising all substances capable of cause a particular toxicological response i.e. antiandrogens or 
only those acting at a particular molecular binding site (Faust et al. 2001). 
Recently, the DA model has been shown to be valid to both similar and dissimilar acting compounds in vivo. 
In some cases the DA model has even made predictions more closely in accordance with the observed effect 
than predictions made using the IA model (Christiansen et al. 2009, Rider et al. 2008). 
There is an important difference between the predictions based on IA and DA that can be of importance for 
risk assessment. If the exposure to chemicals in a mixture is at or below the no observed adverse effect levels 
(NOAELs), the IA model will predict no adverse effect of exposure to the mixture whereas DA can predict 
that adverse effects will in fact occur even if all the chemicals in the mixture are below their individual 
NOAELs (Rider et al. 2008, Silva et al. 2002).  
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In the studies included in this thesis four out of five are mixture studies, however, the prediction calculations 
are not within the scope of this thesis. The endpoints mentioned in the previous sections have all been shown 
to be affected by exposure to endocrine disrupters in female rodents. These endpoints have been measured in 
the studies as part of this thesis and in the following chapters the methods, results and discussion of the 
results will be reported. Moreover, the next sections will also cover some method related considerations. 
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3 Methods 
The results, which are presented in this thesis, were obtained in five developmental toxicology studies. Two 
studies investigated mixtures of endocrine disrupting pesticides (Pestimix), two investigated mixtures of 
endocrine disrupting chemicals based on human exposures (Contamed), and one study tested a positive 
control for estrogenic effects, ethinyl estradiol (EE2). The project with the mixture of the five pesticides 
included two range-finding studies (collectively called Pestimix RF) and a dose response study (Pestimix 
DR). In the Contamed project, mixtures were modeled based on high end human intakes, and the project 
involved two developmental mixture studies in rats, called Contamed 1 and 2. Finally, results from a dose 
response study on the estrogenic drug EE2 were included. In all of these studies, both male and female 
offspring were investigated for adverse effect of the exposure, however, the endpoints which were focused 
on in this thesis, were only in females and included gestational length, anogenital distance (AGD), number of 
nipples, onset of puberty, measurements of Anti-Müllerian hormone (AMH) and estrous cyclicity at several 
time point during the animals life span. 
3.1 Chemicals, doses and composition of the mixtures 
The data included in this thesis originates from several different studies. The first studies investigated the 
effects of mixtures of five pesticides. Pestimix RF consisted of two range finding studies (a and b) but will 
be treated as one study in this thesis. The mixture ratio was based on doses causing no effects on gestation 
lengths and pup survival for the individual pesticides, i.e. Pestimix-175 (100%). Table 1 shows the 
composition of the mixture doses tested in the two range finding studies a and b (paper I). Animals were 
dosed from GD7 to PD16 except in the three highest doses where the animals were sacrificed GD25 due to 
impaired parturition in several of the dosed dams. The term pup day (PD) is used in this thesis and the 
expected day of delivery, GD 23, is designated pup day (PD) 1 for the pups. Thereby, the age of the pups is 
related to the time of conception, but is rather similar to postnatal age. 
Table 1. The composition of mixtures in the Pestimix rangefinding (Pestimix RF). The notation a and b denotes the two studies a and 
b (in mg/kg bw/day).  
Pesticide 
Pestimix-43.75 
(25%
b
)
 
Pestimix-87.5 
(50%
b
)
 
Pestimix-131.25 
(75%
a
) 
Pestimix-175 
(100%
a
)
 
Pestimix-218.75 
(125%
a
) 
Epoxiconazole 3.75 7.50 11.25 15.00 18.75 
Mancozeb 6.25 12.50 18.75 25.00 31.25 
Prochloraz 8.75 17.50 26.25 35.00 43.75 
Tebuconazole 12.5 25.00 37.50 50.00 62.50 
Procymidone 12.5 25.00 37.50 50.00 62.50 
Pestimix, 
total 43.75 87.5 131.25 175.00 218.75 
 
The doses tested in the following dose reponse study Pestimix DR study (Table 2) was chosen based on 
results obtained in the two range finding studies, where higher doses than 43.8 mg/kg bw/day caused effects 
on pup survival, and is described in detail in paper II and III. Dams were administered GD7-GD21 and from 
the day after birth to pup day 16.  
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Table 2. Doses of the pesticides administered individually and in mixture to pregnant rat dam from GD 7 to pup day 16 (in mg/kg 
bw/day) and number of dosed time-mated rats (dams with viable litters) in each group. Epoxiconazole (Epoxi), mancozeb (Manz), 
prochloraz (Prchl), tebuconazole (Tebu) or procymidone (Procy). 
Group Epoxiconazole Mancozeb Prochloraz Tebuconazole Procymidone 
Pesticide 
mixture 
% of 
NOAEL for 
effect on 
parturition 
1: Control - - - - - - - 
2: Pestimix-14.6 1.25 2.08 2.92 4.17 4.17 14.6 8.3 
3: Pestimix-29.2 2.5 4.17 5.83 8.33 8.33 29.2 17 
4: Pestimix-43.8 3.75 6.25 8.75 12.5 12.5 43.8 25 
5: Epoxi-3.75  3.75 - - - - - 25 
6: Epoxi-15 15 - - - - - 100 
7: Manz-6.25 - 6.25 - - - - 25 
8: Manz-25 - 25 - - - - 100 
9: Prchl-8.75 - - 8.75 - - - 25 
10: Prchl-35 - - 35 - - - 100 
11: Tebu-12.5 - - - 12.5 - - 25 
12: Tebu-50 - - - 50 - - 100 
13: Procy-12.5 - - - - 12.5 - 25 
14: Procy-50 - - - - 50 - 100 
 
The Contamed project weas based on human high end exposure to mixtures of environmentally relevant 
endocrine disrupters and consisted of two studies. These studies will be referred to as Contamed 1 and 
Contamed 2 and the composition of the mixtures and dose groups can be seen in Table 3. The reasons for 
choice of chemicals tested the mixtures in the Contamed studies, the dosing scheme as well as reasons for the 
doses chosen in Contamed 1 are described and explained in paper IV (Christiansen et al. 2012). In Contamed 
2 the doses chosen were based on the results obtained in Contamed 1and the Amix (only included 
antiandrogenic chemicals marked with blue color in table 3), unlike in Contamed 1, did not contain 
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paracetamol (PM) because it was important to investigate if paracetamol by itself caused the effects observed 
primarily on the male offspring. Emix only included the chemicals with estrogenic properties (red color in 
Table 3). During gestation dosing occurred GD7-21 and during lactation the exposure period was day after 
birth to PD22. Paracetamol was only present in the mixture or in the vehicle treated with 360 mg/kg bw/day 
paracetamol GD13-19 to avoid effects on implantation and possible effects on birth, respectively 
(Christiansen et al. 2012, Gupta et al. 1981). Paracetamol was not administered PD1-13 in lactation in order 
to be able to compare with data from Contamed 1 and data from an earlier study (Kristensen et al. 2011a) 
and administered PD14-PD22 only to be able to measure blood levels. 
Table 3. The composition of the mixtures in mg/kg bw used in Contamed 1 and 2. The total doses are summed up in the bottom of 
the table. Chemicals in cells with blue coloration were considered to have antiandrogenic modes of action and chemicals in cells with 
red coloration had estrogenic modes of action. 
Study Contamed 1 Contamed 2 
Chemical Ra
tio 
Mix-
150 
Mix-
450 
Amix-
450 
Mix-
100 
Mix-
200 
Mix-
450 
Amix-
200 
Amix-
450 
Emix-200 Emix-
450 
Paracetam
ol 360 
DBP 0.0
1 
1.5 4.5 4.5 1 2 4.5 2 4.5 0 0 0 
DEHP 0.0
2 
3 9 9 2 4 9 4 9 0 0 0 
Vinclozolin 0.0
09 
1.35 4.05 4.05 0.9 1.8 4.05 1.8 4.05 0 0 0 
Prochloraz 0.0
14 
2.1 6.3 6.3 1.4 2.8 6.3 2.8 6.3 0 0 0 
Procymidone 0.0
15 
2.25 6.75 6.75 1.5 3 6.75 3 6.75 0 0 0 
Linuron 0.0
006 
0.09 0.27 0.27 0.06 0.12 0.27 0.12 0.27 0 0 0 
Epoxiconazole 0.0
1 
1.5 4.5 4.5 1 2 4.5 2 4.5 0 0 0 
4-MBC 0.0
6 
9 27 0 6 12 27 0 0 12 27 0 
OMC 0.1
2 
18 54 0 12 24 54 0 0 24 54 0 
ppDDE 0.0
01 
0.15 0.45 0.45 0.1 0.2 0.45 0.2 0.45 0 0 0 
Bisphenol A 0.0
015 
0.225 0.675 0 0.15 0.3 0.675 0 0 0.3 0.675 0 
Butyl-paraben 0.0
6 
9 27 0 6 12 27 0 0 12 27 0 
Paracetamol 0.8 120 360 360 80 160 360 0 0 0 0 360 
Sum 1.1
211 
1681
65 
504.4
95 
395.8
2 
32.1 64.2 144.5 15.9 35.8 48.3 108.7 360 
4-MBC=4-methyl-benzylidene camphor, p,pDDE=1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene, OMC= Octyl methoxycinnamate 
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In the EE2 study, which was originally designed as a positive control study to investigate effects on 
mammary gland but other endpoints were recorded as well and included in this thesis (Paper V). Four groups 
of rats were dosed with the vehicle corn oil (control), 5 µg EE2/kg bw/day, 15 µg EE2/kg bw/day or µg 
EE2/kg bw/day from GD7 to PD21. Husbandry and procedures of sacrifice in this study was as is described 
in papers I-V. Table 4 provides an overview of the studies in this thesis, the exposure and the number of 
dams in the groups. 
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Table 4. . The table gives an overview of the studies and the exposure groups providing the female offspring included in this thesis 
(Denotes number of pregnant female rats) * In group 3 one dam had only still born pups or killed the rest if any alive and in group 4, 
one female had to be euthanized due to dystochia. The doses are in mg/kg /bw/day except in the EE2 study where the doses are 
shown in µg/kg bw/day. The number following the name of the chemical or mixture refers to the dose in mg/kg bw/day. 
Study overview 
Group-dose /studies Exposure  No of mated female 
rats (pregnant) 
Pestimix RF 
1.Control  Vehicle (corn oil) 16 (8) 
2. Pestimix-43.75 25% of NOAEL for effect on parturition and pup survival 8 (4) 
3. Pestimix-87.5 50% of NOAEL for effect on parturition  and pup survival 8 (8) 
4. Pestimix-131.25 75% of NOAEL for effect on parturition  and pup survival 8 (7) 
5. Pestimix-175 100% of NOAEL for effect on parturition  and pup survival 16 (14) 
Pestimix DR 
1.Control  Vehicle (corn oil) 22 (15) 
2. Pestimix-14.58  8.3% of NOAEL for effect on parturition  and pup survival 22 (17) 
3. Pestimix-29.17  17% of NOAEL for effect on parturition and pup survival 22 (10)* 
4. Pestimix-43.75  25% of NOAEL for effect on parturition and pup survival 22 (15)* 
5. Epoxiconazol-3.75 Epoxiconazole (equal to the amount present in the high mixture group 4) 12 (8) 
6. Epoxiconazol-15 Epoxiconazole 10 (4) 
7. Mancozeb-6.25 Mancozeb (equal to the amount present in the high mixture group 4) 12 (5) 
8. Mancozeb-25 Mancozeb 10 (7) 
9. Prochloraz-8.75 Prochloraz (equal to the amount present in the high mixture group 4) 12 (8) 
10. Prochloraz-35 Prochloraz 10 (4) 
11. Tebuconazol-12.5 Tebuconazole (equal to the amount present in the high mixture group 4) 12 (8) 
12. Tebuconazol-50 Tebuconazole 10 (6) 
13. Procymidon-12.5 Procymidone (equal to the amount present in the high mixture group 4) 12 (7) 
14. Procymidon-50 Procymidone 10 (4) 
Contamed 1 
1.Control  Vehicle (corn oil) 14 
2. Mix-150 All 13 chemical substances (Amix+Emix+PM)  14 
3. Mix-450 All 13 chemical substances (Amix+Emix+PM) 14 
4. Amix-450 Env. Anti-androgens and paracetamol 14 
C ontamed 2 
1.Control  Vehicle 20 (20) 
2. Mix-100     All 13 chemical substances (Amix+Emix+PM) 20 (19) 
3. Mix-200 All 13 chemical substances (Amix+Emix+PM) 16 (13) 
4. Mix-450  All 13 chemical substances (Amix+Emix+PM) 18 (16) 
5. Amix-200   Antiandrogens  16 (15) 
6. Amix-450   Antiandrogens  16 (16) 
7. Emix-200  estrogens  16 (16) 
8. Emix-450  estrogens  18 (17) 
9. Paracetamol-360  Paracetamol  16 (16) 
EE2  
1. Control  Vehicle (corn oil) 10 (8) 
2. 5 5 µg EE2/kg bw/day 10 (6) 
3. 15 15  µg EE2/kg bw/day 10 (9) 
4. 50 50  µg EE2/kg bw/day 10 (8)  
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3.2 Gestational length 
From day 21 of gestation the animals were checked twice a day for signs of parturition. The animals were 
checked for signs of discomfort and bleeding from the vaginal area. Parturition was considered to be 
completed when the dam had cleaned herself, the pups and the cage for traces of blood and the pups were 
placed in the nest. The level of precision was 0.5 day, i.e. animals that have given birth in the morning at 8 
am of e.g. GD23 was recorded as 23. If they gave birth during GD23 but before 4 pm on GD23 they were 
recorded as GD23.5. 
3.3 AGD, number of nipples and onset of puberty: 
After delivery, the weights of dams and individual pups were recorded and the pups were counted, sexed, 
checked for anomalies and anogenital distance (AGD) was measured using a stereomicroscope. Additionally, 
anogenital index (AGDI), i.e. AGD/cubic root of body weight was calculated for all offspring. Pups found 
dead were macroscopically investigated for changes when possible. On PD 13 (PD14 in the EE2 study 
because the pups seemed small and areolas/nipples were difficult to see), all female offspring were examined 
for the presence of areolas/nipples described as a dark focal area (with or without a nipple bud). 
Onset of puberty was registered daily in all weaned female offspring until positive. In female offspring sexual 
maturity was assessed by determining day of vaginal opening (VO) as described by (Goldman et al. 2000). 
Registrations were performed in females from PD 30 until all had developed VO in Pestimix DR and since in 
this study some of the animals already displayed VO on day 30 (and registered as having attained VO PD 30, in 
the following studies the registration began a few days earlier, namely PD 27 (Contamed 1&2 and EE2 studies) 
until VO was detected in all animals. The animals that already had developed VO on the first day of registration 
were registered as having VO that first day in all the studies. Age and body weight were recorded on the day that 
vaginal opening was first observed.  
 
3.4 Estrous cycle 
3.4.1 Vaginal Smear 
Vaginal smears were collected every day for 15 or 21 consecutive days in the studies included in this thesis 
(Table 5). Estrous cycle measurements were not performed in Pestimix RF study as the study stopped when 
the offspring were 3 weeks old. In Pestimix DR and Contamed 1 smears were collected for 15 days starting 
when the female rats were 5-6 months old and 5 months, respectively. To evaluate potential effect on 
menopause, smears were also obtained at two later ages in Contamed 1 that is at 9-10 months and again in 
about 12 months old rats. In Contamed 2 the collection of smears were at 3 months of age and 12 months old 
rats. In the two last periods of collecting smears in Contamed 1 and in both studies Contamed 2 and EE2, 
vaginal smears were collected for 21 consecutive days to acquire better data. An overview is provided in 
Table 5. 
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Table 5. Number of periods of collecting smears in the studies and the age of the rats at the time. 
 Number of periods collecting 
smear 
Age at smear (number of days ) 
Pestimix DR 1 5-6 months (15) 
Contamed 1 3 5 months (15), 9-10 (21) months, 12 months (21) 
Contamed 2 2 3 months (21), 12 months (21) 
Ethinyl Estradiol (EE2) 1 2.5 months (21) 
 
Vaginal smears were collected at approximately the same time every day between 8 and 10 am in the 
beginning of the dark period for the animals. A swab moistened in saline was inserted in to the vaginal 
lumen and cells were transferred to a glass microscope slide. The samples were then allowed to air dry. 
When dry the smears were fixed in 96% ethanol  and stained with Gill’s hematoxylin, Orange G6 and eosin-
azure 50 (provided by VWR, Gentofte, Denmark) according to the adapted Papanicolaou (PAP stain) 
procedure reported by (Hubscher et al. 2005). After staining the smears were mounted in Eukit. The stained 
smears were examined blindly to exposure group by light microscopy and stages were classified as Estrus 
(E), Metestrus (M), Diestrus (D) or Proestrus (P) or transitions between stages. These stages were recognized 
by the presence, absence or proportional numbers of epithelial cells, cornified cells and leucocytes as 
described in OECD guidance document 106 and by Goldman and coworkers (Goldman et al. 2007, OECD 
2009a).   
Evaluating the results the animals were categorized as either being regularly cycling (cycles lasting 4 to 5 
days), or as being irregularly cycling which was defined as having cycles lasting less than 4 days or more 
than 5 days (e.g. 3 or 7 days) (Cooper and Goldman 1999). Furthermore, episodes of 3-4 consecutive days of 
vaginal estrus and 4-5 days of diestrus were considered extended. Cycles of longer duration were considered 
abnormal. Pseudo pregnancy was recognized as a period of 12 – 16 consecutive days of diestrus often 
characterized by the presence of strings of mucus in the smear and pyknotic cells (except in the 9-10 months 
old and one-year-old animals because long cycles could be a sign of beginning menopause) (Goldman et al. 
2007). 
In pestimix DR and in Contamed 1 in the five months old rats, every day before smears were collected, a rat 
Vaginal Impedance Checker (VIC), Model MK-10C (Muromachi, Japan) was used. The VIC measures the 
electrical impedance of the epithelial cell layer of vaginal mucosa by inserting a probe into the vagina. If the 
measured value is 3 kohm (kΩ,) of impedance or above, the animal is considered to be in proestrous. Since 
the female rat proestrous lasts for approximately 12-18 hours (Hartman 1944, Mandl 1951) it might be 
possible to use the VIC to assess cycle length. If possible this would be an advantage because the smearing 
procedure is both very time consuming and demands relatively well trained personnel reading the smears. 
38 
 
Also, the VIC method may be gentler to the animals than using a swab every day for 2-3 weeks which may 
irritate the lining of the vagina.  
In Pestimix DR an error in the procedure occurred and swabbing was performed before the vaginal 
impedance measurement leading to possible inaccurate measurements of estrous stage. Unfortunately, the 
error was discovered too late to retrieve useful data on estrus cycle in this study obtained with the VIC. 
3.4.2 Vaginal Impedance Checker vs. smear Contamed 1: 
The cyclicity data obtained from VIC were compared to the data obtained from assessing the smears in 
Contamed 1, 5 months old animals. This comparison was based on the assumption that the smears were 
correctly scored i.e. the smears were chosen as the “golden standard”. However, if the VIC showed proestrus 
a day before estrous appeared in the smear (even if the smear showed diestrus instead of proestrus on that 
day), the result from VIC was considered correct because the diestrus might have been an early proestrus not 
recognized when scoring the smear. Sensitivity and specificity were then calculated. According to Altman 
1991 (Altman 1991) sensitivity is defined as the proportion of positives (here irregularly cycling animals) 
that are correctly identified by the test. Specificity is defined as the proportion of negatives (regularly 
cycling) that are correctly identified by the test. Sensitivity is calculated using the following equation 
(Rockette 2011); 
            
                        
                                                   
 
 
Whereas, specificity was calculated using the equation; 
            
                        
                                                  
 
The definitions were as follows: 
 True positives; are the number of times the VIC correctly identifies an irregularly cycling animal as 
observed in the smear. 
 False positives; number of times the VIC incorrectly identifies an animal as being irregularly 
cycling. 
 True negatives; number of times an animal correctly is identified as cycling regularly by the VIC. 
 False negatives; number of times an animal incorrectly is identified as cycling regularly by the VIC. 
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3.5 Methods AMH 
AMH was measured in 90 day old animals in the EE2 study, in 11 and 14 months old animals in Contamed 1 
and in 3 and 12 months old rats in Contamed 2. On the day blood was drawn the animals were anesthesized 
with Hypnorm
®
 (fentanyl citrate/flunisone)/ Dormicum
®
 (midazolam) and blood was drawn from the tail 
vein. Blood was allowed to clot for about 1 hour after which it was centrifuged for 10 min at 3500 rpm. 
Plasma was then transferred to a vial and stored at -20 °C.  
The concentration of AMH was measured in plasma using an Enzyme-linked Immunosorbant Assay 
(ELISA) kit (CSB-E11162r, Rat Müllerian Inhibiting Substance/Anti-Müllerian hormone, MIS/AMH ELISA 
Kit, CUSABIO BIOTECH CO., Ltd.). The assay was carried out according to manufacturer’s protocol.  
The data were generally normalized to an internal standard, which was run in all plates. However, this was 
not the case for the data from the 10 months old rats in Contamed 1 and 4 months old females in the 
Contamed 2 study. In the Contamed 2 study the data from the 4 months old rats were furthermore not spread 
out on all the plates used, but all the controls, 14/15 in Mix-450 and 11/14 in PM were measured on the same 
plate. The rest of the samples were distributed on several plates. 
3.6 Power calculations 
Power calculations on data from estrous cycle and AMH measurements were made using the program 
G*Power (Faul et al. 2009). The linear regression option with assumed binominal distribution and Lyles’ 
procedure and two tails was used in calculations on estrous cycle data. The program was used to estimate the 
smallest effects possible to detect with the actual distribution of regular and irregularly cycling animals in the 
control groups in the various studies in this thesis. Furthermore, the number of animals necessary in each 
group was estimated if a 20% or 50% change in the number of regularly cycling animals was to be detected. 
A power of 0.8 and α=0.05 was used to perform these calculations. Power calculations were made for data 
on estrous cycle in all the studies except for Pestimix DR and Contamed 2, 3 months old animals, as there 
were possible problems with the methods used in these studies so power calculations were not meaningful. 
Power calculations were based on the control group and the group with the largest effect.   
A crude estimate of power calculations, group sizes and size of effects possible to detect with AMH data 
from Contamed 2, 10 month old animals was also done. These data were selected for the calculations 
because they could be normalized to an intern standard and this was the study with the highest number of 
animals. The calculations were based on a simple t-test and did not take into account that we had more than 
two groups but they were done on litter means. The mean of the standard deviation of the control group and 
the group with the largest difference in response compared to controls were used in the calculations (the 
group treated with paracetamol). Since there is almost never equal sample sizes in these studies, the 
calculations were based on the ratio of number of litters in control and the selected exposed group. The 
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change in AMH that was possible to detect with a power of 0.8 and α=0.05 was calculated and the number of 
animals required to detect changes in AMH of 10%, 20% and 50% were found using the ratio of animals in 
control group to exposed group that was present in that study (Contamed 2). 
3.7 Statistics: 
For all analyses, the alpha level was set at 0.05. Data with normal distribution and homogeneity of variance were 
analyzed using analysis of variance (ANOVA). When more than one pup from each litter was examined, 
statistical analyses were adjusted using litter as an independent, random and nested factor in ANOVA, or 
analysis were done on litter means. Body weight was included as a covariate in analyses when relevant, e.g. for 
onset of puberty and AGD. A Dunnett post hoc test was used to correct for multiple comparisons. In cases where 
normal distribution and homogeneity of variance could not be obtained by data transformation, a non-parametric 
Kruskall-Wallis test was used, followed by a Wilcoxon test for pair wise comparisons. When analyzing 
concentrations of AMH the microtiter plate was used as a random factor where no standard were available to 
normalize data among plates. The number of nipple/areolas was assumed to follow a binomial-distribution with 
a response range between 0 and θmax, with θmax being equal to the biologically possible maximal number of 
nipples in rats, either 12 or 13. The choice of θmax was decided by considering the global fit (information 
criterion of Schwarz). Litter effects on number of nipples and over-dispersion in the data were accounted by 
using Generalized Estimating Equations. Statistical significance were assessed using multiple contrast tests 
(Dunnett contrasts, global error rate α = 5%, two-sided) (Bretz et al. 2005). These tests were chosen as they are 
already implemented in the SAS procedure PROC GENMOD which was used for all statistical analysis. Estrous 
cyclicity data were tested using logistic regression and tested for over dispersion with Deviance and Pearson 
Goodness-of-Fit tests and correction for over dispersion due to litter effects were used when appropriate. 
Furthermore, the data was analyzed using the Cochran-Armitage trend test.  All analyses were performed using 
SAS Enterprise Guide 4.3, SAS Institute Inc, Cary, NC, 274 USA. 
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4 Results 
This thesis deals with endpoints related to female reproductive health after exposure to mixtures of chemicals 
or the positive control EE2 during development. The majority of the results are published in papers I to IV, 
however, not all the endpoints included in this thesis have been published.  The results from the EE2 study 
are included as a manuscript in preparation (Paper V). Furthermore, all results from the Contamed 2 remains 
yet to be published and an overview of all endpoints, both published and unpublished, is provided in Table 6. 
Under the table is an overview of the endpoints that are published, the relevant study and what paper they 
were published in.  
Effects of exposure were observed on all endpoints in the females except for sexual maturation. Gestational 
length was affected in the Pestimix RF and DR studies as well as in the EE2 study. AGD was affected both 
in Pestimix RF and DR studies as well as in the EE2 study. Estrous cycle was affected in the 12 months old 
animals in Contamed 1 and 2 but no effects were seen when measured at an earlier age either in the Pestimix 
DR study, the two Contamed studies or the EE2 study. A decrease in the AMH level was measured in some 
of the groups in the four months old animals in Contamed 2, but no other effects were observed on the level 
of AMH in plasma.  All endpoints will be presented in more detail in the following sections including both 
published and unpublished data. 
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Table 6. Overview of effects on the endpoints included in the thesis. NA denotes not applicable.  
Study no.  Gestational length AGD/AGDI 
Pup Day 1 
Nipples Sexual 
maturation 
Estrous cycle AMH 
1 Pestimix 
RF 
(Paper I) 
Prolonged gestation 
length in all doses 
tested, e.g. from 
Persimix- 43.75 
mg/kg bw/day 
Longer AGD and 
AGDI in females in 
both Mix-43.75 mg/kg 
bw/day (25%) and 
Mix-87.5 mg/kg 
bw/day (50%)  
No effects  NA NA NA 
2 Pestimix 
DR 
(Paper II and 
III) 
Prolonged gestation 
length at Pestimix-
29.17 mg/kg bw/day 
and 43.75 mg/kg 
bw/day and at 15 
mg/kg bw/day 
epoxiconazole 
Longer AGDI in 
Pestimix-29.17 mg/kg 
bw/day (16.67%)  and 
longer AGD and AGDI 
at Pestimix-43.75 
mg/kg bw/day and low 
dose of epoxiconazole 
(3.75mg/kg bw/day) 
No effects  No effects No effects in 5-6 months old 
rats 
NA 
3 Contamed 1 
(Paper IV) 
No effects No effects  No effects  No effects  No effects at 5 months and 9-
10 months. Effect at 12 
months of age (borderline p-
value; p=0.07) in the mixture 
groups. In group dosed with 
Mix-450, p=0.02 if Contamed 
1 and 2 data from control and 
Mix-450 groups are analyzed 
together (12 months old) 
No effects seen in 
11 and 14 months 
old animals 
4 Contamed 2 
(not 
published) 
No effects No effects No effects  No effects  No effects at 3 months. There 
seemed to be an effect in the 
mixture groups (Mix-100, 
Mix-200 and Mix-450)) at 12 
months of age (not 
significant). Mix-200 
compared with control 
(p=0.053). In group dosed 
with Mix-450, p=0.02 if 
Contamed 1 and 2 data from 
control and Mix-450 groups 
are analyzed together (12 
months old) 
Decreased level 
of AMH in group 
4 and (Mix-450, 
p<0.05)  9 (PM, 
p=0.02) in 4 
months old 
animals. No 
effects in 10 
months old 
females. 
5 EE2 (Paper 
V,  in 
preparation) 
Prolonged gestation 
at 50 µg/kg bw/day 
Longer AGD and 
AGDI at 50 µg/kg 
bw/day 
Increased 
number of 
nipples at50 
µg/kg bw/day 
bw(P<0.01) 
No effects  No effects in 2.5 months old 
rats 
No effects in 90 
days old animals  
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Paper I. Jacobsen PR, Christiansen S, Boberg J, Nellemann C, Hass U. Combined exposure to endocrine 
disrupting pesticides impairs parturition, causes pup mortality and affects sexual differentiation in rats. Int J 
Androl. 2010 Apr;33(2):434-42. Endpoints included in this thesis: gestational length, AGD (Pestimix RF). 
Paper II. Hass U, Boberg J, Christiansen S, Jacobsen PR, Vinggaard AM, Taxvig C, Poulsen ME, Herrmann 
SS, Jensen BH, Petersen A, Clemmensen LH, Axelstad M.. Adverse effects on sexual development in rat 
offspring after low dose exposure to a mixture of endocrine disrupting pesticides. Reprod Toxicol. 2012 
Sep;34(2):261-74. Epub 2012 May 29. Endpoints included: Gestational length, AGD, Nipples (Pestimix 
DR). 
Paper III, Jacobsen PR, Axelstad M, Boberg J, Isling LK, Christiansen S, Mandrup KR, Berthelsen LO, 
Vinggaard AM, Hass U. Persistent developmental toxicity in rat offspring after low dose exposure to a 
mixture of endocrine disrupting pesticides.  Reprod Toxicol. 2012 Sep;34(2):237-50. Epub 2012 Jun 4. 
Endpoints included: Puberty onset (Pestimix DR). 
Paper IV. Christiansen S, Kortenkamp A, Axelstad M, Boberg J, Scholze M, Jacobsen PR, Faust M, 
Lichtensteiger W, Schlumpf M, Burdorf A, Hass U.. Mixtures of endocrine disrupting contaminants 
modelled on human high end exposures: an exploratory study in rats. Int J Androl. 2012 Jun;35(3):303-16. 
doi: 10.1111/j.1365-2605.2011.01242.x. Epub 2012 Feb 28. Endpoints included: Gestational length, AGD, 
nipples (Contamed 1). 
Paper V. Mandrup KR, Jacobsen PR, Boberg J, Isling LK, Axelstad M, Hass U. (manuscript in preparation). 
Effects of perinatal ethinyl estradiol exposure in Wistar rats. Endpoints included: Gestational length, AGD, 
number of nipples, onset of puberty, estrous cycle (EE2 study).  
4.1 Gestational length  
As can be seen in Table 7, gestational length was prolonged in all exposed groups of pestimix RF and in 
Pestimix DR the gestational length was longer in the groups receiving Pestimix-29.17 and Pestimix-43.75, 
but also in the group dosed with 15 mg/kg bw/day epoxiconazole (group 6). In the Contamed studies 1 and 2 
there were no significant effects of exposure on gestational length. A significantly prolonged gestation length 
was observed in the group exposed to 50µg/kg bw/day EE2 (p<0.001) (Table 7). 
4.2 Anogenital distance 
AGD and AGDI are shown in Table 7 with the significant effects shown in bold. Female AGD was 
consistently and significantly increased in both the Pestimix RF and Pestimix DR studies in the groups dosed 
with Pestimix-43.75 mg/kg bw/day and above. In Pestimix RF both AGD and AGDI was significantly 
increased in the group dosed with Pestimix-43.75 mg/kg bw/day and  Pestimix-87 mg/kg bw/day.  
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In Pestimix DR a dose-dependent increase in anogenital distance was seen, with significantly longer AGDI, 
in the two highest mixture groups compared to controls (p<0.05 and p< 0.001, respectively). A similar effect 
was seen in animals exposed to both doses of prochloraz (p< 0.05 and p < 0.01) and tebuconazole (p< 0.05 
and p = 0.001) and in the group exposed to the low dose of epoxiconazol (p< 0.01) but not in female pups 
exposed to a four times higher dose of epoxiconazole. When data was analyzed as AGD with bodyweight as 
covariate, besides the significant effect in the group receiving the highest mixture dose, significant effects 
were only detected in the high doses of mancozeb and prochloraz and the low dose of epoxyconazole.  
No effects were observed in Contamed 1 or Contamed 2 compared with control. Significantly increased 
AGD and AGDI were observed in the group dosed with 50 µg/kg bw/day EE2 compared with the control 
females (p<0.01). 
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Table 7. Gestational  length, anogenital distance and the anogenital distance (AGD) index (AGDI) shown as litter mean ±  SEM.. 
Pestimix RF Gestation length AGD PD1 AGDI PD1 
No of mated rats (no. of 
pregnant dams) 
1.Control  23.0 ± 0.0 13.4 ± 0.2 7.3 ± 0.1 16 (8) 
2. Pestimix-43.75 23.5 ± 0.2* 15.0 ± 0.04 * 8.2 ± 0.1*** 8 (4) 
3. Pestimix-87.5 24.1 ± 0.1** 14.5 ± 0.2* 8.2 ± 0.1*** 8 (8) 
4. Pestimix-131.25 24.8 ± 0.1** - - 8 (7) 
5. Pestimix-175 24.6 ± 0.1** - - 16 (14) 
Pestimix DR     
1: Control 23.0  ± 0.0 13.6 ± 0.2 7.4 ± 0.1 22 (15) 
2: Pestimix-14.58 23.0 ± 0.0 13.7 ± 0.2 7.6  ± 0.1 22 (17) 
3: Pestimix-29.17 23.5 ± 0.2** 14.1 ± 0.2 7.8  ± 0.1* 22 (9) 
4: Pestimix-43.75 23.6 ± 0.1*** 15.0 ± 0.2*** 8.2  ± 0.1*** 22 (14) 
5: Epoxiconazol-3.75 23.1 ± 0.1 14.9 ± 0.4** 8.1 ± 0.2* 12 (8) 
6: Epoxiconazol-15 23.8 ± 0.3*** 14.3 ± 0.5 7.8 ± 0.4 10 (4) 
7: Mancozeb-6.25 23.0 ± 0.0 14.2 ± 0.4 7.8 ± 0.2 12 (5) 
8: Mancozeb-25 23.0 ± 0.0 13.5 ± 0.2 7.5 ± 0.1 10 (7) 
9: Prochloraz-8.75 23.2 ± 0.1 14.1 ± 0.2 7.8 ± 0.2* 12 (8) 
10: Prochloraz-35 22.8 ± 0.3 14.5 ± 0.2* 8.0 ± 0.1** 10 (4) 
11: Tebuconazol-12.5 23.0 ± 0.0 14.4 ± 0.4 7.9 ± 0.2* 12 (8) 
12: Tebuconazol-50 23.1 ± 0.1 14.5 ± 0.2* 8.0 ± 0.1** 10 (6) 
13: Procymidon-12.5 23.0 ± 0.0 13.4 ± 0.2 7.3 ± 0.1 12 (7) 
14: Procymidon-50 23.0 ± 0.0 13.3 ± 0.1 7.3 ± 0.1 10 (4) 
Contamed 1     
1.Control  23.0 ± 0.04 10.3 ± 0.1 5.7 ± 0.1 14 
2. Mix-150 23.0 ± 0.0 10.4 ±  0.1 5.8 ± 0.1 14 
3. Mix-450 23.1 ± 0.1 10.7 ± 0.2 5.9 ± 0.1 14 
4. Amix-450 23.0 ± 0.0 10.5 ± 0.1 5.8 ± 0.1 14 
Contamed 2     
1.Control  23.1 ± 0.1 10.9 ± 0.1 6.0 ± 0.1 20 (20) 
2. Mix-100     23.1 ± 0.1 11.0 ± 0.2 6.0 ± 0.1 20 (19) 
3. Mix-200 23.1 ± 0.1 10.4 ± 0.2 5.7 ± 0.1 16 (13) 
4. Mix-450  23.2 ± 0.1 11.0 ± 0.2 6.0 ± 0.1 18 (16) 
5. Amix-200  23.1 ± 0.1 11.2 ± 0.2 6.1 ± 0.1 16 (15) 
6. Amix-450  23.2 ± 0.1 11.1 ± 0.2 6.1 ± 0.1 16 (16) 
7. Emix-200  23.0 ± 0.0 10.9 ± 0.1 6.0 ± 0.1 16 (16) 
8. Emix-450  23.1 ± 0.1 11.0 ± 0.2 6.1 ± 0.1 18 (17) 
9. Paracetamol-360  23.1 ± 0.1 10.7 ± 0.2 5.8 ± 0.1 16 (16) 
EE2      
1. Control  23.0 ± 0.0 10.9 ± 0.3 6.1 ± 0.1 10 (8) 
2. 5 µg/kg bw/day 23.2 ± 0.2 11.0 ± 0.2 6.1 ± 0.1 10 (6) 
3. 15 µg/kg bw/day 23.0 ± 0.0 11.1 ± 0.1 6.3 ± 0.1 10 (9) 
4. 50 µg/kg bw/day 23.7 ± 0.2*** 11.9 ± 0.3** 6.7 ± 0.1** 10 (8)       . 
- No data, significant effects are shown in bold. *p<0.05, **p<0.01,***p<0.001  
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4.3 Puberty onset and nipple retention 
Table 8 gives an overview of the results of the registration of number of nipples on PD 13 or 14 and day of 
VO as well as body weight on the day of VO in female offspring in all the studies where these endpoints 
were recorded.  No effects of chemical exposure were observed on onset of puberty compared to control in 
any of the studies included in this thesis. Compared to vehicle control the only significant result was the 
increased number of nipples seen in the group dosed with 50 µg EE2/kg/day (p<0.01) (Figure 12). In all the 
studies some animals had already developed VO on the first day registration was performed and those 
animals were registered as having attained VO on that day. These animals were found both in control and 
dosed groups.  
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Table 8. Number of nipples pup day 13 or 14 (EE2) and mean age of vaginal opening (VO) and body weight at VO.  
Study 
No of 
nipples 
No of litters 
(nipples) No litters (VO) Age at VO (days) 
body weight at 
VO 
Pestimix DR           
1. Control 12.0 ± 0.1 15 15(#3/2) 34.0 ± 0.4 90.2 ± 3.0 
2. Pestimix-14.58 12.5 ± 0.9 17 16(#2/2) 34.7 ± 0.5 86.9 ± 2.1 
3. Pestimix-29.17 12.4 ± 0.1 9 8 34.4 ± 0.3 84.7 ± 2.6 
4. Pestimix-43.75 12.5 ± 0.1 13 13(#2/2) 33.6 ± 0.5 83.8 ± 1.5 
5. Epoxyconazol-3.75 12.4 ± 0.1 8 8(#2/2) 34.4 ± 0.5 92.0 ± 3.8 
6. Epoxyconazol-15 12.8 ± 0.2 4 4(#1/1) 34.3 ± 1.4 92.7 ± 5.5 
7. Mancozeb-6.25 12.2 ± 0.03 5 5 35.2 ± 0.6 89.4 ± 2.6 
8. Mancozeb-25 12.4 ± 0.05 7 7(#1/1) 34.0 ± 0.3 85.4 ± 1.4 
9. Prochloraz-8.75 12.3 ± 0.1 8 8 34.1 ± 0.5 85.2 ± 2.2 
10. Prochloraz-35 12.1 ± 0.1 4 4 34.4 ± 1.0 82.6 ± 2.0 
11. Tebuconazol-12.5 12.5 ± 0.2 8 7 35.9 ± 0.6 90.0 ± 4.2 
12. Tebuconazol-50 12.2 ± 0.1 6 6 35.3 ± 0.6 90.7 ± 3.4 
13. Procymidon-12.5 12.2 ± 0.1 7 7(#2/2) 34.0 ± 0.7 86.5 ± 3.4 
14. Procymidon-50 12.4 ± 0.2 4 4 34.5 ± 0.5 87.1 ± 4.5 
Contamed 1      
1.Control  12.4 ± 0.1 14 12(#4/3) 32.5 ± 0.8 98.1 ± 3.2 
2. Mix-150 12.1 ± 0.1 13 13(#3/3) 31.5 ± 0.7 81.2 ± 2.8 
3. Mix-450 12.5 ± 0.1 14 14(#3/3) 31.4 ± 0.8 80.8 ± 3.2 
4. Amix-450 12.6 ± 0.1 14 14(#1/1) 31.5 ± 0.4 80.5 ± 2.3 
Contamed 2      
1.Control  12.3  ± 0.1 19 19(#1/1) 34.8  ± 0.6 91.1 ± 2.4 
2. Mix-100     12.4  ± 0.1 18 17 33.1  ± 0.5 87.6 ± 3.3 
3. Mix-200 12.4  ± 0.1 12 13(#1/1) 31.9 ± 0.4 83.2 ± 2.2 
4. Mix-450  12.4  ± 0.1 15 15 33.7 ± 0.5 87.9 ± 2.0 
5. Amix-200  12.4  ± 0.1 14 13 33.1 ± 0.4 85.6 ± 2.1 
6. Amix-450  12.4  ± 0.1 15 15 34.0 ± 0.3 87.3 ± 1.6 
7. Emix-200  12.4  ± 0.1 15 16 33.8 ± 0.4 92.1 ± 2.0 
8. Emix-450  12.3  ± 0.1 17 17 33.4 ± 0.5 87.5 ± 2.5 
9. Paracetamol-360  12.3  ± 0.1 16 15 33.3 ± 0.5 91.8 ± 2.5 
EE2       
1. Control  12.3  ± 0.1 8 8 32.3 ± 1.0 79.0 ± 2.9 
2. 5 µg/kg bw/day 12.3  ± 0.1 5 5 33.9 ± 0.5 82.8 ± 5.8 
3. 15 µg/kg bw/day 12.3  ± 0.1 9 9(#2/1) 32.0 ± 0.9 77.6 ± 3.1 
4. 50 µg/kg bw/day 12.8 ± 0.2* 8 8(#5/3) 31.9 ± 0.4 74.4 ± 6.6 
(#/) Number of animals already showing VO on the first day of registration out of number of litters.* p<0.01  
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Figure 12. Mean number of nipples ± SEM recorded in female offspring from control group and the groups exposed to EE2. * p<0.01.  
 
4.4 Estrous cycle 
Estrous cyclicity was assessed in all studies except for the Pestimix RF study, where the animals were 
sacrificed before puberty. The results of the estrous cycle measurements performed in the studies are 
summarized in the tables below. 
In the Pestimix DR study no significant effects were detected (Table 9). Most of the observed irregular 
cycles were longer than normal cycles characterized by an above normal number of days in diestrus. Two 
animals showed extended estrus (episode of three or four consecutive days of vaginal estrus). There was 
between 10 and 50% of the animals that apparently had a period of pseudopregnancy. No significant 
differences were observed between the groups in frequency of pseudo pregnancies. 
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Table 9. Results of the estrous cycle smear measurements made in 5-6 months old female rats in the Pestimix DR study. The 
proportion of regular and irregularly cycling animals are shown, and the irregular cycles are further divided into categories according 
to the type of effect.  
Group/study 
Pestimix 
Regular 
cycling, 
pct 
excluding 
pseudo 
pregnant 
rats 
Irregularly 
cycling, pct 
excluding 
pseudopregnant 
rats 
Pseudopregnant Extended 
estrous 
Extended 
diestrous 
Abnorma
l 
Total no. 
of rats 
examined 
No. of 
litters 
No of 
litters 
without 
pseudo 
pregnant 
animals 
1. Control 
9 (69%) 4 (31%) 5 (28%) 0 1 (25%) 1 (25%) 18 15 12 
2. Pestimix-
14.58 10 (67%) 5 (33%) 3 (17%) 0 0 3 (60%) 18 17 15 
3. Pestimix-
29.17 5 (63%) 3 (38%) 2 (20%) 
1 
(33.3%) 
2 
(66.6%) 1 (33.3%) 10 8 6 
4. Pestimix-
43.75 6 (75%) 2 (25%) 4 (33%) 0 1 (50%) 0 12 11 7 
5. 
Epoxyconazol-
3.75 5 (63%) 3 (38%) 2 (20%) 0 
1 
(33.3%) 2 (66.6%) 10 7 5 
6. 
Epoxyconazol-
15 3 (60%) 2 (40%) 1 (17%) 0 1 (50%) 0 6 4 4 
7. Mancozeb-
6.25 6 (100%) 0 (0%) 2 (25%) 0 0 0 8 5 4 
8. Mancozeb-25 
5 (71%) 2 (29%) 2 (22%) 0 1 (50%) 0 9 7 6 
9. Prochloraz-
8.75 7 (78%) 2 (22%) 1 (10%) 1 (50%) 0 0 10 9 8 
10. Prochloraz-
35 3 (75%) 1 (25%) 2 (33%) 0 0 0 6 4 4 
11. 
Tebuconazol-
12.5 3 (60%) 2 (40%) 3 (38%) 0 1 (50%) 1 (50%) 8 7 4 
12. 
Tebuconazol-50 2 (50%) 2 (50%) 3 (43%) 0 1 (50%) 1 (50%) 7 7 3 
13. Procymidon-
12.5 3 (50%) 3 (50%) 2 (25%) 0 
1 
(33.3%) 1 (33.3%) 8 7 5 
14. Procymidon-
50 3 (100%) 0 (0%) 3 (50%) 0 0 0 6 4 2 
The percentage (pct) of animals in each category is also shown.The percentage of animals shown in the categories extended estrus or 
diestrus or with abnormal cycle is calculated as percentage out of the number of irregularly cycling animals. Percentage of 
pseudopregnant animals is calculated out of the total number of rats. 
In the Contamed 1 study no significant effects were observed when smears were collected in the 5 or 9-10 
months old animals (Table 10). In the five months old animals there were significantly more pseudopregnant 
animals in the control group compared with Mix-450 and Amix-450 (p<0.01 for both groups). No 
pseudopregnant rats were recorded in the aging rats as this might have been a sign of reproductive 
senescence rather than pseudopregnancy as both conditions can be characterized by extended periods of 
diestrus. The use of the VIC device perhaps in concert with taking a swab every day may have caused the 
large number of pseudopregnancies observed in Pestimix DR and Contamed 1, 5 months old animals. 
Possible pseudopregnant animals would show up in the table as having abnormal cycles in the older animals 
(9-10 and 12 months old). 
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There was a significant effect of exposure in the 12 months old animals on the proportion of animals with an 
irregular cycle compared to control (Table 10 and Figure 13). Analyzing all the groups the overall p-value 
was p=0.07, but with a significant trend towards a larger proportion of irregularly cycling animals with 
increasing dose according to a Cochran-Armitage test (p=0.01). As seen in Table 10 this effect was driven by 
longer cycles with more than 3 days of diestrus.  
Table 10. Results of estrous cycle measurements from Contamed 1 in 5 months, 9-10months and 12 months old rats, respectively. 
The proportion of regular and irregularly cycling animals are shown, and the irregular cycles are further divided into categories 
according to the type of effect. A significant trend was observed in the 12 months old animals towards a larger proportion of 
irregularly cycling females with dosing. 
Contamed 1 Regular  Irregular Pseudo 
pregnant 
Extended 
estrous 
Extended 
diestrous 
Abnormal Total no. 
of rats 
examined 
No of 
litters 
5 months                  
1.Control 6 (86%) 1 (14%) 7 (50%) 0 0 1 (100%) 14 12 
2. Mix-150 9 (75%) 3 (25%) 2 (14%) 1/3 (33%) 0 1 (33%) 14 13 
3. Mix-450 12 
(86%) 
2 (14%) 0 0 0 0 14 14 
4. Amix-450 13 
(82%) 
1 (18%) 0 0 0 0 14 14 
9-10 months                  
1.Control 8 (57 
%) 
6 (43%)  -  - 2 (33%) 1 (17%) 14 12 
2. Mix-150 8 (57%) 6 (43%)  -  - 0 4 (67%) 14 13 
3. Mix-450 7 (50%) 7 (50%)  -  - 1 (14%) 5/7 (71%) 14 14 
4. Amix-450 10 
(71%) 
4 (29%)  -  - 1 (25%) 1 (25%) 14 14 
12 months                  
1.Control 9 (69%) 4 (31%)  - 0 2 (50%) 2 (50%) 13 12 
2. Mix-150 10 
(71%) 
4 (29%)  - 0 1 (25%) 2 (50%) 14 13 
3. Mix-450 5 (36%) 9 (64%)  - 1 (11%) 4 (44%) 5 (56%) 14 14 
4. Amix-450 4 (29%) 10 (71%)  - 0 4 (40%) 5(50%) 14 14 
% regularly and irregularly cycling is calculated without the pseudopregnant animals.   
 Animals are categorized as regularly cycling (4- or 5-day cycles) or irregular ordered in extended (3–4 consecutive days of estrus, or 
4–5 days of diestrus), abnormal (>4 days of estrus or >5 days of diestrus). The percentage of animals shown in the categories 
extended estrus or diestrus or with abnormal cycle is calculated as percentage out of the number of irregularly cycling animals. 
Percentage of pseudopregnant animals is calculated out of the total number of rats. 
51 
 
 
Figure 13.  The percent of regular and irregular cycling 12 months old animals in the four groups in Contamed 1. Overall p-value was 
0.07 and there was a significant trend (p=0.01). 
 
As can be seen in Table 11 no significant effects were observed in the three months old animals in the 
Contamed 2 study. In the 12 months old animals there seemed to be an effect  in the groups receiving the 
combined mixtures but this was not significant (p=0.12, when analyzing control , Mix-100, Mix-200 and 
Mix-450) (Table 11 and Figure 14), however, in the group treated with Mix-200 there was a borderline effect 
compared with control group (p=0.053). No significant effect was observed when all the groups were 
included in the analysis and the Cochran-Armitage trend test was not significant (p= 0.07) in the combined 
mix groups and control only (control, Mix-100, Mix-200 and Mix-450). The irregularly cycling animals 
generally had cycles characterized by extended periods of diestrus or abnormal cycles, whereas very few 
showed extended estrus. No animals were observed to be pseudopregnant in Contamed 2. 
As the animals in Mix-450 from Contamed 1 and 2 were treated with identical doses, the data for the 12 
months old animals were also analyzed together. This lead to a statistically significant difference between 
control and Mix-450 (p-value was 0.02) (Figure 15).   
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Table 11. Data from estrous cycle measurements from Contamed 2 at 3 and 12 months of age. No statistically significant effects were 
observed. 
Contamed 2 Regular  Irregular Pseudo 
pregnant 
Extended 
estrous 
Extended 
diestrous 
abnormal Total no 
of rats 
examined 
No of 
litters 
3 months                 
1. Control  15 (83%) 3 (17%)  - 0 3 (100%) 0 18 18 
2. Mix-100 17 (85%) 3 (15%)  - 0 1 (33%) 1 (33%) 20 17 
3. Mix-200 11 (79%) 3 (21%)  - 0 1 (33%) 0 14 12 
4. Mix-450 10 
(62.5%) 
6 (37.5%)  - 0 3(50%) 2 (33%) 16 14 
5. Amix-
200 
12 (75%) 4 (25%)  - 0 1 (25%) 0 16 13 
6. Amix-
450 
12 (75%) 4 (25%)  - 0 3 (75%) 1 (25%) 16 15 
7. Emix-200 15 
(100%) 
0 1 (6.7%) 0 0 0 16 16 
8. Emix-450 12 (75%) 4 (25%)  - 1 (25%) 3 (75%) 0 16 16 
9. PM-350 12 (86%) 2 (14%)  - 0 1(50%) 1 (50%) 14 13 
12 months                 
1. Control  11 (61%) 7 (39%)  - 0 0 6 (86%) 18 18 
2. Mix-100 5 (25%) 15 (75%)  - 0 2 (13%) 13 (87%) 19 16 
3. Mix-200 2 (18%) 9 (82%)  - 1 (11%) 1 (11%) 7 (78%) 11 10 
4. Mix-450 5 (31%) 11 (69%)  - 0 2 (18%) 9 (82%) 16 14 
5. Amix-
200 
8 (53%) 7 (47%)  - 1 (14%) 1 (14%) 5 (71%) 15 13 
6. Amix-
450 
7 (44%) 9 (56%)  - 0 0 8 (89%) 16 15 
7. Emix-200 5 (31%) 11 (69%)  - 3(27%) 3 (27%) 4 (36%) 16 16 
8. Emix-450 7 (44%) 9 (56%)  - 0 1(11%) 7 (78%) 16 16 
9. PM-350 5 (36%) 9 (64%)  0 1(11%) 6 (67%) 14 13 
% regularly and irregularly cycling is calculated without the pseudopregnant animals. Animals are categorized as regularly cycling 
(4- or 5-day cycles) or irregular ordered in extended (3–4 consecutive days of estrus, or 4–5 days of diestrus), abnormal (>4 days of 
estrus or >5 days of diestrus). Bold (p=0.053). The percentage of animals shown in the categories extended estrus or diestrus or with 
abnormal cycle is calculated as percentage out of the number of irregularly cycling animals. Percentage of pseudopregnant animals is 
calculated out of the total number of rats.. 
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Figure 14. The percentage of regular og irregularly cycling 12 months old animals in the Contamed 2 study. Overall, no significant 
effects were observed, but comparing only control to Mix-200 the p-value was p=0.053.* p=0.053. 
 
Figure 15. The proportion of regular cycling 12 months old animals. Data is pooled from Contamed 1 and 2.* means p<0.05.  
In the EE2 study, as can be seen in Table 12, irregularly cycling females were seen only in the exposed 
groups; however, there were no statistically significant effects of exposure compared with control group. 
None of the irregularly cycling animals showed extended estrous (three or more consecutive days of vaginal 
estrus) and all the long cycles were characterized by an above normal number of days in diestrus. No animals 
were observed to be pseudopregnant in the period where smears were recorded. 
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Table 12. Showing the results of estrous cycle measurements in 2.5 months old rats exposed to ethinyl estradiol perinatally. The 
proportion of regular and irregularly cycling animals are shown. No significant effects were observed. 
Study EE2 Regular 
cycling 
Irregular 
cycling 
Total no of 
rats 
examined 
No of litters 
1. Control 7 (100%) 0 (0%) 7 7 
2. EE2- 5 6 (75%) 2 (25%) 8 5 
3. EE2- 15 7 (70%) 3 (30%) 10 9 
4. EE2- 50 6 (75%) 2 (25%) 8 7 
 
4.5 Results comparing VIC to reading smear 
The use of the Vaginal Impedance Checker (VIC) was assessed as an alternative method to the labor 
demanding process of collecting, fixating, staining and scoring smears to evaluate estrous cycle status in 
female rats. True positives were defined as the number of times the VIC correctly identified an irregularly 
cycling animal as observed in the smear. False positives were the number of times the VIC incorrectly 
identified an animal as being irregularly cycling. True negatives were the number of times an animal 
correctly was identified as cycling regularly by the VIC. False negatives were the number of times an animal 
incorrectly was identified as cycling regularly by the VIC. The data used were from Contamed 1, 5 months 
old animals including the pseudopregnant, and the results were used to calculate the sensitivity and 
specificity of the technique as shown in Table 13.  
Table 13. The sensitivity and specificity of the Vaginal Impedance Checker 
  Gold standard. Smear  
  Condition positive. 
irregular 
Condition negative. 
regular 
VIC Test outcome pos. True positive (17) False positive (24) 
 Test outcome neg. False negative (0) True negative (15) 
  Sensitivity = 1 Specificity = 0.38 
 
The sensitivity was calculated to 1 meaning that the VIC identifies all the animals with irregular cycles. A 
specificity of 0.38 means that 38% of regularly cycling animals is correctly identified as such by the VIC.  
Thus, the VIC measures too many false positives and no false negatives. 
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4.6 AMH results 
AMH was measured in plasma of female rats at different ages to assess if this endpoint can be of use when 
investigating effects on the follicle pool of the ovary. The results are shown in the figures 16-19 of this 
section. 
As seen in Figure 16 a and b, no significant effects were observed in the concentrations of AMH in plasma 
from perinatally exposed females when compared to the plasma levels in the control group in Contamed 1 in 
11 months and 14 months old rats. 
...a)    
..b) 
Figure 16  a) & b). Mean plasma concentration of AMH in 11 months old female rats from Contamed 1±  SEM. No statistically 
significant differences from control were observed when analyzed with or without the outlier in group 4. b) Plasma concentration of 
AMH in 14 months old female rats from Contamed 1, where data were normalized to an intern standard. No statistically significant 
differences from control were observed. Data were also analyzed with plate as a random factor.No of litters, n=11-14. 
In Contamed 2, 4 months old animals a significant decrease in the level of AMH was observed in the group 
dosed with paracetamol (group 9) and a decrease was also observed in Mix-450 when all data were analyzed 
(Figure 17). When only samples measured on the same plate (all the controls, 14/15 in Mix-450 and 11/14 in 
PM) then the p-value was p=0.01 for both groups compared with control. A somewhat similar picture for 
Mix-450 was seen in 10 months old rats, however, no statistically significant effect of any of the exposures 
was found as is shown in Figure 18.  
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Figure 17.  Contamed 2. Mean plasma concentrations of AMH pg/ml ± SEM in four months old female rats. Decreased AMH in 
group 4 p<0.05 and group 9 (PM), *p=0.02. No effect on the other groups. Data were analyzed with plate as a random factor. No of 
litters, n=12-18 
 
 
Figure 18.  Contamed 2. Mean plasma concentrations of AMH pg/ml ± SEM in ten months old rats. No statistically significant 
effects on the dosed groups compared to control. No of litters, n=12-17. 
 
There were no statistically significant changes in AMH as a result of exposure to ethinyl estradiol as can be 
seen in Figure 19.  
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Figure 19. Plasma concentration of AMH (Mean ± SEM) in 90 days old female rats exposed in utero to EE2. No of litters, n=5-9. No 
significant effects were detected. 
 
4.7 Power analysis 
Statistical power was calculated on selected endpoints. The power of a test is the probability of not having a 
false negative outcome. 
Estrous cycle data. 
The achieved power in these studies varied from 0.26 to 0.75 as can be seen in Table 14. In contamed 2 three 
months old animals the power is quite low even with 83% regularly cycling animals in the control. The 
change compared with control, however, in the proportion of regularly cycling animals is also much smaller 
at three months of age than in for example twelve months old rats in Contamed 2. This affects the power 
considerably. 
Table 14. The table shows the power in the studies using the proportion of regularly cycling animals in the control group and the 
proportion of regularly cycling animals in the group that differed most from the control.  
  
study N 
(total) 
prop regular 
cycling animals 
(control group) 
prop 
regular 
cycling 
animals 
(dosed 
group) % change group 
power in 
study 
EE2 7-8 (15) 1.00 0.70 30% 15 µg/kg 0.39 
Contamed 1(9-10 
months) 14 (28) 0.57 0.50 12% Mix-450 0.57 
Contamed 1 (12 months) 13 (27) 0.69 0.29 58% 
Amix-
450 0.56 
Contamed 2 (3 months) 16-18 (34) 0.83 0.63 24% Mix-450 0.26 
Contamed 2 (12 months) 18-16 (34) 0.61 0.18 70% Mix-200 0.75 
 N=total number of animals, prop=proportion 
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As can be seen in Table 15, to detect an effect of 50% depending on the proportion of regular cycling 
animals in the controls, the total needed group size ranged from around 10 to 50. Again, it seems strange that 
the data from contamed 2 young animals with a low calculated power gives a lower N than contamed 2 old 
animals with a higher power. This is because the power in Table 14 is calculated on the basis of the observed 
proportion of regularly cycling animals in the control group and the group with the highest effect and, as 
mentioned, there is a much smaller difference between those groups in the young animals (24%) than in the 
12 months old (70%). N in Table 15 is calculated with a fixed effect of 20 or 50%, a power of 0.8 and 
α=0.05. With the larger proportion of regularly cycling animals in the control group of Contamed 2, 3 
months old animals, than in the control group of the old animals, it is possible to detect a given effect using 
fewer animals at 3 months.  
 
Table 15. The table shows the required proportion of regular cyclers necessary in an exposed group, based on the group sizes and 
control groups in the Contamed studies and the EE2 study, to obtain a power of 0.8, with α=0.05. Furthermore, the table shows the 
required group sizes were we to detect a 20% and 50% change in the proportion of regularly cycling animals, respectively, with 
power of 0.8 and α=0.05. N is total sample size. 
Study total sample size Required prop. Regular 
cycling in a dosed group 
N with 20% change 
(group size) 
N with 50% change 
(group size) 
EE2 7-8 (15) 0.37 68 (approximately 30) 21 (approximately 10) 
Contamed 1(9-10 months) 14 (28) 0.09 647 (approximately 300) 97 (approximately 50) 
Contamed 1 (12 months) 13 (27) 0.09 381 (approximately 150-
200) 
71 (approximately 35) 
Contamed 2 (3 months) 18-16 (34) 0.37 204 (approximately 100) 42 (approximately 20) 
Contamed 2 (12 months) 18-16 (34) 0.15 539 (approximately 250) 86 (approximately 40) 
 
AMH data. 
G*Power was used to make the calculations to estimate how large group sizes is necessary for the AMH kit 
to be able to detect an effect of 10, 20 and 50%, respectively. The results are summarized in Table 16. As is 
apparent from Table 16 the group sizes (number of litters) would range from over 200 pr group with a 10% 
change to around 15 for a 50% change. 
Table 16 The group sizes required to detect a change in AMH levels of 10, 20 and 50%, respectively, with a power of 0.8 and 
α=0.05. These calculations are based on the normalized data from the 10 months old rats in the Contamed 2 study and the ratio  
between the numbers of animals there was in the control group and the exposure group in this study as equal group sizes are seldom 
achieved in these studies. 
10% change N control 343 
  N exposed 281 
20% change N control 87 
  N exposed 71 
50% change N control 15 
  N exposed 13 
 
In Contamed 2, 10 months old animals we would be able to detect an effect around 47% change.  
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5 Discussion 
In the following discussion the endpoints and methods investigated in this thesis will be discussed in more 
detail. The table below gives an overview of the chemicals tested in the studies included in this thesis and 
examples of effects that has been reported previously on each endpoint by other investigators. The table is 
meant to be a starting point for the discussion and give the reader an overview of the effects of the many 
chemicals. Each endpoint as well as the content of this table will be discussed in the following sections. 
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Table 17. Features of the chemicals tested in the mixtures or alone in this thesis. The table also shows reported effects from the open literature, on female rodents on each endpoint 
included in this thesis. 
 A hyphen (-) denotes cases where values could not be located in the open literature.  
Chemical Use Mechanisms of action(s) Gestational length AGD Nipples Estrous  puberty Estropause 
Bisphenol A Plasticizers 
Estrogenic (Salian et al. 2009), in vitro 
AR antagonist (Ermler et al. 2010)  
NOAEL > 600 
mg/kg bw/day (Tyl 
et al. 2008)  
Longer AGD 2 µg/kg 
bw/day but not 20 µg/kg 
bw/day (Honma et al. 
2002)   - 
Longer cycles at  2 
and 20 µg/kg 
bw/day no NOAEL 
(Honma et al. 
2002) 
Early puberty VO, 
LOAEL: 25 µg/kg bw/day, 
no NOAEL (Durando 
2007), LOAEL: 20 µg/kg 
bw/day, NOAEL: 2 µg/kg 
bw/day (Honma et al. 
2002). 
NOAEL: 
(50µg/kg 
bw/day) 
LOAEL: 
(50mg/kg 
bw/day) early 
irreg. cycles 
rats (Adewale 
et al. 2009) 
Butyl paraben 
Antifungal 
preservative in 
cosmetics 
Estrogenic (Kang et al. 2002), in vitro 
AR antagonist (Ermler et al. 2011)  
NOAEL > 200 
mg/kg bw/day 
(Kang et al. 2002) 
NOAEL > 200 mg/kg 
bw/day (Kang et al. 2002)  - 
 NOAEL > 1000 
mg/kg bw/day (Vo 
et al. 2010) 
100 mg/kg bw/day but not 
200 mg/kg bw/day 
advanced VO (Kang et al. 
2002).  - 
DBP 
Phthalate, used as 
plasticizers 
Inhibitor of testosterone synthesis 
(Parks et al. 2000, Shultz et al. 2001)  
Abortions midterm 
NOAEL: 250 
mg/kg bw/day, 
LOAEL: 500 
mg/kg bw/day 
(Gray et al. 2006) 
NOAEL > 500 mg/kg 
bw/day (Zhang et al. 2004)  - 
NOAEL > 
500mg/kg bw/day 
(Gray et al. 2006) 
NOAEL > 1000 mg/kg 
bw/day (Gray et al. 2006)  - 
DEHP 
Phthalate, used as 
plasticizers 
Inhibitor of testosterone synthesis 
(Parks et al. 2000, Wilson et al. 2004) 
NOAEL > 405 
mg/kg bw/day  
(Grande et al. 2006, 
Grande et al. 2007) 
NOAEL > 405 mg/kg 
bw/day (Grande et al. 
2006) 
 NOAEL > 
405 mg/kg 
bw/day 
(Grande et al. 
2006) 
Cycle irregular 
LOAEL: 25 
mg/m3, NOAEL:  5 
mg/m3 (Ma et al. 
2006) 
LOAEL: 5 mg/m3 (VO 
advanced) (Ma et al. 2006). 
VO delayed 2 days. 
LOAEL 15 mg/kg bw/day. 
NOAEL: 5 mg/kg bw/day 
(Grande et al. 2006).   - 
Epoxiconazole Triazole fungicide 
In vitro multiple mechanisms including 
anti-estrogenic, AR-antagonist, weak 
estrogenic activity, inhibit androgen 
and estrogen  synthesis (Kjaerstad et 
al. 2010)  
prolonged gestation 
NOAEL: 15 and 
LOAEL: 50 mg/kg 
bw/day (Taxvig et 
al. 2007) 
Longer AGD. Effect at 15 
but not 50 mg/kg bw/day 
(Taxvig et al. 2007) 
NOAEL > 50 
mg/kg 
bw/day 
(Taxvig et al. 
2007)  - 
early puberty VO  LOAEL:  
150 mg/kg bw/day, 
NOAEL: 100 mg/kg 
bw/day (de Castro and 
Maia 2012)  - 
Ethinyl 
estradiol  
(EE2) 
Estrogenic 
component of 
contraception pills 
Estrogenic (National Toxicology 
Program 2010) 
 NOAEL > 50 
µg/kg bw/day 
(Ryan et al. 2010) 
Increased AGD, LOAEL: 
5 µg/kg bw/day NOAEL: 1 
µg/kg bw/day (National 
Toxicology Program 2010)  - 
(cycle irregular) 
LOAEL: 400 ng/kg 
bw/day, NOAEL: 4 
ng/kg bw/day 
(Fusani et al. 2007) 
Accelerated VO at 
LOAEL: 5 µg/kg bw/day 
NOAEL: 0.5 µg/kg bw/day  
(Ryan et al. 2010)  
, NOAEL > 
50 ppb (5.8 
µg/kg 
bw/day) 
(Delclos et al. 
2009) 
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Chemical Use Mechanisms of action(s) Gestational length AGD Nipples Estrous  puberty Estropause 
Linuron 
Urea-based 
herbicide 
AR-antagonist (Hotchkiss et al. 2004, 
McIntyre et al. 2002), inhibitor of fetal 
testosterone synthesis (Hotchkiss et al. 
2004) 
NOAEL > 50 
mg/kg bw/day/day 
(McIntyre et al. 
2002)  -  -  -  -  - 
Mancozeb 
Dithiocarbamate 
fungicide 
In vivo. affected thyroid function, 
decreased T4 levels in pregnant dams, 
suspected developmental 
neurotoxicants (Axelstad et al. 2011b, 
Hurley 1998) 
NOAEL > 100 
mg/kg bw/day 
(Axelstad et al. 
2011b) 
NOAEL > 100 mg/kg 
bw/day (Axelstad et al. 
2011b) 
NOAEL 100 
> mg/kg 
bw/day 
(Axelstad et 
al. 2011b) 
prolonged 
diestrous, no 
NOAEL, LOAEL: 
500 mg/kg bw/day 
(Baligar and 
Kaliwal 2001)   -  - 
4-MBC UV-filter 
Estrogenic (Schlumpf et al. 2001), 
possess in vitro AR antagonist 
potential(Ermler et al. 2011) 
no reported effects 
NOAEL > 100 
mg/kg bw/day 
(Carou et al. 2009)   -   - 
NOAEL: 47 mg/kg 
bw/day (Faass et 
al. 2009, Schlumpf 
et al. 2008) 
VO advanced  LOAEL: 
100 mg/kg bw/day (Carou 
et al. 2009). NOAEL . 47 
mg/kg bw/day (Schlumpf 
et al. 2008)  - 
OMC UV-filter 
Estrogenic (Schlumpf et al. 2001), 
possess in vitro AR antagonist 
potential(Ermler et al. 2011) 
NOAEL > 1000 
mg/kg bw/day 
(Axelstad et al. 
2011a)  
NOAEL > 1000 mg/kg 
bw/day (Axelstad et al. 
2011a) 
 NOAEL > 
1000 mg/kg 
bw/day 
(Axelstad et 
al. 2011a) 
NOAEL > 1000 
mg/kg bw/day  
(Schneider et al. 
2005) 
Delayed puberty NOAEL: 
150 & LOAEL: 450 mg/kg 
bw/day (Schneider et al. 
2005)   -  
p,p’-DDE 
Metabolite of the 
insecticide DDT AR-antagonist (Kelce et al. 1995) 
NOAEL> 50 mg/kg 
bw/day (Yamasaki 
et al. 2009)  
NOAEL > 100 mg/kg 
bw/day  (You et al. 1998)  - 
NOAEL > 50 
mg/kg bw/day 
(Yamasaki et al. 
2009) 
Early VO, LOAEL: 50 mg 
/kg, NOAEL: 15 mg/kg 
bw/day (Yamasaki et al. 
2009)   - 
Paracetamol 
Analgesic and 
antipyretic 
Inhibitor of prostaglandin synthesis 
(Kristensen et al. 2011a, Kristensen et 
al. 2011b)  - 
LOAEL: 150 mg/kg 
bw/day, no NOAEL 
(Kristensen et al. 2011a)  -  -  -  - 
Prochloraz Imidazole fungicide 
AR-antagonist, inhibitor of foetal 
steroidogenesis (Vinggaard et al. 
2006), estrogen receptor antagonist 
(Laier et al. 2006) 
LOAEL: 30 mg/kg 
bw/day (longer 
gestation length) 
and no NOAEL 
(Vinggaard et al. 
2005)  
longer AGD in female 
LOAEL: 50 mg/kg 
bw/day, no NOAEL (Laier 
et al. 2006)  -  - 
NOAEL > 250 mg/kg 
bw/day (Noriega et al. 
2005)  - 
Procymidone 
Dicarboximide 
fungicide 
AR-antagonist (Hass et al. 2007, Ostby 
et al. 1999, Wolf et al. 1999) 
NOAEL > 50 
mg/kg bw/day 
(paper II) 
NOAEL >50 mg/kg 
bw/day (paper II) 
NOAEL >50 
mg/kg 
bw/day 
(paper II) 
NOAEL >50 
mg/kg bw/day 
Pestimix DR 
NOAEL >50 mg/kg 
bw/day (paper III)  - 
Tebuconazole Triazole fungicide 
In vitro multiple mechanisms including 
anti-estrogenic, AR-antagonist, inhibit 
androgen and estrogen synthesis 
(Kjaerstad et al. 2010) 
prolonged gestation 
NOAEL: 50 and 
LOAEL: 100 
mg/kg bw/day 
(Taxvig et al. 2007) 
female longer AGD, 
LOAEL: 100 mg/kg 
bw/day. NOAEL: 50 
mg/kg bw/day (Taxvig et 
al. 2007) 
 NOAEL: 100 
mg/kg 
bw/day 
(Taxvig et al. 
2007)  - 
NOAEL>60 mg/kg bw/day 
(Moser et al. 2001)  - 
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Chemical Use Mechanisms of action(s) Gestational length AGD Nipples Estrous  puberty Estropause 
Vinclozolin 
Dicarboximide 
fungicide 
AR-antagonist (Gray et al. 1999, Kelce 
et al. 1994)  
NOAEL > 100 
mg/kg bw/day  
(Schneider et al. 
2011)   
LOAEL: 100 mg/kg 
bw/day, decreased AGD 
PND 14 og 21 (but not 
AGDI) but there was lower 
bodyweight. NOAEL: 20 
mg/kg bw/day (Schneider 
et al. 2011)  - 
Cycle irregular 
LOAEL: 100 
mg/kg bw/day, 
NOAEL: 20 mg/kg 
bw/day, (Schneider 
et al. 2011)  
Advanced, LOAEL: 100 
mg/kg bw/day, NOAEL: 
20 mg/kg bw/day 
(Schneider et al. 2011) 
NOAEL: 56-152 mg/kg 
bw/day/day (1000ppm)  
(Matsuura et al. 2005)  - 
The table is modified from Christiansen et al 2012 (Christiansen et al. 2012) 
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5.1 Effects on gestational length 
Effects on gestational length are considered an adverse effect in toxicological risk assessment (OECD 2008, 
U.S. EPA 1996). Gestational length was recorded in all the studies included in this thesis. Compared to 
vehicle control, gestation length was increased in all of the dosed groups in the Pestimix RF study and in the 
two highest mixture groups in the Pestimix DR study as well as in the EE2 study in the highest dose group 
(Table 7).  
In the range-finding studies Pestimix RF (Paper I) an effect on gestation length was evident in all exposed 
groups, including the lowest mixture dose, where each pesticide was present at 25% of the doses that 
individually previously had not caused effect on gestation length or perinatal pup survival (Table 7). In that 
study, combined exposure at higher doses induced severe effects manifested as dystochia (impaired 
parturition) and high perinatal pup mortality (Paper I). 
In the Pestimix DR study gestation length was also significantly increased in the two highest mixture groups 
and in the group exposed to the highest dose of epoxiconazole but not in any of the other single pesticide 
groups at the doses included in the highest mixture dose. The two mixture doses consisted of each of the 
pesticides at 17% or 25% of their NOAEL for effect on gestational length based on results of previous 
studies in our laboratory. These results showed a mixture effect of the pesticides at dose levels where the 
individual pesticides caused no effects. To my knowledge, this is the first study to describe mixture effects 
on gestational length. 
The mixture effect on the length of gestation is probably due to the presence in the mixture of the three azole 
fungicides, epoxiconazole, prochloraz and tebuconazole, which have previously been shown to elicit such 
effects on gestational length (Noriega et al. 2005, Taxvig et al. 2007, Vinggaard et al. 2005, Vinggaard et al. 
2006) (Table 17). Prolongation of the gestation period is possibly caused by an increase in progesterone in 
the dams as suggested for epoxiconazole, prochloraz and tebuconazole (Taxvig et al. 2007, Vinggaard et al. 
2005). It has previously been shown that all three azoles are able to increase progesterone levels in vitro 
(Kjaerstad et al. 2010). As a decline in progesterone levels in the dams is a precondition for on-time delivery 
in rats as mentioned in section 2.2, this may be the cause of the increased gestation length in vivo. In 
agreement with the finding in this study, neither mancozeb nor procymidone have previously been shown to 
affect gestation length or perinatal survival at the doses studied (Axelstad et al. 2011b, Metzdorff et al. 
2007).  
In the Contamed 1 and 2 studies no effects were observed on gestational length even though chemicals were 
included in the mixture which can affect gestational length. The chemicals in the mixtures which has earlier 
been shown to elicit such effects, but at higher doses, are epoxiconazole and prochloraz (effects observed at 
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15 mg/kg bw/day and 25 mg/kg bw/day, respectively) (Taxvig et al. 2007, Vinggaard et al. 2005) Taxvig) 
(Table 17). In comparison the dose of epoxiconazole and prochloraz was 4.5 mg/kg bw/day and 6.3 mg/kg 
bw/day in the highest mixture, respectively. Paracetamol can possibly affect the process of giving birth as it 
inhibits prostaglandin synthesis (Christiansen et al. 2012, Kristensen et al. 2011a). It is plausible that the 
concentration of the chemicals in the mixtures were too low to cause a mixture effect in this study.  
In the EE2 study, a prolonged gestational length was observed in the group treated with the highest dose of 
50 µg/kg bw/day. No such effect was reported by several other investigators who have dosed rats perinatally 
with EE2. Ryan et al (2010) dosed Long Evans rats GD7-PND18 by gavage at the doses 0.05, 0.5, 1.5, 5, 15, 
or 50 µg/kg bw/day and saw no effects on pregnancy length (Ryan et al. 2010). Sawaki and coworkers 
(2003) dosed Sprague-Dawley rats GD7-PND18 with 0.5, 5, or 50 µgEE2/kg/day and found no effects of 
exposure on gestation length (Sawaki et al. 2003). In a dietary multi-generation study performed by the 
National Toxicology Programme (NTP) where Sprague-Dawley rats were exposed to the doses 2, 10 and 50 
ppb (roughly corresponding to 0.2, 1 and 5 µg/kg bw/day) no effects on gestation length was seen nor was 
any effect apparent in their range finding study with doses ranging up to 200 ppb (National Toxicology 
Program 2010).  A possible explanation of the discrepancy between the results reported by these 
investigators and the finding in the present study may be the differences in the rat strains used as Wistar was 
used in this study and the strains used in the other mentioned studies was either Sprague Dawley or Long 
Evans. Since the level of estrogen normally is rising prior to labor onset in rats an estrogenic chemical may 
not be expected to prolong the gestation period (see section 2.2). The effect observed on gestation length in 
the group dosed with 50 µg EE2/kg/day in the present study may thus be a chance finding.  
5.2 Female AGD 
In Pestimix RF a significant effect of exposure to the mixtures compared to vehicle control was evident at 
the doses where dams gave birth (e.g. Pestimix-43.75 and Pestimix-87.5). This effect was consistent with the 
results obtained in the Pestimix DR study. In that study a dose-dependent increase in AGDI was seen, in the 
two highest mixture groups compared with controls (Pestimix 29.17 and Pestimix-43.75) (Table 7). A similar 
effect was seen in female offspring given the low dose levels of epoxiconazole, and both doses of prochloraz 
and tebuconazole, i.e. at doses equal to those included in the highest mixture dose. No effect was seen in 
female offspring dosed with a four times higher dose of epoxiconazole and it was hypothesized that the 
finding at the low dose may be a random finding or alternatively, the lack of effect at the high dose may be 
due to a limited group size. However, the high doses of both prochloraz and tebuconazole did cause 
increased female AGDI in the present study. The effect on AGD caused by the mixture was probably due to 
the three azole fungicides as earlier studies in our laboratory have shown similar effects for epoxiconazole, 
prochloraz and tebuconazole (Taxvig et al. 2007, Vinggaard et al. 2006)(Table 17). The mechanism 
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underlying the increased AGDI in the females may be the increased progesterone levels in the dams causing 
virilization of the female genitals (Willingham et al. 2006). 
 
Exposure to the Contamed mixtures did not induce effects on the AGD of female offspring in the Contamed 
1 or 2 study. A number of the chemicals contained in the mixture of the Contamed studies have earlier been 
shown to alter AGD in females (Table 17). ICR mice exposed subcutaneously with 2 µg BPA/kg GD11-17 
but not 20 µgBPA/kg had longer AGD at day of birth (Honma et al. 2002) and others also found an increase 
in AGD in female Sprague-Dawley rat offspring after continuous dietary exposure to BPA (0.02, 0.3 and 50 
but not 5 and 500 mg/kg) (Tyl et al. 2002). Longer AGD in female pups (measured at day of birth) has been 
reported at 15 but not 50 mg/kg bw/day when the pregnant rat dams were exposed to epoxiconazole from 
GD7-PND16 (Taxvig et al. 2007). Prochloraz has also caused longer AGD in female offspring of rats 
exposed during gestation to 50 mg/kg bw/day prochloraz (Laier et al. 2006). In one study vinclozolin has 
been shown to decrease AGD in female offspring when measured PND14 and 21 at 100 mg/kg bw/day. 
Anogenital index was not affected, indicating that the AGD decrease was secondary to the lower pup body 
weight (Schneider et al. 2011). The doses contained in the Contamed studies were lower than the doses of 
those chemicals that have earlier been shown to affect AGD except for BPA (Table 3 and Table 17). The 
reason no effects were observed in the Contamed studies with a content of BPA between 0.15 and 0.675 
mg/kg bw/day in the mixture, may be the longer, continuous dosing in the rat study or differences in rat 
strains (Tyl et al. 2002) and in the mouse study differences in sensitivity between Wistar and the mouse 
model used (Honma et al. 2002). It is also possible that the other chemicals in the mixtures may have 
interacted with the effects of BPA and thereby reducing it.  
 
In the EE2 study a significant increase of AGD was found in the group treated with 50 µg EE2/kg bw/day. 
Exposure to estrogenic acting compounds like ethinyl estradiol and genistein has been shown to alter AGD 
in female rats. However, the data are sometimes puzzling as both longer and shorter AGD and sometimes no 
effect at all has been reported as outcomes of exposure to these chemicals (Casanova et al. 1999, Delclos et 
al. 2009, Levy et al. 1995, National Toxicology Program 2010). In a multi-generation study, where female 
Sprague-Dawley rats were exposed continuously in the diet (including gestation and lactation), a significant 
increase in AGD in the female offspring of the F2 generation was reported at a dose of 50 ppb (about 5 µg 
EE2/kg bw/day) but not 2 or 10 ppb (and no effect in F1). In the same study the exposure to 50 ppb EE2 in 
the diet induced a decrease in AGD in the F3 generation compared with control (National Toxicology 
Program 2010). Interestingly, the same picture was seen by Delclos et al (2009) in another multi-generation 
study with dietary exposure on Sprague-Dawley rats (Delclos et al. 2009). In agreement with the findings in 
the present EE2 study Ryan et al (2010) found an increase in AGD of female Long Evan rat offspring 
exposed GD7-PND18 to 50 µg/kg bw/day EE2 (Ryan et al. 2010). However, in another study with similar 
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exposure and dosing period in Sprague-Dawley, no effects of treatment were observed in the offspring at 50 
µgEE2/kg bw/day (Sawaki et al. 2003). Thus, the results obtained in this study support an increased AGD 
after EE2 exposure observed by Ryan et al (2010) but the lack of effects seen in the study performed by 
Sawaki et al (2003) cannot readily be explained but perhaps there is a difference among strains or laboratory 
technique.  
 
Generally, in the studies included in this thesis, the AGD analyzed with body weight as a covariate seemed 
to be consistent with AGDI. An exception was the Pestimix DR study where a significant effect on AGDI 
was detected in Pestimix-29.17 and the low dose of prochloraz and tebuconazole which were not significant 
when analyzing AGD with weight as a covariate. It is however, possible that the AGD Index can sometimes 
overcompensate for the effect of body weight as it assumes the pup to be the form of a cube and an animal 
with a low body weight can sometimes be thin and not necessarily short and therefore have a longer AGD. 
AGD did not seem to consistently be the most sensitive endpoints in female offspring in the studies in this 
thesis as disruption of estrous cycle in the one-year-old rats were observed when AGD was unchanged in the 
Contamed studies (with the exception of the Mix-200 in Contamed 2) (Table 7). 
 
5.3 Nipples  
In the EE2 study an increased number of nipples were seen in the highest dose group (50 µg/kg bw/day) 
compared with the number of nipples found in control animals. There are reports of effects on the number of 
nipples in females in the open literature and an effect of androgen exposure during development has in some 
studies resulted in a lower number of nipples in the female offspring (Hotchkiss et al. 2007, Wolf et al. 2002, 
Wolf et al. 2004). An increased number of nipples in female rats have, to my knowledge, not been reported 
earlier in the open literature. Furthermore, no effect on number of nipples in female rat offspring following 
exposure to doses from 0.05 to 50 µgEE2/kg bw/day dosed perinatally has previously been reported (Ryan et 
al. 2010). NTP did find hypertrophy of the nipples as an effect of ethinyl estradiol exposure (National 
Toxicology Program 2010). In males nipple anlagen regression is dependent on the action of androgens in 
the tissue (Barlow et al. 2004, Hotchkiss et al. 2004, Imperato-McGinley et al. 1986, Kratochwil 1977, Ostby 
and Gray 2004) and it is possible that excessive presence of estrogen somehow induces a higher number of 
mammary buds along the mammary streak during mammary development. It may also be speculated that 
some regression of nipple anlagen happens in females as well as in the males which are then counteracted by 
EE2. The lack of effects on nipple retention in males treated perinatally with EE2 may argue against that 
explanation, if it is controlled in the same way in males and females (Ferguson et al. 2011, Howdeshell et al. 
2008). No effects were observed on the number of nipples in Pestimix DR and the Contamed 1 and 2 studies.  
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5.4 Onset of puberty in females 
Effects on onset of puberty has as mentioned in section 2.4.1 been observed as an effect of exposure to 
endocrine disrupters.  
No effects were seen in age or weight at onset of puberty on female offspring in either the groups receiving 
the mixtures or the single chemicals in the mixture studies in this thesis. Others have reported effects on 
onset of puberty of several of the chemicals in the mixtures of Pestimix DR and Contamed 1 and 2 (Table 
17). Epoxiconazole, bisphenol A, p,pDDE, 4-MBC, vinclozolin, butyl paraben and DEHP has been found to 
advance VO (see Table 17). OMC has been reported to delay VO although according to the author the effect 
was within historical range and the controls were in the lower range of normal age of VO (Schneider et al. 
2005). As it is mentioned in section 2.4, puberty is a complex neuroendocrine process and chemicals with 
different properties may affect timing of puberty. In the studies in this thesis no effects of exposure to these 
chemicals on onset of puberty were observed, however, the doses of these chemicals were much smaller in 
the mixture studies than in the studies where effects were observed (Table 17). The exception is bisphenol A 
where an advanced VO in female offspring dosed in utero through subcutaneous exposure of the pregnant 
Wistar dams with 25 µg/kg bw/day, has been reported (Durando et al. 2007). Other investigators have 
observed no effects on onset of puberty when Sprague-Dawley rats were exposed perinatally to bisphenol A 
in higher doses (3.2, 32 or 320 mg/kg bw/day) GD6-PND20 by gavage (Kwon et al. 2000) or observed a 
delay in VO also at higher doses (but also in animals with lower body weights) e.g. 500 mg/kg bw/day 
dietary exposure (Tinwell et al. 2002, Tyl et al. 2002). However that may be, no mixture effects were 
observed on onset of puberty in these studies and it is difficult to know if an effect of bisphenol A was to be 
expected in the present study set-up.  
In the EE2 study no significant effects were seen on the weight or timing of onset of puberty in female 
offspring. In female offspring, earlier age of VO as well as VO occurring at a lower body weight when 
compared to controls has been observed following EE2 exposure at 50 ppb (approximately 5 µgEE2/kg bw) 
in the F1, F2 and F3 generations in a multi-generation study (National Toxicology Program 2010). Ryan et al 
2010 found an accelerated age of VO and at a reduced weight at 5 µgEE2/kg bw (NOAEL 0.5 µg/kg bw/day) 
in female rat offspring exposed GD7-PND18 (Ryan et al. 2010). Therefore, an effect on timing of VO was 
expected in this study. However, a problem occurred in measuring VO as some animals in the two highest 
dose groups had already attained VO on the first day of registration. The recording of VO at PD 27 may thus 
result in a weaker statistical result. Another issue is group size, as a group size of around 20 litters is 
recommended for this endpoint to obtain an acceptable power to detect a 2 days shift (Clark 1999). In 
comparison, our group size was 5-9 litters, so the lack of statistical significance despite a trend to early 
puberty in these females is not surprising. 
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A problem that needs to be considered when assessing these data is the fact that some animals had already 
attained VO when the registration began even in the control groups in all studies making the analysis of the 
data more difficult. In the PestimixDR study we began registering VO on PD 30. This was too late as some 
animals already had reached VO at that day. In the following studies VO was registered on 27 (Contamed 
1&2 and EE2 studies). This age also turned out to be too late as some animals also had reached sexual 
maturation at that point also in the control groups. For later studies on puberty onset it is therefore 
recommend that the recordings of VO begin at weaning (PD22) just to get an idea on how early this strain 
attains VO. This would be especially important when investigating chemicals suspected to give rise to 
advanced VO.  
 
5.5 Estrous cycle measurements in adult animals 
Evaluating estrous cycle is a very useful indicator of chemical insult to the hypothalamic-pituitary-ovarian 
axis in females. Estrous cycle was therefore measured in all the studies except for the Pestimix RF, where the 
animals were sacrificed at an early stage. 
Estrous cyclicity was not affected by pesticide exposure in the Pestimix DR study, but we did have a 
problem with our method, as a large proportion of the animals became pseudopregnant (5/18 animals in the 
control group alone). The abnormal high number of pseudopregnancies may have been caused by excessive 
stimulation of the cervix by the use of both a cotton swab to obtain smears and the Vaginal Impedance 
Checker, as stimulation of the cervix can lead to pseudopregnancy in female rats (Goldman et al. 2007). 
Moreover, in that study the cotton swab was used before the VIC and for that reason the VIC results were not 
useful. Because of the large variation in the control group (50 % and 69% regularly cycling when including 
and excluding pseudopregnant females, respectively), the sensitivity for detecting an increased number of 
animals with irregular cycles was limited.  
Of the tested pesticides in Pestimix DR, only mancozeb has previously been reported in the open literature to 
have affected estrous cyclicity. Mancozeb induced longer cycles characterized by more days of diestrous in 
females rats dosed in adulthood (Baligar and Kaliwal 2001), however, much higher doses of mancozeb were 
used (500 mg/kg bw/day bw. and above) than present in the mixture.  
In the Contamed 1 and 2 studies no effects of exposure was observed in the animals either at 3, 5 or 9-10 
months of age (Table 10 and Table 11). There were, however, more animals in the control group getting 
pseudopregnant in the 5 months old animals in Contamed 1. This could be a chance finding or perhaps the 
animals in the highest mixture group (Mix-450) and AMix-450 are somehow less sensitive to cervical 
stimulation, as no animals in these groups were pseudopregnant. However, in Pestimix DR the 
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pseudopregnancies were more evenly distributed among groups indicating no such effect in that study (Table 
9 and Table 10). 
Chemicals with diverse modes of action have been shown to affect estrous cycle in rodents as mentioned in 
section 2.5.2. The chemicals contained in the mixture that have been shown to affect estrous cycle of female 
rodents are mancozeb (LOAEL 500 mg/kg bw/day, (Baligar and Kaliwal 2001), vinclozolin (LOAEL, 100 
mg/kg bw/day, (Schneider et al. 2011)), DEHP (LOAEL 25 mg/m3, (Ma et al. 2006)) and BPA (LOAEL, 2 
µg/kg bw/day, (Honma et al. 2002)). These chemicals were not present in the mixtures at concentrations 
which showed a significant effect in any of the exposed groups as compared to controls (Table 3and Table 
17). The exception of this is BPA which in a study has shown effects on estrous cycle in offspring of female 
ICR/Jcl mice at doses of 2 and 20 µg/kg bw/day (Honma et al. 2002). Four and six months old Sprague-
Dawley rats exposed to 1.2 mg/kg BPA bw/day in drinking water GD6-PND22 showed signs of alteration of 
the reproductive function as measured by the proportion of animals with regular/irregular cycles. The vaginal 
cytology of some animals revealed intermittent extended periods of diestrus, whereas others exhibited 
extended periods of proestrus and/or estrus (Rubin et al. 2001). In the Contamed studies effects were not 
observed at these ages on the estrous cycle with a content of BPA between 0.15 and 0.675 mg/kg bw/day in 
the mixture and perhaps some of the other chemicals in the mixture somehow counteracted the effect or the 
Wistar rat strain is not as sensitive as ICR/Jcl mice or Sprague-Dawley to these effects. It is known that the 
Sprague-Dawley strain starts having irregular estrous cycles at an early age (approximately 6 months) 
compared with other strains (Eldridge et al. 1999).  
In the EE2 study estrous was monitored for 21 days when the female offspring were 2.5 months old. No 
effects on estrous cyclicity were observed of EE2 exposure compared with control. Others have shown 
effects of EE2 exposure on the estrous cycle of rodents. In a multi-generational study with continuous dietary 
exposure in Sprague-Dawley rats, in generation F1 and F2 an increased length of cycles and an increase in 
number of abnormal cycles were observed due to increased duration of estrus in the groups receiving 50 ppb 
(about 5 µg/kg bw/day). Smears were taken starting 3 days after VO and for 14 consecutive days. 
Furthermore, in the F1 generation the group exposed to 2 (0.2 µg/kg bw/day) or 10 ppb (1 µg/kg bw/day) 
had increased cycle length and animals dosed with 10 ppb had decreased time spent in estrus. The effect on 
estrous cycle was absent in F3 where exposure was attenuated PND21 (National Toxicology Program 2010). 
In another study where Sprague-Dawley rat dams were exposed orally by pipette GD5 to PND21and the 
offspring from weaning to PND32, a larger proportion of irregular animals characterized by persistent 
estrous were seen at 4 ng/kg bw/day when the animals were around 5.5 months old (Fusani et al. 2007). In a 
study where Sprague-Dawley rats were exposed to EE2 in utero and postnatally continuously through dietary 
exposure, effects on estrous cycle (examined for 14 consecutive days starting 3 days after vaginal opening) 
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by means of increased cycle length and prolonged estrous was seen at 50 ppb (corresponding to 5.8 µg/kg 
bw/day) (Delclos et al. 2009). 
 In the EE2 study no effects on estrous cycle were observed but we did have a rather small number of 
animals which meant that we were not able to detect an effect of less than 50% change in animals with 
irregular cycles compared with the control group (Table 15). On the other hand the control group had an 
unusually low number of irregularly cycling animals for our laboratory. Furthermore, our animals were only 
dosed until weaning PD22 and in most of the above mentioned studies where effects on estrous cycle has 
been observed the animals have been exposed continuously. Also, again, there may be a difference in 
sensitivity between the rat strains used. 
5.6 Estrous cycle measurements in the one-year-old animals 
The processes of reproductive aging involve the hypothalamic-pituitary-ovarian axis. These processes can be 
disrupted by EDCs and there is evidence of mechanisms involving both effects in the ovary and 
reprogramming of the hypothalamus as an effect of EDC exposure (Adewale et al. 2009, Armenti et al. 2008, 
Gore et al. 2011). One of the signs of the progression of reproductive aging are getting irregular cycles and 
eventually stop cycling altogether (acyclic). Estrous cycles can be measured in rats and used as a sign of 
possible premature reproductive senescence. 
In the 12 months old animals in the Contamed 1 study, there was an effect (although not statistically 
sigificant) on the number of animals showing irregular cycles with more animals being irregular in the 
exposed groups dosed with Mix-450 and even more pronounced in AMix-450. Moreover, in Contamed 1 
there was a significant trend according to a Cochran-Armitage test. In Contamed 2 there seemed to be an 
effect on the groups treated with Mix-100, Mix-200 and Mix-450 but the effect was not statistically 
significant when data from control and the mixture groups Mix-100, Mix-200 and Mix-450 were analyzed 
together. When comparing the control group with the group treated with Mix-200 a borderline effect was 
observed (p=0.053). However, a significant effect was observed when data from control groups and Mix-450 
from both the Contamed 1 and 2 studies were pooled and analyzed together supporting an effect of exposure 
to the mixture and perhaps reflecting a low power in the studies when analyzed separately (Table 14). The 
larger proportion of irregularly cycling animals in the exposed groups may be indicative of the animals going 
into an earlier estropause as an effect of exposure to the mixture. It did not seem as the mixtures only 
consisting of the antiandrogens, the estrogens or paracetamol, respectively, consistently affected the 
proportion of irregularly cycling animals, suggesting a mixture effect of both the estrogens and the 
antiandrogens together. Only BPA was found to have been investigated earlier in regard to early onset of 
irregular cycles (Table 17). In this study Long Evan rat pups were dosed subcutaneously with either 50 µg 
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BPA/kg or 50 mg/kg bw/day neonatally PND0-PND3. They found animals exposed to 50 mg/kg bw/day 
stopped cycling regularly at an earlier age than animals in vehicle control (Adewale et al. 2009). 
5.6.1 Early exposure and late effects 
As is outlined in section 2.1, the process of follicle assembly and the recruitment of primordial follicles in 
the ovary to enter into growth are thought to be essential for duration of reproductive lifespan (Abbott et al. 
2006, Crain et al. 2008, Diamanti-Kandarakis et al. 2009, Uzumcu and Zachow 2007). Any chemical 
interfering with these processes may advance timing of menopause/estropause. The levels of androgens and 
estrogens during development are important as the development of follicles in the ovary is sensitive to 
increased levels of androgen and estrogens during certain developmental stages and an effect of the estrogens 
alone may therefore be expected (Abbott et al. 2006, Uzumcu and Zachow 2007). Other mechanisms may be 
involved as for example reprogramming of the HPO axis as shown in rats exposed perinatally to 
methoxychlor  (Gore et al. 2011). Of the chemicals tested in the Contamed 1 and 2 studies, most of them 
have been shown to (at least in vitro) affect either estrogen or androgen actions Table 17 or has been shown 
to be able to interfere with folliculogenesis or follicle health in the ovary. Chemicals in the Contamed 1 and 
2 studies that have been shown to interfere with folliculogenesis or follicle health in the ovary includes 
DEHP, mancozeb (Baligar and Kaliwal 2001), vinclozolin (Matsuura et al. 2005), DDE (Chedrese and 
Feyles 2001, Crellin et al. 2001) and BPA (Adewale et al. 2009, Suzuki et al. 2002). Thus, a mixture effect 
on the ovaries resulting in early reproductive aging of the chemicals tested in Contamed 1 and 2 may be 
plausible but this is of course speculative and need more investigation. 
Menopause is a stage associated with considerable health drawbacks and taken together with the fact that 
women are getting children at a late age the effect observed in rats should be considered a severe effect (see 
section 2.6.1).  The effect on estrous cycle was only evident in the 12 months old rats, and normally the 
animals are sacrificed long before the age of 12 months in reproductive toxicity studies. Effects late in life 
are very rarely studied in experimental animals and never after exposure during development in the 
regulatory test guidelines used for risk assessment. None of the reproductive toxicity studies in the OECD 
test guideline program (Two-Generation Reproduction Toxicity Study (OECD TG 416) or the extended one-
generation reproductive toxicity study (OECD TG443)) are able to address effects in old animals and 
therefore this type of effects may be overlooked (OECD 2001, OECD 2011). In the Contamed 1 study the 
exposure caused early endocrine disrupting effects such as increased nipple retention and reduced prostate 
weights in male offspring at the same dose levels and lower (Paper IV). The effects found in the senescent 
animals are therefore not necessarily expected to lead to a lower NOAEL, but certainly underscore that 
severe adverse effects of exposure in early development can be observed late in life. 
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5.7 AMH 
Since the serum levels of AMH has been shown to correlate with follicle pool in rats (Yeh et al. 2007) it 
could have the potential to be used as an endpoint in toxicological tests when assessing exhaustion of follicle 
reserve due to chemical insult. Indeed, it has been used as a biomarker to assess the degree of ovarian 
damage caused by exposure to the chemotherapeutic agent cisplatin (Yeh et al. 2006). Cisplatin is a very 
potent chemical and it must be assumed that most endocrine disrupting chemicals exerts much more subtle 
effects on the follicle pool. If the AMH-measurement is to be a useful biomarker of effects on ovarian 
follicle pool of endocrine disrupters, it could be argued that it must be able to detect the effects caused by 
less potent chemicals than Cisplatin.  
In Contamed 2 a decreased AMH level compared with control was observed in animals exposed to PM and 
Mix-450 in 4 months old animals (Figure 17). It is striking that there was an effect in group Mix-450 but not 
in the group exposed to only the highest dose of antiandrogens (Amix-450, group 6) not including 
paracetamol suggesting paracetamol may be the cause of the decrease in AMH.  
No effects were seen in Contamed 1 or 2 in the one-year-old animals, but we did not measure AMH in four 
months old animals in Contamed 1, so maybe the effect is more pronounced at an earlier age. On the other 
hand this could be a chance finding as no intern standard was included in the analysis of AMH in the four 
months old animals in Contamed 2. Notwithstanding this, analyzing data from only the plate where most of 
the data had been measured did support a significant effect in the groups dosed with Mix-450 and 
Paracetamol.  
In the EE2 study no significant effects of treatment were observed on the levels of AMH.  Effects on the 
ovaries including degeneration of antral follicles (200 ppb, dietary exposure), a lower number of growing 
follicles in F4 (50 ppb), but a higher number of antral follicles in F1 (10 ppb) was observed in a multi-
generational study (National Toxicology Program 2010). In another study where rats were exposed with EE2 
GD7-PND21 by gavage, abnormal estrous cycle in 6/8 animals at 6 months of age was observed in the group 
dosed with 50 µg/kg bw/day EE2 compared with none in vehicle control.  Of the animals with abnormal 
cycles 4 had persistent estrus and these animals also had follicular cysts in the ovary and absence of corpora 
lutera (Sawaki et al. 2003). According to the authors, these ovarian dysfunctions most likely represent 
reproductive senescence or a defect in the HPO axis (Sawaki et al. 2003). If there is an effect of EE2 on the 
follicle pool of the ovary, as these studies may indicate, it may be possible to measure a difference in AMH 
levels compared with AMH levels in vehicle controls. Looking at the Figure 19 it seems as there could be a 
trend towards a decrease in the AMH levels with EE2 exposure but this is non-significant. The group sizes in 
this study only ranged from 5-7 litters and it would have been interesting to investigate if there in fact is an 
effect of EE2 on AMH levels in a larger study at different ages of the female offspring.  
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It is known that deficiencies of estrogen and excess of both estrogen and androgens during sensitive 
windows in development can reduce the number of follicles in the ovary (Abbott et al. 2006). Also more 
direct toxic effects causing increased apoptosis in the ovary can affect AMH levels and number of follicles 
(Yeh et al. 2006) but also chemicals with other modes of actions can disturb the process of folliculogenesis 
as described in section 2.1 and Figure 2. Thus, theoretically, at least some of the chemicals tested in the 
studies in this thesis may be able to affect the AMH levels (Table 17).  
More work on both the method of measuring AMH and a more focused design needs to be used in order to 
judge if AMH is a good marker of early reproductive senescence in rodents as it seems to be in humans 
(section 2.7). These studies were not designed for assessing AMH as a biomarker so the information that 
comes from them is limited by that. It would in that regard be fruitful to examine both the AMH levels and 
the follicle counts in the ovaries to verify if any effect on the number of follicles indeed has occurred in 
groups exposed to an endocrine disrupter known to affect reproductive senescence. If it turns out that an 
effect decreasing the ovarian follicle pool can be measured at an early age using AMH, this could be a very 
useful tool perhaps substituting the time consuming smear method which also requires keeping the rats until 
they are old. More work needs to be done in order to verify the usefulness of this marker.  
  
5.8 Vaginal smear versus Vaginal Impedance checker (VIC)  
Vaginal cytology is considered to be the golden standard in staging female estrous cyclicity because the 
stages can be reliably identified from vaginal smears (Montes and Luque 1988, OECD 2009c). This 
technique, however, requires technical expertise, are time-consuming and labor-intensive. The rat vaginal 
impedance checker (VIC), on the other hand, is technically easy to use, less susceptible to subjective 
interpretation and measurements are very fast to obtain. The theory behind the VIC is that electrical 
impedance resistance changes during the estrous stages in several species which also includes the rat (Bartos 
1977, Ramos et al. 2001, Taradach 1982).  
In our study the VIC did not seem to be a good substitute for vaginal cytology when assessing estrous cycle 
in the rat (Table 13). The VIC was too imprecise even though it had a sensitivity (the proportion of true 
positives, where positives were defined as the irregular cyclers) of 100%, however, it also had a specificity 
(proportion of true negatives where negatives were defined as the regular cyclers) of only 38%, resulting in 
too many animals ended up being categorized as irregular cyclers when compared to visually scoring vaginal 
smears. Furthermore, there seemed to be a connection between the use of the VIC and animals getting 
pseudopregnant. Pseudopregnant animals were primarily observed in the Pestimix DR and Contamed 1 
where both the VIC and cotton swabs measurements were performed. This could be caused by excessive 
stimulation of the cervix by the use of both a cotton swab to obtain vaginal smears and the VIC, as 
stimulation of the cervix can lead to pseudo pregnancy in female rats (Goldman et al. 2007) and has also 
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been observed by others using impedance measurements (Singletary et al. 2005). In the analysis the 
assumption was made that the results of reading the vaginal smears were the true answer or the golden 
standard. It is of course possible that some error has occurred when reading the smears and  possibly 
measuring the hormone levels, which changes during the estrous cycle (see section 2.5.1), would have 
provided some extra accuracy in determining the cycles of the animals (Butcher et al. 1974). Others have 
reported peak impedance in either proestrus or estrus or both in the rat (Bartos 1977, Ramos et al. 2001, 
Singletary et al. 2005) and   Singletary et al (2005) suggest the use of vaginal impedance may be limited for 
chronic estrous cycle monitoring because of the possible risk of inducing pseudo pregnancy (Singletary et al. 
2005).  
5.9 Power calculations 
Power in statistical analysis is the probability of the test will reject the null hypothesis when the null 
hypothesis is false. The calculated power depends on the sample size used in the studies, the chosen α and 
the effect  (Cohen 1992) which in the case of estrous cycle data is the distribution of regular to irregular 
cycling animals in the control group compared to the distribution in the group which the control is being 
compared with. Generally, the power was low when considering the estrous data in the studies included in 
this thesis. Power ranged between 0.26-0.75 (Table 14) and it is generally considered acceptable that power 
should be 0.8 or greater (Lipsey and Hurley 2009). When calculating the number of animals necessary to 
measure an effect on number of regularly cycling animals with a power of 0.8, it is obvious that with the 
distribution of irregularly cycling animals we have in the control groups in our studies, we would have to 
have either quite large sample sizes or a large effect in the exposed groups to find an effect.  From Table 15 
it is seen that it takes sample sizes between 30 and 300 to find an effect of 20% more animals with irregular 
cycles and 10 to 50 animals per group to detect a change of 50% with the control groups in our studies.  In 
other animal studies performed by other groups the proportion of irregularly cycling animals in the control 
group has sometimes been lower than in our studies (Faass et al. 2009, Laws et al. 2000b, Matsuura et al. 
2005, Schlumpf et al. 2008), however, it is not seldom to have up to 20-30% irregularly cycling animals in 
the control females (Cooper and Goldman 1999). In our studies the percentage of irregularly cycling rats 
ranged from 0% in the EE2 study to 43% in the 9-10 months old rats in Contamed 1. Even in 3 months old 
animals from the Contamed 2 study, where there should not have been any irregular cycles caused by aging, 
the proportion of irregular cyclers was 17%. Thus, this endpoint is not very sensitive with the strain used in 
our laboratory and in this type of study design. In studies where estrous cyclicity is measured before and 
after an exposure, irregular cyclers are often omitted before the exposure to increase the sensitivity of the 
measure (Cooper and Goldman 1999, Cooper et al. 1996). 
In three months old animals in Contamed 2 the power is calculated based on a control group with 83% 
regularly cycling animals and only a 24% change as the effect, which is a very small effect and not 
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significant (Table 14). A small effect would normally require a lot of animals to detect compared with a very 
large effect, hence the low power (0.26). In the 12 months old animals power is calculated based on a control 
group with only 63% regularly cycling females but a large effect of 70% compared with control group 
resulting in a fairly high power to detect this specific effect (0.75). Whereas, the power calculations in Table 
14 are based on the “real” numbers in both control group and an exposure group obtained in the studies, the 
calculation of group sizes (Table 15), N, is based on just the control group and the fixed calculated effects of 
20% and 50% and a chosen power of 0.8. Because the control group in the 3 months old animals are 
comprised of 83% regular cyclers compared to only 63% in the 12 months old animals, the calculated 
required group sizes when measuring an effect of 50 %  are (N=around 20) in 3 months old animals 
(N=around 40) in 12 months old animals, respectively (Table 15).  
When measuring the plasma levels of AMH the variability of the measurements were somewhat high and 
consequently the required sample sizes to obtain a power of 0.8 were also high (between 15 and more than 
200, Table 16). With the particular kit used and the group sizes these studies usually have in our laboratory, 
the effect on AMH would have to be a decrease of about 50% for us to be able to detect it. In another study 
where AMH has been measured in serum instead of plasma (but also using their own kit), there seems to be a 
lower variability (Kevenaar et al. 2006). Even though the kit used in this thesis according to protocol should 
be able to measure AMH in plasma, perhaps using serum and/or trying another kit with hopefully a lower 
variability could be a fruitful way to further explore this endpoint.  
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6 Conclusions and perspectives 
In toxicological testing the effects of endocrine disrupters have in most cases been more thoroughly 
investigated in males than females and experimental evidence on the effects on females of combined 
developmental exposure to environmentally relevant endocrine disrupting chemicals with antiandrogenic or 
estrogenic modes of action has been missing. Most of the endpoints investigated on female offspring in this 
thesis were responsive to early exposure to the endocrine disrupters or mixtures of endocrine disrupters 
tested in the studies.  
Interestingly, some pesticides caused prolonged gestational length in dams and in higher doses dystocia 
when administered as a mixture, even though each pesticide were present at doses below their individual 
NOAELs for this endpoint. Some of the pesticides and doses of mixture of pesticides in Pestimix RF and DR 
increased AGD in the female offspring and so did exposure to the highest dose of EE2. For the first time an 
increase in number of nipples has been reported in female offspring after EE2 exposure. It is not known at 
this time whether the effect is real or a chance finding. No effects were observed on puberty onset including 
the study with the positive control EE2, perhaps caused by including too few animals and beginning the 
registration of VO too late. Future studies on this endpoint should start recording of this endpoint at an 
earlier age and using a suitable group size. A very interesting finding in the Contamed studies was an effect 
on the timing of onset of irregular estrous cycles which was evident only in 12 months old animals and not in 
the younger animals. This effect may be a sign of early reproductive senescence in the animals exposed to 
the mixture of antiandrogens and estrogens and is an example of early life exposure causing late effects. The 
effects were probably caused by both the antiandrogens and the estrogens as no consistent effects were 
observed in the groups treated only with mixtures of chemicals with either modes of action.  
Since earlier and more sensitive markers of effects on reproductive senescence of exposure to endocrine 
disrupters would be valuable AMH levels were investigated. AMH measurement needs further development 
to judge whether it can be a useful biomarker in future studies. Power calculations suggested estrous cycle as 
well as AMH measurements are not very sensitive endpoint as only effects of changes around 50% or more 
could be detected in our rat strain and the AMH-kit used. 
 
 
 
 
77 
 
To summarize, the following conclusions can be made regarding the hypotheses proposed in the 
introduction: 
a) Yes, the developing females and gestational length in dams were sensitive to exposure to single 
compounds or mixtures of environmentally relevant compounds. 
b) Estrous cycle effects were observed in 12 months old animals but the endpoint was not quite 
sensitive enough in studies of the sizes included in this thesis. 
c) AMH needs more development to assess if it can be used as a marker of reproductive senescence in 
female rats. 
d) The positive control study showed effects on gestational length, AGD and number of nipples but 
most likely included too few animals to detect effects on estrous cycle, AMH and onset of puberty.  
The results obtained in this thesis indicate that exposure to endocrine disrupters may be able to contribute to 
effects on the reproductive system in girls and women. The fact that mixture effects of exposure during 
development were seen in the Pestimix studies both on gestational length and AGD below the NOAELs or 
close to NOAELs indicate a mixture effect of exposure to these pesticides. Effects on gestational length are 
considered an adverse effect in humans and changes in AGD indicates the normal development of the female 
reproductive system has been affected. Furthermore, the effects observed on estrous cyclicity in the 
Contamed studies may be worrying for some highly exposed population groups because only a fraction of 
the chemicals we are exposed to were present in these mixtures. These studies support the relevance of 
taking mixture toxicology into account in risk assessment. Moreover, no OECD guideline on reproductive 
toxicology covers effects observed in aging animals and this is a limitation in existing guideline studies. 
More work should be focusing on developing sensitive endpoints in model species designed to detect effects 
on females both early and late in life and also on elucidating the mechanisms of the adverse effects on 
reproductive development as for example epigenetic programming. 
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ORIGINAL ARTICLE
Combined exposure to endocrine disrupting pesticides
impairs parturition, causes pup mortality and affects sexual
differentiation in rats
P. R. Jacobsen, S. Christiansen, J. Boberg, C. Nellemann and U. Hass
Department of Toxicology and Risk Assessment, National Food Institute, Technical University of Denmark, Søborg, Denmark
Introduction
Animal laboratory experiments have shown that in utero
exposure to endocrine disrupting chemicals (EDCs)
including some pesticides can cause adverse effects on
male reproductive development (Foster, 2006; Gray et al.,
2006; Hass et al., 2007; Metzdorff et al., 2007; Christian-
sen et al., 2008). Individual pesticides alone have so far
not been shown to contribute to adverse human effects at
relevant exposure levels. However, some studies indicate
increased prevalence of cryptorchidism and decreased
penile length in sons of women working as gardeners or
living on farms where pesticides have been used
(Kristensen et al., 1997; Weidner et al., 1998; Carbone
et al., 2007; Andersen et al., 2008).
Many EDCs have been found as mixtures in humans
(Blount et al., 2000; Swan et al., 2005), including children
(Brock et al., 2002; Swan et al., 2005; Main et al., 2006).
Damgaard et al. (2006) observed an association between
congenital cryptorchidism and the levels of certain
organochlorine pesticides in mothers’ milk (Damgaard
et al., 2006). Earlier, Pierik et al. (2004) identified pater-
nal exposures to pesticides and smoking as factors associ-
ated with these congenital malformations. These initial
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Summary
Risk assessment is currently based on the no observed adverse effect levels
(NOAELs) for single compounds. Humans are exposed to a mixture of
chemicals and recent studies in our laboratory have shown that combined
exposure to endocrine disrupters can cause adverse effects on male sexual
development, even though the doses of the single compounds are below their
individual NOAELs for anti-androgenic effects. Consequently, we have initiated
a large project where the purpose is to study mixture effects of endocrine dis-
rupting pesticides at low doses. In the initial range-finding mixture studies, rats
were gavaged during gestation and lactation with five doses of a mixture of the
fungicides procymidone, mancozeb, epoxyconazole, tebuconazole and prochlo-
raz. The mixture ratio was chosen according to the doses of each individual
pesticide that produced no observable effects on pregnancy length and pup sur-
vival in our laboratory and the dose levels used ranged from 25 to 100% of this
mixture. All dose levels caused increased gestation length and dose levels above
25% caused impaired parturition leading to markedly decreased number of live
born offspring and high pup perinatal mortality. The sexual differentiation of
the pups was affected at 25% and higher as anogenital distance was affected in
both male and female offspring at birth and the male offspring exhibited
malformations of the genital tubercle, increased nipple retention, and decreased
prostate and epididymis weights at pup day 13. The results show that doses of
endocrine disrupting pesticides, which appear to induce no effects on gestation
length, parturition and pup mortality when judged on their own, induced
marked adverse effects on these endpoints in concert with other pesticides. In
addition, the sexual differentiation of the offspring was affected. This as well as
the predictability of the combination effects based on dose-additivity modelling
will be studied further in a large dose-response study.
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observations in epidemiological studies points in the same
direction as laboratory experiments with oestrogenic or
anti-androgenic chemicals in which substantial mixture
effects occurred even though each individual chemical
was present at low, ineffective doses (Rajapakse et al.,
2002; Silva et al., 2002; Hass et al., 2007; Metzdorff et al.,
2007; Christiansen et al., 2008, 2009).
Some pesticides such as vinclozolin and procymidone
antagonize competitively the androgen receptor (AR)
binding of androgens and affect mainly the reproductive
development in male offspring (Kelce et al., 1997; Ostby
et al., 1999). Other pesticides such as mancozeb and propi-
neb act mainly via disruption of the thyroid hormones and
are mainly suspected to disrupt brain development (Hur-
ley, 1998; Hass & Axelstad, Personal Communication).
Our detailed research on prochloraz, combined with
studies on other azole fungicides such as tebuconazole
and epoxyconazole, indicates that these pesticides have
the ability to react through several endocrine disrupting
mechanisms, and to induce various endocrine disrupting
effects (Vinggaard et al., 2005a,b; Taxvig et al., 2007). We
have shown that prochloraz induced anti-androgenic
effects in rats in vivo in a Hershberger test as well as in a
developmental toxicity study (Vinggaard et al., 2002,
2005a). In addition, our studies show that prochloraz
increases gestation length and indicate that prochloraz
may also affect thyroid hormone levels and cause effects
on the sexually dimorphic development of the brain
(Vinggaard et al., 2002, 2005a). Both tebuconazole and
epoxyconazole increase gestation length and pup
mortality and furthermore, these pesticides virilise female
pups, and affect steroid hormone levels in foetuses and ⁄or
dams (Taxvig et al., 2007).
In this article, we present data from two range-finding
studies on the effects of a mixture of five endocrine
disrupting pesticides. We selected procymidone, prochlo-
raz, tebuconazole, epoxyconazole and mancozeb for our
experiments. The choice of these pesticides was motivated
by their common use as pesticides and their multiple
mechanisms. The main aim of our range-finding studies
was to assess whether there would be joint effects on
pregnancy length and pup survival when every mixture
component was present at doses that individually did not,
in our earlier studies, produce observable effects on these
endpoints. In addition, the aim was to obtain preliminary
data on effects on the sexual development of the offspring
to plan a large dose-response study.
Materials and methods
Animals and exposure
Two range finding studies, hereafter referred to as study 1
and study 2, were performed 2 months apart. In both
studies, time-mated nulliparous, young adult Wistar rats
(HanTac : WH, Taconic Europe, Ejby, Denmark) were
supplied at gestation day 3 (GD3) of pregnancy.
The animals were housed in pairs until GD18 and alone
thereafter under standard conditions in semi-transparent
polycarbonate cages (15 · 27 · 43cm) with Aspen bedding
(Tapvei, Denmark) situated in an animal room with con-
trolled environmental conditions (12 h light-dark cycles
with light starting at 21.00 pm, light intensity 500 lux, tem-
perature 21 ± 2 C, humidity 50 ± 5%, ventilation 8 air
changes per hour). A complete rodent diet for growing
animals ALTROMIN 1314 (Soy- and alfalfa-free ALTRO-
MIN GmbH, Lage, Germany) and acidified tap water (to
prevent microbial growth) were provided ad libitum.
On the day after arrival (GD4), the dams were pseu-
dorandomly distributed into groups of eight animals with
similar body weight (bw) distributions. Mixtures were
administered by gavage from GD7 to the day before
expected birth (GD21) and from pup day (PD) 1 until
PD13. However, as most of the exposed dams in study 1
were unable to give birth, only dams from study 2 were
dosed from PD1 to PD13.
The substances used were corn oil (vehicle)
(Sigma-Aldrich, Brøndby, Denmark), and procymidone,
epoxyconazole, tebuconazole, mancozeb and prochloraz.
All chemicals were purchased in a technical quality from
VWR- Bie & Berntsen (Herlev, Denmark).
The composition of the pesticide mixture (Pmix) was
chosen according to the doses of each individual pesticide
that caused no major effects on pregnancy length and
pup survival in our earlier studies (Vinggaard et al.,
2005a; Taxvig et al., 2007). The animals were dosed with
vehicle (control) or 25, 50, 75, 100 or 125% of Pmix (see
Table 1). The doses used in study 1 were 75, 100 and
125%, whereas the doses studied in study 2 were 25 and
50% of Pmix. However, the dams dosed with 125% of
Pmix exhibited signs of acute neurotoxicity after 2 days
of dosing. Consequently, the dose was decreased to 100%
of Pmix and the dams were included in the 100% group.
The dams were inspected twice a day for general toxicity
Table 1 Doses of the five pesticides in mg ⁄ kg ⁄ day in the Pmix doses
Pesticide
Pmix-
25%
Pmix-
50%
Pmix-
75%
Pmix-
100%
Pmix-
125%
Epoxiconazole 3.75 7.50 11.25 15.00 18.75
Mancozeb 6.25 12.50 18.75 25.00 31.25
Prochloraz 8.75 17.50 26.25 35.00 43.75
Tebuconazole 12.5 25.00 37.50 50.00 62.50
Procymidone 12.5 25.00 37.50 50.00 62.50
Pestimix, total 43.75 87.5 131.25 175.00 218.75
The mixture ratio was based on doses causing no effects on gestation
lengths for the individual pesticides, i.e. Pmix-100%.
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including changes in clinical appearance (e.g. sedation
and tremor). Body weights were recorded on GD4 and
daily during the dosing period to monitor a decrease or
increase in weight gain and the number of pregnant dams
is presented in Table 2.
The animal studies were performed under conditions
approved by the Danish Agency for Protection of Experi-
mental Animals and by the in-house Animal Welfare
Committee.
Delivery and post-natal development
In study 1, all control animals gave birth as expected on
GD22–23, whereas most of the exposed dams exhibited
severe problems with parturition. It was therefore decided
to end the study on GD25 and perform caesarean section
on animals that had not yet given birth. The dams that
had already given birth and their pups were sacrificed the
same day. The dams were weighed and decapitated after
CO2 ⁄O2 anaesthesia, uteri were taken out, and the num-
ber of live or dead fetuses, resorptions and implantations
were registered.
The weights of dams and individual pups were
recorded after delivery both in the animals in study 1
which were able to give birth and in all the pregnant
animals in study 2. The pups were counted, sexed and
checked for anomalies. Pups found dead were macroscop-
ically investigated for changes when possible. The
expected day of delivery, GD23, was designated pup
day (PD) 1 for the pups. Thereby, the age of the pups
was not related to the time of conception, but was rather
similar to post-natal age as the animals gave birth on
GD22–24. Body weight of offspring in study 2 was
recorded on PD6 and 13.
Anogenital distance and nipple retention
Anogenital distance (AGD) was measured in the offspring
at birth (PD1) using a stereomicroscope. On PD13, all
male and female pups were examined for the presence of
areolas ⁄nipples (NR), described as a dark focal area (with
or without a nipple bud) located where nipples are nor-
mally present in female offspring. Female rats normally
have 12–13 nipples.
Section PD13, organ weights and assessment of malforma-
tions in male external genitalia
The animals were weighed and decapitated after CO2 ⁄O2
anaesthesia. Testis, epididymis, ventral prostate, seminal
vesicles, and liver were excised and weighed from one
male per litter. From one female per litter, the uterus and
ovary were excised and weighed. The external genitalia of
all male offspring were inspected for genital dysgenesis
and scored on a scale from 0 to 3, with the observer being
blinded with respect to dose group. The scores were:
Score 0 (no effect): Normal genital tubercle, with the
urethral opening found at the tip of the genital tubercle
and the preputial skin intact.
Score 1 (mild dysgenesis of the external genitals): A
small cavity on the inferior side of the genital tubercle or
a minor cleft in the preputial opening was observed, esti-
mated 0.5–1.4 on an arbitrary scale. The size of the geni-
tal tubercle was decreased.
Table 2 Pregnancy and weight data
Controla + b Pmix-25%b Pmix-50%b Pmix-75%a Pmix-100%a
No. pregnant dams 8 4 8 7 14
Maternal bw gain GD7–21 (g) 83.4 ± 3.8 82.6 ± 3.4 74.4 ± 4.7 75.0 ± 10.0 53.7 ± 6.9**
Maternal bw gain GD7–PD1 (g) 9.3 ± 1.8 4.8 ± 3.5 4.9 ± 3.5 – –
Gestational length (d) 23 ± 0.0 23.5 ± 0.1* 24.1 ± 0.2** 24.8 ± 0.1** 24.6 ± 0.2**
Pup perinatal mortality (%) 7.7 ± 3.6 15.7 ± 12.9 72.8 ± 10.7** 93.9 ± 2.8** 92.8 ± 4.4***
Birth weight, male pups (g) 6.3 ± 0.2 6.2 ± 0.3 6.0 ± 0.1 – –
Birth weight, female pups (g) 6.1 ± 0.1 6.0 ± 0.2 5.5 ± 0.03** – –
Prostate weight (mg) 5.8 ± 0.4 3.6 ± 0.4* 2.1 ± 0.3* – –
Left testis weight (mg) 36.9 ± 1.6 33.3 ± 2.5 33.7 ± 1.9 – –
Right testis weight (mg) 36.0 ± 2.0 33.2 ± 3.0 33.0 ± 1.6 – –
Epididymis weight (mg) 23.6 ± 0.5 17.4 ± 1.6* 14.9 ± 1.2* – –
Uterus weight (mg) 17.1 ± 2.4 14.0 ± 1.3 12.1 ± 2.0 – –
Liver weight – male pups (g) 0.64 ± 0.03 0.69 ± 0.09 0.85 ± 0.1* – –
Liver weight – female pups (g) 0.61 ± 0.02 0.7 ± 0.06 0.72 ± 0.01** – –
Liver weight dams (g) 10.4 ± 0.3 12 ± 0.4 11.2 ± 0.2 – –
Data represent group means, based on litter mean ± SEM.
*p < 0.05, **p < 0.01 and ***p < 0.0001.
Birth weight was analysed using the number of offspring as a covariate; organ weights were analysed using body weight as a covariate.
–, no data because of caesarean section in the groups Pmix-75% and Pmix-100%.
aStudy number 1; bStudy number 2; a + bThe control group is representing both study 1 and 2.
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Score 2 (moderate dysgenesis of the external genitals):
The preputial cleft was larger, estimated 1.5–2.4 on an
arbitrary scale. The urethral opening was situated half-
way down towards the base of the genital tubercle
(hypospadias).
Score 3 (severe dysgenesis of the external genitals): The
preputial cleft was large, estimated 2.5–3.5 on an arbitrary
scale. The urethral opening was situated further than
half-way down the inferior side of the genital tubercle to
the base of the genital tubercle (hypospadias). At the base
of the genital tubercle, a groove extending laterally was
observed (similar to control females at PD13).
Hormone analysis
Progesterone were analysed in serum from 1–5 male and
1–3 female pups in 4–5 litters pr. dose group at PD13.
Testosterone and estradiol were analysed in serum from 1
to 3 male or 1 to 3 female pups in 3–5 litters respectively.
Serum from the pups in each litters were pooled by sex.
Testosterone, estradiol and progesterone were extracted
from the serum as previously described (Vinggaard et al.,
2005b) and the hormones were measured by time-resolved
fluorescence using commercially available fluoroimmuno-
assay kits (PerkinElmer Life Sciences, Turku, Finland).
Statistics
For all analyses, the alpha level was set at 0.05 and the lit-
ter was the statistical unit. Data were examined for nor-
mal distribution and homogeneity of variance, and if
relevant, transformed. In cases where normal distribution
and homogeneity of variance could not be obtained by
data transformation, a non-parametric Kruskall–Wallis
test was used, followed by Wilcoxon’s test for pair wise
comparisons. Data with normal distribution and homoge-
neity of variance were analysed using analysis of variance
(anova). When more than one pup from each litter was
examined, statistical analyses were adjusted using litter as
an independent, random and nested factor in anova.
Birth weights were analysed using the number of off-
spring per litter as covariate and organ weights were
analysed using body weight as a covariate.
Anogenital distance data were analysed by the
calculated AGD-index, namely, AGD divided by the cube
root of body weight. The cube root was used because this
converts a three-dimensional end point (weight) into a
one-dimensional such as the AGD (Gallavan et al., 1999;
Gray et al., 1999).
Analysing the level of demasculinization of male pups,
the scores were categorized into a binary variable with
scores 0 and 1 (no hypospadias) and scores 2 and 3 (mild
and severe hypospadias). Statistical analyses of the effects
on level of demasculinization were performed using
Fisher’s exact test.
The number of nipple ⁄ areolas was assumed to follow a
binomial-distribution with a response range between 0
and hmax, with hmax being equal to the biologically possible
maximal number of nipples in rats, either 12 or 13. The
choice of hmax was decided on considering the global fit
(information criterion of Schwarz). To account for litter
effects on NR, correlation structures between number of
nipple ⁄ areolas and litter were modelled by the Generalized
Estimating Equations method as in Hass et al. (2007). All
statistical analyses were performed using the sas procedure
PROC GENMOD (SAS Institute Inc, Cary, NC, USA).
Results
Pregnancy data and post-natal survival
There were no significant effects on maternal body weight
gain from GD7–21 and GD7–PD1 in dams exposed to
Pmix-75% or lower (Table 2). However, maternal body
weight gain from GD7–21 in dams exposed to the highest
dose of the mixture (Pmix-100%) was significantly
decreased (Table 2).
Gestation length was significantly increased in all dosed
groups (Table 2) and 5 of 7 dams in Pmix-75% and 9 of
14 dams in Pmix-100% were unable to give birth and
had to be sacrificed on GD25 (Fig. 1a).
The number of liveborn pups significantly decreased
and the perinatal pup loss was significantly increased at
Pmix-50% and higher when compared with controls
(Table 2, Fig. 1b). No effects on birth weight were
observed in male pups compared with controls, whereas
the female pups exposed to mix-50% had a significantly
decreased birth weight (Table 2).
No data are shown on birth weight in pups exposed to
mix-75% and mix-100%, as there were too few live pups
to asses this end point properly.
AGD and NR
It was only possible to record AGD in a few litters in
study 1 as most of the dams were unable to give birth
(data not shown). In study 2, the mixture produced dose-
dependent changes in AGD index with a significant
increase seen in females and a decrease in males (Fig. 2a).
Nipple retention was significantly and dose-dependently
increased in male pups in both groups exposed to the
mixture i.e. Pmix-25% and Pmix-50% (Fig. 2b).
Autopsy, organ weight and dysgenesis PD13
No effects were observed on weight of the testes or the
uterus in male and female offspring respectively. Weights
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of prostate and epididymis in male pups were decreased
in Pmix-25% and Pmix-50% exposed animals (Table 2).
The liver weights of both male and female pups were ele-
vated in the Pmix-50%-treated animals, but no effects
were observed on liver weights of the dams (Table 2).
The incidence of hypospadias was increased with
increasing dose (Fig. 2c). In the Pmix-25%, the males had
either no, mild or moderate dysgenesis (score 0–2),
whereas all of the males in the Pmix-50% group showed
severe dysgenesis of the genitalia (score 3). No animals in
the control group showed any malformations.
Hormone levels
No statistically significant effects of exposure of Pmix (25,
50%) on progesterone, testosterone or estradiol serum
levels were revealed in dams, male or female pups
(Table 3). However, large standard deviations and the
small number of samples may conceal any real effects.
Discussion
The aim of these range-finding studies was to assess
whether there would be joint effects on pregnancy length
and pup survival when the five pesticides were present at
doses that individually did not produce observable effects
on these endpoints in our earlier studies. Moreover, an
aim was also to find the dose that should be the highest
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dose in a later large dose response study. Detailed
molecular and endocrine analyses were not performed in
the current study because of the limited group sizes, but
will be targeted in a larger study.
Overall, the findings showed clearly that the combined
exposure induced severe effects manifested as dystochia
(impaired parturition) and high perinatal pup mortality.
Effect on gestation length was evident in all exposed
groups, including the lowest mixture dose, where
each pesticide was present at 25% of the doses that
individually previously had not caused effect on gestation
length. The effect is probably because of the presence of
the three azole fungicides in the mixture, which have pre-
viously been shown to elicit such effects (Noriega et al.,
2005; Vinggaard et al., 2006; Taxvig et al., 2007). The
prolonging of the gestation period may possibly be as a
result of an increase in progesterone in the dams as
suggested for prochloraz, epoxyconazole and tebuconazole
(Vinggaard et al., 2005a; Taxvig et al., 2007).
The dystochia and pup mortality seen in the present
studies have previously been observed as common effects
of several of the azole fungicides (Wolf et al., 1999; Moser
et al., 2001; Noriega et al., 2005; Taxvig et al., 2007). Nei-
ther mancozeb nor procymidone has earlier been shown
to cause effects on pregnancy length or perinatal survival
at the doses studied (Metzdorff et al., 2007; Axelstad,
Christiansen & Hass, unpublished data from our labora-
tory). In our large follow-up study, we will aim to avoid
dystochia by including the Pmix-25% dose group as the
highest exposure group. Another possible way to avoid
dystochia without reducing the exposure level would be
to stop the dosing of the animals for some days before
expected birth. However, as increased pregnancy length is
also an important endpoint for endocrine disrupters, we
have not chosen this approach. We thereby have also
selected the most human relevant dosing period, as pesti-
cides are environmental contaminants that humans can
be exposed to throughout pregnancy.
The observed anti-androgenic effects on the sexual
differentiation of the male offspring seen as decreased
AGD, nipple retention, decreased prostate and epididymis
weight and hypospadias are likely because of the
combined exposure to the three azole fungicides and pro-
cymidone as similar effects to some extent have been seen
for the individual pesticides in our earlier studies and by
others (Ostby et al., 1999; Wolf et al., 1999; Noriega et al.,
2005; Vinggaard et al., 2005a; Laier et al., 2006; Hass et al.,
2007; Taxvig et al., 2007; Christiansen et al., 2009).
Prochloraz caused increased AGD at 50 mg ⁄ kg and
nipple retention at 30mg ⁄ kg in male offspring (Vinggaard
et al., 2005a; Laier et al., 2006). Genital malformations
were observed at 150 mg ⁄ kg prochloraz, but no effects on
epididymis or prostate were found at the same dose
(Laier et al., 2006; Christiansen et al., 2009). Prochloraz is
also able to induce increased testicular progesterone
concentrations in male rat foetuses (Vinggaard et al.,
2005a; Laier et al., 2006; Blystone et al., 2007). Recent
studies suggest a previously unidentified role for the
progesterone receptor, possibly interacting with the
androgen receptor, in disturbed genital tubercle develop-
ment (Willingham et al., 2006).
Tebuconazole caused nipple retention at 50 and
100 mg ⁄ kg ⁄day, whereas epoxyconazole did not induce
observable nipple retention at 15 and 50 mg ⁄ kg ⁄day
(Taxvig et al., 2007). Decreased weight of prostate, but
not epididymis, has been observed at 50 mg ⁄ kg epoxyco-
nazole, whereas tebuconazole did not affect prostate or
epididymis weights up to 100 mg ⁄kg in studies performed
in our laboratory (Taxvig et al., 2007).
Procymidone has in our laboratory induced decreased
AGD and nipple retention at 25 mg ⁄ kg ⁄day, but not at
10 mg ⁄ kg ⁄day, while a decreased prostate weight was
observed at 10 mg ⁄ kg (Hass et al., 2007; Metzdorff et al.,
2007). No hypospadias was observed at 25 mg ⁄ kg in adult
male rats or at 14.1 mg ⁄kg in immature male rats
(Metzdorff et al., 2007; Christiansen et al., 2008).
In a similarly designed study in our laboratory,
Mancozeb has not shown effects on NR and AGD at
doses below 100 mg ⁄ kg (Axelstad, Christiansen & Hass,
unpublished data from our laboratory).
Thus, the individual doses (Table 1) of each of the
three azole fungicides and mancozeb in the pesticide mix-
ture Pmix-25% were clearly lower than those causing no
effects on male sexual differentiation, whereas the dose of
procymidone was close to this dose level (12.5 mg ⁄ kg).
The increased AGD observed in the female offspring
is likely to be caused by the combined exposure to the
three azole fungicides as our earlier studies have docu-
mented similar effects of prochloraz, epoxyconazole and
tebuconazole (Laier et al., 2006; Taxvig et al., 2007). This
effect may be caused by increased progesterone levels in
Table 3 Hormone levels in study 2
Control Pmix-25% Pmix-50%
Progesterone levels,
males (nM)
0.7 ± 0.4 1.5 ± 0.4 1.3 ± 0.7
Progesterone levels,
females (nM)
1.2 ± 0.5 0.9 ± 0.8 0.7 ± 0.2
Progesterone levels,
dams (nM)
129.5 ± 44.5 95.0 ± 25.4 82.5 ± 65.6
Testosterone levels,
males (nM)
0.3 ± 0.1 0.3 ± 0.2 0.7 ± 0.4
Estradiol levels,
females (nM)
0.03 ± 0.01 0.04 ± 0.02 0.03 ± 0.01
Data represent group mean, based on pooled serum ± SD, N = 3–5
litters in each group.
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the dams (Willingham et al., 2006). The progesterone as
well as testosterone and estradiol levels in the current
study were not significantly changed in the dams or in
the pups, but this may be as a result of the low number
of samples taken in this range finding study with a lim-
ited number of litters per group.
Prostate and liver weights were reduced in the present
study and it would be relevant to measure changes in
gene expression in these organs. In the prostate,
androgen-regulated genes such as ornithine decarboxylase
and Prostate binding protein subunit C3 (PPB C3) are
known to be altered by anti-androgenic compounds
(Nellemann et al., 2005). Hepatic expression of growth
hormone as well as drug metabolizing enzymes is sexually
dimorphic and may be altered by xenobiotics (Waxman
& Holloway, 2009). As mentioned above, detailed molec-
ular and endocrine endpoints will be addressed in a later
study with more litters per group.
In conclusion, the findings from these range-finding
studies showed that combined exposure to the five pesti-
cides induced marked adverse effects on parturition and
pup survival at doses where the individual pesticides
appear to induce no such effects. The significance of these
findings for human risk assessment must be emphasized
because they clearly indicate that risk assessment based on
single endocrine disrupters alone underestimates the risk
for adverse effects when exposure is to several pesticides
with common effect outcomes regardless of mechanism.
The sexual differentiation of the offspring was also
significantly affected. However, based on a range-finding
study with a limited number of litters, only cautious
conclusions can be drawn. Consequently, sexual differen-
tiation of the offspring, as well as the predictability of the
combination effects based on dose-additivity modelling, is
currently studied more thoroughly in a large mixture
dose-response study in our laboratory.
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Panel discussion
Ana Soto (Boston, USA)
In your 5 chemical mixture experiment with antiandrogens on fetal
rats you observed decreased anogenital distance (AGD) in males and
increased AGD in females. What is the mechanism causing this effect
in females?
Ulla Hass (Søborg, Denmark)
Not many such studies have been performed in females and the
mechanisms are unknown. It is hypothesised that these chemicals in
addition to their antiandrogenic effect also have very weak androgenic
activity. They bind to the androgenic receptor (AR) but have a very
poor stimulatory effect. In males, the binding to AR competes with the
much more strongly acting testosterone and therefore the receptor is
blocked causing reduced AGD. In the females where there is no testos-
terone, the weak androgenic activity causes increased AGD. This is one
possibility but more research is required and the role of progesterone
must also be considered.
Fred vom Saal (Columbia, USA)
Literature from the 1970s described elongated AGD in female rodents
developing in utero between two males. The testosterone in the females
come from the rodent placenta which, unlike the human placenta, has
no aromatase activity and has high levels of C17-20 lyase and 17b
hydroxylase: the major sex steroids from the rodent placenta are andros-
tenedione and testosterone, and not progesterone. Pregnant rodent
females have serum levels of >1ng ⁄ ml testosterone, and 10ng ⁄ ml
androstenedione. The AGD can be reduced in these masculinised rodent
fetuses by antiandrogens such as flutamide or cyproterone acetate.
Papers on this finding have been published by Clemens and myself.
Ulla Hass
Thank you for that valuable information which we shall now be asses-
sing.
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Vasantha Padmanabhan (Ann Arbor, USA)
John Marshall has studied the interaction of progesterone and andro-
gen in the human polycystic ovary syndrome. Progesterone is a major
negative feedback regulator of LH. High androgen levels such as seen
in PCOS can reduce sensitivity to progesterone. A similar scenario
may occur in your studies. You are looking at several antiandrogens in
unison. Have you plans to assess the response to antiandrogenic with
androgenic, or antiandrogenic with oestrogenic EDCs in combination
as occurs in real life situations?
Ulla Hass
We are about to test the Contamed mix, which is a mixture of antian-
drogen and oestrogen; but not antiandrogen with androgen because I
am unaware of environmental pollutants which are androgenic and
therefore this might not be of relevance.
Niels E Skakkebæk (Copenhagen, Denmark)
Your hypothesis concerning increased AGD in females is supported by
older studies performed in the 1970s using cyproterone acetate (CA)
which showed weak virilisation effects on female fetuses when the
pregnant dams were exposed to CA.
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a b s t r a c t
Thepresent study investigatedwhether amixtureof lowdosesofﬁveenvironmentally relevant endocrine
disrupting pesticides, epoxiconazole, mancozeb, prochloraz, tebuconazole and procymidone, would
cause adverse developmental toxicity effects in rats. In rat dams, a signiﬁcant increase in gestation length
was seen,while inmale offspring increased nipple retention and increased incidence and severity of geni-
talmalformationswere observed. Severemixture effects on gestation length, nipple retention and genital
malformationswere seen at dose levelswhere the individual pesticides causedno or smaller effectswhen
given alone. Generally, the mixture effect predictions based on dose-additivity were in good agreement
with the observed effects. The results indicate that there is a need for modiﬁcation of risk assessment
procedures for pesticides, in order to take account of the mixture effects and cumulative intake, because
of the potentially serious impact of mixed exposure on development and reproduction in humans.
© 2012 Elsevier Inc. All rights reserved.
1. Introduction
The high prevalence of disorders related to the endocrine
system, e.g. hormone-dependent cancers, fertility problems and
congenital malformations of reproductive organs, is a point of
increasing concern in the western world [1,2]. Many genetic, envi-
ronmental and lifestyle factors may be involved in these adverse
effects, one of thempossibly being exposures to endocrine disrupt-
ing chemicals (EDCs).
Currently, risk assessment of chemicals including pesticides is
based on the no observed adverse effect levels (NOAELs) for effects
of single compounds. Based on results from animal studies, expo-
sure to single endocrine disrupting chemicals (EDCs) generally
does not cause concern for adverse reproductive effects in humans.
Humans are, however, exposed to a mixture of several EDCs [3,4],
and during the last decade, scientiﬁc and regulatory focus has grad-
ually begun shifting towards examining the effects of mixtures.
∗ Corresponding author. Tel.: +45 35 88 70 44; fax: +45 35 88 70 01.
E-mail address: ulha@food.dtu.dk (U. Hass).
Since 2005 the European Union member states have for example
been obliged to evaluate and if possible reﬁne existing methodolo-
gies in order to take combined actions of pesticides into account
during risk assessment and especiallywhenestablishingmaximum
residue levels (MRLs) [5].
In studies where experimental animals have been exposed to
several endocrine disrupters simultaneously, substantial mixture
effects on reproductive development have been seen even though
each of the individual EDCs were present at low, ineffective doses
[6–8]. In addition, there are indications that cumulative exposure
to EDCs including pesticides may play a role in relation to effects
on human development, as epidemiological studies have reported
increased prevalence of cryptorchidism in sons of women work-
ing as gardeners [9] or living on farms where pesticides have been
used [10,11]. Furthermore, epidemiological studies have found
associations between cryptorchidism and hypospadia and total
estrogenic load measured in mother’s placenta extracts [12], and
association between congenital cryptorchidism and levels of cer-
tain organochlorine pesticides in breast milk [13]. Swan et al. [4]
found that decreases in anogenital distance amongmale infants are
associated with prenatal phthalate exposure, and Pierik et al. [14]
0890-6238/$ – see front matter © 2012 Elsevier Inc. All rights reserved.
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identiﬁed paternal exposures to pesticides and smoking as factors
associated with these congenital malformations. Thus, it is impor-
tant to bear in mind that exposures to endocrine disrupters may
contribute to a combined adverse effect, even though the effects
of the single compounds are undetectable [6,8,15]. The ﬁndings
from animal mixture studies should have major implications for
the human risk assessment of EDCs, as they imply that the current
use of NOAELs for single chemicals may lead to an underesti-
mation of the potential risk for humans exposed to mixtures of
chemicals.
A wide range of pesticides is suspected to act as endocrine dis-
rupters, and there can be many different mechanisms causing the
observed effects in animal studies. The ﬁve presently investigated
pesticides, epoxiconazole, mancozeb, prochloraz, tebuconazole
and procymidone, were selected based on information on pesticide
use in Denmark and within the EU, and on their endocrine disrupt-
ingactivity andeffects. Procymidonecompetitively antagonizes the
binding of androgens to the androgen receptor, and therebymainly
affects the reproductive development in male offspring [16,17].
Common featuresof theazole fungicides epoxiconazole, prochloraz
and tebuconazole are that they increase gestational length in dams,
virilize female pups and affect steroid hormone levels in fetuses
and/or dams [18–20]. Mancozeb acts mainly via disruption of the
thyroid hormone system and is therefore suspected of disrupting
brain development [21,22].
The applied extended developmental toxicity model in rats has
previously been employed by our group to characterize the effects
of developmental exposure to EDCs onmale offspring, and detailed
mixture experiments have revealed that statistically signiﬁcant
mixture effects can be observed when anti-androgenic chemicals
are combined at levels below their individual NOAELs [6,7]. Before
initiating the experimental study presented here, the mixture ratio
and dose levels of the individual pesticides were chosen based on
earlier obtained dose–response relationships for each of the ﬁve
pesticides. Hereafter, range-ﬁnding studieswere performed to ﬁnd
a combined dose that represented the pesticides at doses close to
their individualNOAELs,without causingmajor effects on the preg-
nant animals or on pup survival. Data from these range-ﬁnding
studies are presented in Jacobsen et al. [23] and were used to set
the dose levels of the mixture and of the individual compounds.
Three different doses of the pesticide mixture and two doses of
the individual pesticides were investigated in pregnant rat dams,
and gestation length as well as anogenital distance, nipple reten-
tion and incidence of congenital malformations in the offspring
were registered. Based on single chemical dose–response curves
obtained in both previous and the present study, the effects of the
pesticide mixture were predicted using the mathematical models
dose-addition and independent action. Other endpoints sensitive
to endocrine disruption, such as reproductive organ weights and
histopathology, semen quality and a wide range of neurobehav-
ioral endpointswere alsomeasured in the study, and are presented
in Jacobsen et al. [24]. Furthermore, chemical analysis of the pes-
ticides in blood samples from dams and offspring were used for
evaluating if mixture exposure and exposure to the single pes-
ticides would lead to comparable blood levels. These results are
presented in Herrmann et al. [25].
One goal of mixture toxicology is to estimate the toxicities of
untested mixtures of chemicals on basis of information on indi-
vidual components. For predicting combined effects of the ﬁve
pesticides, we assumed that each pesticide in the mixture did
not exacerbate or diminish the effects of the other pesticides. The
choice of an appropriate model for calculation of additivity expec-
tations is essential for assessments of mixture effects, because it
is in relation to these additivity expectations that combination
effects are judged in terms of synergisms or antagonisms [26].Mix-
ture effects according to “additivity” assumptions can be calculated
by using two alternative concepts, dose addition and independent
action. Dose addition looks atmixture effects in terms of a “dilution
principle”. It assumes that one chemical canbe replaced totally or in
part by an equal fraction of an equi-effective dose of another, with-
out diminishing the overall combined effect [27]. Dose addition is
often used for mixtures composed of chemicals that act through a
similar or common mode of action [28–32]. Its application to the
present mixture of ﬁve pesticides appeared justiﬁed because all
pesticides are endocrine disruptors and – apart from mancozeb –
produce a common effect outcome, i.e. anti-androgenic effects in
male offspring. However, it can be argued with equal justiﬁcation
that the similarity assumption for dose addition is not applicable
to the chosen mixture because the pesticides produce their effects
by a diversity of molecular mechanisms. For this reason, we also
employed the alternative concept of independent action to esti-
mate additivity expectations. Independent action assumes that the
joint effects of a combination of agents can be calculated by adopt-
ing the statistical concept of independent events [33]. It is viewed
as appropriate for mixtures of chemicals with diverse modes of
action [28], however, dose addition and independent action often
yield additive mixture effect predictions within the same range.
The overall aim was to explore whether a mixture of environ-
mentally relevant endocrine disrupting pesticides with dissimilar
modes of action would cause adverse developmental toxicity
effects in rats at dose levels below NOAELs for the individ-
ual pesticides. Furthermore, the aim was to investigate whether
dose-additivity or independent action predictions of the expected
mixture effects resulted in useful estimates compared to the
observed mixture effects for relevant endpoints. The mixture and
the single pesticides were also investigated using in vitro assays, in
order to compare these results with those from the rat study, and
evaluate the usability of alternative in vitro methods for estimating
potential mixture effects.
2. Materials and methods
2.1. Chemicals
The ﬁve pesticides usedwere epoxiconazole (CAS no. 106325-08-8, purity 99.0),
mancozeb (CAS no. 8018-01-7, purity 76.0), prochloraz (CAS no. 67747-09-5, purity
98.5), tebuconazole (CAS no. 107534-96-3, purity 98.5) and procymidone (CAS no.
32809-16-8, purity 99.5). All chemicals were purchased in a technical quality from
VWR-Bie&Berntsen,Herlev, Denmark. Corn oil (Sigma–Aldrich, Brøndby,Denmark)
was used as vehicle.
2.2. Animals and exposure
The animal studies were performed under conditions approved by the Danish
Animal Experiments Inspectorate and by the in-house Animal Welfare Committee.
The study included 198 time-mated nulliparous, young adult animals (Han-
Tac:WH, Taconic Europe, Ejby, Denmark) distributed to 14 groups of animals. It
was performed in 4 blocks with a week between each block and the 14 groups were
as equally as possible distributed among the 4 blocks. The animals were housed
in pairs until GD (Gestation Day) 18 and alone thereafter under standard condi-
tions in semi-transparent polycarbonate cages (15 cm×27 cm×43 cm) with Aspen
bedding (Tapvei, Denmark) situated in an animal room with controlled environ-
mental conditions (12h light–dark cycleswith light starting at 9p.m., light intensity
500 lx, temperature 21±2 ◦C, humidity 50%±5%, ventilation 8 air changes per h).
A complete rodent diet for growing animals ALTROMIN 1314 (Soy- and alfalfa-free
ALTROMIN GmbH, Lage, Germany) and acidiﬁed tap water (to prevent microbial
growth) was provided ad libitum. The animals were observed twice daily for signs
of toxicity and body weights were recorded daily during the dosing period.
On the day after arrival, at gestation day (GD) 4, the time-mated animals were
pseudorandomly distributed into groups with similar body weight (bw) distribu-
tions. Theywere given fourdays after arrival to adapt to the reversed light-dark cycle
before beginning the exposure. Independently of actual dayof delivery, the expected
day of delivery, GD 23, was designated pup day (PD) 1 for the pups. Thereby, the age
of the pups related to the time of conception, butwas rather similar to postnatal age.
Dams were dosed daily by gavage, from GD 7 to 21 and from the day after birth to
pup (PD) 16, and were treated at a constant volume of 2ml/kg/day, with individual
doses based on the body weight of the animal on the day of dosing.
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Table 1
Doses of the pesticides administered individually and in mixture to pregnant rat dam from GD (gestation day) 7 to PD (pup day) 16 (in mg/kg bw/day) and number of dosed
time-mated rats (dams with viable litters) in each group.
Group na Epoxiconazole Mancozeb Prochloraz Tebuconazole Procymidone Pesticide mixture
1: Control 22 (15) – – – – – –
2: Pestimix-14.6 22 (17) 1.25 2.08 2.92 4.17 4.17 14.6
3: Pestimix-29.2 22 (9) 2.5 4.17 5.83 8.33 8.33 29.2
4: Pestimix-43.8 22 (14) 3.75 6.25 8.75 12.5 12.5 43.8
5: Epoxi-3.75 12 (8) 3.75 – – – –
6: Epoxi-15 10 (4) 15 – – – –
7: Manz-6.25 12 (5) – 6.25 – – –
8: Manz-25 10 (7) – 25 – – –
9: Prchl-8.75 12 (8) – – 8.75 – –
10: Prchl-35 10 (4) – – 35 – –
11: Tebu-12.5 12 (8) – – – 12.5 –
12: Tebu-50 10 (6) – – – 50 –
13: Procy-12.5 12 (7) – – – – 12.5
14: Procy-50 10 (4) – – – – 50
Epoxi: epoxiconazole; Manz: mancozeb; Prchl: prochloraz; Tebu: tebuconazole; Procy: procymidon.
a The large difference between the number of exposed time-mated rats and dams with viable litters was mainly due to unusually low pregnancy rate from the animal
breeders and not to high rates of pre- and postnatal mortality in the offspring.
2.3. Mixture composition
To design the mixture of the ﬁve pesticides, developmental toxicity data from
previous studieswith each of the pesticideswere used. Themixture ratio for the ﬁve
pesticides was chosen based on the dose–response relationship and the NOAEL for
effects on increased gestation length in dams andperinatalmortality in the offspring
in previous studies in our laboratory (Supplemental Material Table X1). Epoxicona-
zol, prochloraz and tebuconazol cause effects on pregnancy length and perinatal
survival. The effects on perinatal mortality at the LOAELs were more marked for
epoxiconazol and tebuconazol than for prochloraz. Based on this the doses cho-
sen for epoxiconazol and tebuconazol in the mixture were their NOAELs for these
effects, whereas a slightly higher dose of 35mg/kg/day was chosen for prochloraz.
Neithermancozeb nor procymidone caused effects on pregnancy length or perinatal
survival at the doses studied. Formancozeb, a dose level of 50mg/kg/day in themix-
ture was initially chosen, because our earlier studies have shown that dose levels
of 150mg/kg/day and higher cause marked acute neurotoxicity in pregnant ani-
mals [21]. Due to acute neurotoxicity in a range-ﬁnding study using non-pregnant
animals the mancozeb dose was decreased to 25mg/kg/day in all of the studies in
pregnant animals. The dose level for procymidone was chosen mainly based on the
anti-androgenic potency in our earlier studies (Supplemental Material Table X1).
Upon choosing the mixture ratio, two range-ﬁnding studies were performed.
The ﬁrst was in non-pregnant animals while the second was in pregnant animals,
and they were performed in order to test for toxicity and endocrine disrupting
effects of various mixture doses [23]. The highest dose of the mixture, which did
not cause maternal toxicity in the range-ﬁnding study in pregnant animals, was
used as starting point for the present study.
In Table 1 the composition of the pesticide mixture, the doses of the pesticides
administered individually and inmixture and the number of litters in each group are
shown. Four groups of 22 time-mated ratswere given daily oral doses of 0, 14.6, 29.2
or 43.8mg/kg/day of the mixture of the 5 pesticides, whereas ten groups of 10 or 12
time-mated rats were similarly dosed with two doses of the individual pesticides.
The lowest dose of each pesticide was similar to the dose included in the highest
mixture dose and the highest dose of the single pesticides was 4 times higher.
2.4. Gestation length, anogenital distance and nipple retention
After delivery, which occurred from GD22 to 24, the weights of dams and indi-
vidual pupswere recorded and thepupswere counted, sexed, checked for anomalies
and anogenital distance (AGD) was measured using a stereomicroscope. Addition-
ally, anogenital index (AGDI), i.e. AGD/cubic root of body weight was calculated for
all offspring. Pups found dead were macroscopically investigated for changes when
possible.Weight of pupswas recorded again on days 6, 13, 22. On PD13, allmale and
female offspring were examined for the presence of areolas/nipples (nipple reten-
tion, NR), described as a dark focal area (with orwithout a nipple bud) locatedwhere
nipples are normally present in female offspring.
2.5. Genital malformations in male offspring
On PD 16 and PD 22, 1–3 male pups per litter were randomly selected for
autopsy. On PD 22 the pups were decapitated in CO2/O2 anesthesia. Male reproduc-
tive organs were examined macroscopically for anomalies and testicular descent
and scored for the degree of external genital malformations on a scale from 0 to 3,
with the observer being blinded with respect to dose group.
The scores were:
Score 0 (no effect): Normal genital tubercle, with the urethral opening found at
the tip of the genital tubercle and the preputial skin intact.
Score 1 (mild dysgenesis of the external genitals): A small cavity on the infe-
rior side of the genital tubercle or a minor cleft in the preputial opening was
observed, estimated 0.5–1.4 on an arbitrary scale. The size of the genital tubercle
was decreased.
Score 2 (moderate dysgenesis of the external genitals): The preputial cleft was
larger, estimated 1.5–2.4 on an arbitrary scale. The urethral opening was situated
half-way down towards the base of the genital tubercle (hypospadias).
Score3 (severedysgenesis of the external genitals): Thepreputial cleftwas large,
estimated 2.5–3.5 on an arbitrary scale. The urethral opening was situated further
than half-way down the inferior side of the genital tubercle to the base of the genital
tubercle (hypospadia). At thebaseof thegenital tubercle agrooveextending laterally
was observed (similar to control females).
Gubernacular length was determined as a measure of testicular descent, as an
increased gubernacular length would indicate cryptorchidism.
All weaned male offspring were scored alive for external genital malformations
shortly after sexual maturation (around PD 50) using a similar scoring system, that
was modiﬁed to reﬂect the development of the external male sex organs.
At the age of approximately 9months, the 1–2males per litter were decapitated
in CO2/O2 anesthesia, and external genitalswere inspected for the following anoma-
lies: descendent testes, alopecia in the perineal area, cleft phallus and hypospadia.
Malformations were scored using a system with 0 denoting the normal and 3 the
most severe changes. The observer was blinded with respect to dose groups.
2.6. Statistics
For all analyses, the alpha level was set at 0.05 and the litter was the statisti-
cal unit. Data were examined for normal distribution and homogeneity of variance,
and if relevant, transformed. In cases where normal distribution and homogene-
ity of variance could not be obtained by data transformation, a non-parametric
Kruskall–Wallis test was used, followed by Wilcoxon’s test for pair wise compar-
isons. Data with normal distribution and homogeneity of variance were analyzed
using analysis of variance (ANOVA). When more than one pup from each litter was
examined, statistical analyseswere adjusted using litter as an independent, random
and nested factor in ANOVA or litter means were used. Where an overall signiﬁcant
treatment effect was observed, two-tailed comparison was performed using least
squaremeansorDunnett. Birthweightswereanalyzedusing thenumberofoffspring
per litter as covariate and AGDwas analyzed using bodyweight as a covariate. Addi-
tionally, anogenital-index (AGDI), i.e. AGD divided by the cube root of body weight,
was analyzed. The cube root was used because this converts a three-dimensional
end point (weight) into a one-dimensional such as the AGD [34].
When analyzing the level of dysgenesis or malformations of external male
organs the scores were categorized into a binary variable with score 0 (normal)
and scores 1, 2 and 3 (mild to severe effect). The results are generally shown both
as number of offspring and number of litters affected per group, because malforma-
tions are rare events that may only affect very few litters. Statistical analysis based
on the litter as unit is therefore rather insensitive and consequently it is current
practice also to include offspring data in the toxicological evaluation. The statistical
analyses of the malformations were done using Fisher’s exact test on litter data.
The number of nipple/areolas was assumed to follow a binomial distribution
with a response range between 0 and max, with max being equal to the biologically
possible maximal number of nipples in rats, either 12 or 13. The choice of max was
decided on considering the global ﬁt (information criterion of Schwarz). To account
for litter effects onNR, correlation structures between number of nipple/areolas and
litter were modeled by the Generalized Estimating Equations method as in Hass
et al. [6]. The number of nipples in the all control group males was zero and it was
therefore necessary to put in 1 nipple in 3 pups from the control group to perform
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the statistical model. All statistical analysis was performed using the SAS procedure
PROC GENMOD.
Asterisks in tables and ﬁgures, indicate a statistically signiﬁcant difference com-
pared tocontrols *p≤0.05; **p<0.01. ***p<0.001.All analyseswereperformedusing
SAS Enterprise Guide 3.0, SAS Institute Inc, Cary, NC, USA.
2.7. Mixture modeling
The data for the single pesticides comprised the raw data from our previous
studies (overview in Supplemental Material Table X1) and the data for both single
pesticides and the mixture obtained in the present study.
Endpoints considered relevant for this modeling were those observed to show
an effect at mixture dose levels at which the individual pesticides when given alone
causednoor signiﬁcantly smaller effects. These endpoints includedgestation length,
anogenital distance in female offspring, nipple retention and genital malformations
in male offspring. The modeling was, however, not done for the latter endpoint due
to lack of sufﬁcient data for the single pesticides.
Data were normalized to the control groups of each year (experiment) so that
year did not have to be included in the model as an extra factor. The effect of year
was tested and either t test or lmein R was used.
The increase in gestation length was normalized to lie between zero and one,
where the mean of the control group was the minimum (0) and the mean of the
control group plus 2 was the maximum (1).
The endpoint nipple retention (NR) was scaled using the mean of the female
controls (approximately 12–12.5). Values larger than this maximum were thresh-
olded to the maximum. After scaling according to the female controls, the controls
were not included in the analyses, but they are plotted in the ﬁgures as reference
points.
The endpoint AGDI in female offspring was transformed for each experiment
to lie between zero and one, scaled with the mean of the female controls as the
minimum value, and the mean of the male controls as the maximum value.
For NR in males and AGDI in females, the same model and ﬁtting method was
used since these endpoints have several observations per litter. First, a binomial
logit curve was ﬁtted to the observations for each of the pesticides. Generalized
Estimating Equations (GEEs) were used to perform the ﬁt [35–37]. This method is
particularly good when accounting for correlations within subject (here litter), but
independence across litters, i.e. the model is based on pup level but taking the litter
effect into account. The variance of the estimates can be incorrect if the correlation
structure is not accounted for. In order to keep the number of parameters to a min-
imum in this model we assumed that the correlation is so called “exchangeable”,
meaning that it is the same for any pair of litters.
The models were ﬁtted using the function gee [38] in the R package gee from
CRAN.
For gestation length, a generalized linear model with a binominal logit (GLM)
was ﬁtted to all observations for the ﬁve pesticides and the pesticide mixture. As
gestation length was measured on dam level, there was only one observation per
litter, and therefore a GLM rather than a GEE was used. The glm() function in the
statistics program R was used for estimation and prediction.
Either a GEE or GLM was ﬁtted to the same endpoints for both single pes-
ticides and the mixture. Two models for prediction were considered. First, the
dose-additivity predictions were estimated. These are deﬁned by the effect dose
of the pesticide mixture:
EDxmixture =
(
p1
EDx1
+ p2
EDx2
+ p3
EDx3
+ p4
EDx4
+ p5
EDx5
)−1
for the effect doses of the ﬁve pesticides in question, and where pi is the pro-
portion of pesticide i in the mixture. The parametric delta method (closely related
to parametric bootstrapping) was performed to estimate the EDxmixture from the ﬁt-
ted models and their variance estimates [39]. The distributions of the parameter
estimates were sampled using the estimated variances of the parameters ˛ and ˇ.
Random normal samples were used to sample new parameters and thereby obtain
predictions using a Monte Carlo sampling strategy assuming a normal distribution
of the parameters ˛ and ˇ. A thousand sampleswere drawn for each parameter, and
a dense grid of the doses was used to estimate the effect doses.
Secondly, the independent actions model [33]:
Exmixture = 1 − (1 − Ex1) × (1 − Ex2) × (1 − Ex3) × (1 − Ex4) × (1 − Ex5)
was likewise estimated using such a Monte Carlo sampling. Here, Exi denotes the
fractional effect (in %) of the ith pesticide, where we have xi = xmixture·pi . Note that
the independent actions formula is given for the effect whereas the dose-additivity
model is given in terms of the effect dose.
The same analyses were also performed with winsorization, as described by
Scholze et al. [40]. This means that the ﬁtting was performed iteratively with obser-
vations which fall outside 3 times the standard deviation of the mean prediction are
adjusted to the value of 3 times the SD and then a new ﬁt is performed etc.
2.8. In vitro assays
The pesticide mixture for the in vitro studies was designed based on the mix-
ture applied for the in vivo studies. The ratio of the 5 pesticides (epoxiconazole,
mancozeb, prochloraz, tebuconazole and procymidone) was:
Epoxiconazole Mancozeb Prochloraz Tebuconazole Procymidone
mg basis 15 25 35 50 50
Molar basis 3 2 6 11 12
2.8.1. Androgen receptor reporter gene assay
The ability of the pesticides to activate the androgen receptor (AR) and to inhibit
androgen-inducedactivationof theARwas tested in anAR reporter geneassaybased
onAR-transfectedChineseHamsterOvary (CHO) cells as describedbyKjaerstad et al.
[41]. The test compounds were tested in triplicates within the range 0.03–30M,
and luciferase activity was measured as described by Kjaerstad et al. [41].
Cytotoxicity experiments were performed as described by Kjaerstad et al. [41].
2.8.2. T-screen for thyroid receptor activity
The T-screen assay was used for in vitro detection of the agonistic and antago-
nistic properties of the test compounds at the level of the thyroid hormone receptor
(TR). The GH3 cells employed in the T-screen assay is a rat pituitary tumor cell line,
which growth is dependent on the thyroid hormone (TH) 3,3′ ,5-triiodothyronine
(T3), and which has a high expression of TR. The growth stimulatory effect of T3
is mediated by speciﬁc, high-afﬁnity TRs that upon binding of THs bind to thyroid
hormone responsive elements (TREs) in the cell nucleus ultimately leading to gene
expression and subsequent cell proliferation [42]. The rat pituitary cell line GH3
were obtained from American type culture collection (ATCC), and the assay was
carried out as described by Taxvig et al. [43].
All compounds or mixtures were tested in triplicate (0, 0.01, 0.375, 1, 3, 10,
and 30M) and were tested both in the absence or presence of 0.22nM T3 (T3-
EC50) to test for agonistic and antagonistic potency. Control wells contained cells
and test medium with the same amount of DMSO [0.1%] as the exposed cells. After
incubation for 96h, cell growthwasmeasured using the dye resazurine [44]. 100l,
of a 0.005mg/ml resazurine solution in PBS,was added to eachwell, and plateswere
incubated 3h at 37 ◦C, protected from light. Fluorescence was measured (excitation
wavelength 560nm/emission. 590nm) on a Wallac Victor 1420 multilabel counter
(PerkinElmer Life Sciences).
2.8.3. Steroid synthesis in the H295R cell line
The pesticides were investigated for effects on the synthesis of estradiol, pro-
gesterone, and testosterone in the human adrenocortical carcinoma cell line H295R
(ATCC, CRL-2128) as described previously [45]. In brief, cells were seeded at a den-
sity of 3×105 cells/well in 24-well culture plates (Costar 3524, Corning, NY, USA)
with DMEM/F12 medium (Gibco, Paisley, UK) supplemented with 2.0% Nu-serum
(BD Sciences Denmark) along with 1% ITS +premix (containing 6.25g/ml insulin,
6.25g/ml transferrin, 6.25ng/ml selenium, 1.25mg/ml BSA and 5.35g/ml linoic
acid; BDSciences Denmark) and incubated for 24h at 37 ◦C in a humidiﬁed atmo-
sphere of 5% CO2/air.
The pesticides were added (1ml) to the cells in triplicates at six concentra-
tions. Control wells contained the same amount of DMSO (0.1%) as exposed cells.
After 48h incubation the medium was removed and stored at −20 ◦C until analy-
sis. Hormones were measured using commercial hormone kits from Wallac Delﬁa
(PerkinElmerDenmark, Hvidovre, Denmark). Cytotoxicity was evaluated by means
of theMTT assay as described byMosman [46],measuring the absorbance at 570nm
after 1.5–2h incubation on a Wallac multilabel 1420 counter.
3. Results
3.1. Pregnancy, litter and offspring data
Pregnancy and litter data are shown in Table 2. There were no
statistically signiﬁcant effects on maternal body weight gain from
GD 7 to GD 21 or from GD 7 to PD 1 in exposed dams compared to
controls. No clinical signs of toxicitywere observed in the dams and
the number of implantation scars in the uterus, postimplantation
and perinatal loss was similar among groups.
Gestation length was signiﬁcantly increased in the two highest
mixture groups (groups 3 and 4) compared to controls (p<0.01 and
p<0.001, respectively) and in thegroupexposed to thehighest dose
of epoxiconazole (p<0.001), but not in any other groups (Table 2).
Offspring data are shown in Table 3. Pup body weights were
unaffected by pesticide exposure at birth and on PD 6, 13 and 22.
Nipple retention inmale offspring, an indication of anti-androgenic
activity,was signiﬁcantly increased in allmixture groups compared
to controls (p<0.001) (Fig. 1). There was also a signiﬁcant increase
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Table 2
Pregnancy and litter data. Data represent group means based on litter means± SD.
Dams and litters 1: Control 2: Pesti-
mix-14.6
3: Pesti-
mix-29.2
4: Pesti-
mix-43.8
5:
Epoxi-3.75
6:
Epoxi-15
7:
Manz-6.25
8:
Manz-25
9:
Prchl-8.75
10:
Prchl-35
11:
Tebu-12.5
12:
Tebu-50
13:
Procy-12.5
14:
Procy-50
No. of dams
(litters)
15 17 10 (9) 15 (14) 8 4 5 7 8 4 8 6 7 4
Maternal weight
gain GD7–GD21
88.1±13.2 88.6±11.6 86.7±8.6 77.1±12.8 87.3±16.1 84.0±21.1 87.4±5.7 84.1±11.4 85.9±9.6 85.0±5.0 85.4±15.6 82.5±10.2 86.6±10.0 85.0±3.7
Maternal weight
gain GD7–PD1
18.5±9.8 17.4±9.5 10.7±8.3 14.6±17.7 22.9±10.2 20.8±9.4 15.4±7.3 13.3±6.5 14.8±4.8 8.8±10.4 11.0±9.6 17.3±15.8 11.6±8.2 6.3±5.5
Body weight gain
PD1–13
33.0±9.5 35.5±9.2 31.2±9.3 22.9±19.0 30.9±9.7 33.5±4.0 34.8±8.6 37.3±3.3 34.7±6.1 36.0±8.4 44.8±9.2 33.7±4.2 39.1±6.5 41.8±11.4
Gestation length
(days)
23.0±0.0 23.0±0.0 23.5±0.5** 23.6±0.5* 23.1±0.4 23.8±0.5* 23.0±0.0 23.0±0.0 23.2±0.4 22.8±0.5 23.0±0.0 23.1±0.2 23.0±0.0 23.0±0.0
% Post-
implantation
loss
11.0±24.9 5.4±6.9 6.4±9.9 16.7±25.9 11.7±11.7 4.0±4.6 0.0±0.0 2.3±4.0 3.7±6.0 1.8±3.6 7.9±10.5 5.5±6.5 13.4±35.1 0.0±0.0
% Perinatal loss 14.9±25.2 7.3±8.6 23.4±28.3 23.3±28.6 13.2±12.6 10.3±15.8 1.8±4.1 3.3±4.2 5.4±7.0 1.8±3.6 8.6±12.3 9.5±5.7 17.3±36.9 1.9 ±3.8
Born alive per.
litter
11.1±2.3 11.9±2.5 11.6±2.4 9.8±2.0 10.4±1.8 8.8±3.7 12.2±1.2 12.9±1.7 11.7±1.8 12.0±1.7 11,8±1.9 11.5±2.5 10.8±3.0 12.8±2.4
% Postnatal death 4.4±9.4 2.1±4.3 17.4±30.8 8.9±18.1 1.8±5.1 6.8±13.6 1.8±4.1 1.0±2.7 1.7±5.1 0.0± .0 1.0±2.9 4.1±6.6 2.0±5.4 1.9±3.9
% Males 48.4±18.8 47.4±17.5 52.4±13.5 51.6±16.3 44.9±28.1 36.0±29.6 49.8±13.7 45,4±12.9 40.2±11.9 54.3±12.7 56.2±15.2 47.4±16.8 44.6±19.6 53.6±17.3
Epoxi: epoxiconazole; Manz: mancozeb; Prchl: prochloraz; Tebu: tebuconazole; Procy: procymidon; Perinatal loss: loss from implantation to weaning; Postnatal death: death after birth.
* p<0.05.
** p<0.01.
Table 3
Offspring data. Data represent group means based on litter means± SD. Mix=mixture.
Offspring (data
from viable litters)
1: Control 2:
pestimix-
14.6
3: pesti-
mix-29.2
4:
Pestimix-
43.8
5:
Epoxi3.75
6:
Epoxi15
7:
Manz-6.25
8:
Manz-25
9:
Prchl-8.75
10:
Prchl-35
11:
Tebu-12.5
12:
Tebu-50
13:
Procy-12.5
14:
Procy-50
Male birth weight (g) 6.5 ± 0.4 6.1 ± 0.4 6.2 ± 0.4 6.4 ± 0.5 6.5 ± 0.2 6.6 ± 0.6 6.2 ± 0.1 6.2 ± 0.2 6.4 ± 0.4 6.3 ± 0.4 6.3 ± 0.4 6.1 ± 0.4 6.2 ± 0.3 6.4 ± 0.3
Female birth weight (g) 6.1 ± 0.4 5.9 ± 0.4 5.9 ± 0.5 6.1 ± 0.6 6.1 ± 0.3 6.3 ± 0.6 6.1 ± 0.2 5.9 ± 0.1 6.0 ± 0.4 6.0 ± 0.4 6.0 ± 0.3 5.9 ± 0.2 6.1 ± 0.2 6.1 ± 0.3
Male AGD (units) 24.5 ± 1.1 23.4 ± 1.2 24.1 ± 1.0 24.0 ± 1.2 25.7 ± 0.9 ***23.9 ± 1.3 23.9 ± 1.0 24.0 ± 0.9 24.8 ± 0.6 24.6 ± 0.7 24.7 ± 1.3 24.6 ± 0.8 22.8 ± 0.9 ** 22.0 ± 0.7 ***
Male AGD/cubic root bw
(AGDI)
13.1 ± 0.5 12.8 ± 0.7 13.1 ± 0.5 12.9 ± 0.4 13.8 ± 0.4 ** 12.7 ± 1.0 13.0 ± 0.6 13.1 ± 0.4 13.4 ± 0.4 13.4 ± 0.4 13.4 ± 0.7 13.5 ± 0.4 12.4 ± 0.4 ** 11.9 ± 0.3 ***
Female AGD (units) 13.6 ± 0.6 13.7 ± 0.8 14.1 ± 0.5 15.0 ± 0.8 *** 14.9 ± 1.0 ** 14.3 ± 0.9 14.2 ± 0.9 13.5 ± 0.5 14.1 ± 0.8 14.5 ± 0.4 * 14.4 ± 1.0 14.5 ± 0.5 * 13.4 ± 0.4 13.3 ± 0.2
Fem. AGD/cubic root bw
(AGDI)
7.4 ± 0.3 7.6 ± 0.5 7.8 ± 0.3 * 8.2 ± 0.3 *** 8.1 ± 0.6 ** 7.8 ± 0.7 7.8 ± 0.5 7.5 ± 0.2 7.8 ± 0.5 * 8.0 ± 0.2 ** 7.9 ± 0.6 * 8.0 ± 0.2 ** 7.3 ± 0.2 7.3 ± 0.2
No. Areolas malesa 0.0 ± 0.0 1.9 ± 1.6*** 3.3 ± 0.9*** 5.3 ± 1.1*** 0.1 ± 0.2 0.5 ± 1.0 0.1 ± 0.1 0.6 ± 0.6* 0.3 ± 0.2 1.7 ± 1.2*** 0.5 ± 0.8 1.6 ± 0.4*** 2.8 ± 1.2*** 6.0 ± 2.0***
No. Areolas. females 12.0 ± 0.4 13.4 ± 3.9 12.4 ± 0.4 12.5 ± 0.4 12.4 ± 0.3 12.8 ± 0.5 12.2 ± 0.1 12.4 ± 0.1 12.3 ± 0.2 12.1 ± 0.2 12.5 ± 0.6 12.2 ± 0.2 12.2 ± 0.2 12.4 ± 0.4
Male body weight PD 6 (g) 12.9 ± 1.3 12.2 ± 1.3 12.0 ± 1.3 12.5 ± 1.5 13.1 ± 0.9 13.2 ± 1.0 12.3 ± 0.7 11.8 ± 0.4 12.7 ± 1.2 12.9 ± 1.7 12.1 ± 1.7 12.3 ± 1.2 12.4 ± 0.7 12.2 ± 1.4
Female body weight PD 6
(g)
12.5 ± 1.2 11.9 ± 1.4 11.6 ± 1.4 11.9 ± 1.3 12.8 ± 1.4 12.2 ± 1.0 12.1 ± 0.6 11.4 ± 0.5 12.1 ± 1.2 12.2 ± 1.7 11.9 ± 1.7 12.1 ± 1.2 12.2 ± 0.7 12.0 ± 1.1
Male body weight PD 13 (g) 26.1 ± 4.1 24.0 ± 2.7 25.1 ± 2.9 26.7 ± 3.9 25.9 ± 3.0 28.0 ± 2.4 24.6 ± 2.4 23.0 ± 1.0 25.6 ± 1.5 24.9 ± 2.7 24.2 ± 2.7 24.8 ± 2.0 24.9 ± 1.0 24.3 ± 2.9
Fem. body weight PD 13 (g) 25.4 ± 3.9 23.7 ± 3.0 24.4 ± 2.8 24.3 ± 4.6 26.0 ± 4.1 26.5 ± 2.2 24.4 ± 2.5 22.7 ± 1.4 24.6 ± 1.8 24.0 ± 2.7 23.9 ± 2.1 24.4 ± 2.4 24.5 ± 1.4 23.6 ± 2.8
Male body weight PD 22 (g) 45.6 ± 6.7 41.5 ± 4.4 44.0 ± 5.6 46.8 ± 7.0 43.3 ± 4.6 46.8 ± 3.5 42.9 ± 4.2 40.4 ± 1.6 43.2 ± 3.3 42.4 ± 5.0 43.0 ± 4.6 43.8 ± 4.5 42.5 ± 1.3 43.0 ± 4.4
Fem. body weight PD 22 (g) 45.2 ± 6.5 41.1 ± 4.2 41.9 ± 3.9 44.8 ± 5.8 46.3 ± 7.7 46.7 ± 3.2 42.6 ± 3.5 40.3 ± 2.2 42.3 ± 4.0 41.3 ± 4.9 42.7 ± 3.4 42.8 ± 4.5 42.4 ± 1.3 41.3 ± 4.9
Epoxi: epoxiconazole; Manz: mancozeb; Prchl: prochloraz; Tebu: tebuconazole; Procy; procymidon.
a The number of nipples in the control group males was zero and it was therefore necessary to put in 1 nipple in 3 pups from the control group to perform the statistical model.
* p<0.05.
** p<0.01.
*** p<0.001.
266 U. Hass et al. / Reproductive Toxicology 34 (2012) 261–274
Fig. 1. Effects of single and combined exposure to procymidone, prochloraz, tebu-
conazole, epoxiconazole and mancozeb on nipple retention in male pups PD 13.
Results shown are group means± standard deviation. See Table 3 for more details.
The number of nipples in female controls is normally 12. ***p-Values are <0.001.
#The difference between Pestimix-43.8 (group 4) and procymidone-12.5 (group13)
is statistically signiﬁcant (p<0.001).
in the groups exposed to the high dose of mancozeb (p<0.05),
prochloraz (p<0.001), tebuconazole (p<0.001) and both doses of
procymidone (p<0.001) (Fig. 1). The magnitude of the effects in
the highest mixture group was signiﬁcantly higher than the effect
induced by the low dose of procymidone (p<0.001), although the
procymidone dose was the same in the two groups.
In the male offspring, no statistically signiﬁcant changes on
anogenital distance (AGD) were seen in the mixture groups. The
data for the single chemical exposures showed that the low dose
of epoxiconazole induced longer AGD in male pups compared to
controls (p<0.01), whereas the high dose had no effect. Both doses
of procymidone induced shorter male AGD (p<0.01, and p<0.001,
respectively). In the female offspring, a dose-dependent increase
in anogenital distance was seen, with signiﬁcantly longer AGDI,
in the two highest mixture groups compared to controls (p<0.05
and p<0.001, respectively). A similar effect was seen in animals
exposed tobothdoses of prochloraz (p<0.05 andp<0.01) and tebu-
conazole (p<0.05andp=0.001) and in thegroupexposed to the low
dose of epoxiconazol (p<0.01) but not in female pups exposed to a
four times higher dose of epoxiconazole (Table 3).
3.2. Genital malformations in male offspring
The results of the scoring of external genital malformations in
male offspring sacriﬁced on PD16 and 22 indicated increased num-
ber and severity of genital malformation in the highest mixture
group and the highest dose of procymidone, but the differences
were not statistically signiﬁcant compared to controls shown in
SupplementalMaterial TablesX2).Noanimalshad increasedguber-
nacular length as an indication of cryptorchidism.
The rest of the male animals were scored for external genital
malformations alive shortly after sexual maturation (around PD
50) and the results were combined for all time points (see Fig. 2
and Table 4). The combined results showed signiﬁcantly increased
number and severity of external genital malformation in the high-
est mixture group (p=0.006) and the highest dose of procymidone
(p=0.035), compared to controls. Thegroupmeanof thepercentage
of animals within each litter with external genital malformations
was markedly higher in the highest mixture group than in any of
the groups dosed with the individual pesticides alone at the dose
Fig. 2. Genital malformations in male offspring. Results shown are the group mean
of the % of the male offspring within each litter given score 1 (white), score 2
(gray) or score 3 (black). The rest of the animals, i.e. up to 100%, within each group
were given score 0. The incidence of genitalmalformations is signiﬁcantly increased
(p=0.017) in the highest mixture group (Pestimix-43.8, group 4) and the high dose
of procymidone (group 14) (p=0.035).
included in themixture (around 17% compared to 0–4%, Fig. 2). The
individual pesticides alone caused no statistically signiﬁcant effect
at the dose levels included in the mixture.
External malformations related to the reproductive system and
seminal vesicles were observed in a few of the nine months old
animals (Supplemental Material Table X3). Cryptorchidism and
alopecia, in the perineal area, were not observed in any of the adult
males. Two males in the highest mixture group had penile mal-
formation: one had both a severe cleft penis and hypospadia with
urethral opening at the basis of the penis (score 3), the other had a
cleft phallus (score1). A thirdmale in thehighestmixturegrouphad
a malformed seminal vesicle. One male in each of the groups dosed
withmancozeb showedmalformation of the seminal vesicle. In the
groupdosedwith thehighest level ofprocymidone twoanimalshad
cleft phallus (scores 2 and 3, respectively), and a third animal had
malformed seminal vesicle. However, none of the observed effects
were signiﬁcantly different from control animals.
3.3. Mixture modeling – gestation length
General linear model (GLM) ﬁts for the ﬁve pesticides are illus-
trated in Supplemental Material Fig. X1. The effect on gestation
length of mancozeb and procymidone was not statistically sig-
niﬁcant (p=0.25 for both pesticides). Therefore, mancozeb and
procymidone were not included in the predictions for the mix-
ture. A ﬁt of the observed pesticide mixture was performed similar
to the single pesticide observations. In addition, predictions were
performed based on the models for the single pesticides and the
dose-additivity and independent addition formulas. The results are
shown in Table 5 and Fig. 3A and B. At high doses, there was a
signiﬁcant difference between the observed and predicted mixture
effects, and both of themodels underestimated themixture effects.
However, the underestimation was generally smaller for the dose-
additivity prediction than the independent action prediction. The
dose-addition prediction at the lower doses gave a good predic-
tion of the observed effects. In Supplemental Material Table X4
the effect doses for increased gestation length for individual pes-
ticides are summarized. The overall results were the same when
winsorization was used (data not shown).
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Table 4
External genital malformations in male pups scored on PD 16 or 22 at sectioning or in vivo on PD 50. Values show the number of animals with score 0 (normal), score 1
(slight), score 2 (moderate), or score 3 (severe).
Dose group No. animals (litters) Score 0 Score 1 Score 2 Score 3 Score 1, 2 or 3 Statistics
1: Control 71 (15) 71 (15)
2: Pestimix-14.6 96 (17) 92 (17) 4 (4) 4 (4) NS
3: Pestimix-29.2 53 (9) 50 (9) 2 (2) 1 (1) 3 (2) NS
4: Pestimix-43.8 67 (14) 56 (14) 4 (3) 5 (4) 2 (2) 11 (6)* p=0.006
5: Epoxi-3.75 38 (7) 36 (7) 2 (1)
6: Epoxi-15 11 (4) 11 (4)
7: Manz- 6.25 31 (5) 31 (5)
8: Manz-25 39 (7) 39 (7)
9: Prchl-8.75 44 (9) 43 (9) 0 1 (1) 1 (1) NS
10: Prchl-35 26 (4) 25 (4) 1 (1) 1 (1) NS
11: Tebu-12.5 48 (8) 48 (8)
12: Tebu-50 27 (6) 26 (6) 1 (1) 1 (1) NS
13: Procy-12.5 38 (7) 38 (7)
14: Procy-50 25 (4) 19 (4) 2 (2) 3 (2) 1 (1) 6 (2)* p=0.035
Values in parentheses are the number of litters with offspring having the indicated score. Epoxi: epoxiconazole; manz: mancozeb; Prchl: prochloraz; Tebu: tebuconazole;
Procy: procymidon.
* p<0.05.
Table 5
Observed and predicted mixture effect doses for increased gestation length (GL). Results shown are mean dose [95% conﬁdence interval].
Relative GL 10% 25% 50% 75% 90%
GL (rounded) 23.2 23.5 24.0 24.5 24.8
Observeda 18.0 [3.4–31.0] 46.5 [37.5–57.5] 75.5 [64.5–93.5] 104.0 [85.0–127.0] 133.0 [101.5–159.0]
Dose-additivity 9.49 [8.50–10.5] 64.0 [61.6–66.5] 135.3 [132.8–137.9] 197.8 [195.1–200.5] 256.2 [253.2–259.3]
Independent action 0.5 [0.14–0.86] 0.5 [0–4.05] 173.0 [167.4–178.6] 316.5 [310.5–322.5] 439.5 [433.0–446.0]
a Based on the curve ﬁt shown in Fig. 3A.
3.4. Mixture modeling – nipple retention in male offspring
In SupplementalMaterial Fig. X1 the nipple retention results for
the single chemicals are shown with the estimated model and ±2
standard errors. No statistically signiﬁcant effect on NR by man-
cozeb was observed and the effect was therefore set to zero in the
predictions
The ﬁtted model of the observed results and the dose-additivity
predictions are illustrated in Fig. 4A and B. Furthermore, the 95%
conﬁdence intervals and the estimates of observed data, the dose-
additivity predictions, and the independent actions predictions are
summarized in Table 6. The results show that for the low doses,
the conﬁdence intervals overlapped and there were no apparent
statistical differences between the observed dose effects and the
dose-additivity predictions. However, at the high doses no over-
lap in the conﬁdence intervals between the observed dose effects
and those predicted by dose-additivitywas found. In fact, the dose-
additivity formula underestimated the effects for the high doses of
the mixture. The independent action predictions were seen to like-
wise underestimate the effects for high doses, and overestimated
the effect at low doses. Furthermore, the independent actions
model gave poorer estimates in relation to the observed effects, in
comparison to thedose-additivitymodel. In SupplementalMaterial
Table X5 the effect doses for increased nipple retention in male
offspring for individual pesticides are summarized. By using win-
sorization similar results were obtained (data not shown).
3.5. Mixture modeling – AGDI in female offspring
As there was a signiﬁcant effect of year on AGDI in female off-
spring, transformed AGDI observations were used in the analysis.
The same model and ﬁtting method (GEE) as for NR was used
for effects on AGDI. However, only prochloraz could, based on
this, be assumed to have a statistically signiﬁcant effect on AGDI
(data not shown). The relatively few data available for epoxicona-
zole and tebuconazole suggest that accepting the null-hypothesis
of no effect from these pesticides without further examination is
arguable.
The ﬁtted model of the observed results is illustrated in Fig. 5A.
The results in Table 7 andFig. 5B showthat both independent action
and dose-additivity predictions highly underestimated the effect
of the pesticide mixture. So, although no statistical effect was seen
for epoxiconazole,mancozeb, tebuconazole and procymidone indi-
vidually, a marked contribution to the effect of the mixture was
evident. In Supplemental Material Table X6, the effect doses for
longer AGDI in female offspring for prochloraz are shown. Using
winsorization, the estimated effect doses were slightly higher for
the low effect doses and slightly lower for the high effect doses
(data not shown). However, the overall picture was the same.
3.6. In vitro studies
All pesticides except for mancozeb exhibited AR antagonism
in vitro (Fig. 6).The lowest observed effect levels (LOEC) and
cytotoxic concentrations are shown in Supplemental Material
Table X7. The ranking of potencies for AR antagonism was: mix-
ture∼procymidone>prochloraz∼ epoxiconazole > tebuconazole.
As the content of procymidone in the mixture constitutes only
approximately 1/3 of the total mixture dose, these results indicate
combination effects on AR antagonism in vitro.
In theH295R steroid synthesis assay, epoxiconazole, prochloraz,
tebuconazole, and the mixture were shown to reduce testosterone
levels in the cells, whereas mancozeb and procymidone had no
effect (Fig. 7). Epoxiconazole, prochloraz, tebuconazole and the
mixture also reduced estradiol levels (Fig. 7). Generally the pes-
ticides and the mixture caused an increase in progesterone levels,
although for the mixture and for procymidone the effect was only
seen at the highest concentrations tested (Fig. 7). In general the
effects of prochloraz was most pronounced on all three hormones.
Triiodothyronine (T3) induced dose-dependent proliferation of
the GH3 cells in the T-screen assay as expected (data not shown).
No agonistic effect was observed for the mixture (Supplemental
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Table 6
Observed and predicted mixture effect doses for the increased nipple retention (NR) in male offspring. Results shown are mean dose [95% conﬁdence interval].
Relative NR 10% 25% 50% 75% 90%
NR (rounded) 1 3 6 9 11
Observeda 2.3 [0.01–4.9] 27.0 [25.5–28.5] 51.5 [49.5–53.5] 76.0 [72.5–79.5] 100.5 [95.0–105.5]
Dose-additivity 0.021 [0.020–0.022] 18.85 [17.6–20.1] 98.39 [97.3–99.5] 153.53 [151.9–155.1] 206.45 [204.3–208.5]
Independent action 0.01 [0.01–0.01] 0.01 [0.01–0.01] 41.5 [39.8–43.1] 184.0 [182.5–185.5] 289.0 [287.4–290.6]
a Based on the curve ﬁt shown in Fig. 4A.
Table 7
Observed and predicted mixture effect doses for increased anogenital index (AGDI) in female offspring. Results shown are mean dose [95% conﬁdence interval].
Relative AGDI 10% 25% 50% 75% 90%
AGDI (rounded) 8.04 8.89 10.30 11.72 12.56
Observeda 38.0 [34.0–42.0] 104.0 [92.0–124.0] 170.0 [147.0–202.5] 236.0 [199.0–275.0] 302.0 [245.0–346.5]
Dose-additivity 224.0 [217.8–230.3] 720.6 [709.6–731.6] 1217 [1200–1234] 1714 [1691–1737] 2210 [2180–2239]
Independent action 209.5 [202.9–216.1] 694.5 [687.9–701.1] 1228 [1211–1245] 1750 [1726–1773] 2255 [2226–2285]
a Based on the curve ﬁt shown in Fig. 5A.
Fig. 3. (A) GLM ﬁt of mixture effect on gestation length (GL). The observations are
shown as box plots, red marks =median of observations at a given dose. (B) The
observed and predicted mixture effects on gestation length GL. The dose-additivity
prediction of the mixture effect doses are in green and the observed curve is in
blue. In dotted lines ±2 standard errors are illustrated. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of
the article.)
Fig. 4. (A) GEE ﬁt of mixture effects on nipple retention in male offspring ±2 stan-
dard errors are illustrated with dashed lines (in blue). The observations are shown
as box plots of each litter with red marks at the litter medians. (B) The observed and
predicted mixture effect on nipple retention in male offspring. The dose-additivity
predictions of the mixture effect doses are in green and the observed curve is in
blue. In dotted lines ±2 standard errors are illustrated. (For interpretation of the
references to color in this ﬁgure legend, the reader is referred to the web version of
the article.)
U. Hass et al. / Reproductive Toxicology 34 (2012) 261–274 269
Fig. 5. (A) GEE ﬁt of mixture effects on anogenital index (AGDI) in female offspring
±2 standard errors are illustrated with dashed lines (in blue). The observations are
shown as box plots of each litter with red marks at the litter medians. (B) The
observed and predicted mixture doses for effects on anogenital index in female
offspring. The dose-additivity predictions are in green, the independent action pre-
dictions are in purple. And the observed curve in blue. In dotted lines ±2 standard
errors are illustrated. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of the article.)
Fig. 6. Androgen receptor antagonism of single pesticides and the mixture (pes-
timix) in vitro.
Fig. 7. Changes in levels of testosterone (top) estradiol (middle) and progesterone
(bottom) in the H295 steroid synthesis assay after exposure to increasing concen-
trations of the 5 pesticides singly or in combination.
Material Fig. X3a). A weak antagonistic effect of the mixture was
observed at concentrations at and above 3.13M (Supplemental
Material Fig. X3b). A summary of all in vitro results is shown in
Supplemental Material Table X7.
4. Discussion
This study generally aimed to explore the hypothesis that com-
bined developmental exposure to endocrine disrupting pesticides
could lead to adverse developmental toxicity effects at dose lev-
els below NOAELs for the single pesticides, and to investigate if
dose-additivitymodelingof the expectedmixture effects couldgive
useful estimates of the observed mixture effects.
4.1. Developmental mixture study and mixture modeling
There were no statistically signiﬁcant effects of pesticide expo-
sure on maternal body weight gain or on pup body weights at birth
or in the postnatal period. For the mixture, this was consistent
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with the results from a previous range-ﬁnding study [23] in which
maternal and pup body weight gains were only affected at much
higher doses of the mixture.
Several of the investigated endocrine and reproductive end-
points were affected by the combination of the ﬁve pesticides, and
the effects were seen at dose levels at which the individual pesti-
cides caused no, or only minor, effects (Table 8). Gestation length
was signiﬁcantly increased in the two highest mixture groups and
in the group exposed to the highest dose of epoxiconazole, but not
in any other group. The mixture doses consisted of each of the pes-
ticides at 17% or 25% of their NOAEL for effect on gestation length
basedon results of previous studies inour laboratory. As thehighest
dose of epoxiconazole given alone was four times higher than the
dose included in the highest mixture group, these results showed a
combination effect of the pesticides at dose levels where the indi-
vidual pesticides caused no effects. Increased gestation length of
very similar magnitude was also observed in a similarly exposed
mixture group in the range-ﬁnding study [23]. In that study, com-
bined exposure at higher doses induced severe effects manifested
as dystochia (impaired parturition) and high perinatal pup mortal-
ity [23].
To our knowledge, this is the ﬁrst study to describe mixture
effects ongestation length. Themixture effect is probablydue to the
presence of the three azole fungicides in the mixture, epoxicona-
zole, prochloraz and tebuconazole, which have previously been
shown to elicit such effects on gestation length [18,47,48]. Prolon-
gation of the gestation period may possibly be due to an increase in
progesterone in the dams as suggested for epoxiconazole, prochlo-
raz and tebuconazole [18,20]. It has previously been shown that all
three azoles are able to induce progesterone levels in vitro [41] and
this may be the cause of the increased gestation length in vivo as
a decline in progesterone levels in the dams is a prerequisite for
on-time delivery in rats [49].
The dystochia and pup mortality seen in the range ﬁnding stud-
ies have previously been observed as common effects for several
azole fungicides [18,47,50,51]. The mode of action for these end-
points may be increased progesterone levels as well, and if this
is the case, then these azole fungicides should be considered as
similarly acting. However, further data are needed to make ﬁrm
conclusions. Neither mancozeb nor procymidone have previously
been shown to affect gestation length or perinatal survival at the
doses studied [7,21].
For the endpoint gestation length, application of the dose-
addition model at low doses resulted in a good prediction of the
observed mixture effects. Both dose-additivity and independent
action model predictions underestimated the mixture effects at
high doses. However, the underestimation was generally smaller
for the dose-additivity prediction than the independent action
prediction. Our hypothesis is that the underestimation at high
doses may be due to toxicokinetic interactions as e.g. saturation
of metabolism. We have preliminary data to support this view as
higher pup blood levels of some of the pesticides was found after
mixture exposure than after exposure to the pesticides alone [25].
This is the ﬁrst study to show mixture effects on the complex end-
point gestation length, and also the ﬁrst study to show that it is
possible to predict mixture effects using dose-additivity for this
more ‘functional’ and biologically relevant endpoint as well.
Nipple retention inmale offspringwas signiﬁcantly increased in
all mixture groups. For the highest mixture group, the results were
consistent with the results from the range-ﬁnding study [23]. Nip-
ple retention was also increased at the highest dose of mancozeb,
prochloraz and tebuconazole and at both doses of procymidone.
However, the effect of the high dose of mancozeb (25mg/kg) was
numerically quite small. As an earlier study of mancozeb includ-
ing larger groups and higher dose levels (up to 100mg/kg) did not
show any effect on nipple retention [21], the signiﬁcant effect in Ta
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the present study is likely to be a random ﬁnding. For the other
pesticides, similar effects have to some extent been seen for the
individual pesticides [6,16,18,20,26,47,51–53]. No statistically sig-
niﬁcant effects on nipple retention of mancozeb, prochloraz and
tebuconazole were found at the low dose level, whereas pro-
cymidone caused a signiﬁcant effect (Table 8). Results on nipple
retention indicatemixture effects, since themagnitude of the effect
in thehighestmixturegroupwas signiﬁcantlyhigher than theeffect
induced by procymidone alone at the dose level included in the
highest mixture. Mixture effects for nipple retention have earlier
been shown after exposure to other mixtures of both similarly and
dissimilarly acting anti-androgens in several rat studies [6,26,54].
The mixture effect prediction based on dose-additivity was
in agreement with the observed effects at low doses, as there
were no statistically signiﬁcant differences between the predicted
and the observed effect doses. However, dose-additivity generally
underestimated the effects for the high doses of the mixture. The
independent action predictions resulted in even stronger under-
estimations of the effects for high doses, and overestimations
of the effect for the low doses. It has been reported previously
that dose-additivity gives a good prediction of mixture effects of
nipple retention with both similarly and dissimilarly acting anti-
androgens [6,26,54].
In male offspring, no statistically signiﬁcant effects on anogen-
ital distance (AGD) were seen in the mixture groups. At the dose
levels included in the mixture, epoxiconazole induced longer AGD,
whereasprocymidone induced shorterAGD.Consequently, the lack
of effect in the mixture group might be due to opposite actions of
these compounds.
In the female offspring, signiﬁcantly longer AGDI, was seen at
the two highest mixture doses. A similar effect was seen in female
offspring given the low dose levels of epoxiconazole, prochloraz
and tebuconazole, i.e. at doses equal to those included in thehighest
mixture dose. No effect was seen in female offspring dosed with a
four times higher dose of epoxiconazole and we hypothesize that
theﬁndingat the lowdosemaybea randomﬁndingoralternatively,
the lack of effect at the high dose may be due to a limited group
size. However, the high doses of both prochloraz and tebuconazole
did cause increased female AGDI in the present study. The AGD
effect caused by the mixture is probably due to the three azole
fungicides as earlier studies in our laboratory have shown similar
effects for epoxiconazole, prochloraz and tebuconazole [18,53]. The
mechanism underlying the increased AGDI in the females may be
the increased progesterone levels in the dams causing virilization
of the female genitals [55].
Both independent action and dose-additivity predictions highly
underestimated the effect of the pesticide mixture on AGDI in
females. So, althoughstatistically signiﬁcant effectwasneither seen
in the combined analysis of the results in the present study, nor in
the historical data for epoxiconazole, mancozeb, tebuconazole and
procymidone individually, someof thepesticides seemtohave con-
tributed to the effect observed after mixture exposure. The present
study showed signiﬁcant effects of the low doses of epoxicona-
zole, prochloraz and tebuconazole, whereas no effect on female
AGDI was seen for mancozeb and procymidone. Earlier studies in
our laboratory have also shown similar effects of epoxiconazole,
prochloraz and tebuconazole [18,53]. The effect in the mixture
groups was therefore most likely caused by the combined expo-
sure to the three azole fungicides. The ﬁnding that mixed exposure
to endocrine disrupters can lead to increased female AGD is new
and more knowledge on this endpoint is needed.
An increased incidence and severity of malformations in the
highest mixture group and the highest dose of procymidone was
found. At the same mixture dose, the incidence of genital dysge-
nesis in the range-ﬁnding study [23] was around 40%, whereas
the incidence in the present mixture study was around 17%. This
difference may be related to the lower number of litters in the
groups in the range-ﬁnding study and hence greater uncertainty
in results. The percentage of offspring with genital malformations
was markedly higher in the highest mixture group than in any of
the groups dosed with the individual pesticides alone at the dose
included in the mixture (Table 8). The individual pesticides alone
caused no statistically signiﬁcant effect at this dose level. As such,
these results show severe mixture effects at dose levels where the
individual pesticides caused no effect when given alone. Similar
results were found in another mixture study of three similarly act-
ing anti-androgens, i.e. the AR antagonists ﬂutamide, procymidone
and vinclozolin [6]. Modeling was not done for genital malforma-
tions, because there were insufﬁcient data for the single pesticides
regarding this endpoint.
4.2. In vitro studies
The objective of performing the in vitro assays was to eval-
uate the predictability of in vitro methods for estimating in
vivo developmental effects. The ranking of the potencies for
AR antagonism was: mixture∼procymidone>prochloraz∼ epox-
iconazole > tebuconazole. As the content of procymidone in the
mixture actually constituted only approximately 1/3 of the total
mixture dose, these results indicate combination effects on this
endpoint. This is in line with previous observations that chemicals
act additively to antagonize AR [56].
Epoxiconazole, prochloraz and tebuconazole and the mixture
were all shown to reduce testosterone and estradiol levels and
increase progesterone levels inH295R cells. In general the effects of
prochlorazwasmost pronounced on all three hormones. In regards
to translating the in vitro results into in vivo effects in developmen-
tal rat studies, the lack of effects of mancozeb on steroid hormone
synthesis in vitro ﬁt well with the lack of observed anti-androgenic
effects of mancozeb in vivo. Based on the in vitro results, one might
also expect to see an effect on the measured hormone levels, par-
ticularly on the progesterone levels in the rats. In the present study,
progesterone levels were unfortunately only investigated in the
offspring at 50 days of age, and here no signiﬁcant effects were
seen [24]. However, results fromprevious in vivo studieswith azole
fungicides show that pregnant rats dosed with epoxiconazole (15
and 50mg/kg bw/day) and tebuconazole (50 and 10mg/kg bw/day)
during gestation had a marked increase in progesterone levels in
plasma at GD 21 [18].
Concerning the prediction of anti-androgenic effect (e.g. nipple
retention), we would expect from the in vitro studies that procymi-
done and the three azole fungicides had the potential to induce
this effect. Procymidonewas themost potent AR antagonist in vitro
and had also effects on nipple retention. Prochloraz was the most
potent testosterone inhibiting chemical in vitro and was found to
affect nipple retention in the present study and has previously
been shown to reduce male AGD in vivo, although higher doses
than those used in this project were necessary to induce this effect
[53]. All taken together, the in vitro studies gave good indications
of whether to expect in vivo anti-androgenic effects and effect on
gestation length. Overall, application of predictable in vitro assays
may contribute to faster and cheaper data generation for evalua-
tion of chemicals and a reduction of the number of experimental
animals that have to be used for risk assessment of chemicals.
4.3. Regulatory perspectives
In the present paper mixture effects of endocrine disrupting
pesticides have been shown, and as such the results support that
there is a need for risk assessment of the cumulative exposure to
chemicals. Below the mixture results are discussed in relation to
values used in regulatory risk assessment of single chemicals such
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Table 9
LOAELs for effect on gestation length (GL) in dams and nipple retention (NR) in male offspring after exposure to the single pesticides alone or in mixture.
Pesticide Epoxiconazole Prochloraz Tebuconazole Procymidone
Single Mixture Single Mixture Single Mixture Single Mixture
LOAEL-GL 15 2.5 >35 5.8 >50 8.3 – –
LOAEL-NR >15.0 1.3 5.8 2.9 8.3 4.2 4.2 4.2
Mancozeb and procymidone are not included for GL, and mancozeb is not included for nipple retention, as the pesticides did not affect these endpoints.
Table 10
ADI and derived no effect level (DNEL) in mg/kg bw/day for nipple retention in male
offspring after exposure to the single pesticides alone or in mixture.
ADIa DNEL single DNEL mix
Epoxiconazole 0.008 0.050 0.004
Prochloraz 0.010 0.019 0.010
Tebuconazole 0.030 0.028 0.014
Procymidone 0.003 0.014 0.014
DNEL is calculated as LOAEL divided by 300. Mancozeb is not included as this pes-
ticide did not affect nipple retention.
a The ADI values for the four pesticides respectively are from EC (2008a), FAO
(2004), EC (2008b) and EFSA (2009).
as LOAELs, Derived No Effect Levels (DNELs) and Acceptable Daily
Intake (ADI).
The observed LOAELs for the pesticides singly and the doses of
the pesticides in the mixture at the mixture LOAEL were compared
for the endpoints gestation length and nipple retention (Table 9).
This was done only for, the relevant pesticides in the mixture, i.e.
those that singly caused effects on these endpoints. The main pur-
pose was to estimate whether mixture exposure would lead to
lower LOAELs than seen after single chemical exposure. For ges-
tation length, the doses of the single pesticides at the mixture
LOAEL were approximately 6 times lower than the LOAELs for the
pesticides given alone. This is an important ﬁnding, as it further
illustrates that mixture exposure leads to lower effect levels. For
nipple retention, several of doses of the single pesticides at the
mixtureLOAELwerealso lower than those for single chemical expo-
sure. However, for procymidone, there was no difference between
single and mixture LOAELs. Also, the differences between single
and mixture LOAEL for prochloraz and tebuconazole was only 2
times, and not 6 times like it was seen for gestation length. It must,
however, be kept in mind that the mixture caused effect on nip-
ple retention at the lowest mixture dose studied, i.e. the mixture
LOAELs may have become lower if lower doses of the mixture had
been studied. LOAELs determined experimentally depend on many
factors such as the selection of strain or species, the selection of
doses levels, sample size, the end points assessed and biological
variation. Thus some variability is to be expected among LOAELs
and may range from less than twofold up to a factor of 10 [57].
However, the LOAELs in this study are from studies in the same
strain of rats, the dose levels were carefully selecting based on the
previous results in our laboratory and the same endpoints were
assessed. Also, the results were quite reproducible for both the sin-
glepesticides and themixturewhencomparing the results fromour
previous studies on the single pesticides, the range-ﬁnding study
with the mixture and the large mixture study where both mix-
ture doses and doses of the single pesticides were included ([23],
Supplemental Material Table X1). Thus, the variation in our study
LOAELs are clearly below a factor of 6 substantiating that this fac-
tor represents an increase beyond variation within and between
studies.
In Table 10, the Acceptable Daily Intakes (ADIs) are compared
to the DNELs for effect on nipple retention for each of the pesti-
cides. The DNEL was calculated from the LOAELs shown in Table 9
using the normally used uncertainty factors for deriving ADIs, i.e.
10 for extrapolation from animals to humans, 10 for different
sensitivity among humans and 3 for extrapolation from an effect
level to NOAEL. All of the DNELs for single chemical exposure to the
pesticideswerehigher or similar to theADIs, reﬂecting that the cur-
rent ADI probably protects against the endocrine disrupting effect
of the studied pesticides, when the pesticides are evaluated chem-
ical by chemical. The mixture DNELs were, however, in most cases
lower than the ADIs. This was especially the case for epoxiconazole
and tebuconazole,where theDNELsbasedon the respective LOAELs
were half of the ADI. This indicates that the ADIs are not sufﬁciently
low to protect against the mixture effects of the pesticides studied
in this project. An exception was procymidone where the ADI was
lower than the mixture DNEL.
A survey of the dietary cumulative intake using the probabilis-
tic approach did not show a reason for concern in relation to mixed
exposure of Danish consumers to the ﬁve investigated pesticides
(Jensen et al. [58]). The risk assessment included an additional
uncertainty factor of 3 to allow room for human exposure to other
endocrine disrupting chemicals. However, it is somewhat uncer-
tainwhether this factor is sufﬁcient for covering the already known
endocrinedisruptersandespecially the thousandsof chemicals that
are potential endocrine disrupters based on in vitro data and QSAR
modeling [59,60].
4.4. Conclusions
Combined developmental exposure to endocrine disrupting
pesticides at dose levels below NOAELs for the single pesticides
caused adverse effects on male sexual development and gestation
length and the mixture effects were well predicted by dose-
addition at low doses.
The in vitro data showed that the AR reporter gene assay and the
H295R steroidogenesis assay gave good indications of the observed
in vivo effects. As humans may be exposed to thousands of chem-
icals for which we still have no data about endocrine disrupting
properties, further in vitro studies as well as QSAR modeling are
important for progress in this area. In vitro data are especially
important for decisions on how to group endocrine disrupters for
cumulative risk assessment.
Comparisonsof theDNELs for themixtureeffect onnipple reten-
tion to the Acceptable daily intake (ADI) indicate that ADIs are
not sufﬁciently low to protect against the mixture effects of the
pesticides shown in this study. Thus, the results imply that risk
assessments based on NOAELs for single chemicals likely under-
estimate the risk and that there is a need for modiﬁcation of risk
assessment procedures for pesticides, in order to take account of
mixture effects and the potentially serious impact of mixed expo-
sure on development and reproduction. One possibility is to allow
each pesticide to use only a fraction of the ADI, where the fraction
should depend on the number of relevant endocrine disrupters in
the speciﬁc exposure scenario. Another possibility is to base the
cumulative risk assessment on dose-additivity modeling. Observa-
tions of similar type of effect are recommended as the basis for
grouping chemicals for cumulative risk assessment as the results
of our study support ﬁndings from previous studies showing dose-
additivemixture effects of endocrine disrupters that induce similar
types of effects, but have dissimilar mechanisms of action. Last
but not least, it is recommended when considering cumulative
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risk assessment to include all kinds of chemicals e.g. pesticides,
industrial chemicals, environmental contaminants, as endocrine
disrupters exist within all of these chemicals classes and humans
may be exposed to several of them simultaneously.
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a b s t r a c t
There is growing concern of permanent damage to the endocrine and nervous systems after devel-
opmental exposure to endocrine disrupting chemicals. In this study the permanent reproductive and
neurobehavioral effects of combined exposure to ﬁve endocrine disrupting pesticides, epoxiconazole,
mancozeb, prochloraz, tebuconazole and procymidone, were examined. Pregnant and lactating rat dams
were dosed with a mixture of the ﬁve pesticides at three different doses, or with the individual pesticides
at one of two doses.
Adverse effects were observed in young and adult male offspring from the group exposed to the
highest dose of the mixture. These included reduced prostate and epididymis weights, increased testes
weights, altered prostate histopathology, increased density of mammary glands, reduced sperm counts,
and decreased spatial learning. As no signiﬁcant effects were seen following single compound exposure
at the doses included in the highest mixture dose, these results indicate cumulative adverse effects of
the pesticide mixture.
© 2012 Elsevier Inc. All rights reserved.
1. Introduction
Exposure to endocrine disrupting chemicals (EDCs) during early
life may cause long-term health effects, and can inﬂuence both the
sexual and neurological development of the offspring, even until it
reaches maturity or middle age [1–3]. In the Western world, ﬁnd-
ings of declining human semen quality and a high prevalence of
congenital malformations of reproductive organs and hormone-
dependent cancers [4–6], as well as a high prevalence of children
being diagnosed with ADHD and other neurological disorders [7,8]
are causing concern.
Previous research indicates that a wide range of pesticides may
act as endocrine disrupters. The azole fungicides prochloraz, tebu-
conazole and epoxiconazole have been shown to react through
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several endocrine disrupting mechanisms, and to induce various
endocrine disrupting effects [9–15]. Common features for the azole
fungicides are that they increase gestational length and affect
steroid hormone levels in fetuses and/or dams. In addition, stud-
ies indicate that prochloraz may also affect thyroid hormone levels
and cause effects on the sexually dimorphic development of the
brain [11]. Furthermore, it has been shown that procymidone com-
petitively antagonizes binding to the androgen receptor (AR), and
consequently affects the reproductive development in male off-
spring [16,17]. Mancozeb, a fungicide from the dithiocarbamate
group, mainly acts via disruption of the thyroid hormone system
and is therefore suspected of affecting brain development [18,19].
Although animal studies have shown that some pesticides can
disrupt male sexual differentiation during development, the indi-
vidual pesticides alone have so far not been shown to contribute to
adverse human effects at relevant exposure levels. However, ini-
tial observations in epidemiological studies [20–22] point in the
same direction as what has been seen in laboratory experiments
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with endocrine disrupting chemicals, namely that substantial
mixture effects occur even though the individual chemicals are
present at low, ineffective doses [23–25]. Cumulative effects can
be seen when small and statistically insigniﬁcant effects of each
compound are added to induce statistically signiﬁcant effects
when these compounds are mixed. These ﬁndings have stimulated
interest in exploring the consequences of combined exposures to
environmentally relevant mixtures of endocrine disrupting pesti-
cides.
Currently, there are no data on the effects of combined devel-
opmental exposure to endocrine disrupting pesticides, which have
the potential for affecting both reproductive and brain develop-
ment. It is important to keep in mind that some pesticides may act
through both sex- and thyroid hormone related mechanisms. Fur-
thermore thyroid hormone disrupting pesticides may also affect
testicular development [26] while anti-androgenic pesticides may
disturb the sexually dimorphic development of the brain [11,27].
Consequently, it is relevant to study combined effects of pesti-
cides with such dissimilar modes of action. Therefore, this study
aimed at exploring whether combined developmental exposure
to endocrine disrupting pesticides at low doses, i.e. doses below
NOAEL for the single pesticides, would lead to adverse develop-
mental toxicity effects. In the present paper we report results on
thyroid and reproductive organs and behavioral endpoints from
pre-pubertal and adult animals that have been exposed pre- and
postnatally to amixture of the ﬁve endocrine disrupting pesticides;
procymidone, prochloraz, tebuconazole, epoxiconazole and man-
cozeb. Data on maternal endpoints, postnatal development and
genital malformation frequencies from this study as well as math-
ematical modeling of the mixture results and in vitro studies with
the same mixture of pesticides are presented in Hass et al. [28].
2. Materials and methods
2.1. Chemicals
Before initiating the study, the mixture ratio and dose levels of the individual
pesticides were chosen as presented in Hass et al. [28]. In summary, the mixture
ratio for the ﬁve pesticides was chosen based on the NOAEL for effects on increased
gestation length in dams and perinatal mortality in the offspring. Upon choosing
the mixture ratio, two range-ﬁnding studies were performed in order to test for
toxicity and endocrine disrupting effects of various mixture doses. The ﬁrst was in
non-pregnant animals while the second was in pregnant animals [29].
The 5 pesticides used were procymidone (CAS no. 32809-16-8, purity 99.5),
epoxiconazole (CAS no. 106325-08-8, purity 99.0), tebuconazole (CAS no. 107534-
96-3, purity 98.5), mancozeb (CAS no. 8018-01-7, purity 76.0) and prochloraz (CAS
no. 67747-09-5, purity 98.5). All chemicals were purchased in a technical quality
from VWR – Bie & Berntsen, Herlev, Denmark. Corn oil (Sigma–Aldrich, Brøndby,
Denmark) was used as vehicle.
2.2. Animals and exposure
The mixture study was performed under conditions approved by the Danish
Animal Experiments Inspectorate and by the in-house Animal Welfare Committee.
Animals received a complete rodent diet and acidiﬁed tap water ad libitum, and
were housed under standard conditions with 12h reverse light–dark cycle with
light starting at 9 p.m. and continuing throughout the night until 9 a.m. In this way
behavioral testing could be performed during the animals’ active period. For further
information on housing conditions please consult Hass et al. [28].
The study included 14 groups of animals, and was performed in 4 blocks with
a week between each block. The 14 groups were as equally as possible distributed
among the 4 blocks, and the animals used were 198 time-mated nulliparous, young
adult female Wistar rats (HanTac:WH, Taconic Europe, Ejby, Denmark). The animals
were observed twice daily for signs of toxicity andbodyweightswere recordeddaily
during the entire dosing period.
On the day after arrival at gestation day (GD) 4, the dams were distributed into
groups with similar body weight (bw) distributions. They were given 4 days after
arrival to adapt to the reversed light–dark cycle before beginning the exposure.
Dams were dosed daily by gavage, from GD 7 to pup day (PD) 16. For more detailed
information on dosing scheme please consult Hass et al. [28].
In Table 1 the composition of the pesticide mixture, the doses of the pesticides
administered individually and in mixture and the number of litters in each group
are shown. Four groups of 22 rat dams were given daily oral doses of 0, 14.6 (8.3%
of NOAEL), 29.2 (17% of NOAEL) or 43.8 (25% of NOAEL) mg/kg/day of the mixture
of the 5 pesticides, whereas ten groups of 10 or 12 time-mated rats were similarly
dosed with two doses of the individual pesticides. The lowest dose of each pesticide
was similar to the dose included in the highest mixture dose and the highest dose
of the single pesticides was 4 times higher, corresponding to 25% of NOAEL and
to NOAEL, respectively, for effects on gestation length and perinatal mortality. Due
to low pregnancy rate the number of litters in each dose group was unfortunately
somewhat lower (Table 1).
In Fig. 1 anoverviewof the studydesign is given.Results fromoffspring sacriﬁced
on PD16 and afterweaning are presented in the present paper,whereas results from
dams and the younger pups are presented in Hass et al. [28].
2.3. Sacriﬁce on PD 16
On PD 16, 1–3 male and 1–3 female pups per litter were randomly selected for
autopsy. Pups were weighed, decapitated and trunk blood was collected for hor-
mone analysis. Uterus, ovaries, thyroids and liver were dissected from one female
pup per litter. Uterus, ovaries and livers were weighed, whereas the thyroid was
excised on the thyroid cartilage in order to obtain optimal histological preservation.
Uterus, one ovary, alternately left and right, a section of the liver and the thyroid
were ﬁxed in formalin and processed for parafﬁn embedding.
Testes, epididymides, ventral prostate, seminal vesicle, levator
ani/bulbocavernosus muscle (LABC), bulbourethral glands, liver and thyroids
were dissected from one male pup per litter and weighed. One testis per male
(alternately left and right) was ﬁxed in Bouin’s ﬁxative and processed for parafﬁn
embedding. Epididymides, seminal vesicles and thyroids (cleared from the thyroid
cartilage) were ﬁxed in formalin and processed for parafﬁn embedding.
Histological evaluationwasmadeof testes, thyroids andof thoseorgans inwhich
statistically signiﬁcant changes in organ weights were seen. One section per organ
was stainedwith hematoxylin and eosin for histological evaluation, and for thyroids
only the mixture groups were evaluated.
2.4. Sacriﬁce on PD 22 and 50
On PD 22, 1–3 male and 1–3 female pups per litter were weaned. Dams were
decapitated in CO2/O2 anesthesia and the numbers of uterine implantation sites
was counted. Trunk blood was collected and used for hormone analysis. The male
and female pups which were not to be kept after weaning were decapitated on PD
22 in CO2/O2 anesthesia and blood samples were collected for hormone analyses.
On PD 50 1–2 males and females per litter from control and mixture groups were
decapitated in CO2/O2 anesthesia and blood samples were collected for hormonal
analyses.
2.5. Mammary glands
From controls and the three mixture groups (groups 1–4), one male and one
female per litter at PD 22 and 1–2 males and 1–2 females per litter at PND 50
were used for investigation of effects on mammary gland development. At both
ages, the 4th abdominal mammary gland was excised for whole mount prepara-
tion, and on PD 50 the contralateral 4th abdominal mammary gland from males and
females was excised for histological analysis. Alternately left and right glands were
used for each purpose. For histologic examination, mammary glands were ﬁxed in
formalin and stained with hematoxylin and eosin. Female mammary glands were
evaluated for tubuloalveolar and lobuloalveolarmorphology.Malemammaryglands
were evaluated for secretory material in the ducts and vacuolization of the epithe-
lium in controls and the highest mixture group. The mammary gland whole mounts
were ﬁxed in formalin, stained with alum carmine, dehydrated and mounted. The
mammary glands were scanned on a ﬂatbed scanner and outline area, longitudi-
nal growth, and transverse growth were measured using Image Pro Express (Media
Cybernetics). Thedensitywas scoredona scale from1 to5 (with5 representingmost
densemammary glands)with appropriate scoring criteria according to age and gen-
der. The number of terminal end buds (TEBs) was counted in the mammary glands
at PD 22. Whole mounts of females PD 50 were only evaluated for density due to
the large gland size and overlapping branches hampering outgrowthmeasurements
and TEB number assessment.
2.6. Onset of puberty
Onset of puberty was registered in all weaned male and female offspring. In
female offspring sexual maturity was assessed by determining day of vaginal open-
ing (VO) as described by Goldman et al. [30]. All weaned females were examined
daily from PD 30 to PD 42. In male offspring the onset of puberty was assessed as
time of preputial separation (PPS) [31,32]. Males were examined daily from PD 34
to PD 50. On the day of VO or PPS the age and weight of the animals were recorded.
2.7. Behavioral testing
The investigations were performed during the animals’ dark cycle, i.e. their
active period, from 9 a.m. to 4 p.m., in dimly lit rooms. The experimenter was kept
unaware as to which group an individual rat belonged, and exposed and control
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Table 1
Composition of pesticide mixture.
Group na Epoxiconazole Mancozeb Prochloraz Tebuconazole Procymidone Pesticide mixture
1: Control 22(15) – – – – – –
2: Pestimix-14.6 22(17) 1.25 2.08 2.92 4.17 4.17 14.6
3: Pestimix-29.2 22(9) 2.5 4.17 5.83 8.33 8.33 29.2
4: Pestimix-43.8 22(14) 3.75 6.25 8.75 12.5 12.5 43.8
5: Epoxi-3.75 12(8) 3.75 – – – –
6: Epoxi-15 10(4) 15 – – – –
7: Manz-6.25 12(5) – 6.25 – – –
8: Manz-25 10(7) – 25 – – –
9: Prchl-8.75 12(8) – – 8.75 – –
10: Prchl-35 10(4) – – 35 – –
11: Tebu-12.5 12(8) – – – 12.5 –
12: Tebu-50 10(6) – – – 50 –
13: Procy-12.5 12(7) – – – – 12.5
14: Procy-50 10(4) – – – – 50
The number of dosed dams (viable litters) in each group and the doses of the pesticides, that were administered individually and in mixture in mg/kg/day, are shown in the
table. Epoxiconazole (Epoxi), mancozeb (Manz), prochloraz (Prchl), tebuconazole (Tebu) or procymidone (Procy).
a The large difference between the number of dosed dams and viable litters was mainly due to very low pregnancy rate from the animal breeders, and not to high rates of
pre- and postnatal deaths in the offspring.
animals were tested alternately as were female and male animals. All statistics
on behavioral data were conducted on litter means, and therefore the presented
n-values describe the number of litters in each dose group.
2.7.1. Motor activity and habituation capability
In the tests of motor activity, all weaned offspring (140 males and 138 females)
were tested (n=9–17 for control and mixture groups and n=2–9 for single pesticide
groups). The offspring were tested on PD 28 and again at PD 59. The motor activity
of the animals was recorded in activity boxes with photocells for 10×3min (as
described in Axelstad et al. [33]). The total activity during the 30min was used as
a measure of general activity. In order to assess habituation capability, the 30min
was divided into two time periods of 15min.
2.7.2. Learning and memory (Morris Water Maze)
The number of animals used for the test of spatial learning, was somewhat
smaller than for activity testing, as 90 males and 90 females were used (n=9–10
for control and mixture groups and n=2–6 for single pesticide groups). The animals
were tested at age of 4–5 months in a maze with a diameter of 220 cm, ﬁlled with
water at room temperature, as described in [33,34]. A circular transparent platform
was situated on a solid support and submerged below the water surface. When the
rat swam to and climbed onto the platform, the trial was completed. If the animal
failed to locate the platform within 60 s, it was led to the platform. A video-tracking
device (Viewpoint video tracking system, Sandown Scientiﬁc, Middlesex, England)
was used to collect data about latencies to ﬁnd the platform, the path lengths and
swimming speeds of the animals.
Learning was tested with the platform situated at the center of the southwest
quadrant of the pool, and the animals were trained in 4 trials per day for 7 days
(ﬁve consecutive days, two day break and then two more days of training). Reversal
learningwas testedwith a newplatformposition, the day after the last learning day.
The animals were tested in a reversal procedure with the platform placed opposite
the original location, again with 4 trials a day, but only for two consecutive days, i.e.
days 8 and 9.
2.7.3. Mating behavior in male offspring
The males tested for mating behavior were the animals previously tested in the
MorrisMaze. For the assessment ofmalemating behavior, non-ovariectomized sex-
ually mature female Wistar rats (weight 170±20g) were purchased from Taconic
Europe. These female rats were treated with -oestradiol-3-benzoate (25g/rat)
48h before the mating and progesterone (500g/rat) 4h before mating to obtain
‘chemical estrus’. Both solutions were injected subcutaneously. The effects of pro-
gesterone dosing lasts for about 4h and the females could therefore be used several
times. Male rats need to be sexually experienced before a successful mating session
can take place [35]. Therefore the males were placed with a female in ‘chemical
estrus’ for 20min before the test trial. It was required that the female showed pro-
ceptive behavior (described below) otherwise it was replaced by another female rat.
The male rats had one training trial before the mating behavior test session, which
was scored as described below.
The mating test was performed between 12.00 and 16.00 (in the active period
of the animals) and the female rats were brought into ‘chemical estrus’ in relation to
that timepoint. Themale from the couplewas placed in a transparent polycarbonate
cage (59.5×38×20 cm (D×W×H)) with a ﬂat lid and with no bedding in an unlit
room. A female in “chemical estrus” was then introduced into the male cage and
allowed to stay for 20min. The same cage was used for all animals in the study. The
mating behavior was recorded from the side of the cage using a standard Phillips
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Fig. 1. Schematic overview of the design of the mixture study. Pregnant dams were dosed from gestation day 7 to postnatal day 16 with a mixture of pesticides, or the
individual chemicals. In the present paper the results from organ weights, histopathology, mammary glands, hormone levels, timing of sexual maturation, behavioral tests
and semen quality are presented (shown in italic in highlighted black boxes). The results from endpoints before PD 16 as well as malformation scores are presented in Hass
et al. [28].
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CCD-MOS video camera (black and white) with sensitivity in the infra-red area
(800–950nm). The recordings were stored on a hard disk/DVD recorder (LVW-545
HDD+DVD recorder).
All mating behavior data were scored using a Psion Workabout (ProInfo) with
the softwarePocketObserver® (Noldus, TheNetherlands) installed. Thiswasdoneby
trained observers blind to experimental groups. The observer looked at the record-
ings of mating behavior on a computer and registered the behavioral elements
Mount, Intromission and Ejaculation.
2.8. Necropsy of adult female offspring
Female offspring were autopsied at approximately 6 months of age. Stage of
estrous cycle was determined using a rat Vaginal Impedance Checker (Model MK-
10C (Muromachi, Japan). When an impedance value was higher than 3, the female
was assumed to be in proestrus and was sacriﬁced. Animals were decapitated in
CO2/O2 anesthesia and trunk blood was collected for hormone analysis. Thyroids
(on the thyroid cartilage) were ﬁxed in formalin and later embedded in parafﬁn.
Histopathological evaluation was made of the thyroid. One section of the thyroid
from rats belonging to groups 1, 4, 7 and 8 was stained with hematoxylin and eosin
for histological evaluation by an examiner blinded to treatment groups.
2.9. Necropsy of adult male offspring
Sexually mature male offspring (261–280 days of age to around 9 months of
age) were weighed, anesthetized in CO2/O2 and decapitated, and trunk blood was
collected for hormone analysis.
Semen motility was analyzed in all dose groups, whereas sperm counts were
only performed in the control males and in the males from the highest mixture
dose group. For sperm motility analysis, spermatozoa were obtained from the distal
cauda epididymis (alternately left and right) and sperm samples were prepared and
analyzed by computer assisted sperm analysis (CASA) as described in Jarfelt et al.
[36]. For sperm count analysis, cauda epididymis was weighed and prepared as
described by Jarfelt et al. [36], and samples were analyzed using 10× UV ﬂuorescent
objective and IDENT OPTIONS. Ten ﬁelds were analyzed for each sample and three
counts were performed for each suspension. Counts were averaged and data are
presented as number of sperm per gram cauda.
The rats were further autopsied and macroscopically examined. The following
organs were excised and weighed: right and left testis, ventral prostrate, semi-
nal vesicles with seminal ﬂuid, epididymis, bulbourethral glands, LABC, liver and
thyroid.
The right or left testis (alternately)was ﬁxed in Bouin’s ﬁxative, parafﬁn embed-
ded and stained with hematoxylin and eosin. The epididymis not used for motility
analysis was excised and weighed.
The following organs were ﬁxed in formalin and subsequently embedded in
parafﬁn: caput epididymis, ventral prostrate, seminal vesicles and liver. One sec-
tion per organ was stained with hematoxylin and eosin for histological evaluation
byanexaminerblinded to treatmentgroups. Inventral prostate thedegreeof epithe-
lial atrophy, epithelial infolding and inﬂammation was scored in the following way:
Epithelial atrophy: Score 0: no or minimal epithelial atrophy (≤5 acini affected);
Score 1: moderate epithelial atrophy (>5% and <50% of the section affected); Score
2: marked epithelial atrophy (≥50% of the section affected). Papillary growth: Score
1: mild; Score 2: moderate; Score 3: marked. Inﬂammation: Score 1: no or very few
scattered interstitial mononuclear cells; Score 2: focal to few multifocal interstitial
accumulations of few mononuclear cells; Score 3: multifocal interstitial accumula-
tions of mononuclear cells; Score 4: diffuse interstitial inﬁltrations of mononuclear
cells. Additionally, prostates were evaluated for intraepithelial vacuolation, acini
with concretions in the lumen, presence of areas with multilayering of epithelial
cells, and focal acinar atrophy.
Ventral prostates from animals in dose groups 1 and 4 were further evaluated
with regard to acini with atypical hyperplasia: score 0: no acini; score 1: few acini
(<5% acini with atypical hyperplasia); score 2:moderate level (>5% and <50% of acini
with atypical hyperplasia); score 3:marked level (>50%aciniwith atypical hyperpla-
sia), acini with cribriform pattern: score 0: no acini; score 1: single acinus affected;
score2: 2–4acini affected; score3: >4acini affected, andaciniwith columnar epithe-
lium and papillary growth: score 0: no acini affected; score 1: <25% acini affected;
score 2: >25% and <50% acini affected; score 3: >50% and <75% acini affected; score
4: >75% acini affected.
2.10. Hormone analysis
Trunk blood for hormone analysis was collected in Na–heparine coated tubes
and centrifugated for 10min, 4000 rpm at 4 ◦C. Plasma samples were stored at
−20 ◦C. Progesterone, testosterone, and estradiol levels were analyzed in rat plasma
at PD 16, PD 50/51 and in the dams at PD 22. T4 was measured in male and female
pups at PD 50. The progesterone levels were analyzed in plasma from 1–5 male
and 1–3 female pups in 4–5 litters per dose group. Testosterone and estradiol were
analyzed in plasma from 1–3 male or 1–3 female pups in 3–5 litters, respectively.
Plasmasamples fromthepups ineach litterwerepooledby sex. Furthermore, testos-
terone and progesterone levels were analyzed in plasma from 9 months old male
and female offspring, respectively. Testosterone, estradiol, and progesterone were
extracted from the plasma on IST Isolute C18 SPE columns as previously described
[12] and samples were resuspended in heptanes. All hormones including T4 were
analyzed using Delﬁa time-resolved ﬂuorescence kits (PerkinElmer Life Sciences,
Turku, Finland), and measured by use of a Wallac Victor 1420 multilable counter
(PerkinElmer Life Sciences, Turku, Finland).
2.11. Statistics
For all analyses, the alpha level was set at 0.05 and the litter was the statisti-
cal unit. Data were examined for normal distribution and homogeneity of variance,
and if relevant, transformed. In cases where normal distribution and homogene-
ity of variance could not be obtained by data transformation, a non-parametric
Kruskall–Wallis test was used, followed by Wilcoxon’s test for pair wise compar-
isons. Data with normal distribution and homogeneity of variance were analyzed
using analysis of covariance (ANCOVA). When more than one pup from each litter
was examined, statistical analyses were adjusted using litter as an independent,
random and nested factor in ANOVA or litter means were used. Where an overall
signiﬁcant treatment effect was observed, two-tailed comparison was performed
using least square means.
Dunnett’s test corrects for multiple comparisons, but applying this test on a
studywith 14 groupsmay lead to over-compensation andmay lead to false negative
results. For the analysis of reproductive organ weights an alternative approach to
using a Dunnett’s post hoc test on each group of chemicals separately was applied
(i.e. separate analysis of controls and mixture groups 2–4, and separate analysis
of controls and the two doses of each of the single pesticides). This separation of
the study into one mixture study and ﬁve studies on single pesticides increases the
likelihood of ﬁnding statistically signiﬁcant differences, but also increases the risk
of false positive ﬁndings. Results of both approaches are evaluated bearing these
differences in mind.
A similar approach was taken in analysis of the behavioral data, however here
the statistical analysis of controls and the two doses of the individual compounds
were not performed, because of the low number of animals tested in these groups.
The statistics on the Morris Maze data (i.e. swim length, swim speed and latencies)
were calculated both for each separate test day, and for the combined total swim
length and total latency, as this equals a ‘repeated measures’ test of these endpoints
Data obtained from prostate- and thyroid histology were analyzed statistically
by Fisher’s exact test. Prostate data from each mixture groups as well as each single
compound groups were compared with the control group. If statistically signiﬁ-
cant differences (p<0.05) were observed when all scores for a given endpoint were
included, then individual scores were compared separately. For the densities of the
mammary glands a one-way ANOVA with heterogeneous variance was used. For
mammary gland densities PD 50, a threshold based on densities of control animals
was set andaFisher’s exact testwasused tomakegroupcomparisonsof thenumbers
of animals with densities above this threshold.
Asterisks in tables and ﬁgures, indicate a statistically signiﬁcant difference com-
pared to controls *: p≤0.05; **: p<0.01. ***: p<0.001. All analyses were performed
using SAS Enterprise Guide 3.0, SAS Institute Inc, Cary, NC, USA.
3. Results
3.1. Pregnancy, litter and offspring data
None of the applied exposures caused adverse effects on dam
body weight gain, litter size or pup mortality. For further informa-
tion regarding pregnancy and litter data please consult Hass et al.
[28].
3.2. Section PD 16, organ weights
Absolute weights of male reproductive organs are listed in
Table 2. In the comparisons of absolute organweights, bodyweight
was taken into consideration as this was included as a covariate in
the statistical analysis. Reduced absolute weights of epididymis,
prostate and seminal vesicle were seen in the highest mixture
dose group compared with controls, in a model using Dunnett’s
post hoc test on all 14 dose groups. Epididymis weight was dose-
dependently reduced in all three mixture groups compared with
controls, though this effect was only statistically signiﬁcant in the
low and high mixture groups due to fewer animals in the mid-
dle dose group. Additionally, a statistically signiﬁcant increase in
absolute prostate weight was seen in animals exposed to the high-
est dose of epoxiconazole. Possible differences in weights of LABC,
glandula bulbourethralis, liver and thyroid were not statistically
signiﬁcant in a Dunnett’s test on all 14 groups. Comparable effects
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Table 2
Absolute male organ weights on PD 16 and in adult male rats (PD 260–280) exposed to the pesticides singly or in mixture during fetal and neonatal life.
Absolute organ weights (mg) n Body weight (g) Testis (g) Epididymis (g) Prostate (g) Seminal vesicle (g) LABC (g) Bulbo (g) Liver (g) Thyroid (mg)
Male offspring PD 16
1: Control 15 30.8 ± 5.7 103 ± 15 23.3 ± 2.3 10.6 ± 2.5 10.4 ± 3.6 26.5 ± 5.8 1.7 ± 0.4 786 ± 128 4.4 ± 0.7
2: Pestimix-14.6 16 28.9 ± 2.8 101 ± 11 20.3 ± 2.5*,## 8.8 ± 1.7 8.0 ± 2.0 22.7 ± 3.8 1.5 ± 0.4 735 ± 68 4.0 ± 0.6
3: Pestimix-29.2 9 30.2 ± 3.9 109 ± 13# 20.8 ± 2.2# 8.5 ± 1.9# 8.6 ± 1.8 26.4 ± 6.7 1.5 ± 0.4 811 ± 120 4.4 ± 0.8
4: Pestimix-43.8 12 30.7 ± 4.5 110 ± 15# 19.4 ± 1.7***,### 7.1 ± 1.9***,### 7.2 ± 1.8**,## 24.3 ± 5.6 1.5 ± 0.6 811 ± 123 4.4 ± 1.6
5: Epoxi-3.75 6 30.9 ± 4.5 106 ± 7 22.3 ± 1.6 10.9 ± 1.7 9.5 ± 1.0 26.1 ± 15.5 2.2 ± 0.8 789 ± 135 4.8 ± 1.4
6: Epoxi-15 3 33.7 ± 4.0 120 ± 10 27.6 ± 0.9## 14.9 ± 2.7*,# 9.8 ± 3.0 25.1 ± 3.5 2.2 ± 0.6 902 ± 87 4.3 ± 1.0
7: Manz-6.25 5 28.5 ± 3.6 100 ± 8 21.0 ± 2.0 9.6 ± 1.0 10.6 ± 2.2 23.4 ± 2.8 1.7 ± 0.4 718 ± 99 4.4 ± 0.7
8: Manz-25 7 27.2 ± 1.1 97 ± 7 22.6 ± 1.5 9.8 ± 3.1 8.6 ± 2.2 25.7 ± 4.7 1.7 ± 0.3 690 ± 38 4.3 ± 0.9
9: Prchl-8.75 9 30.2 ± 2.0 108 ± 8 23.3 ± 2.5 11.4 ± 0.8 8.6 ± 2.0 25.7 ± 3.2 1.6 ± 0.4 765 ± 77 3.8 ± 0.6
10: Prchl-35 4 30.0 ± 3.5 107 ± 19 20.1 ± 2.6# 10.8 ± 2.4 7.8 ± 1.8 22.8 ± 2.5 1.5 ± 0.5 760 ± 130 3.4 ± 0.4#
11: Tebu-12.5 8 28.7 ± 3.8 104 ± 16 22.4 ± 2.4 12.0 ± 2.6 9.8 ± 3.2 25.0 ± 3.6 1.7 ± 0.4 746 ± 96 4.1 ± 1.2
12: Tebu-50 5 30.5 ± 2.8 105 ± 8 22.0 ± 2.7 9.8 ± 2.9 11.5 ± 2.2 24.5 ± 2.2 1.7 ± 0.3 839 ± 99## 5.3 ± 1.2
13: Procy-12.5 6 29.8 ± 1.0 112 ± 7*,## 22.3 ± 3.5 8.6 ± 1.5 7.6 ± 1.4 27.8 ± 6.3 1.5 ± 0.2 786 ± 46 4.3 ± 0.9
14: Procy-50 3 28.1 ± 4.6 102 ± 16 18.7 ± 3.0# 6.5 ± 0.7# 8.2 ± 1.0 18.5 ± 2.4 1.1 ± 0.4# 771 ± 194 4.2 ± 0.6
Adult male offspring
1: Control 16 497 ± 34 3.89 ± 0.31 0.70 ± 0.07 0.63 ± 0.15 1.91 ± 0.37 1.38 ± 0.19 0.22 ± 0.07 13.2 ± 1.4 22 ± 3
2: Pestimix-14.6 18 458 ± 29# 3.88 ± 0.24 0.69 ± 0.07 0.67 ± 0.17 1.94 ± 0.30 1.27 ± 0.17 0.24 ± 0.08 11.6 ± 0.9 24 ± 10
3: Pestimix-29.2 12 469 ± 50 4.03 ± 0.69 0.74 ± 0.11 0.63 ± 0.12 2.11 ± 0.40 1.28 ± 0.19 0.18 ± 0.07 12.0 ± 1.8 24 ± 4
4: Pestimix-43.8 16 457 ± 32 4.01 ± 0.26 0.69 ± 0.06 0.47 ± 0.19# 2.08 ± 0.38 1.15 ± 0.23*,# 0.21 ± 0.06 12.0 ± 1.2 20 ± 3
5: Epoxi-3.75 10 472 ± 41 4.00 ± 0.17 0.66 ± 0.07 0.63 ± 0.14 1.94 ± 0.35 1.24 ± 0.17 0.21 ± 0.05 11.9 ± 0.6 20 ± 2
6: Epoxi-15 2a 396 ± 31 4.06 ± 0.03 0.75 ± 0.001 0.64 ± 0.13 2.09 ± 0.001 1.28 ± 0.08 0.29 ± 0.06 11.4 ± 0.1 23 ± 1
7: Manz-6.25 8 464 ± 55 3.79 ± 0.27 0.69 ± 0.03 0.53 ± 0.25 1.82 ± 0.46 1.30 ± 0.28 0.22 ± 0.07 12.0 ± 1.6 30 ± 22
8: Manz-25 10 478 ± 36 3.89 ± 0.34 0.72 ± 0.08 0.61 ± 0.14 1.90 ± 0.43 1.23 ± 0.09 0.21 ± 0.07 12.9 ± 1.1 29 ± 15
9: Prchl-8.75 10 492 ± 30 4.15 ± 0.25 0.71 ± 0.05 0.64 ± 0.15 2.05 ± 0.25 1.31 ± 0.21 0.28 ± 0.06 12.9 ± 1.6 22 ± 3
10: Prchl-35 6 437 ± 18# 3.69 ± 0.19 0.64 ± 0.03 0.65 ± 0.11 1.98 ± 0.20 1.31 ± 0.20 0.22 ± 0.09 10.7 ± 0.9 21 ± 2
11: Tebu-12.5 8 455 ± 27# 3.84 ± 0.41 0.69 ± 0.12 0.59 ± 0.13 1.80 ± 0.29 1.24 ± 0.16 0.17 ± 0.06 11.3 ± 0.8 21 ± 2
12: Tebu-50 8 481 ± 62 3.83 ± 0.22 0.66 ± 0.03 0.55 ± 0.11 1.92 ± 0.41 1.23 ± 0.19 0.16 ± 0.02 12.7 ± 1.9 24 ± 4
13: Procy-12.5 8 481 ± 62 4.02 ± 0.43 0.73 ± 0.09 0.52 ± 0.10 1.95 ± 0.25 1.21 ± 0.21 0.18 ± 0.06 12.3 ± 1.3 21 ± 3
14: Procy-50 6 481 ± 47 4.03 ± 0.35 0.72 ± 0.07 0.43 ± 0.19# 1.73 ± 0.25 1.16 ± 0.22 0.21 ± 0.07 11.5 ± 2.0**,# 20 ± 4
Bulbo: glandula bulbocavernosus; LABC: levator ani/bulbocavernosus muscle.
Statistically signiﬁcant differences between controls and exposed are marked with asterisks which indicate signiﬁcance levels: *indicates p<0.05; ** indicates p<0.01; *** indicates p<0.001. p values result from ANCOVA using
body weights as a covariate followed by Dunnett’s test on all 14 groups. # Indicates signiﬁcantly different from controls in a model including only control and different doses of the same compound or the mixture using Dunnett’s
post hoc test. # p<0.05, ## p<0.01, ### p<0.001. All signiﬁcant results are written in bold. Epoxiconazole (Epoxi), mancozeb (Manz), prochloraz (Prchl), tebuconazole (Tebu) or procymidone (Procy). a Data for adults in the Epoxi-15
group were left out of statistical analysis due to only 2 animals in this group.
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were seen for analyses of relative organ weights (Table S1, Supple-
mentary data).
In addition to the Dunnett’s test on 14 groups, an alternative
approachusingaDunnett’s posthoc test oneachgroupof chemicals
separately was also applied, as described in the statistics section.
Using this approach, epididymis weights were reduced in all three
mixture groups, prostate weights were reduced and paired testis
weights increased in the two highest mixture groups and semi-
nal vesicles were reduced in the highest mixture group, compared
to controls. Furthermore, statistically signiﬁcant changes in organ
weights were also seen for high doses of some of the individual
pesticides compared with controls. The high dose of epoxicona-
zole increased epididymis and prostate weights, the high dose of
prochloraz decreased epididymis and thyroid weights, the high
dose of tebuconazole increased liver weights, the high dose of pro-
cymidone reduced weights of epididymis, prostate and the bulbo
urethral gland, while the low dose procymidone increased paired
testes weights (Table 2).
Because someof the single pesticide groupswere quite small, an
additional statistical approach was used, where data from the low
and the high dose groups for each chemicalwere pooled, increasing
the number of litters per chemical group. No statistically signiﬁcant
changes could be observed between controls and individual chem-
ical groups, except for an increase in testis weight in the pooled
procymidone group (data not shown). It may be noted that in some
of these pooled chemical groups the n was still somewhat lower
than the n of 12 litters in the high dose mixture group (n=9–13, for
exact number please consult Table 2).
In female offspring no changes in absolute or relative weights of
uterus, ovary or liverwere seen. Furthermore no statistically signif-
icant changes in body weights compared to control were observed
(data not shown).
3.3. Section on PD 16, histology
No clear alterations were observed in the histological examina-
tion of testes, seminal vesicles and epididymides. Thyroid histology
of controls and all three mixture groups was evaluated in female
offspring, and no clear differences between groups were observed
with respect tomarkers of activity, i.e. epithelial height and amount
of colloid (data not shown).
3.4. Section adult offspring, organ weights
Absolute weights of male reproductive organs are listed in
Table 2 and relative weights can be found in Table S1, Supple-
mentary data. In the comparisons of absolute organ weights, body
weight was taken into consideration as this was included as a
covariate in the statistical analysis. Data from the high dose epoxi-
conazole group were omitted from the statistical analysis because
only two males were available for data analysis. Reduced absolute
weights of LABCwere seen in the highestmixture dose group, using
both statistical approaches. When the groups were analyzed sepa-
rately, signiﬁcant reductions were also seen on prostate weight in
the highest mixture group and in the highest procymidone group.
Bodyweight appeared slightly reduced inmost dose groups though
thiswas not statistically signiﬁcant in the statistical approach using
Dunnett’s test on all 14 groups. When separating the dataset into
single compound groups the reduction in body weight was statis-
tically signiﬁcant in the low mixture group, high prochloraz, and
low tebuconazole groups.
The low body weight observed in mainly the epoxiconazole
groups resulted in increased relative, but not absolute, weights
of testes in the low epoxiconazole group (Table S1, Supple-
mentary data). Statistical analysis of relative organ weights also
revealed signiﬁcantly decreased relative liver weight in the groups
Fig. 2. Numberof spermper gramcaudaepididymis in the adultmales fromthe con-
trol group, and the group dosed with the highest dose of the pesticide mix during
gestation and lactation. The control group included measurements from 15 males
(representing 13 litters) and the mixture group included data from 16 males (rep-
resenting 14 litters). Group means± standard deviations for the two dose groups
were 522.0±178 and 326.4±69.2, respectively. ***p<0.001.
exposed to the high doses of prochloraz and procymidone,whereas
absolute liver weights analyzed with body weight as a covariate
were not signiﬁcantly decreased by the high dose of prochloraz but
only by the high dose of procymidone.
Thyroid weights were not affected by treatment. One animal
from each of the mancozeb groups and one animal from the low
dose mixture group had more than double thyroid weight com-
pared to controls and to other pesticide exposed animals, but no
treatment-related effectswere observedwith orwithout these out-
liers.
No dose related effects were observed on weights of uterus,
ovary or liver in adult female offspring (data not shown).
3.5. Semen quality
The sperm count in the adult males was signiﬁcantly lowered
in the highest mixture group compared to controls (p<0.0005)
(Fig. 2). The sperm count results are shown as number of sperm
per gram cauda epididymis, and the observed reduction was not
due to effects on the weight of the cauda epididymis, as this
was unaffected by the exposure (data not shown). Sperm motil-
ity parameters were investigated in all 14 dose groups, but neither
% motile sperm nor % progressive sperm were signiﬁcantly affected
by pesticide exposure (data not shown).
3.6. Section adult offspring, histology
Testicular histology appeared normal in most animals, whereas
twoanimals had testeswith tubular degeneration in approximately
20% of seminiferous tubule cross-sections. As this ﬁnding may also
be seen in controls and as these animals were from two different
low dose groups (tebuconazole and procymidone), this was not
considered to be dose related (data not shown). Due to the ﬁnding
of reduced sperm number in the high mixture group, the histolog-
ical examination was repeated on a new set of testicular sections
(high mixture group and controls only) including the rete testis to
see if examination of the rete testis would reveal subtle changes in
histology. This examination showed no differences between dose
groups (data not shown).
Caput epididymides were examined in groups 1 and 4, and both
groups had normally appearing epithelium, equally high sperm
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content, and had no sloughed cells or cell debris in lumen (data
not shown).
In the ventral prostate, various lesions were observed in both
controls and exposed animals, and acinar epithelial atrophy was
observed less frequently in the high dose mixture compared with
the control group (Table 3). In the single compound groups, no sta-
tistically signiﬁcant differences were found with respect to scores
for epithelial atrophy (data not shown). Increasing scores for pap-
illary growth were found in a few dose groups (low dose mixture
and low dose prochloraz) compared to controls (data not shown).
No statistically signiﬁcant differenceswere seenwith respect to the
following ﬁndings: interstitial inﬂammation, intraepithelial vac-
uolation, acini with concretions in the lumen, presence of areas
with multilayering of epithelial cells, and focal acinar atrophy. The
observation of lower scores for atrophy in the high dose mixture
was followed up by an evaluation of hyperplastic lesions including
presence of atypical hyperplasia and cribriform patterns in con-
trols and the high dose mixture group. Animals in the high dose
mixture group showed higher scores for atypical hyperplasia and
cribriform pattern (p=0.011 and p=0.031, respectively, Table 3)
compared with controls.
In the seminal vesicle a large degree of variation in lumen size,
epithelial height, epithelial infolding and secretory content were
seen, and overall, no treatment-related ﬁndings were observed
(data not shown).
The activity of the thyroid was generally not very marked in
the adult female offspring. Follicles with high columnar vacuo-
lated epithelial cells indicating higher degree of secretory activity
were only observed in few animals, mainly belonging to the high
dose mancozeb group. Correspondingly, a statistically signiﬁcant
increase in the number of animals with follicles dominated by
columnar to cuboidal epithelium was seen in mancozeb exposed
animals compared to the control group (observed in 4 of 9 animals
from the high dose mancozeb group compared to 1 of 17 control
animals, p=0.03). Mild diffuse C-cell hyperplasia was observed in
thyroids of all groups with no statistically signiﬁcant differences.
No clear differences were observed in liver histopathology
between controls and the exposed groups (data not shown).
3.7. Mammary glands PD 22 and 50
Examination of mammary gland whole mounts of males and
females at PD 22 showed no statistically signiﬁcant changes in
longitudinal growth, transverse growth, glandular area, glandular
density or in the number of terminal end buds (Table S2, Supple-
mentary data). Histopathology of female mammary glands PD 50
showed a lobuloalveolar pattern in one animal from each of the 3
mixture groups (not statistically signiﬁcant) (Table S2). At PD 50,
mammary glands of both male and female rats showed higher den-
sities with increasing mixture doses (Fig. 3 and Table S2). When
evaluated using an ANOVA approach this apparent increase in den-
sity was not statistically signiﬁcant. However, when considering
the distribution of density scores, it was evident that density score
4 and 5 were only present in males of the mixture groups (Fig. 3).
This increase in the incidence of high density scores for males was
statistically signiﬁcant in a Fisher’s exact test comparing animals
with scores above 3 in exposed groups versus controls (p=0.03 in
both high mixture groups). For females, a slightly higher frequency
of scores 4 and 5 was seen in exposed animals than in controls, but
this was not statistically signiﬁcant. Male mammary glands PD 50
were also evaluated for growth and area. The longitudinal growth
was increasedwith dosing andwas statistically signiﬁcantly higher
in males PD 50 in group 3 (p=0.04) (Table S2). No changes were
found in the transverse growth and area of male mammary glands
PD 50 (data not shown). Ta
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Fig. 3. (a,b) Mammary gland whole mounts PD 50. Glandular density was evaluated
as described in Section 2 and the distribution of density scores is presented as % of
animals with a given score for each group separately. For males, scores 4 and 5 are
only present in exposed groups indicating a dose-related inﬂuence on mammary
development in some individuals. Number of animals examined PD 50; males n=14
(control), n=17 (Pestimix-14.6), n=12 (Pestimix-29.2), n=16 (Pestimix-43.8), in
femalen=18 (control),n=18 (Pestimix-14.6),n=10 (Pestimix-29.2),n=9 (Pestimix-
43.8).
3.8. Onset of puberty
No treatment related effects were observed in age or weight at
onset of puberty determined as VO or PPS in either male or female
offspring (data not shown).
3.9. Activity
In 28 day old offspring motor activity levels did not show any
effects of pesticides exposure or any differences between male and
female pups (data not shown). When the offspring were tested
again in adulthood, there was a statistically signiﬁcant sexual
dimorphism, with females showing signiﬁcantly higher activity
levels than males (p<0.0001) (Table S3, Supplementary data). The
results from the two sexes were therefore analyzed separately.
No statistically signiﬁcant effects were seen in either males or
females exposed to the pesticide mixture, compared with con-
trols (Table S3, Supplementary data). In the animals dosed with the
single pesticides, no signiﬁcant effects were seen in the male off-
spring, whereas signiﬁcantly higher activity level were observed
in females from the high dose mancozeb group (p=0.007), the
low dose prochloraz group (p=0.029) and low dose tebucona-
zole group (p=0.029) (Table S3, Supplementary data). None of
the observed effects were due to effects on habituation (data not
shown).
3.10. Spatial learning
During the last four days of the learning period (days 4–7), a
statistically signiﬁcant sexual dimorphism in Morris Maze perfor-
mancewasobserved,with females spendingmore time in thewater
and swimming further before ﬁnding the platform than males
(p<0.0001) (Table S4, Supplementary data). The results from the
two sexes were therefore analyzed separately.
InFig. 4, total swimlengthsduring the learningperiod (days1–7)
(Fig. 4a) and total latency to reach the platform during this period
(Fig. 4b), are shown for male and female offspring from controls
and the three mixture groups. In males, both endpoints showed a
dose-dependent increase, which reached signiﬁcance in the high-
est mixture dose group compared to controls, when all 14 groups
were included in the statistical analyses (p=0.03 and 0.02, for swim
length and latency respectively). When the test was performed on
just the data from the control and mixture groups, the p-values
were no longer statistically signiﬁcant but only borderline (p=0.11
and 0.07 respectively). As shown in Fig. 5, the effect of pesticide
exposure on male swim length and latency was primarily observed
at the end of the learning period (days 6 and 7) and reached signif-
icance for swim latency on day 7, with high mixture group males
spending signiﬁcantly more time to ﬁnd the platform than control
males (p=0.01). Thepicturewas similar for swimlength, butdidnot
reach signiﬁcance, even on day 7 (Table S4, Supplementary data).
The effect on swim latency on day 7 was also signiﬁcant when the
data form control and mixture groups were analyzed separately
(p=0.049). The higher group mean values in the highest mixture
groupwere primarily caused by a fewanimals still having very high
latencies and swim length values at the end of the learning period,
whereas all males in the control group had efﬁciently learned to
ﬁnd the platform at this time point. In the female offspring, there
were no statistically signiﬁcant effects of exposure to the mixture
on either swim length or latencies to reach the platform (Fig. 4a and
b), and in both sexes, no statistically signiﬁcant effects of pesticide
exposurewere observed on the animals’ swimming speed (data not
shown).
In the female animals exposed to the single pesticides, no statis-
tically signiﬁcant effectswere seen (Table S4, Supplementary data).
In the males, statistically signiﬁcant increases in total latency and
swim length were seen only in the low dose tebuconazole group
and the high dose procymidone group (see Table S4, Supplemen-
tray data). Like in the mixture groups, these increases were most
marked on day 7 of testing.
No effects of pesticide exposure were seen in neither males nor
females during reversal learning, on days 8 and 9 (data not shown).
3.11. Mating behavior
Mating behavior was assessed in 87 males (from all groups), as
one of the 88 recordings was spoiled. No statistically signiﬁcant
differences in mating behavior (assessed as frequency of mount-
ing, intromissionandejaculation, andas intromission latency)were
revealed between the control and the three mixture groups. More-
over, no statistically signiﬁcantdifferencesbetween the control and
the single pesticides groups inmating behaviorwere revealed (data
not shown).
When the animals were characterized, as belonging to either a
low (i.e. number of mounts below or equal to 5), medium (number
ofmounts between5 and30) or high (number ofmounts equal to or
above 30) group with regards to general mating activity, the males
from the highest dose of prochloraz showed signiﬁcantly increased
mating activity (p<0.001) compared to the controls. In Fig. 6, the
distribution in these different groups in relation to mounting fre-
quency is shown.
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Fig. 4. (a,b) Total latency to reach the platform (a) and total swim length (b) in adult male and female offspring exposed to 0, 14.6, 29.2 or 43.8mg/kg/day of the pesticide
mixture during fetal and neonatal life. Data is shown as group means± SEM for total latency and swim length to reach the platform in the Morris Water Maze, n=9–10.
Statistically signiﬁcant differences between controls and exposed are marked with asterisks which indicate signiﬁcance levels: *p<0.05. The results from these groups and
the 10 single pesticide exposed are shown in Table S4, Supplementary data.
3.12. Hormone levels
There were no statistically signiﬁcant effects of exposure to the
mixture on any of the measured plasma hormone levels in dams or
in male or female pups (data not shown).
Also, there were no statistically signiﬁcant effects of exposure
to the single pesticides on progesterone and testosterone levels in
adult offspring.
4. Discussion
This study generally aimed at exploring whether combined
perinatal exposure to low doses of ﬁve endocrine disrupting pes-
ticides could lead to adverse reproductive and neurobehavioral
effects, including effects observed months after ended exposure.
It was also the intention to investigate whether effects of the mix-
ture were present at dose levels where single compounds were
ineffective, i.e. at NOAELs for single compounds. However, due to
very low pregnancy rates, some dose groups were unintentionally
small, and as discussed in the following, the reader should bear this
in mind when interpreting the data on single compound effects.
Alterations in reproductive organ weights and altered histology
were seen in both young and adult offspring, and decreased sperm
count and impaired spatial learning was observed in adult male
offspring. Furthermore, reproductive organ weights changes gen-
erally showed cumulative effects, conﬁrming the mixture effects
also described by Hass et al. [28].
4.1. Mixture effects on reproductive organ weights
As can be seen in Table 2, weights of male reproductive organs
in both 16 day old and adult offspring were affected by a com-
bination of the 5 pesticides at dose levels where the individual
pesticides caused no or only small effects. Fig. 7 shows the relative
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Fig. 5. Mean daily latency to reach the platform in adult male rat offspring exposed to 0, 14.6, 29.2 or 43.8mg/kg/day of the pesticide mixture during fetal and neonatal
life. Data is shown as group means± SEM for latency in the Morris Water Maze for the ﬁrst seven days of the learning testing, n=9–10. Statistically signiﬁcant differences
between controls and exposed group on each day of testing are marked with asterisks which indicate signiﬁcance levels: *p<0.05. The results from these groups and the 10
single pesticide exposed are shown in Table S4, Supplementary data.
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Fig. 6. Mating behavior, % mounting activity and distribution in 3 groups. Low (number of mounts ≤5), medium (number of mounts >5 and <30) or high (number of mounts
≥30), during a 20min. period, shown as group means (%). The number of males is shown as n, while the number in parenthesis is the number of litters. ***p<0.001.
epididymis, prostate and seminal vesicle weight data from day 16
offspring and relative prostate and LABC weights from adult males
compared to control values. Results are shown for the highest mix-
ture group and for the individual pesticides in the low doses, which
were included in this mixture, and the ﬁgure illustrates how the
slight effects of individual compounds add up to a marked effect in
themixture group at the same dose levels. Similar results have pre-
viously been obtained in another mixture study of three similarly
acting anti-androgens, i.e. the androgen receptor (AR) antagonists
ﬂutamide, procymidone and vinclozolin [24]. For chemicals act-
ing via the same mode of action, e.g. AR antagonists, effects will
be in the same direction (e.g. decreased organ weights) and dose-
additive effects are expected when such compounds are given in
combination. Evidently, exposure to antagonists in combination
with agonists for the same receptor, may result in opposite direc-
tions of effects and thus one compound compensating the effect of
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Pesmix 43.8 mg/kg
Epoxi 3.75 mg/kg
Manz 6.25 mg/kg
Prchl 8.75 mg/kg
Tebu 12.5 mg/kg
Procy 12.5 mg/kg
Fig. 7. Organ weight changes compared with controls in male rat pups exposed to the low dose of epoxiconazole (Epoxi), mancozeb (Manz), prochloraz (Prchl), tebuconazole
(Tebu), procymidone (Procy) or the highest mixture dose of these pesticides (Pestimix) from GD 7 to PND 16. Values are expressed as percent of control values for relative
organ weights. Horizontal line indicates control level 100%. n=2–16 as listed in Table 2.
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another. For compounds with multiple modes of action, the effects
of each chemical may be in opposite direction (increase versus
decrease) and the effect of the mixture is more difﬁcult to predict.
In the current study, procymidone appears to be the dominating
compound in themixture asprocymidonehas the largest individual
effect reducing prostate and seminal vesicle weights at the applied
doses. In contrast, the low dose of tebuconazole slightly increased
prostate weights and the high dose of epoxiconazole signiﬁcantly
increased prostate weights at PD 16. These azole fungicides have
multiple modes of action, i.e. anti-androgenic, anti-estrogenic and
steroid synthesis disrupting actions, which may inﬂuence prostate
weight in opposing directions. However, when these azole fungi-
cideswere given in combinationwith procymidone, the joint effect
is a signiﬁcant reduction in prostate weight at a lower dose of pro-
cymidone than is effective alone. Currently, little is known about
combination effects on endpoints inﬂuenced in opposite directions
by endocrine disrupters with different modes of action and more
research is needed in this area.
It should be noted that the low doses of the individual com-
poundswere similar to thedosesused in thehighestmixture group.
As the numbers of animals in the individual chemical groups were
lower than the number of animals in the mixture groups, it could
be argued that the low “n” of the individual chemical groups might
reduce the likelihood for detecting statistically signiﬁcant changes.
However, even after pooling weight data from the low and the high
dose groups for each chemical where “n” was increased to 9–13 lit-
tersper chemical group, no statistically signiﬁcant changes couldbe
observed between controls and individual chemical groups, except
for an increase in testis weight in the pooled procymidone group.
Thus, increasing the number of litters in the individual chemical
low dose groups would not change the overall picture that effects
on male reproductive organ weights occur in mixture groups but
not in individual chemical groups using the same doses. The reduc-
tions in weights of male accessory reproductive organs on PD 16 in
only the highest mixture group indicates a cumulative effect seen
at dose levels where each compound does not have a statistically
signiﬁcant effect. Cumulative effects, in relation to mixtures tox-
icology, has previously been introduced by Silva et al. [23] who
showed that in mixture studies, every chemical in the mixture, in
proportion to its toxic unit, can contribute to the overall effect –
even when it is present at concentrations below the threshold of
statistically detectable effects. The concept has subsequently been
proven several times during the last decade in both in vivo and
in vitro studies [23,25,37–43].
A statistically signiﬁcant increase in testisweightswas observed
in animals exposed to the lowest dose of 12.5mg/kgbw/day of pro-
cymidone on PD 16 but not at 50mg/kgbw/day. Interestingly, our
own previous study on procymidone showed a statistically signif-
icant increase in testis weight at 10mg/kgbw/day, no change at
25–100mg/kgbw/day and a decrease at 150mg/kgbw/day point-
ing to a non-monotonous dose–response curve [24]. Testis weight
may be affected by chemically induced changes such as ﬂuid
accumulation or impaired proliferation/differentiation, and these
changes will likely have opposing effects on testis weight. If these
changes appear at different doses, it may be speculated that this
could result in non-monotonous dose–response curves for testis
weight.
In adult offspring, reduced absoluteweight of LABC andprostate
were seen in the highest mixture dose group compared to controls,
but not in any of the groups exposed to the pesticides alone at the
same dose levels, again conﬁrming a cumulative effect seen at dose
levels where each compound did not have a statistically signiﬁcant
effect (Table 2 and Fig. 7). The decreased weights of prostates in
the high dose mixture group corresponded well with the ﬁnding of
low weights of prostates, seminal vesicles and epididymides on PD
16 and revealed that pesticide effects on male reproductive organs
persisted into adulthood. The decreased weight of the LABC in the
adult but not prepubertal male offspring may indicate long-term
delayed mixture effects, but could also reﬂect a higher degree of
variation (biological or procedural) at PD 16 than in adulthood. No
changes in seminal vesicle or epididymis weight were observed in
adult animals, indicating that PD 16 may be a more sensitive time
point for observing impaired growth of male reproductive organs
due toanti-androgenic effects of thesepesticides.Ourownprevious
studies on perinatal exposure to other anti-androgenic chemicals
have shown that prostate weight on PD 16 is often affected at low
doses. For different anti-androgenic chemicals, it differs whether
LABC, seminal vesicle or epididymis weights are also affected at
the same doses that affect prostate weight, i.e. prostates appear to
bemost sensitive to anti-androgenswhereasweights of othermale
reproductive organs vary in their sensitivity depending on the type
of chemical exposure.
4.2. Effects on sperm count, semen quality and adult reproductive
organs
Exposure to the pesticide mixture lowered sperm counts in the
highest dose group. Control values did not differ from historical
control values and our ﬁnding therefore indicates that the low-
ered sperm counts were caused by developmental exposure to this
mixture of endocrine disrupting pesticides. This is a very important
and potentially quite alarming result in relation to the low sperm
counts and declining sperm quality in humans reported during the
last decades [6,44]. No effects on sperm motility parameters were
seen in the exposed animals in the present study, which indicates
that the mixture affected the number but not the function of the
sperm cells.
Histological evaluation of testes and caput epididymides
showed no differences between controls and the high mixture
group. The epididymis is well known to be a sensitive indica-
tor of spermatogenic disturbance showing increased numbers of
sloughed cells and cell debris in case of endocrine disruption such
as anti-androgen effects [45]. However, in this study the effects
were seen months after exposure, and any histological changes
were likely to be much more subtle than would be expected from
studies on direct exposure. It should also be noted that no histo-
logical examination of corpus or cauda epididymis was performed
and that functional and/or histological changes in these parts may
be present.
Although theweightsofprostate inadultoffspringwere reduced
in the highest mixture group compared to the control group, this
was not associated with any increase in prostate atrophy. Interest-
ingly, in the present study a higher degree of atypical hyperplasia
and cribriform patterns together with less epithelial atrophy was
observed in the highest mixture dose group compared with the
control group. In rats, epithelial atrophy is a known age-related
ﬁnding in prostate, probably caused by a decline in circulating
testosterone [46]. This apparent change from epithelial atrophy (as
a normal age-related ﬁnding) towards epithelial hyperplasia (as an
abnormal change)may be related to endocrine disruption. It is gen-
erally agreed that early exposure to endocrinedisrupting chemicals
can initiate imbalances in the prostatic cells which may contribute
to prostatic pathology with aging [47,48]. Neonatal exposure to
bisphenol A resulted in an increased susceptibility to precancer-
ous lesions in the adult rat ventral prostate [48]. An adult onset of
mainly augmented atrophic changes and to a lesser extent hyper-
plastic changes were seen in aged ventral prostates through four
generations of rats following neonatal exposure to Vinclozolin in
F0 [47]. The ﬁndings of atypical hyperplasia and cribriform pattern
in ventral prostates of thehighestmixturedose group in the current
study may similarly reﬂect alterations caused by early exposure to
this pesticide mixture. A comparable shift from atrophy towards
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hyperplasia of prostatic epithelium has been observed in another
study on aging rats exposed perinatally to anti-androgenic chemi-
cals ([47] manuscript in preparation).
4.3. Thyroid and liver effects
Since at least one (mancozeb) and possibly more of the tested
pesticides (the azole pesticides) may affect the thyroid hormone
system, several endpoints which can be used to investigate thyroid
disruption were included in the present study.
On pup day 16, reduced thyroid weights were seen in animals
exposed to the high dose of prochloraz. Similar effects have not
been described in the literature and have not been investigated in
our previous studies on prochloraz [11,13]. In adults an increase in
thenumberof ratswith folliclesdominatedbycolumnar tocuboidal
epithelium was found in group 8 compared to the control group
indicating thyroid hyperactivity. This conﬁrms previous ﬁndings
that Mancozeb produces structural and functional changes in rat
thyroids [49,50].
No thyroid weight or histological changes were seen in mixture
groups, and T4 levels were measured in male and female pups at
PD 50 in control and mixture groups, and at this age no statistically
signiﬁcant changes were seen in any dose group, indicating that
possible effects of prochloraz and mancozeb would require higher
doses than those included in the mixture. Thyroid hormones are
important to growth and mental development, and in the activity
test, a signiﬁcantly elevated activity level was seen in the high dose
Mancozeb females. This could reﬂect a real effect on activity levels,
however other studies on Mancozeb performed in our laboratory
using a larger group size did not show similar effects [19], and this
may therefore be considered a chance ﬁnding due to the relatively
low number of offspring in the mancozeb group. Also, no changes
in the learning and memory of the animals were observed in the
Mancozeb groups. All in all, no signiﬁcant changes indicating anti-
thyroid properties of the pesticide mixture were observed.
The observed increase in absolute and relative liver weight
observed at PD 16 in animals exposed to 50mg/kgbw/day of tebu-
conazolewere comparable toﬁndings ina studybyMoser et al. [51],
who described increased liver weights at PD 46 in rats following
perinatal exposure to 60mg/kgbw/day of tebuconazol.
4.4. Effects on mammary glands
Mammary glands of offspring from the three mixture groups
showed no altered growth or development on PD 22. On PD 50
increased densities of male mammary glands appeared in the high
dose mixture groups. The female form of the mammary glands in
rodents is the default morphology of the mammary glands and
testosterone is responsible for the development of the male mor-
phology of the mammary glands (Goldman et al. [52]). Hence, the
anti-androgenic effects of the mixture in the present study may
impart the virilisation of the fetalmalemammary glands. The dose-
related increase in density of the male mammary glands may thus
reﬂect the anti-androgenic properties of the mixture. In addition,
nipple retention is strongly linked to endocrine disrupting chemi-
cals [25]. More nipples were found in the male offspring exposed
to the mixtures, as reported in Hass et al. [28]. This ﬁnding may
comply with the increased density in the male mammary glands
PD 50 reﬂecting a possible permanent feminization of the mam-
mary glands. Likewise, more male mammary glands in the high
mixture group had secretory material in the ducts and more vac-
uolated epithelium, suggesting an increased secretory activity of
the glands. This may be linked to an increased feminization of the
male mammary glands. However, in some of the animals, it was
not evident if the material in the ducts were of secretory origin.
Further investigation with other staining techniques will be neces-
sary to determine the nature of the material in the ducts.
4.5. Effects on onset of puberty
No effects were seen in age or weight at onset of puberty on
male or female offspring in either the groups receiving themixtures
or the single chemicals in the present study. However, as some of
the pesticides have been shown to affect timing of sexual matu-
ration and several of the pesticides used in this study can act as
anti-androgens [14,15,17,53,54] onset of puberty could have been
affected in the tested animals [55].
4.6. Behavioral studies
In the behavioral studies ofmotor activity, no statistically signif-
icant exposure-related effects were seen in males or females from
the threemixturegroups, compared to controls. Asbehavioral stud-
ies conductedwith the small group sizeswhichwere present in the
single pesticides groups are very difﬁcult to interpret, the signiﬁ-
cantly elevated activity levels observed in female rats exposed to
the low doses of prochloraz and tebuconazole and the high dose of
mancozebwere probably randomﬁndings. No dose–response rela-
tionship was seen for the two ﬁrst groups, and a previous study of
mancozeb [19] did not show any effect on activity level usingmuch
larger group sizes and higher dose levels.
In the Morris Maze spatial learning test signiﬁcant effects of
mixed pesticide exposure were seen in the male offspring. On
the last day of the learning period (day 7), males from the high-
est mixture group spent signiﬁcantly more time in the maze and
swam signiﬁcantly longer than control males before reaching the
platform, indicating decreased learning ability in these animals.
Even though the effect was most marked on day 7, a similar dose-
dependent increase in swim length and latency was seen over the
last three days of the learning period. The fact that no effects on
activity levelswere seen in themales from three groups dosedwith
the pesticide mixture indicates that the signiﬁcant effects seen in
the Morris Water Maze were not related to alterations in the level
of general motor activity. As male rats generally perform better
than females in tests of spatial learning [56,57], a result that was
also conﬁrmed in the present study, the signs of decreased learning
ability seen in the pesticide exposed males could be interpreted as
being in the direction of female performance.
Spatial learning ability after perinatal pesticide exposure has
previously been investigated for prochloraz, mancozeb and pro-
cymidone, but none of the compounds affected learning ability
when tested alone, as a dose of 30mgprochloraz/kg/day [11], doses
of 50–100mg mancozeb/kg/day [19] and doses of 25–100mg pro-
cymidone/kg/day [27] did not result in any signiﬁcant alterations
of spatial learning ability in male or female offspring. However,
demasulinization of another sexually dimorphic behavior, sweet
preference, was seen in the males from the prochloraz study
[11]. Moreover, spatial learning ability was impaired in males
dosed perinatally with a mixture of the three anti-androgenic
chemicals vinclozolin, ﬂutamide and procymidone, as both tested
doses of the mixture resulted in impaired Morris Maze perfor-
mance in the adult male offspring [27]. The same mixture doses
caused increased nipple retention as well as decreased weights
of epididymis, ventral prostate and bulbouretral glands [24,25].
These results indicate that behavioral effects induced by com-
bined exposure to anti-androgenic chemicals may be caused by
altered sexual differentiation of the male brain. More studies
are however needed before clear conclusions on this matter can
be drawn.
For the single pesticide exposures, group sizes were gener-
ally quite small in regard to assessment of behavioral results
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(n=2–6). Therefore, conclusions on whether the statistically sig-
niﬁcant increase in swim length and latency seen in the low but
not the high dose tebuconazole males, could be involved in the
observed mixture effect in the males are only speculative.
In the behavioral studies of mating behavior, males from the
highest dose of prochloraz showed signiﬁcantly increased mating
activity compared to the controls. However, due to the limited
number of animals in the single pesticide exposure groups this
ﬁnding can only be considered as suggestive.
4.7. Overall conclusions
The study showed that a mixture of the endocrine disrupting
pesticides epoxiconazole,mancozeb, prochloraz, tebuconazole and
procymidone, was able to cause adverse developmental toxicity
effects, including long-term delayed effects, at dose levels where
the single pesticides had no effects. The adverse effects, which
included decreased weight of reproductive organs, decreased
sperm count, altered mammary gland development and decreased
spatial learning ability in male offspring, were seen after exposure
to a mixture, where the individual pesticides were present at dose
levels below their respective NOAEL values. These results imply
that risk assessment based on NOAELs for single chemicals can
underestimate the risk, and that there is a need for modiﬁcation of
risk assessment procedures for pesticides in order to take account
ofmixture effects and thepotentially serious impact ofmixedexpo-
sure on development and reproduction. This issue is discussed in
much more detail in the paper by Hass et al. [28], and is supported
by the present ﬁndings.
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Introduction
Normal development of the male reproductive tract
depends on a balanced action of androgens and oestro-
gens (Hotchkiss et al., 2004; Delbes et al., 2005; Hass
et al., 2007; Metzdorff et al., 2007; McPherson et al.,
2008; Prins & Korach, 2008; Chen et al., 2009; Zhu &
Imperato-McGinley, 2009; Walters et al., 2010). Male
reproductive organs such as the prostate express
5alpha-reductase and aromatase, and are thus capable of
converting testosterone to AR ligand dihydrotestosterone
(DHT) as well as to oestradiol (Zhu & Imperato-McGinley,
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Summary
By diminishing the action of androgens during gestation, certain chemicals can
induce irreversible demasculinization and malformations of sex organs in the
male rat after gestational exposure. Studies with mixtures of such anti-andro-
gens have shown that substantial combined effects occur even though each
individual chemical is present at low, ineffective doses, but the effects of mix-
tures modelled based on human intakes have not previously been investigated.
To address this issue for the first time, we selected 13 chemicals for a develop-
mental mixture toxicity study in rats where data about in vivo endocrine
disrupting effects and information about human exposures was available,
including phthalates, pesticides, UV-filters, bisphenol A, parabens and the drug
paracetamol. The mixture ratio was chosen to reflect high end human intakes.
To make decisions about the dose levels for studies in the rat, we employed
the point of departure index (PODI) approach, which sums up ratios between
estimated exposure levels and no-observed-adverse-effect-level (NOAEL) values
of individual substances. For high end human exposures to the 13 selected
chemicals, we calculated a PODI of 0.016. As only a PODI exceeding 1 is
expected to lead to effects in the rat, a total dose more than 62 times higher
than human exposures should lead to responses. Considering the high uncer-
tainty of this estimate, experience on lowest-observed-adverse-effect-level
(LOAEL) ⁄NOAEL ratios and statistical power of rat studies, we expected that
combined doses 150 times higher than high end human intake estimates should
give no, or only borderline effects, whereas doses 450 times higher should pro-
duce significant responses. Experiments indeed showed clear developmental
toxicity of the 450-fold dose in terms of increased nipple retention (NR) and
reduced ventral prostate weight. The 150-fold dose group exhibited significantly
increased NR. These observations suggest that highly exposed population
groups, especially women of reproductive age, may not be protected sufficiently
against the combined effects of chemicals that affect the hormonal milieu
required for normal male sexual differentiation.
international journal of andrology ISSN 0105-6263
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2009; Ellem & Risbridger, 2010). DHT in turn can further
be converted to ER beta ligand 3 beta-diol (Oliveira et al.,
2007).
A wide range of chemicals can disrupt male sexual dif-
ferentiation by interfering with the physiological action of
either androgens or estrogens during foetal and early
postnatal life, by suppressing foetal androgen synthesis,
blocking the androgen receptor or activating oestrogen
receptors. The present investigation aims at elucidating
the effect of environmentally relevant mixtures of endo-
crine active chemicals on male sexual differentiation.
Many chemicals with anti-androgenic action have been
shown to act together in combination (Hass et al., 2007;
Metzdorff et al., 2007; Howdeshell et al., 2008; Rider
et al., 2008, 2010; Christiansen et al., 2009). There is also
experimental evidence that anti-androgens in combina-
tion can produce effects at doses that individually are not
associated with any observable responses (Hass et al.,
2007; Howdeshell et al., 2008; Christiansen et al., 2009).
Although the doses applied in these experiments were in
the range of no-observed-adverse-effect-levels (NOAELs),
they were still quite far removed from environmental
exposures experienced by humans. Furthermore, these
studies were designed primarily to explore the predictabil-
ity of mixture effects using various assessment concepts,
but not to investigate environmentally relevant combina-
tions. Chemicals with oestrogenic action can also disturb
the development of male reproductive organs (Kang et al.,
2002; Timms et al., 2005; Durrer et al., 2007; Prins et al.,
2008; Salian et al., 2009; Axelstad et al., 2011), but little is
known about the effects of mixtures of oestrogenic and
anti-androgenic chemicals.
Consequently, experimental evidence about the ways in
which a wider range of endocrine disrupting chemicals
behaves at doses approaching environmental levels has so
far been missing. In the current study, for the first time,
an in vivo rat experiment with mixtures of endocrine dis-
rupting chemicals, modelled on information about envi-
ronmental exposures, has been performed.
Considering the role of androgens and estrogens in
sexual development, we selected chemicals known to exert
anti-androgenic or oestrogenic actions. In composing the
mixture to be assessed for endocrine disrupting effects in
the rat, we encountered several difficulties. First, it was
necessary to select chemicals where at least rudimentary
information about their endocrine disrupting effects
in vivo was available. It turned out that this demand
already placed significant restrictions on the choice of
possible candidate chemicals. Secondly, data about human
exposures had to be available to guide the choice of doses
to be combined in the mixture. However, reliable infor-
mation about human exposures was patchy for certain
chemicals, e.g. parabens and UV-filter substances.
On the basis of the available information, we selected
13 chemicals to be included in the test mixture. These
were the phthalates di-n-butyl phthalate (DBP) and di-(2-
ethylhexyl) phthalate (DEHP), the pesticides vinclozolin,
prochloraz, procymidone, linuron and epoxiconazole, the
UV-filter substances octyl methoxycinnamate (OMC) and
4-methyl-benzylidene camphor (4-MBC), the pesticide
metabolite p,p’-DDE, the phenolic compound bisphenol
A(BPA), the preservative butyl paraben (BP) and the
analgesic drug paracetamol (PM). Table 1 gives an over-
view of the uses of these chemicals, their presumed modes
of action in causing reproductive tract alterations in
experimental animals, some of the relevant effects seen in
rodents, together with the NOAELs and lowest-observed-
adverse-effect-levels (LOAELs) reported in the literature
for these effects.
For the majority of the selected chemicals, disruption
of male sexual differentiation in vivo by an anti-andro-
genic mode of action is quite well documented. One
group of anti-androgens were phthalates. DBP (di-n-butyl
phthalate), DEHP (di-(2-ethylhexyl) phthalate) and other
phthalates are used to impart flexibility on plastic materi-
als. They are known to exert demasculinizing effects by
suppressing foetal testosterone synthesis during critical
stages of sex differentiation in the rat where they induce
malformations of internal sex organs and changes in ano-
genital distance (AGD) and nipple retention (NR) (Parks
et al., 2000; Schultz et al., 2001; Wilson et al., 2004; NRC
2008; Christiansen et al., 2010). Vinclozolin is a widely
used dicarboximide fungicide for the treatment of fruits,
vegetables, ornamental plants and turf grasses (Kelce
et al., 1994; Kavlock & Cummings, 2005). Another group
of anti-androgens were the pesticides. Vinclozolin metab-
olites compete with androgens for AR binding (Kelce
et al., 1994), suppress androgen-dependent gene tran-
scription (Kelce et al., 1997) and induce reproductive
tract abnormalities including hypospadias, AGD changes
and NR in rats (Gray et al., 1994, 1999). The imidazole
fungicide prochloraz is used for the preparation of soil
for planting (Vinggaard et al., 2005). Prochloraz is an AR
antagonist and can interfere with testosterone synthesis by
inhibiting the CYP450 17a-hydroxylase ⁄ 17,20-lyase as
shown in vitro studies (Vinggaard et al., 2005, 2006). In
the rat, it induces hypospadias, cryptorchidism and affects
the development of several androgen-dependent tissues
(Ostby et al., 1999; Laier et al., 2006). The dicarboximide
fungicide procymidone is structurally related to vinclozo-
lin; however, its potency as an anti-androgenic agent in
vivo is approximately twofold lower (Ostby et al., 1999).
Procymidone is an AR antagonist and induces inhibitions
of AR-mediated gene expression (Simard et al., 1986;
Ostby et al., 1999; Wolf et al., 1999; Hass et al., 2007). In
the rat, it induces an effect spectrum similar to that of
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vinclozolin (Ostby et al., 1999; Hass et al., 2007). Linuron
is a urea-based pre- and post-emergence herbicide applied
to suppress broadleaf and grassy weeds. Linuron has been
recognized as a weak AR antagonist (McIntyre et al.,
2002; Hotchkiss et al., 2004) with a chemical structure
quite similar to that of the AR-antagonist flutamide
(McIntyre et al., 2001). Linuron also affects foetal testis
testosterone synthesis in a way similar to DBP (Hotchkiss
et al., 2004). Epoxiconazole is a triazole fungicide used
for the control of fungi in horticultures. The mechanism
of action of epoxiconazole is suggested to be at the lyase
function of CYP 17 in the steroidogenesis (Taxvig et al.,
2007). The DDT metabolite p,p’-DDE continues to be
relevant as an environmental pollutant because DDT is
still manufactured in some countries, although it has been
banned in the USA and in Europe (You et al., 1998).
DDE is an AR-antagonist (Kelce et al., 1995) and causes
hypospadias, altered AGD and NR in male rats after peri-
natal exposure (Kelce et al., 1995; You et al., 1998; Wolf
et al., 1999). One drug was included in the group of anti-
androgens. Paracetamol, in the USA known as acetamino-
phen, is one of the most popular over-the-counter and
prescribed analgesic and antipyretic medicine in the world
(Ghanem et al., 2009; Hass et al., 2010). A recent Danish
cohort study showed that intrauterine exposure (maternal
intake during pregnancy) to mild analgesics (paracetamol)
increased the risk of cryptorchidism among newborn boys
and rat in vivo studies supported these anti-androgenic
effects in humans (Jensen et al., 2010; Kristensen et al.,
2011).
The oestrogenic chemicals contained in the mixture
also affect male reproductive development, although the
data in the literature are somehow less comprehen-
sive.OMC and 4-MBC are frequently used as UV-filter
substances in sunscreens and other cosmetics, and both
have been found in human milk and blood samples
(Hany & Nagel, 1995; Schlumpf et al., 2010). OMC and
4-MBC are oestrogenic in vitro and in acute and 90-day
in vivo models (Schlumpf et al., 2001; Schreurs et al.,
2002; Tinwell et al., 2002; Seidlova-Wuttke et al., 2006).
Pre- and postnatal administration of OMC caused
reduced testosterone levels, relative testes and prostate
weights and sperm counts in male offspring (Axelstad
et al., 2011). Pre- and postnatal exposure to 4-MBC
delayed onset of puberty in male rat offspring, reduced
prostate weight and, at higher doses, increased testis
weight in adult offspring (Durrer et al., 2007). Bisphenol
A is used in the manufacture of polycarbonate plastic and
is present in many consumer products. It can leach from
the inner lining of tin cans and microwave containers
into food during heating (Salian et al., 2009), and in ani-
mal studies, exposure to BPA has been shown to cause
decreased sperm counts and motility (Salian et al., 2009)
and affect the prostate (Timms et al., 2005; Prins et al.,
2008). BP has anti-bacterial and anti-fungal properties,
and is used as a food and cosmetic preservative. It is a
well-recognized oestrogenic agent and has AR antagonist
properties in vitro (Ermler et al., 2010). BP has also been
shown to reduce sperm counts and motility in rats (Kang
et al., 2002) All four selected estrogens have further been
shown to antagonize the androgen receptor in vitro
(Ermler et al., 2010), but data on 4-MBC are conflicting
(Ma et al., 2003; Schreurs et al., 2005). However, there
are no in vivo reports showing typical anti-androgenic
effects such as changes in AGD or NR for any of the sub-
stances. Both UV-filters and bisphenol A also interact
with thyroid hormones (Moriyama et al., 2002; Schmut-
zler et al., 2004; Zoeller et al., 2005); such effects may also
interfere with developmental processes. Inclusion of these
compounds offered the additional possibility of investi-
gating if combined exposure to both anti-androgens and
oestrogenic agents would magnify or counteract any
adverse reproductive effects in the offspring.
In selecting the chemicals for the experimental mixture,
we had to make compromises in terms of the number of
chemicals that could be included, to keep the experiments
manageable. Although we used high end human intake
estimates to guide the choice of mixture ratio, we made
adjustments to compensate for certain omissions. For
example, we did not incorporate the phthalates DiBP,
BBP and DINP and therefore adjusted the estimated high
end intakes for DBP and DEHP upwards. These two
phthalates now functioned as ‘placeholders’ to represent
total exposure to phthalates with anti-androgenic activi-
ties. Similarly, epoxiconazole was used as a proxy for the
entire group of anti-androgenic azole fungicides. For cer-
tain chemicals, we made downward adjustments to reflect
the fact that only certain population groups are highly
exposed. This was the case with BP and 4-MBC. Table 2
documents how the high intake estimates compared with
the adjusted exposures that we used as a basis for setting
the mixture ratio of the selected 13 compounds. The
adjusted high end human exposures summed up to a
value of 1.12 mg ⁄kg ⁄day.
Finally, we had to decide on the combined dosages that
were to be used in the experimental study. We
approached this by utilizing the so-called point of depar-
ture index (PODI), an application of the mixture assess-
ment concept of dose addition:
PODI ¼
Xn
i¼1
ELi
PODi
;
where EL denotes the estimated exposure level, and POD
the Point of Departure which is a LOAEL, NOAEL or
benchmark dose for a common endpoint (Wilkinson
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et al., 2000). Assuming that all mixture components act
together according to dose addition, significant combina-
tion effects are only expected to occur if the PODI is sig-
nificantly greater than one. We calculated the PODI using
NOAELs for anti-androgenic endpoints such as changes
in AGD and NR. Where these were not available, LOAELs
were used (p,p’-DDE and paracetamol). In view of the
fact that 4-MBC, OMC, bisphenol A and BP are not
known to affect AGD or NR, we assumed that these sub-
stances make no contribution to the anti-androgenic mix-
ture effect. As shown in Table 3, the ratios of adjusted
high exposure estimates (EL) and PODs summed up to a
PODI of 0.016. This meant that a mixture dose of
1.12 mg ⁄ kg ⁄day, equal to the sum of the adjusted high
end human intakes, was not expected to produce any
anti-androgenic effects in the rat. Even an increase of all
individual doses by a factor of 62, where the PODI
reaches 1, should not produce significant joint effects.
It is obvious that there are considerable uncertainties
with these theoretical assumptions and calculations. We
also had to consider the fact that experimental LOAELs
determined in the listed studies exceed the corresponding
NOAELs by a factor of two to three (see Table 1). Finally,
the statistical power that was available with the chosen
study design (see below) had to be taken into account. As
a result of these considerations, it was our expectation
that combined dosages 150 times higher than the adjusted
human intakes in Table 2 (Mix150) should still be in the
borderline range between a NOAEL and a LOAEL of the
mixture, whereas dosages that are 450 times higher
(Mix450) should lead to clear signs of disruption of sex-
ual differentiation, with statistically significant changes in
AGD and NR. Exclusion of the four estrogens 4-MBC,
OMC, bisphenol A and BP from this mixture (AA-
Mix450) should not diminish the overall effect.
We were conscious of the fact that the design of this
exploratory mixture experiment had certain limitations.
We used fewer animals than normally used in regulatory
testing (14 instead of 20 per group) and, consequently,
the statistical power was slightly reduced.
Furthermore, we did not test any of the single compo-
nents in parallel with the mixture experiment, which
prevented us from ascertaining their effectiveness after
single administration. It was also not possible to conduct
statistical dose-response regression analyses with the mix-
tures; as only two doses of the 13-component mixture
Table 2 Estimates for human intake of anti-androgenic chemicals and selection of dosages for the experimental mixture study
Chemical
High Intake
(lg ⁄ kg d)
Adjusted intakes chosen
as basis for mixture
study (lg ⁄ kg d) Comments and explanations
DBP 6 10 The high intake values are for a US population, based on the data communicated by
Kohn et al. (2000) and NHANES, as collated by Benson (2009). The higher doses
chosen as the basis for the mixture study reflect high exposures to other
anti-androgenic phthalates
DEHP 3.6 20
Vinclozolin 9 9 High intake is the life time Theoretical Maximum Daily Intake (TMDI) for France, as
estimated by Menard et al. (2008)
Prochloraz 14 14 High intake is the life time TMDI for France (Menard et al., 2008)
Procymidone 9 15 High intake is the life time TMDI for France (Menard et al., 2008), this estimate was
adjusted upwards to reflect exposure to other AR-antagonistic pesticides
Linuron 0.6 0.6 High intake is the life time TMDI for France (Menard et al., 2008)
Epoxiconazole 1 10 Intake estimate by the European Standing Committee on the Food Chain and Animal
Health, July 2008. The exposure chosen as a basis for the mixture study doses is
intended to reflect high intakes of other azole pesticides. The combined life time TMDI
(France) for all azole pesticides authorized for use in the European Union is around
5 lg ⁄ kg d (Menard et al., 2008).
4-MBC 100 60 Based on intake estimates of the European Scientific Community on Consumer Products
(SCCP) in their 2008 opinion on 4-MBC (SCCP, 2008)
OMC 100 120 Intakes were assumed to be similar to 4-MBC, based on the levels found in mother’s
milk. The higher doses chosen as the basis for the mixture study reflect that OMC is
more frequently detected in human milk than 4-MBC (Schlumpf et al., 2010).
p,p’-DDE 1 1 Estimates for a Polish population (Galassi et al., 2008)
Bisphenol A 1.5 1.5 High intake estimate from EFSA (2006)
BP 100 60 The worst case systemic exposure dose was estimated to be 0.6 mg ⁄ kg ⁄ day by the
European Cosmetic Toiletry and Perfumery Association (COLIPA), cited in VKM (2006).
Cross & Roberts (2000) estimated a high intake of 0.1 mg ⁄ kg ⁄ day
Paracetamol – 800 The dose in the mixture was chosen as around 10% of a pill a day to reflect the likely
intermittent exposure.
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(Mix150 and Mix450) and one dose of a mixture excluding
4-MBC, OMC, bisphenol A and BP (AAMix450) were
tested.
Materials and methods
Test compounds
The test compounds in this study were DBP (purity
>99.0%, CAS no. 84-74-2), DEHP (purity >99.5%, CAS
no. 117-81-7), vinclozolin (purity >99.5%, CAS
no. 50471-44-8), prochloraz (purity >98.5%, CAS no.
67747-09-5), procymidone (purity >99.5%, CAS no.
32809-16-8), linuron (purity >99.0%, CAS no. 330-55-2),
epoxiconazole (purity >99.0%, CAS no. 106325-08-8),
OMC (purity >98.0%, CAS no. 5466-77-3) and p,p’-DDE
(purity >98.5%, CAS no.72-55-9), which were all pur-
chased from VWR – Bie & Berntsen (Herlev, Denmark).
The rest of the test compounds 4-MBC (purity >98.0%,
CAS no. 36861-47-9), Bisphenol A (purity >99.5%, CAS
no. 80-05-7), BP (purity > 99.0%, CAS no. 94-26-8) and
paracetamol (purity > 99.0%, CAS no. 103-90-2), were all
purchased from Sigma-Aldrich (Brøndby, Denmark).
Corn oil, used both as a control compound and as a
vehicle, was purchased from VWR – Bie & Berntsen.
Animals and exposure
Fifty-six time-mated nulliparous, young adult Wistar rats
(HanTac:WH, SPF, Taconic Europe, Ejby, Denmark) were
supplied at gestation day 3 (GD 3) of pregnancy. The
study was performed using two blocks of 28 dams (sepa-
rated by 1 week), and all dose groups were equally repre-
sented in the blocks, i.e. 14 mated rats per dose group
were allocated. Dams that did not give birth were elimi-
nated from the experiment.
The animals were housed in pairs until GD 17, and
alone thereafter under standard conditions in semi-trans-
parent polycarbonate type III cages (1291H Eurostandard
Type III, Tecniplast) (15 · 27 · 43 cm) with Aspen wood
chip bedding (Tapvei, Gentofte, Denmark), Enviro Dri
nesting material (Brogaarden, Denmark) and plastic shel-
ters (Brogaarden, Denmark). They were placed in an ani-
mal room with controlled environmental conditions with
a 12 hour light–dark cycle with light intensity 500 lux
starting at 9 pm, humidity 55% ± 5, temperature at
21 C ± 1 C and ventilation changing air 10 times per
hour. All animals were fed on a standard diet with
ALTROMIN 1314 (soy- and alfalfa-free, ALTROMIN
GmbH, Lage, Germany). Acidified tap water (to prevent
microbial growth) in polycarbonate bottles (Tecniplast)
was provided ad libitum.
On the day after arrival (GD 4), the time-mated dams
were pseudo-randomly distributed into groups of 14 (6–8
per block) animals with similar body weight (BW) distri-
butions. Mixtures and vehicle were administered by oral
gavage with a stainless steel probe 1.2 · 80 mm (Scanbur,
Karlslunde, Denmark) from GD 7 to the day before
expected birth (GD 21) and again after birth from PND 1
to 22 to cover the most sensitive periods of the develop-
ment of the reproductive system. However, PM was only
added to the mixture groups at GD 13–19. The later initi-
ation of PM exposure during pregnancy, i.e. GD 13
Table 3 Dose selection for the experimental studies
Chemical
Adjusted intakes chosen
as basis for mixture
study (mg ⁄ kg ⁄ day)
Points of departure,
POD (AGD, NR)
(mg ⁄ kg ⁄ day)
Ratio of adjusted
intakes to POD
Mixture dose (mg ⁄ kg ⁄ day)
Mix150 Mix450 Mix450A
DBP 0.01 50 (1) 0.0002 1.5 4.5 4.5
DEHP 0.02 3 (1) 0.0067 3 9 9
Vinclozolin 0.009 5 (1) 0.0018 1.35 4.05 4.05
Prochloraz 0.014 5 (1) 0.0028 2.1 6.3 6.3
Procymidone 0.015 10 (1) 0.0015 2.25 6.75 6.75
Linuron 0.0006 25 (1) 0.000024 0.09 0.27 0.27
Epoxiconazole 0.01 15 (1) 0.0007 1.5 4.5 4.5
4-MBC 0.06 – (3) 0 9 27 0
OMC 0.12 – (3) 0 18 54 0
p,p’-DDE 0.001 10(2) 0.0001 0.15 0.45 0.45
Bisphenol A 0.0015 – (3) 0 0.225 0.675 0
BP 0.06 – (3) 0 9 27 0
Paracetamol 0.8 350(2) 0.0023 120 360 360
Sum (mg ⁄ kg ⁄ day) 1.12 168 504 396
PODI 0.016
Footnotes: (1) = NOAEL, (2) = LOAEL, see Table 1, (3) = because of lack of information about doses affecting AGD or NR.
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instead of GD 7, was chosen to avoid potential effects on
implantation of the embryos (Gupta et al., 1981). The last
dosing in this group during pregnancy was also earlier,
i.e. GD 19 instead of GD 21, to avoid potential effects on
the ability of the dams to give birth. The dams were not
dosed with paracetamol in the mixture during lactation,
because that would make the results more relevant in
relation to our previous results based on only prenatal
exposure (Kristensen et al., 2011).
The animals were dosed by qualified animal technicians
with vehicle (control, corn oil) or the three mixtures
described in Table 3. All doses were given in vehicle
(2 mL ⁄ kg) via oral gavage at the beginning of the ani-
mals’ active period from 8 to 11 am. The solutions were
prepared by a technician just before the study was per-
formed as a stock solution, and during exposure period,
they were stored in the animal rooms.
The dams were inspected twice a day for general toxic-
ity including changes in clinical appearance (e.g. sedation
and tremor). BWs were recorded on GD 4 and daily dur-
ing the dosing period to monitor a decrease or increase
in weight gain and to adjust dose according to weight.
We designated the day when a vaginal plug was detect-
able as gestation day (GD) 1 and the expected day of
delivery, GD 23 as pup day (PD) 1.
The animal study was performed under conditions
approved by the Danish Animal Experiments Inspectorate
(Council for Animal Experimentation) and by the
in-house Animal Welfare Committee.
Pregnancy and postnatal development
The weights of dams and individual pups were recorded
after delivery in all the pregnant animals in the study.
The pups were counted, sexed and checked for anomalies.
Pups found dead were macroscopically investigated for
changes when possible. The BW of offspring was recorded
on PD 6 and 13.
Anogenital distance and nipple retention
Anogenital distance (AGD) was measured in all the off-
spring at birth using an ocular stereomicroscope. On PD
13, all male and female pups were examined for the pres-
ence of areolas ⁄nipples (NR), described as a dark focal
area (with or without a nipple bud) located where nipples
are normally present in female offspring. Female rats nor-
mally have 12–13 nipples while male rats normally have
0–1 nipples.
Section PD 16, male organ weights
The animals, 1 male pup per litter, N = 11–13 was
weighed (bw) and decapitated. Testes, epididymides, ven-
tral prostate, seminal vesicles, LABC (Levator ani ⁄bulbo-
cavernosus muscle), bulbouretral gland and liver were
excised and weighed.
Statistics
For all analyses, the litter was the statistical unit. Data
from continuous endpoints were examined for normal
distribution and homogeneity of variance, and if relevant,
transformed. AGD data were analysed by the AGD index,
namely, AGD divided by the cube root of BW. The cube
root transformation was used because it improves the
comparison between the three-dimensional end point
weight and the one-dimensional AGD (Gallavan et al.,
1999; Gray et al., 1999). When more than one pup from
each litter was examined, statistical analyses were adjusted
using litter as an independent, random and nested factor.
Organ weights were analysed using BW as a covariate,
and maternal BWs were assessed with the number of off-
spring per litter as covariate. The number of nipple ⁄ are-
olas (NR) was assumed to follow a binomial distribution
with a response range between 0 and hmax, with hmax
being equal to the biologically possible maximal number
of nipples in rats, either 12 or 13. The choice of hmax was
decided by considering the global fit (information crite-
rion of Schwarz). Litter effects on NR and over-dispersion
in the data were accounted using generalized estimating
equations. Statistical significance were assessed using mul-
tiple contrast tests (Dunnett contrasts, global error rate
a = 5%, two-sided) (Bretz et al., 2005). These tests were
chosen as they are already implemented in the SAS proce-
dure PROC GENMOD which was used for all statistical
analysis (SAS Institute Inc., Cary, NC, USA).
Results
There was no general maternal toxicity at any of the
doses administered. The pregnancy proportion of the
dams was 100%, which compares very favourably with
the normal proportion of 80–90%. Consequently, the
number of pregnant rats did not differ from the number
of mated rats. One litter from the control group included
only female pups, all other litters contained at least one
pup from both genders.
The mixture exposures had no significant effect on the
maternal weight gain during pregnancy (GD 7 to GD 21)
or on the maternal weight on PND 1, and the mean ges-
tation length was also unaffected (data not shown). More-
over, no changes in post-implantation loss, litter size,
birth weights, sex ratio or perinatal loss were seen after in
utero and lactational exposure to the different mixtures
(data not shown).
The male offspring of dams treated with Mix150
already exhibited signs of anti-androgenic effects. The
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numbers of retained nipples were slightly elevated com-
pared with untreated controls, and although the effect
was small, it reached statistical significance, because the
background occurrence in both untreated control groups
was relatively low, even in comparison to previous studies
in the same research facility (Table 4 and Fig. 1). At this
mixture dose (168 mg ⁄ kg ⁄day), the dosages of most indi-
vidual components were considerably lower than their
individual NOAELs or LOAELs. Changes in anogenital
index were not observed with this mixture and the
weights of liver, epididymis, seminal vesicle, LABC and
bulbourethral gland were similar to untreated controls
(Table 4). There were also no changes in female AGD,
number of nipples or birth weights (data not shown). As
anticipated on the basis of our PODI calculations, the
male offspring of rats exposed to Mix450 were quite
clearly affected by exposure. With an average number of
nipples and areolas of 3.27, the effect was statistically sig-
nificantly different from controls. There were no changes
in male or female anogenital index. However, reductions
in the weights of the ventral prostate and the left testis
reached statistical significance, whereas right testis weights
and pooled (left + right) testis weights could not be
detected as significantly different from controls (Table 4).
Exposure to AAmix450, in which the four estrogens
(4MBC, OMC, BPA and BP) were excluded, did not
diminish the anti-androgenic effect in comparison to
Mix450 exposure. The effect on NR even increased slightly,
although this was not significantly different from the effect
seen with Mix450 exposure (see Table 4 and Fig. 1).
The decreases in testes and prostate weights that were
seen with Mix450 were, however, not observable with AA-
Mix450 (Table 4). Interestingly, comparison of Mix450
with AAMix450 revealed a statistically significant increase
in testis weights. This was seen for pooled testis weights
as well as for left and right testis weights.
Discussion
Despite some uncertainties and knowledge gaps about the
anti-androgenic potencies of the chosen chemicals, the
PODI approach proved to be a surprisingly accurate tool
for anticipating their combined effects on male rat off-
spring exposed during gestation and perinatally. For two
compounds, p,p’-DDE and paracetamol, NOAELs were
not accessible to us, but only their LOAELs were accessi-
ble, and consequently, we might have slightly underesti-
mated the PODI. This uncertainty corroborated our
expectation that doses 62-fold higher than the adjusted
high end human exposure estimates should lead to no
detectable disruption of sexual differentiation in the rat,
and given our experimental design, we expected a 150-
fold higher dose (Mix150) to be between a NOAEL and a Ta
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LOAEL for this mixture. As we found indications of anti-
androgenic responses in terms of retained nipples at this
mixture dose, our expectation was confirmed.
We had expected that Mix150 would be at the bor-
derline between a NOAEL and a LOAEL, but found
indications of anti-androgenic responses in terms of
retained nipples. It appears that the exquisite sensitivity
of this endpoint, combined with the low background
occurrence in control animals made it possible that the
effects became observable. Our experimental block-design
lead to the testing of control animals in two indepen-
dent blocks, and for both groups, we observed the same
low incidence rate. Similar low incidences in control
animals have been detected in our ongoing studies, and
thus we rule out the possibility of singular control
behaviour.
The results of our study suggest that highly exposed
population groups, especially women of reproductive age,
may not be protected sufficiently against the combined
effects of chemicals that affect the hormonal milieu
required for proper male sexual differentiation. Our
PODI calculations indicated that doses 62-fold higher
than the adjusted high end human exposure estimates
should be tolerated by the rat without signs of disruption
of sexual differentiation. As this exploratory experiment
already allowed us to demonstrate effects with 150-fold
higher doses, it is to be feared that an experiment with
larger numbers of animals might have shown responses at
even lower doses. This conjecture is speculative, but could
be substantiated by a dose-response analysis with carefully
spaced dosages. However, our study clearly shows that
the PODI approach is very useful in formulating testable
hypotheses to address that point.
Our concerns about insufficient margins of safety for
highly exposed population groups have to be discussed
critically in the context of the exposure estimates that
were accessible to us, and in the light of the constraints
that we faced when selecting the chemicals for our study.
The intake estimates we used for the chosen chemicals
are based on those also employed by regulatory bodies;
data of better quality are difficult to obtain or not avail-
able. Many of the intake estimates are based on maxi-
mum residue levels for the pesticides on food items and
commodities, and can therefore be regarded as sufficiently
conservative for the purpose of high intake estimates.
However, the estimates for the UV-filter substances and
BP relied on quite crude data. A notion implicit in our
summing up of exposures ⁄POD ratios to calculate the
PODI is that certain populations might experience high
exposures to all of the selected chemicals simultaneously.
The case can be made that this is quite unlikely. To
resolve this point, information about the co-occurrence
of several chemicals in one and the same individual
would be needed, but such data are not normally gath-
ered in biomonitoring studies. It may be that more realis-
tic data about simultaneous exposures to the selected 13
chemicals would have produced lower estimated high end
intakes, with a lower estimated PODI and accordingly
larger margins of safety.
However, these considerations need to be balanced
against the constraints we had to deal with while selecting
chemicals to be included in the mixtures. The knowledge
gaps concerning the in vivo effects of other candidate
compounds prevented us from including a wider range of
chemicals in our mixtures. At least rudimentary informa-
tion about the potency of chemicals in disrupting male
sexual differentiation in vivo was required to safeguard
against the risk of incorporating chemicals at too high
doses. For example, there are more than 20 pesticides
with in vitro AR antagonist properties in current use in
the European Union (Kojima et al., 2004; Vinggaard
et al., 2008; Orton et al., 2011), but published in vivo
data on NR and AGD are only available for a small num-
ber of these substances. Similar considerations apply to
the large numbers of industrial chemicals and those used
in consumer products that have also shown in vitro
activity (Vinggaard et al., 2008). Quantitative structure–
activity relationship analyses have predicted that
approximately 10% of the 30 000 chemicals listed in the
European Inventory of Existing Commercial Chemical
Substances display AR antagonism (Vinggaard et al.,
2008; Jensen et al., 2011). Inevitably therefore our selec-
tion was biased, and cannot be regarded as being entirely
representative of the spectrum of combined exposures
Figure 1 Effects of combined exposure to 13 and 9 endocrine
disrupting chemicals on NR from perinatally exposed male rats on
PND13. Results are shown as mean ± 95% confidence belt (Nlitter =
13–14). Statistical significance is indicated by *, with p < 0.01. Mix-
ture doses Mix150 and Mix450 refer to the 13-compound mixture,
AAMix450 to the 9-compound mixture.
S. Christiansen et al. Mixtures of environmentally relevant contaminants
ª 2012 The Authors International Journal of Andrology, 2012, 35, 303–316
International Journal of Andrology ª 2012 European Academy of Andrology 311
encountered by human populations. It is likely that the
inclusion of a wider range of chemicals would have led to
more pronounced disrupting effects in our developmental
toxicity model, with a larger PODI and correspondingly
lower margins of safety.
The PODI approach assumes that the joint action of
anti-androgens can be approximated by dose addition,
and that antagonisms or synergisms are not relevant. That
conjecture is supported by the available empirical evidence
(Hass et al., 2007; Howdeshell et al., 2008; Rider et al.,
2008, 2010; Christiansen et al., 2009). Antagonisms with
mixtures of anti-androgens, which would lead to lower
risk estimates, have not yet been reported. Of note is a
synergism in relation to penile malformations in the rat
that was observed with a mixture of anti-androgens with
diverse modes of action (Christiansen et al., 2009). How-
ever, in the same experiment, similar synergisms where
not found with other anti-androgenic endpoints such
changes in AGD or NR. As we applied the PODI method
to these endpoints, it can be assumed with some plausibil-
ity that the premises of that approach are fulfilled.
Another aim of the study was to compare the effects of
combined exposure to oestrogenic and anti-androgenic
agents with exposures to anti-androgens alone. With
regard to NR, an endpoint that is not affected by either
one of the four included estrogens, we saw that adding
oestrogens to the mixture did not enhance the observed
endocrine effect. In fact, inclusion of the estrogens may
even have led to small reductions of the effect. NR in the
group without estrogens (AAMix450) was more pro-
nounced than in the group including all 13 chemicals
(Mix450), but the difference between these two groups
was not statistically significant. With regard to postnatal
prostate weight, the oestrogens alone can affect this end-
point, and it therefore fits well with the present results
that a significant reduction was seen in animals exposed
to all 13 of the compounds (Mix450), but not when only
exposed to the nine anti-androgens (AAMix450). The
reduction in right testes weight in the Mix450 group
may have been a chance finding, as no effect on the
left testes or the combined testes weights were seen. We
are currently addressing these issues by assessing the
effects of the oestrogenic chemicals in the absence of anti-
androgens.
The PODI approach is helpful in identifying the chemi-
cals that contribute most to the joint effect of the
mixture, and could pinpoint substances that should be
targeted for risk management measures, with high impact.
As can be seen in Table 3, the intake estimate ⁄POD ratios
were particularly high for the phthalates, the dicarboxi-
mide and imidazole pesticides and paracetamol, which
means that these substances are expected to have a large
impact on the observed combined effects. However, it
should be noted that human exposure to many of these
agents is intermittent, and not continuous, as in our
experiment. The average human exposures may therefore
be lower, but if peak exposures during a vulnerable per-
iod are critical, as is suspected with anti-androgens, infor-
mation about average exposures may be of limited value
in predicting risks.
These considerations are relevant in the context of recent
developments in Denmark where the Environmental Pro-
tection Agency has submitted a proposal to the European
Chemicals Agency (ECHA) for restricting the four phtha-
lates DEHP, BBP, DBP and DIBP. The proposal seeks to
ban these phthalates in products for indoor use or in prod-
ucts with which consumers are in direct contact. This is the
first proposal on restrictions to the ECHA on combined
exposure data (Chemical Watch 2011; Milmo, 2011). Fur-
thermore, in May 2011, the Danish Minister of the Envi-
ronment announced the intention of introducing a Danish
ban on the use of these four phthalates. She justified this
with reference to alternative chemicals in use today which
can readily replace phthalates in toys and children’s prod-
ucts (Danish Ministry of the Environment 2011). As this is
the first time that a ban is motivated by cocktail effects of
chemicals, it may seem that the traditional focus of risk
assessment on single chemicals is shifting towards consider-
ing combination effects. Our work shows that such efforts
can be supported by using the PODI method, perhaps even
without conducting time-consuming and costly animal
experiments.
The present data demonstrates that exposure of the
developing mammal to human high end mixture of oes-
trogenic and anti-androgenic chemicals can affect male
sexual development. The investigation will be extended to
include observations in both sexes and in reproductive
organs as well as brain, during early stages of develop-
ment and in adult offspring. As follow-up to this explor-
atory study, we are also currently carrying out studies
aimed at exploring mixture effects of anti-androgenic and
other chemicals at mixture doses around 150 times
human high end exposures.
Significant efforts will be needed to close the gap
between the increasing amount and diversity of chemi-
cal micro-pollutants and the available data for risk
assessment, in particular, with respect to developmental
exposure.
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Panel discussion
David Kristensen (Copenhagen, Denmark):
Did you measure the weight of the rats at post-natal day
13 to see if there was a difference between the exposed
and unexposed groups?
S. Christiansen et al. Mixtures of environmentally relevant contaminants
ª 2012 The Authors International Journal of Andrology, 2012, 35, 303–316
International Journal of Andrology ª 2012 European Academy of Andrology 315
Ulla Hass (Søborg, Denmark):
There was no difference either in birth weight or in pup
weight during lactation.
Philippe Grandjean (Odense, Denmark):
What is the mechanism of action on the effect of parace-
tamol in anogenital distance (AGD) and nipple retention?
It is used extensively as an analgesic, but should we be
concerned about its endocrine disrupter effect?
Ulla Hass:
I study effects but I have less understanding of the underly-
ing mechanisms. We have previously found that prenatal
exposure to paracetamol causes reduced AGD in male
fetuses and now we have seen increased nipple retention in
male rat pups. Clearly there is an anti androgenic action
during pregnancy but I do not know the precise mechan-
isms. I think that pregnant women should be aware of the
potential hazards and should only take paracetamol when
absolutely necessary, and under medical advice.
Mixtures of environmentally relevant contaminants S. Christiansen et al.
International Journal of Andrology, 2012, 35, 303–316 ª 2012 The Authors
316 International Journal of Andrology ª 2012 European Academy of Andrology
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Abstract 
In order to better be able to evaluate effects on a wide range of endocrine sensitive 
endpoints after developmental exposure to estrogenic substances, a developmental 
toxicity study with the potent estrogenic chemical ethinyl estradiol was performed. 
Time-mated Wistar rat dams (n=10) were exposed to 0, 5, 15 or 50μg/kg body 
weightday of ethinyl estradiol by gavage during gestation and lactation. Male and 
female offspring were evaluated for AGD, nipple retention, weight and 
histopathology of reproductive organs, timing of sexual maturation, external 
malformations, development of mammary glands and motor activity levels. 
Additionally estrous cyclicity was investigated in the female offspring, and all 
offspring were sacrificed at 3 months of age. 
The highest ethinyl estradiol dose caused increased anogenital distance and increased 
urethal slit length the in female offspring, findings that were expected after perinatal 
estrogen exposure. Additionally, an increased number of nipples at PD14 and a 
decreased ovary weight at PD22 were seen in the female offspring in the highest dose 
group. Changes in mammary gland histology, timing of sexual maturation and estrous 
cyclicity were not statistally significant, but showed trends in the same direction as 
the effects reported in previous studies performed in Sprague Dawley and Long Evans 
rats. It is possible that the lack of statistically significant effects on these endpoints are 
due to differences in rat strains and/or low power due to large variations within 
groups, a relatively low number of litters in the current study, and the dichotomous 
nature of the collected data. In male offspring, the only statistically significant effect 
was a decreased ventral prostate weight at the middle dose at PD21.  
Although ethinyl estradiol is a potent estrogen, for which significant effects were 
expected, these results stress the importance of ensuring appropriate group sizes, 
particularly when planning a study with other than quantitative data. Future 
development of sensitive and preferably quantitative endpoints may facilitate the 
detection of adverse effects of estrogenic compounds and concomitantly reduce the 
present need for a high number of experimental animals in toxicological studies. 
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Introduction 
In humans, ethinyl estradiol is used in contraceptive pills. The present study aimed at 
exposing  pregnant rat dams to ethinyl estradiol  at dose levels expected to affect 
reproductive parameters while avoiding foetal/neonatal morbidity (Howdeshell et al. 
2008; Latendresse et al. 2009; Masutomi et al. 2004; Takagi et al. 2004). 
Contraceptive pills contain 20-50µg ethinyl estradiol, corresponding to 0.2-0.7µg/kg 
bw/day, and thus the doses selected in the present study (5, 15 and 50 µg/kg ) were 
approximately 10 to 100 times higher than exposure of women taking contraceptive 
pills while unaware of a pregnancy. 
Exposure to other estrogenic chemicals during gestation, such as diethylstilbestrol 
(DES), has also been shown to adversely affect the reproductive development in 
humans. The effects have especially been seen in women, but men could also be 
affected and perinatal DES exposure is also associated with an increased risk of 
cancer in adulthood (Hatch EE 1998; Mittendorf 1995; Wilcox et al. 1995).  
In toxicological in vivo studies several endocrine disrupting chemicals with an 
estrognic mode of action have been shown to adversly affect offspring after perinatal 
exposure. These include the phytoestrogens (found in vegetables), and endocrine 
disrupting chemicals such as butyl- and propylparaben (used as preservatives in 
cosmetics), bisphenol A (used in polycarbonate plastics), and UV-filters such as OMC 
and 4-MBC (used in sunscreens and packaging) (Axelstad et al. 2011; Kang et al. 
2002; Schlumpf et al. 2001; Schlumpf et al. 2008; Schneider et al. 2005; Soto et al. 
2008). These are all compounds that humans are exposed to (Christiansen et al. 2012) 
and it is therefore very important to obtain more knowledge about endpoints that in 
toxicological studies are sensitive to effects of estrogenic action.  
 
Some studies have previously examined the reproductive effects of ethinyl estradiol, 
as a model for estrogenic activity, however mostly in Sprague-Dawley and Long-
Evans rats. The present study was conducted in Wistar rats to investigate whether rat 
strain is of importance when assessing endpoints that are affected by estrogens. 
Furthermore, some endpoints that have not previously been investigated thoroughly 
after perinatal ethinyl estadiol exposure, including malformations of female genitalia 
and changes in male mammary glands, were included in the present study.    
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Anogenital distance (AGD) and nipple retention are commonly used measurements in 
reproductive toxicity studies investigating endocrine disruption, as these endpoints are 
very sensitive to antiandrogenic activity in male offspring (Boberg et al. 2011; 
Christiansen et al. 2010; Ostby et al. 1999). In female offspring AGDs can also be 
affected by endocrine disruption. This has previously been seen after treatment with 
estrogenic compounds like ethinyl estradiol and genistein which have been shown to 
increase  AGD in female Long Evan and Sprague-Dawley rats (Ryan et al 2010; 
Casanova et al 1999). However, this finding does not always appear to be consistent 
among studies, and sometimes either no effects on female AGDs or even shortened 
AGDs have been reported, especially in the later generations of multigeneration 
studies (Casanova et al. 1999; Delclos et al. 2009; Levy et al. 1995; National 
Toxicology Program 2010; Ryan et al. 2010; Sawaki et al. 2003b) .  
In males estrogenic compounds do not seem to affect AGD (Ferguson et al. 2012; 
Howdeshell et al. 2008). 
 
In contrast to anti-androgenic exposure, perinatal estrogen exposure does not seem to 
affect nipple retention in male offspring (Ferguson et al. 2012; Howdeshell et al. 
2008). In the majority of previous studies this endpoint has not been registered in 
females after perinatal exposure to estrogenic compounds (Delclos et al. 2009; Fusani 
et al. 2007; Sawaki et al. 2003b; Takagi et al. 2004) and when investigated, female 
nipple retention has been found to be unaffected  (Axelstad et al. 2011; Ryan et al. 
2010). Furthermore, few studies have investigated the effects on external genital 
malformations in females. Two studies by Sawaki et al (2003) found an increase in 
the urethal slit length in Sprague-Dawley rats exposed to ethinyl estradiol (Sawaki et 
al. 2003a; Sawaki et al. 2003b).  
 
Several estrogenic compounds, including ethinyl estradiol, 17β-estradiol and 
bisphenol A have been show to advance puberty in female rats, measured as time to 
vaginal opening (VO) (Durando et al. 2007; Laws et al. 2000; Marty et al. 1999; 
Ryan et al. 2010). In males,  exposure to estrogenic compounds seems to delay sexual 
maturation, i.e. preputial separation (PPS) (Gray et al. 1989; Shin et al. 2009; Stoker 
et al. 2000; Takagi et al. 2004). Estrous cyclicity in the rodent model has also been 
shown to be affected by treatment with estrogenic compounds like ethinyl estradiol, 
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genistein and bisphenol A, by causing more animals to cycle irregularly (Jefferson et 
al. 2009; National Toxicology Program 2010; Rubin et al. 2001).  
Estrogenic compounds are known to enhance female mammary development and 
ethinyl estradiol has been shown to cause lobular hyperplasia in adult females 
(Masutomi et al. 2004; Takagi et al. 2004). For male mammary glands little is still 
known about effects of estrogenic chemicals. Studies have shown male mammary 
glands showing female-like morphology after exposure to estrogenic or other 
endocrine disrupting chemicals (Andrews et al. 2002; Biegel et al. 1998; Cardy 1991; 
Wang et al. 2006). Male mammary glands are normally characterised by a 
lobuloalveolar pattern and in some cases, the typical female tubuloalveolar pattern is 
seen in Sprague-Dawley males after exposure to estrogenic chemicals or other 
chemiclas with endocrine disrupting effects (Biegel et al. 1998; Cardy 1991; Wang et 
al. 2006). However, another study on the effects of ethinyl estradiol on male 
mammary gland did not reveal changes in presence of lobuloalveolar patterns in 
Sprague-Dawley males (Latendresse et al. 2009). Thus in the present study male 
mammary glands were investigated for a female-like lobuloalveolar pattern. Data on 
mammary whole mounts from male and female mammary glands on pup day (PD) 
21-22 are presented in Mandrup et al (2012) (Mandrup et al. 2012), and showed that 
ethinyl estradiol affected the density in both males and females, caused increased 
number of terminal end buds in males and increased outgrowth in females. In the 
present paper elaborated examinations of female and male mammary glands in whole 
mounts at PD 50 and in histological sections at PD 50 and 90 are presented. The aim 
was to determine whether examination of early mammary development by whole 
mount examination is a more or less sensitive marker of estrogenic influences on 
mammary gland development than standard histological evaluation in adult animals. 
 
Investigation of a sex specific behaviour was also included in the present study.  Since 
reproductive hormones do not only organize development of the reproductive system 
but also affect the neurological development, sex differences in certain non-
reproductive behaviours exist. One of these is general motor activity levels, and in 
rats, adult females generally show higher activity levels than adult males (Axelstad et 
al. 2011; Dawson et al. 1975; Ryan et al. 2010). Since male activity levels have 
previously been shown to increase after postnatal estradiol exposure (Dawson et al. 
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1975), assessment of this behaviour was investigated in the adult male and female 
offspring in the present study.   
 
To examine the sensitivity of Wistar rats to the expected estrogenic effects previously 
investigated by others in Sprague-Dawley or Long-Evans rats, , the present study on 
perinatal exposure to ethinyl estradiol included evaluation of AGD, nipple retention, 
weight and histopathology of reproductive organs, timing of sexual maturation, 
external genital malformations, mammary gland and motor activity levels in male and 
female offspring, and investigation of estrous cyclicity in female offspring. 
 
Materials and methods 
Animals and study design 
40 time-mated nulliparous female Wistar rats (HanTac:WH, Taconic Europe, Ejby, 
Denmark) arrived on gestation day (GD) 3. The day after arrival (GD4), the dams 
were assigned to four groups of 10 animals with similar weight distributions in all 
groups. The animals were housed in pairs until GD17 and alone thereafter until birth 
in semi-transparent polycarbonate cages (15x27x43 cm) with Aspen bedding (Tapvei, 
Brogaarden, Gentofte, Denmark). They were housed under the following controlled 
environmental conditions: 12h light/dark cycle with dark at 9AM to 9PM, 22°C ± 
1°C, humidity of 55% ± 5, 8 air changes per hour, diet, tap water ad libitum. A diet 
for growing rodents Altromin 1314 (soy- and alfalfa-free, Altromin GmBH, Lage 
Germany) and acidified tap water was provided ad libitum.   
The dams were dosed by gavage from GD7 to the day before expected birth (GD21) 
and from pup day (PD) 1 to PD 22 with 0, 5, 15 or 50μg per kg body weight (bw) per 
day of ethinyl estradiol (CAS 57-63-6 from Steraloids, nr. E1550-000). The control 
group was dosed with vehicle (corn oil, Sigma, Brøndby, Denmark, nr. C8267-2.5L). 
Independently of actual day of delivery, the expected day of delivery, GD 23, was 
designated pup day (PD) 1. The animal studies were performed under conditions 
approved by the Danish Animal Experiments Inspectorate and by the in-house Animal 
Welfare Committee of the National Food Institute at the Technical University of 
Denmark.  
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Evaluation of dams and offspring 
Dams were distributed equally into four dose group, according to body weight on GD 
4, and body weight gain of the dams was registered daily from GD7 to GD21 and 
during lactation from the day after birth to PD22. Day of delivery was registered 
together with the weight and the distribution of male and female pups, and all live 
offspring were weighed again on PDs 6, 14, 22, 50-55, 76 and 90.  
 
Evaluation of endocrine sensitive endpoints in live offspring after delivery 
After delivery the weights of dams and individual pups were recorded and the pups 
were counted, sexed, checked for anomalies and anogenital distance (AGD) was 
measured using a stereomicroscope. Additionally, anogenital index (AGDI), i.e. 
AGD/cubic root of body weight was calculated for all offspring. Pups found dead 
were macroscopically investigated for changes when possible Thereby, the age of the 
pups was related to the time of conception, but was rather similar to postnatal age. On 
PD 14, all male and female offspring were examined for the presence of 
areolas/nipples (NR), described as a dark focal area (with or without a nipple bud) 
located where nipples are normally present in female offspring.  
 
Necropsy PD21-22 
On PD21 one to two male pup per litter and on PD22 one to two female pup per litter 
were randomly selected for autopsy. The pups were decapitated in CO2/O2 anesthesia. 
Liver, testis, ventral protate, epididymis, seminal vesicle, levator ani/bulbocavernosus 
muscle (LABC) and bulbourethal glands, uterus were dissected from one male and 
one female per litter and weighed. Ovaries were dissected and weighed from 2 
females per litter. Thyroids from female pups was excised from the thyroid cartilage 
and weighed, and thyroids from male pups were excised together with the thyroid 
cartilage to obtain optimal histological preservation. The abdominal (4
th
) mammary 
gland and male thyroid glands were fixed in formalin for histological examination. 
The contralateral 4
th
 mammary gland was used for whole mount as described in 
Mandrup et al., 2012 (Mandrup et al. 2012). One testis, alternately left and right, was 
fixed in Bouin’s fixative.  
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On PD27, 2 males and 2 females per litter were weaned for assessment of puberty 
onset, testing of motor activity levels and later sacrifice on PD50 and 90. The rest of 
the pups were sacrificed on PD22. Genital malformations were evaluated for all male 
and female pups sacrificed on PD22. Dams were anesthetised in CO2/O2 and 
decapitated on PD27 and the number of implantations in the uterus were counted.  
 
Onset of puberty  
Onset of puberty was registered in all weaned male and female offspring. In female 
offspring sexual maturity was assessed by determining day of vaginal opening (VO) 
as described by Goldman et al (2000) (Goldman et al. 2000). All weaned females 
were examined daily from PD 27 until VO had emerged. In male offspring the onset 
of puberty was assessed as time of preputial separation (PPS) (Ostby and Gray, Jr. 
2004; Stoker et al. 2000). Males were examined daily from PD 34 until PPS was 
observed. On the day of VO or PPS the age and weight of the animals were recorded. 
 
Motor activity levels  
On PD 57 all weaned offspring had their motor activity levels assessed during a 30 
minute test. At testing, the animals were placed individually in clean plastic cages 
without bedding, food or water, and the cages were placed in activity boxes with 
photocells which measured activity as described in Axelstad et al (Axelstad et al. 
2008). A computer automatically recorded output from photocells and collected data. 
Total activity during the 30 min observation period was used as a measure of general 
activity. In order to assess habituation, the 30 minute period was divided into shorter 
time intervals (3 x 10 minutes and 2 x 15 minutes) when analyzing the data. 
 
Estrous cyclicity 
Vaginal smears were collected from PD75 at approximately the same time every day 
between 8 and 10 am in the beginning of the dark period for the animals. A swab 
moistened in saline was inserted in to the vaginal lumen and cells were transferred to 
a glass microscope slide. The samples were then allowed to air dry. When dry the 
smears were fixed in 96% ethanol  and stained with Gill’s hematoxylin, Orange G6 
and eosin-azure 50 (provided by VWR, Gentofte, Denmark) according to the adapted 
Papanicolaou (PAP stain) procedure reported by (Hubscher et al. 2005). After 
staining the smears were mounted in Eukit. The stained smears were examined 
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blindly to exposure group by light microscopy and stages were classified as Estrus 
(E), Metestrus (M), Diestrus (D) or Proestrus (P) or transitions between stages. These 
stages were recognized by the presence, absence or proportional numbers of epithelial 
cells, cornified cells and leucocytes as described in OECD guidance document 106 
and by Goldman and coworkers (2009) (Goldman et al. 2007; OECD 2009).  
 
Necropsy PD50 and 90 
On PD 50 (females), 55(males) and PD90 one female and one male pup was 
anesthetised in CO2/O2 and decapitated. Male and female genital malformations were 
evaluated and males were evaluated for testicular descent. 
On PD50 vaginal smear was performed after sacrifice and stained with PAP stain to 
evaluate the specific stage of cycle. Ovaries and uterus were dissected, weighed and 
processed for histology. Abdominal (4
th
) mammary glands from male and female 
pups were dissected for whole mount and histology. 
 
On PD90 female pups were sacrificed in diestrous, evaluated by unstained vaginal 
smear (macroscopic and microscopic evaluation). The vaginal smear was stained 
according to the same protocol for PAP staining and re-evaluated to confirm the stage 
of cycle. The following organs were excised and weighed: Liver, testis, epididymis, 
ventral prostate, seminal vesicle, levator ani/bulbocavernosus muscle (LABC), 
bulbourethal glands, ovaries and uterus. Thyroids were dissected with the thyroid 
cartilage and epididymis and thyroids were fixed in formaline for histology. One testis 
was placed in Bouin’s fixative for histology. Additionally, 4th mammary glands were 
excised from males and females for histology. Ovaries and uterus from females PD50 
and 90 were fixed in formaline for histology for staging of the stage of estrous cycle. 
 
Genital malformations 
Males were evaluated for testicular descent, external genital malformations and loss 
of hair as described by Christiansen et al (2008) (Christiansen et al. 2008) at necropsy 
on PD21, 55 and 90. On PD55 all live males were similarly evaluated for genital 
malformations.  
Additionally, all female pups were evaluated for malformations of the external 
genitalia and female cleft phallus (CP) of the external genital papilla at necropsy on 
PD22, 50 and 90. The urethral slit length was measured using a stereomicroscope 
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with a scale. The urethral slit length was assessed and a threshold for normal urethral 
slit length was set according to the deepest slit measured in controls.  
 
Mammary gland whole mounts and histology 
Whole mounts from PD50 females and PD 55 males were scanned on a flatbed 
scanner (4800 dpi), and evaluation of the glands was performed using Image-Pro Plus 
7.0 software (Media Cybernetics, Bethesda, MD, USA). For male whole mounts 
PD50 the following parameters were measured: longitudinal growth, transverse 
growth, and the area (smallest polygon enclosing the mammary gland). The growth 
towards the lymph node was given a score (1-2 describing if the gland had reached 
the lymph nodes or not), and the density of the mammary glands was scored from 1 to 
5 with 5 being a gland with high branching and budding. Female whole mounts PD50 
were evaluated for the presence of beaded ducts as described by Vandenberg et al 
(2008) (Vandenberg et al. 2008) and the density (score 1-5) in a standardised area 
between the nipple and the lymph nodes. The density scores for males and females 
were not comparable, as the scoring criteria were adjusted for the normal gender 
differences at this age. Additionally,  the development of lobules was evaluated in the 
female mammary glands PD50, both for predominant type of lobules present and the 
most developed type of lobule present in the gland (lobules type 1 to 3, as described 
by Russo et al 1988) (Russo et al. 1988).  
Mammary glands for histology were fixed in formalin, processed for paraffin 
embedding and stained with hematoxylin and eosin (H&E). At PD50, female 
mammary glands were evaluated in controls and in the highest dose group and were 
evaluated for lobule development (no lobular development, type 1 or type 2 lobules), 
alveolar epithelium (single- or multi-layered) and the presence of terminal end buds. 
At PD90, female mammary glands were evaluated for lobuloalveolar pattern, lobule 
development, amount of fibrous tissue in the stroma , secretory material and dilation 
of ducts. Only mammary glands from females confirmed to be in estrus after staining 
of the smears and confirmed by histology of uteri and ovaries were used for statistical 
evaluation of the histological findings PD90. On PD50 female mammary glands were 
evaluated bearing the stage of estrous cycle in mind, verified by stained smear and 
uterus histology. Male mammary glands PD55 were evaluated in controls and the 
highest dose group for vacuolation, secretory material in the ducts and tubuloalveolar 
pattern. Male mammary glands PD90 were evaluated in all dose groups for 
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hypertrophy, epithelial vacuolisation and secretory material in the ducts. Additionally, 
male mammary glands were stained with periodic acid Schiff (PAS) and mucicarmine 
(Diagnostic BioSystems, Hague, Netherlands). PAS-stained mammary glands were 
evaluated for PAS positive secretory material and PAS positive granula in the cells. 
Mucicarmine stained mammary glands were evaluated for mucin positive secretory 
material.  
 
Histology of reproductive organs 
Uteri and ovaries PD90 and uterus PD50 were stained with H&E and evaluated for 
determination of stage of the estrous cycle. 
Adult testes and epididymides: Testes were examined with emphasis on effects that 
may be related to endocrine disruption: a) spermatid retention, b) tubular dilation, c) 
degeneration of germ cells at specific stages, d) Leydig cell hyperplasia or adenoma. 
In the epididymal caput, examination focused on a) presence of sloughed testicular 
cells in epididymal lumen, b) amount of spermatids c) vacuolization and degeneration 
in epithelium of main caput segment, d) disorganization of epithelium in initial 
segment, and e) interstitial inflammation. 
 
Statistics 
For all statistical tests was used SAS Enterprise Guide 3.0 statistical software (SAS 
Institute Inc, Cary, NC, USA) or GraphPad Prism (GraphPad Software, Inc., La Jolla, 
CA,  USA). The level of significance was set at 0.05. Data with normal distribution 
and homogeneity of variance were analyzed using analysis of variance (ANOVA). 
When more than one pup from each litter was examined, statistical analyses were 
adjusted using litter as an independent, random and nested factor in ANOVA, or 
analysis were done on litter means. Body weight and number of pups in a litter was 
included as a covariate in analyses when relevant. A Dunnett post hoc test was used to 
correct for multiple comparisons. In cases where normal distribution and homogeneity 
of variance could not be obtained by data transformation, a non-parametric Kruskall-
Wallis test was used, followed by a Wilcoxon test for pair wise comparisons. Discrete 
data were analysed using a one-way analysis of variance (ANOVA) with body weight 
(bw) as a covariate.   
The number of nipple/areolas was assumed to follow a binomial-distribution with a 
response range between 0 and θmax, with θmax being equal to the biologically 
 12 
 
possible maximal number of nipples in rats, either 12 or 13. The choice of θmax was 
decided by considering the global fit (information criterion of Schwarz). Litter effects 
on number of nipples and over-dispersion in the data were accounted by using 
Generalized Estimating Equations. Statistical significance were assessed using 
multiple contrast tests (Dunnett contrasts, global error rate α = 5%, two-sided) (Bretz 
et al. 2005). These tests were chosen as they are already implemented in the SAS 
procedure PROC GENMOD which was used for all statistical analysis. Estrous 
cyclicity data were analyzed using logistic regression and tested for over dispersion 
with Deviance and Pearson Goodness-of-Fit tests and correction for over dispersion 
due to litter effects were used when appropriate. 
Histological data were analysed as dichotomous scores using a Fisher’s exact test.  
 
Results 
Reproductive parameters 
The weight gain of dams from GD7 to GD21 was decreased in a dose-dependent 
manner with a statistically significant decrease in group 4 (50µg/kg) (p=0.0001) 
(Table 1). Additionally, the gestation length was increased in the highest dose group 
(p=0.0002) (Table 1). There were no statistically significant effects on the number of 
implantations or perinatal loss of pups. No statistically significant difference in the 
distribution of females and males in the litters of dosed animals compared to controls 
was observed. At delivery, the weight of female pups was not different in the dosed 
groups compared to controls. In contrast, the weight of male pups was decreased at 
delivery in group 4 (p=0.03).  
 
AGD, nipple retention and body weight gain after delivery 
In male offspring no statistically significant effects were observed in AGD. Female 
offspring from the high dose group had a significantly longer AGD and AGI 
(p<0.01for both) (Figure 1). 
 
No effects were observed on nipple retention in male offspring. In females there were 
more nipples present in offspring  from group 4 (50µg/kg)  than in controls and this 
effect was statistically significant  (p<0.01) (Figure 2). 
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After delivery, no effects on weight gain of dams was observed (Table 1). Offspring 
body weights are shown in table 1. In general, pups were smaller and had delayed 
growth when exposed to high doses of ethinyl estradiol. Growth in the exposed 
groups was delayed leading to smaller male pups PD6 in the highest dose group and 
in both group 3 and 4 (15 and 50µg/kg ethinyl estradiol) when the animals reached 
PD14. Female pups were not statistically significantly smaller in any of the exposed 
groups compared to controls at delivery, but growth was delayed leading to smaller 
pups in the highest dose-group at PD6 and PD14 and smaller female pups in both the 
highest dose-groups at PD22. The delay in growth was expressed as a decreased 
weight gain from PD1 to PD6 in both males and females in the highest dose-group 
(p=0.007 and p=0.002, respectively). From PD6 to PD14 males gained less weight in 
groups 3 and 4 than controls (p=0.05 and p=0.01, respectively). On PD50-55 and 
PD90 no statistically significant differences were seen in the bw in dosed pups 
compared to controls.  
 
Onset of puberty and estrous cycle determination 
No statistically significant effects were observed on onset of puberty on either male or 
female offspring compared to control. In the females 5 of 16 animals representing 3 
litters in the high dose (50 µg/kg) were scored as already having developed VO on the 
first day of VO registration (PD27).  In the group dosed with 15 µg/kg 2 out of 18 
animals were already showing VO on the first day of registration and these animals 
were from the same litter. No animals in the control group or the group receiving 5 
µg/kg were scored as having VO on PD 27. 
No effects were observed on estrous cyclicity although irregularly cycling animals 
were only observed in exposed groups. 0/7 animals had irregular cycles in the control 
group, 2/8 (5 litters) in the group treated with 5 µg/kg , 3/10 (9 litters) in the group 
treated with 15 µg/kg and 2/8 (7 litters) in the highest exposure group, respectively. 
 
Motor activity levels 
No statistically significant effects on total motor activity levels or on habituation were 
seen after ethinyl estradiol exposure in any dose group compared to controls. Also no 
significant differences between male and female activity levels were seen (data not 
shown).  
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Organ weights 
At PD 21, the ventral prostate weights were statistically significantly decreased in the 
group exposed to 15 µg/kg (p= 0.03; Table 2). Interestingly, also other androgen-
dependent male reproductive organs appeared smaller at the middle dose than at the 
high dose, though no statistically significant differences to controls were observed 
(epididymides p=0.07, seminal vesicle p=0.5) (Table 2). No organs were weighed 
from males PD55. No statistically significant changes were found in organweights of 
males PD90 (Table 3). 
At PD 22, weights of ovaries were statistically significantly descreased in the highest 
dose group (p=0.02) for both the ANOVA with body weight as a covariate and for 
relative ovary weights (Table 2) (data not shown for relative organ weights). On 
PD50 and 90, no changes in the weights of ovaries and uterus were found (Table 3). 
The uterus was both weighed when intact and after draining. On PD90, one female in 
the lowest dose-group was distinctively smaller than other females PD90 and was 
perceived as an outlier and thus removed from the dataset. The liver of female 
offspring PD90 was statistically significantly decreased in the lowest dose group 
(5µg/kg) when analysed with a Dunnett’s test. This difference in the liver weight can 
not be explained.  
 
Genital malformations 
In female pups, the urethral slit length of the cleft phallus was measured on PD22, 50 
and 90. A statistically significant increase in urethral slit length was measured PD90 
in females exposed to 50 µg/kg of ethinyl estradiol (p=0.02) (Figure 3). Similarly, on 
PD50 the mean urethral slit length showed a trend to increased slit length, and a 
statistical significant increase was seen in the number of animals in the highest dose 
group showing larger clefts than controls (p=0.04) (Figure 3). No differences were 
observed in the urethral slit length between dosed and control animals on PD22. 
Upon examination of the female genitalia on PD22, two pups from the same litter in 
the highest dose-group showed starting development of VO. The same animals had an 
enlarged uterus with a markedly increased uterus weight compared to the rest of the 
female pups. 
No genital malformations were observed in males at necropsy on PD 21 or 90. On PD 
55, examination of live males showed two animals, one from each of the two highest 
dose groups, with unilateral chryptorchidism and a single animal in the highest dose 
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group with minimal hair loss. At necropsy on PD55, three animals (one from group 2 
and two from group 3) were found to have a mildly split penis  and one animal had 
unilateral chryptorchidism.There were no statistically significant differences between 
groups. 
  
Mammary glands 
Overall, females PD50 were mainly presenting no lobular development or type 1 
lobules as the predominant lobule development in the whole mounts of mammary 
glands. However, an increase in the type of the most developed lobule was observed. 
All females PD50 had lobules type 1 or 2 as the most developed lobules present in the 
gland. One control animal had lobules type 2 as the most developed type of lobule. In 
the highest dose group 50% of the female offspring PD50 had lobules type 2 as the 
most developed lobules present (Figure 4). However, this apparent shift form lobule 
type 1 to lobule type 2 as the most developed type of lobule in the high dose group 
was not statistically significant. No beads were found in the ducts of the mammary 
glands in the whole mounts. One control female PD50 had prolonged dioestrous, thus 
showing different morphology in both whole mounts and histology and was not 
included in the statistics and the data presented. 
 
Histologic examination of controls and high-dose H&E stained female mammary 
glands PD50 showed an increase in the number of animals with multi-layered alveolar 
epithelium, however this increase was not statistically significant (Figure 4). Lobule 
development (lobules type 1 or 2) was present in all animals in the high-dose group, 
whereas two animals were not presenting any lobular development in the controls 
(Figure 4). Female mammary glands PD90 were evaluated for females in diestrous or 
metestrous. Few animals were in an other estrous stage and were omitted (2 controls, 
2 low dose, 0 middle dose and 3 high dose animals). All 10 females in the 15µg/kg 
dose group were in diestrous. The evaluation of the female mammary histology PD90 
showed an increase in the number of animals with lobular development (lobules type 
1 or 2), dilated ducts and increased amounts of fibrous tissue in the stroma. However, 
this increase was not statistically significant. No treatment related differences were 
found in the distribution or the amounts of secretory material in the mammary glands. 
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Mammary gland whole mounts from high dose male offspring PD55 showed no 
statistically significant changes in LG, TG, area or density. However, a trend to an 
increased number of animals with mammary glands reaching the lymph node was 
observed (Figure 5) and an increase in the number of animals with a high density 
score (score 5) was observed in the highest dose group. Yet, no changes in male 
whole mounts were statistically significant.  
Histology of mammary glands from 3 controls PD55 were not possible to evaluate 
due to technical difficulties in sectioning the glands. Hence, the number of controls 
PD55 was reduced to 5 and trends for histological changes were difficult to interpret. 
Consequently, data from male mammary glands PD55 were omitted. Although 
mammary glands PD55 for histology were too few to evaluate dose dependent effects, 
mammary glands were evaluated and seemed not to be fully differentiated to the 
lobuloalveolar pattern typically seen in adult males (Cardy 1991).  
On PD90 an increase in the number of males with hypertrophic mammary epithelium 
was observed (Figure 5). However, a Fisher’s exact test showed no difference 
between the groups. No other differences in tubuloalveolar pattern, vacuolisation of 
mammary epithelium or distribution of secretion filled ducts in the glands were 
observed. PAS positive granula were found more often and were more aboundant in 
the highest dose group compared with controls, however, no statistically significant 
differences between the groups was found for  mucin -positive or PAS -positive 
secretion or granula (data not shown).  
 
Histology of reproductive organs  
The stage of oestrous cycle of females at necropsy on PD 50 and PD90 was confirmed 
by vaginal smear and histologic examination of uterus PD50 and for PD90 with 
histology of uterus and ovaries. One control PD50 and one female in the in the 
highest dose-group PD 90 were acyclic and were omitted from the data of mammary 
glands.  
Testes and epididymides of PND 90 animals had a normal appearance and there were 
no differences between dose groups.  
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Discussion 
Although several studies have examined reproductive effects of ethinyl estradiol, the 
current study reveals developmental changes that have not been described previously. 
In female offspring, an increased number of nipples, an increased anogenital distance, 
and an increased urethral cleft length were observed following perinatal exposure to 
ethinyl estradiol.  
  
Reproductive parameters 
Ethinyl estradiol showed adverse effects when pregnant dams were dosed GD7-21. 
Dams in the high dose group lost weight during gestation, which is in accordance with 
findings in other studies with perinatal exposure to ethinyl estradiol (Howdeshell et 
al. 2008; Masutomi et al. 2004; Takagi et al. 2004). Additionally, gestational length 
was increased in the highest dose-group. To our knowledge, a longer gestation length 
has not been reported for ethinyl estradiol before, as other studies with perinatal 
exposure to ethinyl estradiol showed no effects on the gestational length (National 
Toxicology Program 2010; Ryan et al. 2010; Sawaki et al. 2003a). At the end of 
pregnancy, estrogen levels normally rise (Mesiano and Welsh 2007), thus a prolonged 
gestational length would not be expected as a cause of exposure to estrogenic 
compounds and the finding in the present study may be a chance finding .  
In general, pup weight gain from delivery and onwards was decreased in the highest 
dose group while dosing was ongoing. However, at weaning, this effect was 
decreasing and only apparent in female offspring. This delayed growth of offspring 
may reflect a decreased lactation especially affecting the offspring in the earliest 
period of lactation when supplementary intake of other food is absent.   
This is in accordance findings in several papers reporting decreased body weight at 
PND2 or 3 and decreased weight gain of male and female pups PND3-10 after 
perinatal exposure to ethinyl estradiol (Masutomi et al. 2004; Sawaki et al. 2003b; 
Takagi et al. 2004). 
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Changes in female external sexual characteristics and puberty timing 
Female pups exposed perinatally to ethinyl estradiol showed increased AGD and 
AGDi, an increased number of nipples and an increased urethral slit length in the 
present study.  
Exposure to estrogenic acting chemicals like ethinyl estradiol and genistein have been 
shown to alter AGD in female rats (Casanova et al. 1999; Delclos et al. 2009; Levy et 
al. 1995; National Toxicology Program 2010). In the present study an increased AGD 
was observed in the group treated with 50 µg/kg ethinyl estradiol compared with 
control. In agreement with these results Ryan et al (2010) found an increased AGD of 
female Long Evans rat offspring exposed GD7-PND18 to 50 µg/kg ethinyl estradiol 
(Ryan et al. 2010). However, in another study with similar exposure and dosing 
period no effects of treatment were observed on Sprague-Dawley rats at 50 µg ethinyl 
estradiol/kg (Sawaki et al 2003). Thus, the results obtained in this study support an 
increased AGD after ethinyl estradiol exposure observed in Long Evans rats by Ryan 
et al (2010) but the lack of effects observed in the study performed by Sawaki et al 
(2003) cannot readily be explained but may be connected with the different strains 
used.  
An increased number of nipples in female offspring was seen in the highest dose 
group (50 µg/kg) compared to the number of nipples found in control animals. An 
increased number of nipples in female rats have not been reported earlier in the open 
literature. There are only few reports describing significant effects on the number of 
nipples in females in the open literature but an effect of androgen exposure during 
development has in some studies resulted in a lower number of nipples in the female 
offspring (Hotchkiss et al. 2007; Wolf et al. 2002; Wolf et al. 2004). NTP did find 
hypertrophy of the nipples as an effect of ethinyl estradiol exposure (National 
Toxicology Program 2010). Ryan et al (2010) did not see increased number of nipples 
in female offspring in Long-Evans rats after ethinyl estradiol exposure to comparable 
doses and dosing period as in the present study (Ryan et al. 2010). If the observed 
effect in the present study is a true effect it is possible that excessive presence of 
estrogen somehow induces a higher number of mammary buds along the mammary 
streak during mammary development. It may also be speculated that some regression 
of nipple anlagen happens in females as well as in the males, a process which is then 
counteracted by ethinyl estradiol. 
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Female pups PD90 had a increased urethral slit length in the highest dose-group. 
These results of statistically significant changes in the external female genitalia are in 
accordance with Sawaki et al showing an increase in the urethral slit length and an 
increased number of animals having a deep urethral slit at post natal week (PNW) 7-8, 
PNW18-20 and at the age of 6 months after perinatal exposure to 50µg/kg ethinyl 
estradiol (Sawaki et al. 2003a; Sawaki et al. 2003b).   
 
In this study some females exposed to the two highest doses of ethinyl estradiol were 
in puberty at the first day of registration, but no statistically significant effects were 
seen on the weight or timing of onset of puberty. Other studies have reported an 
earlier age of sexual maturation following perinatal exposure to ethinyl estradiol. The 
NTP reported that earlier age of VO as well as VO occurring at a lower body weight 
when compared to controls was observed at 50 ppb (National Toxicology Program 
2010). Ryan et al 2010 found an accelerated age of VO and at a reduced weight at 5 
µg/kg in female rat offspring exposed GD7-PND18 (Ryan et al. 2010) and an advance 
of VO was therefore expected in this study. However, in the current study, some 
animals in the two highest dose groups had already reached VO on the first day of 
registration of VO. It is unknown when these animals really attained VO, but they 
might have gone into puberty one or more days earlier than PD 27. The registration of 
VO at PD 27 may thus result in a weaker statistical result . Another issue is group 
size,  as a report from ILSI 1998 estimated that a group size of 20 litters is appropriate 
when measuring effects on PPS and VO (Clark 1999). In comparison, our group size 
was 5-9 litters, so the lack of statistical significance despite a trend to early puberty in 
these females is not surprising. 
 
Motor activity levels 
No statistically significant effects were seen in motor activity levels in either male or 
female offspring exposed perinatally to estradiol, and in control animals no 
statistically significant gender difference was seen. Usually a sex difference is seen in 
this behaviour, with adult females exhibiting higher activity levels than adult males, 
irrespective of the rat strain used (Axelstad et al. 2011; Dawson et al. 1975; Ryan et 
al. 2010). The lack of sex difference seen in the present study may either be due to the 
fact that the animals were tested at a quite young age, i.e. relatively shortly after 
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sexual maturation or that the number of animals per dose group was too low to show a 
statistically significant sex difference. This lack of difference between male and 
female activity levels would have made it difficult to interpret any effects of ethinyl 
estradiol treatment, had any been present. In previous studies investigating motor 
activity levels after perinatal exposure to esatradiol, increased motor activity levels 
were seen in adult male offspring that had been injected with 100μg β-estradiol on 
PND 3 and 5, indicating a feminizing effect on the male offspring (Dawson et al. 
1975). Female activity levels were not investigated in that study. In a more recent 
study, activity levels in adult ovariectomized and subsequently ethinyl estradiol 
treated females were investigated after developmental exposure to doses of 0.05-50 
μg ethinyl estradiol / kg (Ryan et al. 2010).  This perinatal ethinyl estradiol expose 
did not seem to affect the sexual differentiation of the brain with regard to this 
behaviour, as activity levels were not different in the ovariectomized and ethinyl 
estradiol treated females with or without early ethinyl estradiol exposure (Ryan et al. 
2010). This result indicated that early estradiol treatment did not affect differentiation 
of the female brain, however, the activity levels of the animals were not tested prior to 
ovariectomy, and it is therefore impossible to know if the developmental ethinyl 
estradiol treatment would have had an effect in the intact animal. In the present study 
it is possible that the relatively low number of animals per dose group made it 
difficult to detect a significant effect of the ethinyl estradiol exposure. 
 
Mammary glands 
Our previous study on offspring from the same litters showed advanced development 
of prepubertal mammary glands (Mandrup et al. 2012). Increased lobular 
development (lobular hyperplasia) of the female mammary glands and feminization of 
male mammary glands were expected in adult animals based on literature (Biegel et 
al. 1998; Masutomi et al. 2004; Takagi et al. 2004). 
Although no statistically significant effects of ethinyl estradiol were found for the 
mammary glands of female and male adult offspring, some trends to increased 
development of female mammary glands were observed. As a small number of glands 
were evaluated the power to detect statistically significant changes on score measures 
is low. Hence, it is important to pay attention to trends and findings that, although not 
statistically significant, may suggest an effect of exposure to the test material, as 
stressed in OECD guidance documents for histological evaluation (OECD 2010). 
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Even though no apparent difference was observed in the types of lobules predominant 
in female mammary glands PD50, a dose-response-like increased number of females 
had lobules type 2 as the most developed lobules present in the whole mounts of the 
mammary glands. An increased proliferative index has been shown in the literature in 
females in metestrous, leading to a lobular morphology of the adult mammary glands 
in metestrous and early diestrous (Hvid et al. 2010; Schedin et al. 2000). However, 
Schedin et al (2000) describes a large variation in the morphological appearance 
within each stage of estrous cycle (Schedin et al. 2000). In the present study, 
investigation of the lobular development did not show a clear difference between the 
different stages of estrous cycle for either females PD50 or PD90 in whole mounts or 
histologic evaluation and if e.g. all females PD90 were evaluated, the same trend in 
lobular development was seen (Figure 4D). On PD 90 females in metestrous or 
diestrous were evaluated, and a tendency to an increased prevalence of females with 
lobular development (type 1 or 2) was observed. Together, these data indicate a trend 
towards more differentiated mammary glands in adult females after perinatal 
exposure to ethinyl estradiol, though not statistically significant. In accordance with 
these trends, Takagi et al (2004) found increased lobular hyperplasia in adult female 
mammary glands after perinatal exposure to ethinyl estradiol and Murril and co-
workers (1996) observed a significant increase in  lobules type 2 in 50 days old 
females exposed postnatally to genistein (Murrill et al. 1996; Takagi et al. 2004).  
The dilated ducts observed in the present study PD90 were not associated with 
secretion of the mammary glands, thus the dilation of ducts did not indicate an 
increased secretory activity of the mammary glands of adult females perinatally 
exposed to ethinyl estradiol. However, Biegel et al (1998) found an increase in the 
secretory dilation of alveoli in adult females after perinatal exposure to 17β-estradiol 
(Biegel et al. 1998). Yet, in Biegels study, pups were exposed continuously through 
the diet until the day of necropsy and the same changes were found in adults exposed 
exclusively in adulthood until necropsy. Hence, increased secretory activity may be 
expected during exposure to estrogens, but is a reversible change not found in adults 
after exposure early in life.   
 
Male mammary glands had a tendency to be larger with dosing compared to controls 
as shown by an increased number of animals with mammary glands reaching the 
lymph node at PD 55. Additionally, histology showed a tendency to a higher 
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prevalence of adult males with hypertrophic mammary epithelium. Consistent with 
these results, a study by Delclos et al (2001) observed increased hypertrophy of male 
mammary glands PD50 exposed perinatally to genistein (Delclos et al. 2001). 
However, in the present study hypertrophy was present in 50% of controls and a 
difference between the dosed group and controls may not be present. 
In the present study, no sign of feminization of the male mammary glands were 
present as no increase in secretion or tubuloalveolar pattern was observed. Biegel et al 
(1998) found an increase in tubuloalveolar morphology in male mammary glands 
after postnatal exposure to 10 and 50ppm (50ppm approximately equal to 2,5µg/kg) 
of 17β-estradiol (Biegel et al. 1998). However, Latendresse et al (2009) did not 
observe feminization of the male mammary glands (with tubuloalveolar growth) after 
continuous exposure to 50ppb ethinyl estradiol (approximately equal to 5µg/kg) from 
conception until post natal day 140 of the pups (Latendresse et al. 2009). In another 
study with perinatal exposure to genistein or a mixture of estrogenic chemiclas, 
female-like branches were observed sporadically in all groups, including controls, in 
whole mounts of male mammary glands PD150 (Boberg et al. submitted). Thus, 
perinatal exposure to estrogenic chemicals may not always induce feminization of 
male mammary glands by developing a tubuloalveolar pattern.  
 
Results from whole mounts of mammary glands PD21-22 reported in Mandrup et al 
(2012), showed an enhanced development of female and male mammary gland 
represented by statistically significant differences in the density, number of terminal 
end buds and outgrowth (Mandrup et al. 2012). Thus, prepubertal mammary glands 
seem to be more markedly affected by ethinyl estradiol compared to adult mammary 
glands in this study. This may be a real finding reflecting e.g. that effects on 
prepubertal mammary glands is more marked than effects on adults if effects are only 
transient. However, persistent effects of perinatal exposure to endocrine disrupting 
compounds have been shown  (Fenton et al. 2002). Another explanation for the 
apparently more marked effects in prepuberty may be that a statistically significant 
difference is more easily found in prepubertal mammary glands as the endpoints 
evaluated are quantitative, whereas the histological findings in adults are qualitative 
and often dichotomous in nature.  
Changes in both female and male adult mammary glands were expected as lobular 
hyperplasia in female and feminization of male mammary glands has been described 
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previously in Sprague-Dawley rats in the literature (Biegel et al. 1998; Masutomi et 
al. 2004; Murrill et al. 1996; Takagi et al. 2004). Although a trend to increased lobular 
development was observed in female Wistar rats in the present study, the effect was 
not statistically significant and male mammary glands did not show signs of 
feminization. This lack of sensitivity of histological examination of adult mammary 
glands in the present study may be explained by the low power due to large 
variations, a low number of animals and the dichotomous nature of the histological 
data, but could also be explained by a difference in strains. Differences in sensitivity 
of different rat strains have been reported before and is important to get more 
knowledge about strains and their respective sensitivity to toxicological endpoints. To 
our knowledge, most studies examine mammary gland  morphology and histology in 
Sprague-Dawley or Long-Evans rats and further knowledge on sensitivity of 
mammary glands in Wistar rats is important for evaluation of e.g. regulatory 
toxicological studies, which are often performed in Wistar rats. 
 
Estrous cyclicity and ovaries 
No statistically significant effects on estrous cyclicity were observed of ethinyl 
estradiol exposure compared to control, although irregularly cycling females were 
only observed in ethinyl estradiol exposed groups (7 of 26 exposed females). Others 
have shown effects of ethinyl estradiol exposure on the estrous cycle of rodents. In a 
multi-generational study with continuous dietary exposure in Sprague-Dawley rats, in 
generation F1 and F2 an increased length of cycles and an increase in number of 
abnormal cycles were observed due to increased duration of estrus in the groups 
receiving 50 ppb (about 5 µg/kg). Furthermore, in the F1 generation the group 
exposed to 2 (0.2 µg/kg) or 10 ppb (1 µg/kg) had increased cycle length and animals 
dosed with 10 ppb had decreased time spent in estrus (National Toxicology Program 
2010). In another study where Sprague-Dawley rats were exposed orally by pipette 
GD5 to PND21 and the offspring from weaning to PND32,  a larger proportion of 
irregular animals characterized by persistent estrus were seen at 4 ng/kg when the 
animals were around 5.5 months old (Fusani et al. 2007).  In a study where Sprague-
Dawley rats were exposed to ethinyl estradiol in utero and postnatally continuously 
through dietary exposure, effects on estrous cycle (examined for 14 consecutive days 
starting 3 days after vaginal opening) by means of increased cycle length and 
prolonged estrus was seen at 50 ppb (5.8 µg/kg) (Delclos et al. 2009). In the present 
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study, the number of animals per group may have been too low to detect a possible 
real effect. On the other hand the control group had an unusually high number of 
regularly cycling animals for our laboratory, where we normally have around 85 % 
with regular cycles. Furthermore, our animals were only dosed until weaning PD22 
and in most of the above mentioned studies where effects on estrous cycle has been 
observed the animals have been exposed continuously. Also, there may be a 
difference in sensitivity between the rat strains used. 
 
Effects on male offspring 
In prepubertal males, ethinyl estradiol reduced prostate weight at 15µg/kg, but a 
normal prostate weight was seen at 50 µg/kg. More marked effects on male 
reproduction organ weights have been observed in other studies on perinatal exposure 
to EE. Statistically significant reductions of testes and seminal vesicle weights and 
slight reduction of prostate weigths were seen at 5 µg/kg, and statistically significant 
reduction of prostate, LABC and glans penis weights were seen at 50 µg/kg of EE in a 
study on LE rats exposed from GD 7 to PND 18 (Howdeshell et al. 2008). Although 
mean weights of testes, epididymides, seminal vesicle, bulboutrethal gland and LABC 
did appear reduced in the current study, these changes were not statistically 
significant. 
Prostate weight has previously been found to be affected by estrogenic compounds in 
a non-monotonous manner, but in those studies the opposite pattern was observed, i.e. 
increased prostate weight at low levels (0.015 µg/kg of estradiol benzoate) and 
decreased prostate weight at high doses (1.5 and 15 mg/kg bw) (Putz et al. 2001). 
Comparable patterns were seen with prenatal exposure to diethylstilbestrol (DES) or 
17-beta estradiol in mice (vom Saal et al. 1997) and with perinatal exposure of 
androgen-responsive reporter mice to hexachlorbenzene (Ralph et al. 2003). Our 
observation of reduced prostate weight at 15 µg/kg was thus expected, but the lack of 
effect at 50 µg/kg cannot be readily explained. 
 
No treatment related effects were observed on male AGD in the present study. In a 
multi-generation study on continuous dietary exposure to ethinyl estradiol, decreased 
AGD in Sprague-Dawley male rats was reported at 50 ppb (approximately 6 ug/kg) 
though only in the F3 generation (National Toxicology Program 2010). However, in 
accordance with the results in this study, other studies have reported no effect on 
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AGD in Long Evans and Sprague-Dawley male rat offspring perinatally treated with 
ethinyl estradiol at doses in the same range as tested in the present study (Ferguson et 
al. 2012; Howdeshell et al. 2008; Masutomi et al. 2004; Takagi et al. 2004).  
In this study no significant effects were seen on the weight or timing of onset of 
puberty in the male offspring. Several studies report a delayed preputial separation 
following exposure to estrogenic compunds. PPS was delayed in Sprague-Dawley 
male rats perinatally exposed to 0.5 ppm ethinyl estradiol (27-63 ug/kg ) in the diet 
(Masutomi et al. 2004; Takagi et al. 2004)and developmental exposure to other 
estrogenic compounds has been reported to delay puberty in male rats (Gray et al. 
1989; Schlumpf et al. 2008; You et al. 2002). A delay in PPS was therefore expected 
in the present study. However, accelerated PPS was observed in the groups treated 
with 5 and 25 ppb (approximately 1.1 and 5.5 ug/kg , respectively) but not at higher 
doses in a range-finding study by NTP (National Toxicology Program 2010). The lack 
of effects on PPS and AGD in the current study cannot just be attributed to the low 
group sizes, as no trends to altered male AGD or towards the expected delay in PPS 
was found . 
 
In agreement with the lack of genital malformations of males at PD21 or PD90, 
Sawaki et al found no malformations of the penis of the males (Sawaki et al. 2003a; 
Sawaki et al. 2003b). However, the few mild genital changes observed in live animals 
at PD 55 may point to subtle changes also in external male genitalia, though 
examination of a higher number of animals would be required before a solid 
conclusion can be made. 
 
Conclusion 
The present study investigated well-described and new endpoints in male and female 
Wistar rats following perinatal ethinyl estradiol exposure. This potent estrogenic 
compound was found to induce an unusual increased number of nipples in female 
offspring. Additionally, ethinyl estradiol had effects on the development of the 
external female genitalia, which were observed in both young and adult offspring as 
an increased AGD at birth and a deeper urethral slit length in adulthood.  
 
Changes in mammary gland histology, timing of sexual maturation and estrous 
cyclicity were not statistally significant, but showed trends in the same direction as 
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the effects reported in previous studies performed in Sprague Dawley and Long Evans 
rats. It is possible that the lack of statistically significant effects on these endpoints are 
due to differences in rat strains and/or low power due to large variations within 
groups, a relatively low number of litters in the current study, and the dichotomous 
nature of the collected data. In male offspring, the only statistically significant effect 
was a decreased ventral prostate weight at the middle dose at PD21.  
Although ethinyl estradiol is a potent estrogen, for which significant effects were 
expected, these results stress the importance of ensuring appropriate group sizes.  
A large number of animals is needed to see a difference between the dosed groups and 
the controls for many of the endpoints evaluated, even in the present case of a potent 
estrogenic chemical. The statistical power is low for several classical estrogen-
sensitive endpoints such as sexual maturation, estrous cyclicity, motor activity and 
mammary gland histology, and this should be carried in mind when evaluating or 
planning studies on possible endocrine disrupters, as low power may result in false 
negative conclusions.  
Future development of sensitive and preferably quantitative endpoints may facilitate 
the detection of adverse effects of estrogenic compounds and concomitantly reduce 
the present need for a high number of experimental animals in toxicological studies. 
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Figures and Tables 
 
Table 1. Pregnancy and litter data. Data represent group means based on litter means ± SD. 
*p<0.05, ** p<0.01, ***p<0.001. AGD is analyzed with birth weight as a covariate. # male 
birth weight in group 3 seems to be decreased but it is not significant when bw and number af 
pups per litter as covariates in the statistical analysis. 
 
 
 
 
 
1: Control 2:EE2 5 
µg/kg/bw 
3:EE2 15 
µg/kg/bw 
 4: EE2 50 
µg/kg/bw 
No. Of dams  
( litters) 
10 (8) 10 (6) 10 (9) 10 (8) 
Maternal weight gain 
GD7-GD21 70.4 ± 7.8 64.8 ± 14.7 65.7 ± 12 41.0 ± 16.5*** 
Maternal weight gain 
GD7-PD1 14.2 ± 7.7 13.6 ± 5.9 9.4 ± 8.6 -3.7 ± 6.3 *** 
Maternal weight gain 
PD1-22 4.6 ± 10 1.7 ± 11.7 1.6 ± 10.3 7.6 ± 7.5 
Gestation length (days) 
23 ± 0.0 23.2 ± 0.41 23 ± 0.0 23.7 ± 0.46*** 
% post-implantation loss 
2.2  ± 4.3 8.2  ± 7.5 4.5  ± 9.2 2.1  ± 5.9 
% perinatal loss   
8.0  ± 8.6 11.0  ± 6.9 7.9  ± 13.0 5.7  ± 12.0 
Born alive per. Litter 
10.4 ± 1.9 9.7 ± 2.9 11.1 ± 2.7 9.1 ± 3.9 
% Postnatal death 
8.4 ± 9.5 8.9 ± 9.0 3.4 ± 4.9 4.1 ± 7.8 
% Males 
57.6 ± 14.0 48.3 ± 18.9 48.5 ± 16.8 53.0 ± 17.0 
Birth weight male 
offspring 6.2 ± 0.3 6.4 ± 0.4 6.0 ± 0.2# 6.0 ± 0.5* 
Birth weight female 
offspring 5.9 ± 0.3 5.9 ± 0.3 5.6 ± 0.2 5.7 ± 0.5 
AGD males 
21.3 ± 0.7 21.5 ± 0.7 21.2 ± 0.8 21.9 ± 0.8 
AGD females 
10.9 ± 0.7 11.0 ± 0.5 11.1 ± 0.3 11.9 ± 0.9** 
AGDi males 
11.6 ± 0.5 11.6 ± 0.3 11.7 ± 0.4 12.1 ± 0.4 
AGDi females 
6.1 ± 0.4 6.1 ± 0.4 6.3 ± 0.2 6.7 ± 0.3*** 
Males bw PD6  
13.0 ± 1.2 12.6 ± 1. 12.0 ± 1.2 10.9 ± 1.1*** 
Females bw PD6 
12.5 ± 1.0 11.7 ± 1.1 11.6 ± 1.1 10.5 ± 1.1*** 
Males bw PD14  
27.6 ± 2.6 26.2 ± 2.8 24.8 ± 3.0* 23.5 ± 3.2*** 
Females bw PD14 
26.4 ± 2.2 24.6 ± 1.9 24.2 ± 2.9 22.8 ± 2.8*** 
Males bw PD21 
39.6 ± 5.1 39.2 ± 4.9 36.8 ± 5.1 36.1 ± 5.9* 
Females bw PD22 
42.4 ± 3.5 38.8 ± 3.1 39.1 ± 5.7 38.1 ± 5.3*** 
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Table 2. Female and male prepubertal organ weights (PD21-22). Mean ±SD. * Indicates a 
statistically significant difference from controls in a Dunnett’s test (p<0.05).  
 
 Control 5µg/kg 15µg/kg 50µg/kg 
Female PND22 (n=7) (n=5) (n=8) (n=7) 
Body weight (g) 42.3±4.5 39.0±2.2 37.6±4.3* 38.0±5.7* 
Liver (mg) 1528±207 1379±144 1360±197 1393±205 
Thyroid gland (mg) 8,0±4.01 5.2±1.55 6.7±3.59 5.8±2.57 
Uterus (mg) 26,7±3.7 25.2±5.3 25.6±6.0 27.2±10.5 
Ovaries (mg) 15,1±3.4 14.5±2.9 14.1±1.5 10.4±3.6* 
Male PD21 (n=8) (n=5) (n=9) (n=7) 
Body weight 39.4±4.3 38.2±5.0 36.6±5.2 33.7±3.9 
Liver (mg) 1333.2±168.5 1367±156.3 1236,0±232.2 1132,6±240.6 
Testis (mg) 196.1±21.5 194.9±17.0 183,1±24.9 172.5±24.4 
Epididymides 35.8±5.2 32.0±3.5 29.6±5.4 32.0±5.6 
Prostate (mg) 25.5±5.3 22.4±4.4 18.7±5.1*
 23.8±2.6 
Seminal vesicle (mg) 20.4±5.2 18.8±4.2 17.0±4.5 19.5±4.1 
Bulbourethral glands 2.3±0.6 2.4±0.3 2.0±0.9 1.9±0.4 
LABC (mg) 35.7±5.9 33.5±4.7 29.3±5.9 26.8±6.2 
Prostate (g) 0.45±0.1 0.43±0.1 0.44±0.1 0.50±0.1 
Vesicula seminalis 
(g) 
1.25±0.3 1.31±0.2 1.22±0.2 1.27±0.2 
gl. Bulbourethralis 
(g) 
0.09±0.04 0.10±0.03 0.10±0.02 0.10±0.02 
M. levator ani (g) 0.95±0.2 0.83±0.1 0.96±0.1 0.92±0.1 
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Table 3. Postpubertal female and male organ weights. *Indicates a statistically significant 
different from controls (p<0.05) in ANOVA with body weight as a covariate.  
 Control 5µg/kg 15µg/kg 50µg/kg 
Female PD50 (n=8) (n=8) (n=8) (n=8) 
Body weight 143±8 141±14 140±8 136±8 
Uterus (g) 0.64±0.33 0.41±0.20 0.47±0.25 0.44±0.22 
Uterus drained (g) 0.30±0.12 0.24±0.04 0.32±0.09 0.29±0.07 
Ovaries (mg) 62.8±7.9 58.5±13.3 66.1±9.8 61.7±10.7 
Female PD90 (n=8) (n=7) (n=10) (n=8) 
Body weight (g) 209±8 205±3 208±21 203±1 
Liver (g) 6.7±0.4 7.3±0.65* 6.8±0.8 6.9±0.6 
Uterus (g) 0.42±0.09 0.44±0.15 0.38±0.07 0.40±0.09 
Uterus drained (g) 0.41±0.08 0.40±0.08 0.37±0.07 0.38±0.08 
Ovaries (mg) 95.1±9.2 91.6±13.4 86.7±8.8 90.3±13.3 
Male PD55 (n=8) (n=10) (n=10) (n=8) 
Body weight 214±18 206±15 212±20 197±8 
Male PD90 (n=8) (n=8) (n=10) (n=8) 
Body weight 351±34 354±17 347±38 354±16 
Liver (g) 11.8±1.4 11.6±0.6 11.2±1.5 11.5±0.6 
Testis (g) 3.5±0.3 3.5±0.2 3.5±0.3 3.4±0.2 
Epididymides (g) 0.57±0.05 0.58±0.03 0.56±0.05 0.55±0.05 
Prostate (g) 0.45±0.1 0.43±0.1 0.44±0.1 0.50±0.1 
Vesicula seminalis 
(g) 
1.25±0.3 1.31±0.2 1.22±0.2 1.27±0.2 
gl. Bulbourethralis 
(g) 
0.09±0.04 0.10±0.03 0.10±0.02 0.10±0.02 
M. levator ani (g) 0.95±0.2 0.83±0.1 0.96±0.1 0.92±0.1 
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Figure 1. Ano-genital distance index (AGDI). Ano-genital distance adjusted for body 
weight for male and female offspring PD14.  
 
 
 
Figure 2. Number of nipples in female offspring PD14.   
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Figure 3. Female external genital malformations (cleft phallus). A, control animal with a 
shallow cleft. B, female from high dose group with a deep cleft/ large urethral slit length. C, 
schematic drawing of female B showing how the urethral slit length was measured. D, 
Prevalence of females with deep clefts (large urethral slit length) in females PD50. E, Mean 
urethral slit length PD90 (in units of the scale). 
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Figure 4: Adult female mammary glands. A, Predominant type of lobule in female whole 
mounts PD50. B, Most developed type of lobule in female whole mounts PD50. C, 
Histological evaluation of lobule development in female mammary glands PD50. D, 
Histological evaluation of lobule development in female mammary glands PD90. E, 
Histological evaluation of alveolar epithelium PD90. F, Histological evaluation of dilatation 
of mammary ducts PD90. D: diestrous. M: metestrous. 
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Figure 5: Male mammary glands. A, male mammary glands reaching the lymph node, 
evaluated in whole mounts PD55. B, Hypertrophy of mammary epithelium evaluated in 
histologic sections PD90. C, Secretory material evaluated in histologic sections PD90. D, 
Vacuolated epithelium evaluated in histologic sections PD90.   
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